<SEC-DOCUMENT>0001213900-24-084217.txt : 20241002
<SEC-HEADER>0001213900-24-084217.hdr.sgml : 20241002
<ACCEPTANCE-DATETIME>20241002063316
ACCESSION NUMBER:		0001213900-24-084217
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20241002
DATE AS OF CHANGE:		20241002

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Zhongchao Inc.
		CENTRAL INDEX KEY:			0001785566
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-EDUCATIONAL SERVICES [8200]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-256190
		FILM NUMBER:		241345167

	BUSINESS ADDRESS:	
		STREET 1:		841 YAN AN MIDDLE ROAD, JING AN DISTRICT
		STREET 2:		NANXI CREATIVE CENTER, SUITE 218
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			200040
		BUSINESS PHONE:		021-32205987

	MAIL ADDRESS:	
		STREET 1:		841 YAN AN MIDDLE ROAD, JING AN DISTRICT
		STREET 2:		NANXI CREATIVE CENTER, SUITE 218
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			200040
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>ea0216068-424b5_zhongchao.htm
<DESCRIPTION>PROSPECTUS SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B>Filed Pursuant to Rule
424(b)(5)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B>Registration No.&nbsp;333-256190</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>PROSPECTUS SUPPLEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">(To Prospectus dated December 17, 2021)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>ZHONGCHAO INC.</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>3,094,000 Class A Ordinary
Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
are selling 3,094,000 Class A Ordinary Shares, par value $0.001 per share (&ldquo;Class A Ordinary Shares&rdquo;), in a registered direct
offering to certain purchasers in a privately negotiated transaction pursuant to this prospectus supplement at a price of $0.30 per share.
We have not retained an underwriter or placement agent with respect to this offering and therefore are not paying any underwriting discounts
or commissions. We estimate the total expenses of this offering will be approximately $45,000. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Pursuant
to General Instruction I.B.5. of Form F-3, in no event will we sell the securities covered hereby in a public primary offering with a
value exceeding more than one-third of the aggregate market value of our Class A Ordinary Shares in any 12-month period so long as the
aggregate market value of our outstanding Class A Ordinary Shares held by non-affiliates remains below $75,000,000. &nbsp;The aggregate
market value of our outstanding voting and non-voting common equity held by non-affiliates is approximately $2.81 million based on the
closing price of $1.559 per Class A Ordinary Share on August 9, 2024 and 1,802,508 Class A Ordinary Shares held by non-affiliates. &nbsp;During
the 12 calendar months prior to and including the date of this prospectus supplement, we have offered or sold only $928,200 of securities
pursuant to General Instruction I.B.5 of Form F-3.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
Class A Ordinary Shares are listed on the Nasdaq Capital Market under the symbol &ldquo;ZCMD.&rdquo; The last reported sale price of our
Class A Ordinary Shares on the Nasdaq Capital Market on September 30, 2024 was $2.46 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><B>Investing
in our Class A Ordinary Shares involves risks. See &ldquo;Risk Factors&rdquo; beginning on page&nbsp;S-13 of this prospectus
supplement and on page 11 of the accompanying prospectus.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Zhongchao Inc. (the &ldquo;Company&rdquo;
or &ldquo;Zhongchao Cayman&rdquo;) is an offshore holding company incorporated as an exempted company with limited liability in the Cayman
Islands. We are not a Chinese operating company, but a Cayman Islands holding company with no material operations of our own, Zhongchao
Cayman, through the contractual arrangements (the &ldquo;Contractual Arrangements&rdquo;), between Beijing Zhongchao Zhongxing Technology
Limited (&ldquo;Zhongchao WFOE&rdquo;), a wholly subsidiary of Zhongchao Cayman incorporated in the PRC, and a variable interest entity
(the &ldquo;VIE&rdquo;), Zhongchao Medical Technology (Shanghai) Co., Ltd. (&ldquo;Zhongchao Shanghai&rdquo;) and its subsidiaries or
collectively &ldquo;the PRC operating entities&rdquo;, consolidate the financial results of the PRC operating entities. We chose such
VIE structure due to the restrictions imposed by PRC laws and regulations on foreign ownership of companies engaged in value-added telecommunication
services and certain other businesses, and the PRC operating entities operate their businesses in which foreign investment is restricted
or prohibited in the PRC through certain PRC domestic companies. If in the future the PRC laws and regulations change, and the PRC regulatory
authorities disallow the VIE structure, it would likely result in a material adverse change in our operations, and the securities of Zhongchao
Cayman may decline significantly in value or become worthless. For a description of the VIE contractual arrangements, see &ldquo;Prospectus
Supplement Summary - Our Corporate Structure &mdash; <I>Contractual Arrangements between the Zhongchao WFOE and Zhongchao Shanghai</I>&rdquo;
starting on page S-2 of this prospectus supplement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>The securities offered
under this prospectus are securities of Zhongchao Cayman, the Cayman Islands holding company, rather than any securities of the PRC operating
entities, <FONT STYLE="font-family: Times New Roman, Times, Serif">therefore, our investors may never hold equity interests in the PRC
operating entities. You are not investing in the PRC operating entities. Neither we nor our subsidiaries own any share or equity interest
in the PRC operating entities. Instead, we consolidate financial results of the PRC operating entities through the Contractual Arrangements
between Zhongchao WFOE and the VIE. As a result of Zhongchao Cayman&rsquo;s direct ownership in Zhongchao WFOE and the Contractual Arrangements,
we treat the VIE and the VIE&rsquo;s subsidiaries as the consolidated entities under U.S. GAAP, but we do not own share or equity interests
in the VIE or its subsidiaries. We have consolidated the financial results of the VIE and the VIE&rsquo;s subsidiaries in our consolidated
financial statements for accounting purposes in accordance with U.S. GAAP.</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>As we chose such VIE structure,
we are subject to certain unique risks and uncertainties that may not otherwise exist if we had direct equity ownership in the PRC operating
entities. We do not hold equity interests in the VIE and its subsidiaries. Further, we are subject to risks due to uncertainty of the
interpretation and the application of the PRC laws and regulations, including but not limited to limitations on foreign ownership and
regulatory review of overseas listing of PRC companies through a special purpose vehicle, and the validity and enforcement of the Contractual
Arrangements. We are also subject to the risks of uncertainty of any future actions of the PRC government in this regard that could disallow
the VIE structure, which would likely result in a material change in the operations of the PRC operating entities and/or cause the value
of our securities to decrease significantly or become worthless. However, as of the date of this prospectus supplement, the agreements
under the Contractual Arrangements have not been tested in any courts of law. See &ldquo;Prospectus Supplement Summary - <I>Permission
Required from the PRC Authorities for Our and PRC Operating Entities&rsquo; Operation in China</I>&rdquo; starting on page S-5 of this
prospectus supplement, and &ldquo;Item 3. Key Information D. Risk Factor &ldquo;<I>We depend upon the VIE Arrangements in consolidating
the financial results of the PRC operating entities, which may not be as effective as direct ownership</I>&rdquo; in our most recent annual
report on Form 20-F filed on April 30, 2024 (the &ldquo;Annual Report&rdquo;) and &ldquo;Risk Factors &ndash; <I>We conduct our business
through Zhongchao Shanghai and its subsidiaries by means of VIE Arrangements. If the PRC courts or administrative authorities determine
that these VIE Arrangements do not comply with applicable regulations, we could be subject to severe penalties and our business could
be adversely affected, and our securities may decline in value or become worthless. In addition, changes in such PRC laws and regulations
may materially and adversely affect our business</I>&rdquo; on page S-14 of this prospectus supplement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Investing in our securities
is highly speculative, involves a high degree of risk and should be considered only by persons who can afford the loss of their entire
investment.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>We face risks and uncertainties
associated with the complex and evolving PRC laws and regulations and as to whether and how the recent PRC government statements and regulatory
developments. The Chinese government may intervene or influence the operation of the PRC operating entities and exercise significant oversight
and discretion over the conduct of PRC operating entities&rsquo; business and may intervene in or influence the operations of the PRC
operating entities at any time, or may exert more control over offerings conducted overseas and/or foreign investment in China-based issuers,
which could result in a material change in the operations of the PRC operating entities and/or the value of our securities. Further, any
actions by the Chinese government to exert more oversight and control over offerings that are conducted overseas and/or foreign investment
in China-based issuers could significantly limit or completely hinder our ability to offer or continue to offer securities to investors
and cause the value of such securities to significantly decline or be worthless.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Recently, the PRC government
initiated a series of regulatory actions and statements to regulate business operations in China with little advance notice, including
cracking down on illegal activities in the securities market, adopting new measures to extend the scope of cybersecurity reviews, and
expanding the efforts in anti-monopoly enforcement. On February 17, 2023, the China Securities Regulatory Commission (the &ldquo;CSRC&rdquo;)
promulgated the Trial Administrative Measures of the Overseas Securities Offering and Listing by Domestic Companies, or the Trial Measures,
and five supporting guidelines, which became effective on March 31, 2023. Under the Trial Measures, a filing-based regulatory system applies
to &ldquo;indirect overseas offerings and listings&rdquo; of companies in mainland China, which refers to securities offerings and listings
in an overseas market made under the name of an offshore entity but based on the underlying equity, assets, earnings or other similar
rights of a company in mainland China that operates its main business in mainland China. The Trial Measures states that, any post-listing
follow-on offering by an issuer in an overseas market, including issuance of shares, convertible notes and other similar securities, shall
be subject to filing requirement within three business days after the completion of the offering. Further, at the press conference held
for the Trial Measures on February 17, 2023, officials from the CSRC clarified that the PRC domestic companies that have already been
listed overseas on or before the effective date of the Trial Measures, March 31, 2023, shall be deemed as existing issuers, or the Existing
Issuers. Existing Issuers are not required to complete the filing procedures immediately but shall carry out filing procedures as required
if they conduct refinancing or are involved in other circumstances that require filing with the CSRC. Therefore, in the opinion of our
PRC legal counsel, Han Kun Law Offices, we are required to go through filing procedures with the CSRC within three business days after
the completion of the offerings under this prospectus supplement and for our future offerings and listing of our securities in an overseas
market under the Trial Measures. We will begin the process of preparing a report and other required materials in connection with the CSRC
filing, which will be submitted to the CSRC in due course. If we fail to complete such filing requirement, Chinese regulatory authorities
may impose fines and penalties upon the PRC operating entities&rsquo; operations in China, limit the PRC operating entities&rsquo; operating
privileges in China, delay or restrict the repatriation of the proceeds from the offerings in connection with this registration statement
into China, or take other actions that could have a material adverse effect upon the PRC operating entities&rsquo; business, financial
condition, results of operations, reputation and prospects, as well as the trading price of our securities. The officials from the CSRC
have also confirmed that for the PRC domestic companies that seek to list overseas with VIE structure, the CSRC will solicit opinions
from relevant regulatory authorities and complete the filing of the overseas listing of companies with VIE structure which meet the compliance
requirements. As the Trial Measures were newly published, there are substantial uncertainties as to the implementation and interpretation,
and how they will affect our current listing, and future offering or financing. If we are required by the Trial Measures for any future
offering or any other financing activities to file with the CSRC, we cannot assure you that we will be able to complete such filings in
a timely manner, or even at all. Any failure of us to fully comply with new regulatory requirements may significantly limit or completely
hinder our ability to continue to offer our securities, cause significant disruption to the business operations of the PRC operating entities,
severely damage our reputation, materially and adversely affect our financial condition and results of operations and cause our securities
to significantly decline in value or become worthless.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>As of the date of this
prospectus supplement, in the opinion of PRC legal counsel, Han Kun Law Offices, although we are required to complete the filing procedure
in connection with our offerings under the Trial Measures, no relevant PRC laws or regulations in effect require that we or the PRC operating
entities obtain permission from any PRC authorities to issue securities to foreign investors in connection with a potential offering made
pursuant to this prospectus supplement as of the date of this prospectus supplement, and neither we nor the PRC operating entities have
received any inquiry, notice, warning, sanction, or any regulatory objection to the offerings in connection with this registration statement
from the CSRC, the CAC, or any other PRC authorities that have jurisdiction over our operations.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>In the opinion of our PRC
counsel, Han Kun Law Offices, neither we nor the PRC operating entities are subject to cybersecurity review with the Cyberspace Administration
of China, or the &ldquo;CAC,&rdquo; under the Cybersecurity Review Measures which became effective on February 15, 2022, since we or the
PRC operating entities have not been notified by the regulatory authorities as critical information infrastructure operators, and we or
the PRC operating entities currently do not have over one million users&rsquo; personal information and do not anticipate that we will
be collecting over one million users&rsquo; personal information in the foreseeable future, which we understand might otherwise subject
us, our subsidiaries or the PRC operating entities to the Cybersecurity Review Measures. On November 14, 2021, the CAC released the Regulations
on the Network Data Security Management (Draft for Comments), or the Data Security Management Regulations Draft, to solicit public opinion
and comments. Pursuant to the Data Security Management Regulations Draft, data processor holding more than one million users/users&rsquo;
individual information shall be subject to cybersecurity review before listing abroad. Data processing activities refers to activities
such as the collection, retention, use, processing, transmission, provision, disclosure, or deletion of data. As of the date of this prospectus
supplement, the MDMOOC online platform has more than 194,370 registered users, and we and the PRC operating entities currently do not
hold more than one million users/users&rsquo; individual information. However, we or the PRC operating entities may be deemed as a data
processor under the Data Security Management Regulations Draft. As of the date of this prospectus supplement, we or the PRC operating
entities have not been informed by any PRC governmental authority of any requirement that we file for a cybersecurity review. However,
if we are deemed to be a critical information infrastructure operator or a company that is engaged in data processing and holds personal
information of more than one million users, we could be subject to PRC cybersecurity review. See &ldquo;Prospectus Supplement Summary
&ndash; <I>Permission Required from the PRC Authorities to Issue Our Securities to Foreign Investors.</I>&rdquo;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>As of the date hereof,
in the opinion our PRC legal counsel, Han Kun Law Offices, we are in compliance with the applicable PRC laws and regulations governing
the data privacy and personal information in all material respects, including the data privacy and personal information requirements of
the Cyberspace Administration of China, and we have not received any complaints from any third party, or been investigated or punished
by any PRC competent authority in relation to data privacy and personal information protection. However, as there remains significant
uncertainty in the interpretation and enforcement of relevant PRC cybersecurity laws and regulations, we could be subject to cybersecurity
review, and if so, we may not be able to pass such review in relation to the offerings in connection with this registration statement.
In addition, we could become subject to enhanced cybersecurity review or investigations launched by PRC regulators in the future. Any
failure or delay in the completion of the cybersecurity review procedures or any other non-compliance with the related laws and regulations
may result in fines or other penalties, including suspension of business, website closure, removal of our app from the relevant app stores,
and revocation of prerequisite licenses, as well as reputational damage or legal proceedings or actions against us, which may have material
adverse effect on our business, financial condition or results of operations.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Pursuant
to the Holding Foreign Companies Accountable Act (the &ldquo;HFCAA&rdquo;), if the Public Company Accounting Oversight Board, or the
PCAOB, is unable to inspect an issuer&rsquo;s auditors for three consecutive years, the issuer&rsquo;s securities are prohibited to trade
on a U.S. stock exchange. Furthermore, on June 22, 2021, the U.S. Senate passed the Accelerating Holding Foreign Companies Accountable
Act (&ldquo;AHFCAA&rdquo;), which, if signed into law, would amend the HFCA Act and require the SEC to prohibit an issuer&rsquo;s securities
from trading on any U.S. stock exchanges if its auditor is not subject to PCAOB inspections for two consecutive years instead of three
consecutive years. Pursuant to the HFCA Act, the PCAOB issued a Determination Report on December 16, 2021 which found that the PCAOB
is unable to inspect or investigate completely registered public accounting firms headquartered in: (1) mainland China of the PRC, and
(2) Hong Kong. In addition, the PCAOB&rsquo;s report identified the specific registered public accounting firms which are subject to
these determinations. On August 26, 2022, the CSRC, the Ministry of Finance of the PRC, and PCAOB signed a Statement of Protocol, or
the Protocol, governing inspections and investigations of audit firms based in China and Hong Kong. Pursuant to the Protocol, the PCAOB
has independent discretion to select any issuer audits for inspection or investigation and has the unfettered ability to transfer information
to the SEC. Under the PCAOB&rsquo;s rules, a reassessment of a determination under the HFCA Act may result in the PCAOB reaffirming,
modifying or vacating the determination. On December 15, 2022, the PCAOB Board determined that the PCAOB was able to secure complete
access to inspect and investigate registered public accounting firms headquartered in mainland China and Hong Kong and voted to vacate
its previous determinations to the contrary. However, whether the PCAOB will continue to be able to satisfactorily conduct inspections
of PCAOB-registered public accounting firms headquartered in mainland China and Hong Kong is subject to uncertainty and depends on a
number of factors out of our, and our auditor&rsquo;s, control. The PCAOB is continuing to demand complete access in mainland China and
Hong Kong moving forward, as well as to continue pursuing ongoing investigations and initiate new investigations as needed. The PCAOB
has indicated that it will act immediately to consider the need to issue new determinations with the HFCA Act if needed and does not
have to wait another year to reassess its determinations. In the future, if there is any regulatory change or step taken by PRC regulators
that does not permit our auditor to provide audit documentations located in China or Hong Kong to the PCAOB for inspection or investigation,
or the PCAOB expands the scope of the Determination so that we are subject to the HFCA Act, as the same may be amended, you may be deprived
of the benefits of such inspection which could result in limitation or restriction to our access to the U.S. capital markets and trading
of our securities, including trading on the national exchange and trading on &ldquo;over-the-counter&rdquo; markets, may be prohibited
under the HFCA Act. On December 29, 2022, a legislation entitled &ldquo;Consolidated Appropriations Act, 2023&rdquo; (the &ldquo;Consolidated
Appropriations Act&rdquo;), was signed into law by President Biden. The Consolidated Appropriations Act contained, among other things,
an identical provision to AHFCAA, which reduces the number of consecutive non-inspection years required for triggering the prohibitions
under the Holding Foreign Companies Accountable Act from three years to two. See &ldquo;Item 3. Key Information&mdash;D. Risk Factor
&mdash; <I>The recent joint statement by the SEC and the PCAOB, proposed rule changes submitted by Nasdaq, and the Holding Foreign Companies
Accountable Act all call for additional and more stringent criteria to be applied to emerging market companies upon assessing the qualification
of their auditors, especially the non-U.S. auditors who are not inspected by the PCAOB. These developments could add uncertainties to
our offering</I>.&rdquo; in the Annual Report.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Marcum Asia CPAs LLP (&ldquo;MarcumAsia&rdquo;
formerly known as &ldquo;Marcum Bernstein &amp; Pinchuk LLP&rdquo;) was our auditor for the financial statements for the fiscal year ended
December 31, 2021. The Company then appointed Prager Metis CPAs, LLC (&ldquo;Prager Metis&rdquo;) as the independent registered public
accounting firm. Prager Metis replaced MarcumAsia, which the Company dismissed effective as of September 27, 2022. Both MarcumAsia and
Prager Metis are headquartered in New York, New York, registered with PCAOB and subject to laws in the United States pursuant to which
the PCAOB conducts regular inspections to assess its compliance with the applicable professional standards. Neither our former auditor,
MarcumAsia, nor our current auditor, Prager Metis, was/is headquartered in mainland China or Hong Kong or was identified in the Determination
Report as a firm subject to the PCAOB&rsquo;s determination.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>We intend to keep any future
earnings to re-invest in and finance the expansion of the business of the PRC operating entities, and we do not anticipate that any cash
dividends will be paid in the foreseeable future. Under Cayman Islands law, a Cayman Islands company may pay a dividend on its shares
out of either profit or share premium amount, provided that in no circumstances may a dividend be paid if this would result in the Company
being unable to pay its debts due in the ordinary course of business. <FONT STYLE="font-size: 10pt">Cash proceeds raised from overseas
financing activities, including the cash proceeds from this offering, may be transferred by Zhongchao Cayman to Zhongchao HK, and then
transferred to Zhongchao WFOE via capital contribution or shareholder loans, as the case may be. Cash proceeds may flow to the VIE from
Zhongchao WFOE pursuant to certain contractual agreements between Zhongchao WFOE and the VIE as permitted by the applicable PRC regulations.
The process for sending such proceeds back to mainland China may be time-consuming after the closing of this offering. We may be unable
to use these proceeds to grow the business of the PRC operating entities until the PRC operating entities receive such proceeds in mainland
China. Any transfer of funds by us to our PRC subsidiaries, either as a shareholder loan or as an increase in registered capital, are
subject to PRC regulations. As a holding company, for Zhongchao Cayman&rsquo;s cash and financing requirements, Zhongchao Cayman may rely
on transfer of funds, dividends and other distributions on equity paid by Zhongchao HK, which relies on transfer of funds, dividends and
other distributions by Zhongchao WFOE, which relies on payment by the PRC operating entities pursuant to the Contractual Arrangement.
If any of these entities incurs debt on its own behalf in the future, the instruments governing such debt may restrict their ability to
pay dividends, make distribution or transfer funds to Zhongchao Cayman. See &ldquo;Prospectus Supplement Summary &ndash; <I>Dividend Distributions
or Transfers of Cash among the Holding Company, Its Subsidiaries, and the Consolidated VIE</I>&rdquo; on page S-6 of this prospectus
supplement.</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>For the year ended December
31, 2023, Zhongchao Cayman made cash transfer of $0.1 million to Zhongchao USA. For the year ended December 31, 2022, Zhongchao Cayman
made cash transfer of $1.5 million to Zhongchao USA. Except as otherwise disclosed above, for the years ended December 31, 2023 and 2022,
no other cash transfer or transfer of other assets have occurred between Zhongchao Cayman, its subsidiaries, the consolidated VIE and
the subsidiaries of the VIE. For the years ended December 31, 2023 and 2022, none of our subsidiaries, the consolidated VIE, or the subsidiaries
of the VIE have made any dividends or distributions to Zhongchao Cayman. For the years ended December 31, 2023 and 2022, no dividends
or distributions have been made to any U.S. investors.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>We plan to distribute earnings
or settle amounts owed under the Contractual Arrangements with the VIE when required in the future. As of the date of this prospectus
supplement, none of Zhongchao HK, Zhongchao WFOE and the PRC operating entities have made any dividends to Zhongchao Cayman. As of the
date of this prospectus supplement, we have not made any dividends or distributions to any U.S. investors. As of the date of this prospectus
supplement, Zhongchao Cayman and its subsidiaries, as well as the PRC operating entities have not adopted or maintained any other cash
management policies and procedures, and each entity needs to comply with applicable law or regulations with respect to transfer of funds,
dividends and distributions with other entities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>The PRC government also
imposes controls on the conversion of RMB into foreign currencies and the remittance of currencies out of the PRC. Cash in mainland China
may not be available to fund operations or for other use outside of the PRC due to interventions in or the imposition of restrictions
and limitations on the ability of the Company, it subsidiaries and the PRC operating entities by the PRC government to transfer cash or
assets. Therefore, we may experience difficulties in completing the administrative procedures necessary to obtain and remit foreign currency
for the payment of dividends from our profits, if any. Furthermore, if our subsidiaries in the PRC incur debt on their own in the future,
the instruments governing the debt may restrict their ability to pay dividends or make other payments. If we or our subsidiaries are unable
to receive all of the revenues from the PRC operating entities&rsquo; operations through the current Contractual Arrangements, we may
be unable to pay dividends on our Class A Ordinary Shares. See &ldquo;Item 3. Key Information&mdash;D. Risk Factor &mdash; <I>Governmental
control of currency conversion may limit our ability to use our revenues effectively and the ability of our PRC subsidiaries to obtain
financing</I>&rdquo; in the Annual Report.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>The transfer of funds among
the PRC operating entities are subject to the Provisions of the Supreme People&rsquo;s Court on Several Issues Concerning the Application
of Law in the Trial of Private Lending Cases (2020 Second Amendment Revision, the &ldquo;Provisions on Private Lending Cases&rdquo;),
which was implemented on January 1, 2021 to regulate the financing activities between natural persons, legal persons and unincorporated
organizations. In the opinion of our PRC counsel, Han Kun Law Offices, the Provisions on Private Lending Cases does not prohibit using
cash generated from one PRC operating entity to fund another affiliated PRC operating entity&rsquo;s operations. We or the PRC operating
entities have not been notified of any other restriction which could limit the PRC operating entities&rsquo; ability to transfer cash
among each other. In the future, cash proceeds from overseas financing activities, including this offering, may be transferred by Zhongchao
Cayman to Zhongchao HK, and then transferred to Zhongchao WFOE via capital contribution or shareholder loans, as the case may be. Cash
proceeds may flow to Zhongchao Shandong from Zhongchao WFOE pursuant to the Contractual Arrangements between Zhongchao WFOE and Zhongchao
Shandong as permitted by the applicable PRC regulations. For more details, see &ldquo;Prospectus Supplement Summary &mdash; <I>Dividend
Distributions or Transfers of Cash among the Holding Company, Its Subsidiaries, and the PRC Operating Entities</I>&rdquo; starting on
page S-6 of this prospectus supplement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Cash dividends, if any,
on our Class A Ordinary Shares will be paid in U.S. dollars. If we are considered a PRC tax resident enterprise for tax purposes, any
dividends we pay to our overseas shareholders may be regarded as China-sourced income and as a result may be subject to PRC withholding
tax at a rate of up to 10.0%. In order for us to pay dividends to our shareholders, we will rely on payments made from Zhongchao Shanghai
to Zhongchao WFOE, pursuant to the Contractual Arrangements between them, and the distribution of such payments to Zhongchao HK as dividends
from Zhongchao WFOE. Certain payments from Zhongchao Shanghai to Zhongchao WFOE are subject to PRC taxes, including business taxes and
value added tax.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Further, any transfer of
funds by us to our PRC subsidiaries, either as a shareholder loan or as an increase in registered capital, are subject to PRC regulations.
Capital contributions to our PRC subsidiaries are subject to the report to the Ministry of Commerce of the People&rsquo;s Republic of
China, or the MOFCOM, in its local branches and registration with a local bank authorized by the China&rsquo;s State Administration of
Foreign Exchange, or the SAFE. Any foreign loan procured by our PRC subsidiaries is required to be registered or filed with the SAFE or
its local branches or satisfy relevant requirements as provided by the SAFE. Any medium- or long-term loan to be provided by us to the
VIEs must be registered with the National Development and Reform Commission, or the NDRC, and the SAFE or its local branches. We may not
be able to obtain these government approvals or complete such registrations on a timely basis, if at all, with respect to future capital
contributions or foreign loans by us to our PRC subsidiaries. If we fail to receive such approvals or complete such registration or filing,
our ability to use the proceeds of our financing activities and to capitalize our PRC operations may be negatively affected, which could
adversely affect our liquidity and our ability to fund and expand our business.&nbsp;See &ldquo;Item 3. Key Information&mdash;D. Risk
Factors&mdash; Risks Related to Doing Business in China&mdash;<I>PRC regulation of loans and direct investment by offshore holding companies
to PRC entities may delay or prevent us from using the proceeds of the initial public offering or any subsequent offerings to make loans
or additional capital contributions to our PRC subsidiary, which could materially and adversely affect our liquidity and our ability to
fund and expand our business</I>&rdquo; in the Annual Report.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>We are a Cayman Islands
company and consolidate the financial results of the PRC operating entities through the Contractual Arrangement. The substantially all
of the operations and assets of the PRC operating entities are located in China. In addition, our management consists of five officers
who are all located in China and three independent directors, among which two (Mr. John C. General and Mr. Kevin Dean Vassily) are located
in the United States and one (Ms. Dan Li) is located in China. A substantial portion of the assets of these persons is located outside
the United States. As a result, it may be difficult for you to effect service of process within the United States upon these persons.
It may also be difficult for you to enforce the U.S. courts judgments obtained in U.S. courts including judgments based on the civil liability
provisions of the U.S. federal securities laws against us and our officers and directors, none of whom (except two independent director)
are residents in the United States, and whose significant assets are located outside the United States.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><B>Neither
the Securities and Exchange Commission, any state securities commission, nor any other regulatory body has approved or disapproved of
these securities or determined if this prospectus supplement and the prospectus to which it relates are truthful and complete. Any representation
to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Per<BR> Share</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; text-indent: -12pt; padding-left: 12pt">Registered Direct Offering Price</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">0.30</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">928,200</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -12pt; padding-left: 12pt">Proceeds to Zhongchao Inc. (before expenses)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.30</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">928,200</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><B>The date of this prospectus
supplement is October 1, 2024.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><B>Prospectus Supplement</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 90%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 10%"><B>Page</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#z_001">ABOUT THIS PROSPECTUS SUPPLEMENT</A></TD>
    <TD STYLE="text-align: center">S-iii</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#z_002">COMMONLY USED DEFINED TERMS</A></TD>
    <TD STYLE="text-align: center">S-iv</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#z_003">FORWARD-LOOKING STATEMENTS</A></TD>
    <TD STYLE="text-align: center">S-v</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="text-transform: uppercase"><A HREF="#z_004">Prospectus Supplement Summary</A></FONT></TD>
    <TD STYLE="text-align: center">S-1</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#z_005">RISK FACTORS</A></TD>
    <TD STYLE="text-align: center">S-13</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#z_006">USE OF PROCEEDS</A></TD>
    <TD STYLE="text-align: center">S-18</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#z_007">DILUTION</A></TD>
    <TD STYLE="text-align: center">S-18</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#z_008">PLAN OF DISTRIBUTION</A></TD>
    <TD STYLE="text-align: center">S-19</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#z_009">LEGAL MATTERS</A></TD>
    <TD STYLE="text-align: center">S-19</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#z_010">EXPERTS</A></TD>
    <TD STYLE="text-align: center">S-19</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#z_011">WHERE YOU CAN FIND MORE INFORMATION</A></TD>
    <TD STYLE="text-align: center">S-19</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#z_012">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></TD>
    <TD STYLE="text-align: center">S-20</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><B>Prospectus</B></P>

<P STYLE="text-indent: 0.25in; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 90%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 10%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Page</B></FONT><FONT STYLE="font-size: 10pt">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><A HREF="#a_001"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">About this Prospectus</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><A HREF="#a_002"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Commonly Used Defined Terms</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><A HREF="#a_003"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Note Regarding Forward-Looking Statements</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_004">Our Business</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_005">Risk Factors</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">11</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_006">Use of Proceeds</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">12</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_007">Dilution</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">12</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_008">Description of Share Capital</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">12</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_017">Description of Debt Securities</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">18</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_018">Description of Warrants</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">23</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_020">Description of Units</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">25</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_009">Plan of Distribution</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">26</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_010">Legal Matters</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">28</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_011">Experts</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">28</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_012">Financial Information</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">28</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_013">Information Incorporated by Reference</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">29</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_014">Where You Can Find More Information</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">29</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_015">Enforceability of Civil Liabilities</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">30</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_016">Indemnification for Securities Act Liabilities</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">30</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white"><A NAME="z_001"></A>ABOUT
THIS PROSPECTUS SUPPLEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><I>You
should carefully read this entire prospectus supplement and the accompanying base prospectus, including the information included and referred
to under &ldquo;Risk Factors&rdquo; below, the information incorporated by reference in this prospectus supplement and in the accompanying
base prospectus, and the financial statements and the other information incorporated by reference in the accompanying base prospectus,
before making an investment decision.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">This
prospectus supplement and the accompanying base prospectus form part of a registration statement on Form&nbsp;F-3&nbsp;that we filed with
the Securities and Exchange Commission, or SEC, using a &ldquo;shelf&rdquo; registration process. This document contains two parts. The
first part consists of this prospectus supplement, which provides you with specific information about this offering. The second part,
the accompanying base prospectus, provides more general information, some of which may not apply to this offering. Generally, when we
refer only to the &ldquo;prospectus,&rdquo; we are referring to both parts combined. This prospectus supplement may add, update, or change
information contained in the accompanying base prospectus. To the extent that any statement we make in this prospectus supplement is inconsistent
with statements made in the accompanying base prospectus or any documents incorporated by reference herein or therein, the statements
made in this prospectus supplement will be deemed to modify or supersede those made in the accompanying base prospectus and such documents
incorporated by reference herein and therein&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus supplement
and the accompanying base prospectus relate to the offering of Class A Ordinary Shares. Before buying any securities offered hereby, we
urge you to carefully read this prospectus supplement and the accompanying base prospectus, together with the information incorporated
herein and therein by reference as described under the headings &ldquo;Where You Can Find More Information&rdquo; and &ldquo;Incorporation
of Certain Information by Reference.&rdquo; These documents contain important information that you should consider when making your investment
decision. This prospectus supplement may add, update, or change information in the accompanying base prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><B>You
should rely only on the information contained or incorporated by reference in this prospectus. We have not authorized anyone to provide
you with additional or different information. The prospectus may be used only for the purposes for which it has been published. If you
receive any other information, you should not rely on it. You should assume that the information contained in this prospectus is accurate
only as of the date on the front cover. Our business, financial condition, results of operations or prospects may have changed since that
date. You should not rely on or assume the accuracy of any representation or warranty in any agreement that we have filed as an exhibit
to the registration statement of which this prospectus is a part or that we may otherwise publicly file in the future because any such
representation or warranty may be subject to exceptions and qualifications contained in separate disclosure schedules, may represent the
parties&rsquo; risk allocation in the particular transaction, may be qualified by materiality standards that differ from what may be viewed
as material for securities law purposes or may no longer continue to be true as of any given date. No offer of these securities is being
made in any jurisdiction where such offer or sale is prohibited.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><I>Unless
we otherwise specify, when used in this prospectus supplement, the terms &ldquo;Zhongchao,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo;
&ldquo;our&rdquo; and &ldquo;us&rdquo; refer to Zhongchao Inc. and its subsidiaries, except that when such terms are used in this prospectus
supplement in reference to the common shares, they refer specifically to Zhongchao Inc..</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I>&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center; background-color: white"><A NAME="z_002"></A>COMMONLY
USED DEFINED TERMS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify">All references to &ldquo;RMB,&rdquo; &ldquo;yuan&rdquo; and &ldquo;Renminbi&rdquo; are to the legal currency of China, all references to &ldquo;HKD&rdquo; is to the legal currency of Hong Kong, and all references to &ldquo;USD,&rdquo; and &ldquo;U.S. dollars&rdquo; are to the legal currency of the United States;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Beijing Boya&rdquo; refers to Beijing Zhongchao Boya Medical Technology Co., Ltd., a PRC company;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Beijing Yisuizhen&rdquo; refers to Beijing Yisuizhen Technology Co., Ltd., a PRC company.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;China&rdquo; and &ldquo;PRC&rdquo; refer to the People&rsquo;s Republic of China;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Class A Ordinary Shares&rdquo; refers to the Class A ordinary shares, $0.001 par value per share in the capital of the Company;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Class B Ordinary Shares&rdquo; refers to the Class B ordinary shares, $0.001 par value per share in the capital of the Company;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Controlling Shareholder&rdquo; refers to Mr. Weiguang Yang, the CEO of the Company;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Hainan Muxin&rdquo; refers to Hainan Muxin Medical Technology Co., Ltd., a PRC company.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Liaoning Zhixun&rdquo; refers to Zhixun Internet Hospital (Liaoning) Co., Ltd., a PRC company.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Maidemu Health&rdquo; refers to Shanghai Maidemu Health Management Co., Ltd., a PRC company.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Ordinary Shares&rdquo; refers to Class A Ordinary Shares and Class B Ordinary Shares, collectively;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;SAIC&rdquo; refers to State Administration for Industry and Commerce in China and currently known as State Administration for Market Regulation;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Shanghai Huijing&rdquo; refers to Shanghai Huijing Information Technology Co., Ltd., a PRC company;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Shanghai Jingyi&rdquo; or &ldquo;Shanghai Zhongxin&rdquo; refers to Shanghai Zhongxin Medical Technology Co., Ltd, a PRC company, which was formerly known as Shanghai Jingyi, or Shanghai Jingyi Medical Technology Co., Ltd., a PRC company and changed to its current name as Shanghai Zhongxin on November 16, 2020.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Shanghai Maidemu&rdquo; refers to Shanghai Maidemu Cultural Communication Corp., a PRC company;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Shanghai Xingzhong&rdquo; refers to Shanghai Xingzhong Investment Management LP, a PRC company;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Shanghai Xinyuan&rdquo; refers to Shanghai Xinyuan Human Resources Co., Ltd., a PRC company;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Shanghai Zhongxun&rdquo; refers to Shanghai Zhongxun Medical Technology Co., Ltd., a PRC company;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;West Angel&rdquo; refers to West Angel (Beijing) Health Technology Co., Ltd., a PRC company.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Xinjiang Pharmaceutical&rdquo; refers to Chongqing Xinjiang Pharmaceutical Co., Ltd., a PRC company.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Zhongchao BVI&rdquo; refers to Zhongchao Group Inc., a British Virgin Island company;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Zhongchao HK&rdquo; refers to Zhongchao Group Limited, a Hong Kong company;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Zhongchao Shanghai&rdquo; refers to Zhongchao Medical Technology (Shanghai) Co., Ltd., a PRC company; and</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">&ldquo;Zhongchao WFOE&rdquo; refers to Beijing Zhongchao Zhongxing Technology Limited, a PRC company.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 55.45pt; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B>&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white"><A NAME="z_003"></A>FORWARD-LOOKING
STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">This
prospectus supplement and the accompanying prospectus, including the documents that we incorporate herein and therein by reference, contain
forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, and Section&nbsp;21E of the
Securities Exchange Act of 1934, as amended. Any statements about our expectations, beliefs, plans, objectives, assumptions or future
events or performance are not historical facts and may be forward-looking. These statements are often, but are not always, made through
the use of words or phrases such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;could,&rdquo; &ldquo;should,&rdquo; &ldquo;expects,&rdquo;
&ldquo;intends,&rdquo; &ldquo;plans,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;predicts,&rdquo;
&ldquo;projects,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue,&rdquo; and similar expressions, or the negative of these terms, or similar
expressions. Accordingly, these statements involve estimates, assumptions, risks and uncertainties which could cause actual results to
differ materially from those expressed in them. Any forward-looking statements are qualified in their entirety by reference to the factors
discussed throughout this prospectus supplement and the accompanying prospectus, and in particular those factors referenced in the section
&ldquo;Risk Factors.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">This
prospectus supplement and the accompanying prospectus contain forward-looking statements that are based on our management&rsquo;s belief
and assumptions and on information currently available to our management. These statements relate to future events or our future financial
performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity,
performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed
or implied by these forward-looking statements. Forward-looking statements include, but are not limited to, statements about:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the direct and indirect impact of the novel coronavirus, or&nbsp;COVID-19,&nbsp;on
our business and operations;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to continue normal operations and interactions
with our users during the&nbsp;COVID-19&nbsp;pandemic;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our dependence upon external sources for the financing of
our operations;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to obtain and maintain our strategic collaborations
and to realize the intended benefits of such collaborations;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to effectively execute our business plan;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to continue to innovate and develop new products;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to maintain and grow our reputation and to achieve
and maintain the market acceptance of our products;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to manage the growth of our operations over time;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to maintain adequate protection of our intellectual
property and to avoid violation of the intellectual property rights of others;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to gain and maintain regulatory approvals;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to maintain relationships with existing customers
and develop relationships with new customers; and</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to compete and succeed in a highly competitive
and evolving industry.</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">These
forward-looking statements are neither promises nor guarantees of future performance due to a variety of risks and uncertainties and other
factors more fully discussed in the &ldquo;Risk Factors&rdquo; section in this prospectus supplement and the risk factors and cautionary
statements described in other documents that we file from time to time with the SEC, specifically under &ldquo;Item&nbsp;3D. Risk Factors&rdquo;
and elsewhere in our most recent Annual Report on&nbsp;Form&nbsp;20-F&nbsp;for the year ended December&nbsp;31, 2023, and our Reports
on&nbsp;Form&nbsp;6-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Given
these uncertainties, readers should not place undue reliance on our forward-looking statements. These forward-looking statements speak
only as of the date on which the statements were made and are not guarantees of future performance. Except as may be required by applicable
law, we do not undertake to update any forward-looking statements after the date of this prospectus supplement or the respective dates
of documents incorporated by reference that include forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 55.1pt; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white"><A NAME="z_004"></A>prospectus
supplement summary</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Company Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our Corporate History and Structure</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a holding company incorporated
on April 16, 2019, as an exempted company under the laws of the Cayman Islands. We have no substantive operations other than holding all
of the issued and outstanding shares of Zhongchao Group Inc., or Zhongchao BVI, established under the laws of the British Virgin Islands
on April 23, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Zhongchao BVI is also a holding
company holding all of the outstanding equity of Zhongchao Group Limited, or Zhongchao HK, which was established in Hong Kong on May 14,
2019. Zhongchao HK is also a holding company holding all of the outstanding equity of Beijing Zhongchao Zhongxing Technology Limited,
or Zhongchao WFOE, which was established on May 29, 2019 under the laws of the PRC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We conduct our business through
the VIE, Zhongchao Medical Technology (Shanghai) Corp., or Zhongchao Shanghai, a PRC company, and through 11 subsidiaries of Zhongchao
Shanghai, including Shanghai Zhongxun, Shanghai Zhongxin, Maidemu Health, Beijing Boya, Shanghai Xinyuan, Hainan Muxin, Shanghai Huijing,
Xinjiang Pharmaceutical, Beijing Yisuizhen, West Angel and Liaoning Zhixun, each a PRC company. They commenced their operations under
the name Zhongchao Medical Consulting (Shanghai) Limited, or Shanghai Zhongchao Limited, a limited liability company established under
the laws of the PRC, to provide medical online and offline training services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Zhongchao Shanghai was incorporated
on August 17, 2012 by Juru Guo and Baorong Xue, who held 60% and 40% equity interests in Zhongchao Shanghai respectively. On May 25, 2015,
the two shareholders transferred all equity interests to Weiguang Yang who held 100% equity interests in Zhongchao Shanghai after the
transfer. On January 15, 2016, the name was changed to Zhongchao Medical Technology (Shanghai) Co., Ltd. On February 5, 2016, the management
completed its registration with the State Administration for Industry and Commerce, or SAIC, to convert Shanghai Zhongchao Limited into
a company limited by shares, or Zhongchao Shanghai. Through direct ownership, Zhongchao Shanghai has established subsidiaries and branch
offices in various cities in PRC, including Beijing, Shanghai, Hainan, Liaoning and Chongqing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 16, 2019, Zhongchao
Cayman was incorporated in the Cayman Islands as an exempted company with limited liability, shortly following which More Healthy Holdings
Limited acquired 5,497,715 Class B Ordinary Shares of par value US$0.0001 per share as founder shares, representing, at that time, 80.94%
of total voting power of the Company, on converted basis, given that each Class B Ordinary Share was entitled to 15 votes and each Class
A Ordinary Share was entitled to 1 vote and assuming the exercise of the HF Warrant (as defined below). More Healthy Holdings Limited
is a BVI company 100% owned by Weiguang Yang (&ldquo;More Healthy&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As part of the Company&rsquo;s
organization for the purpose of the initial public offering and listing on Nasdaq, on August 1, 2019, the Company and HF Capital Management
Delta, Inc., a company incorporated under the laws of the Cayman Islands (&ldquo;HF Capital&rdquo;) entered into a certain warrant agreement
to purchase Class A Ordinary Shares of the Company (the &ldquo;HF Warrant&rdquo;). At the issuance of the HF Warrant, Yantai Hanfujingfei
Investment Centre (LP), a limited partnership incorporated under PRC laws (&ldquo;Yantai HF&rdquo;, whose managing partner, Hanfor Capital
Management Co., Ltd., was the sole member of HF Capital, and together with &ldquo;HF Capital&rdquo; hereinafter collectively referred
to as &ldquo;HF&rdquo;) was a 6.25% shareholder of Zhongchao Shanghai and planned to withdraw its capital contribution in Zhongchao Shanghai
but to contribute the same amount of capital to Zhongchao Cayman directly via HF Capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 5, 2023, the Company
held an annual general meeting of shareholders at which shareholders resolved to amend and restate the Company&rsquo;s memorandum and articles
of association, pursuant to which each holder of Class B Ordinary Shares became entitled to one hundred (100) votes for each Class B Ordinary
Shares held. Each shareholder of the Company&rsquo;s Class A Ordinary Shares remains entitled to one (1) vote for each Class A Ordinary
Share held.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 20, 2024, the
Company held an extraordinary general meeting of shareholders at which shareholders resolved that: (a) with effect upon the commencement
of the second business day following the extraordinary general meeting or such later date as the Company&rsquo;s board of directors may determine,
that the authorized, issued, and outstanding shares of the Company be consolidated and divided by consolidating: (i) every ten (10) Class
A Ordinary Shares with a par value of US$0.0001 each into one (1) Class A Ordinary Share with a par value of US$0.001 each; and (ii) every
ten (10) Class B Ordinary Shares with a par value of US$0.0001 each into one (1) Class B Ordinary Share with a par value of US$0.001 each,
with such consolidated shares having the same rights and being subject to the same restrictions (save as to par value) as the previously
existing shares of such class (the &ldquo;Share Consolidation&rdquo;); (b) subject to and immediately following the Share Consolidation
being effected, the authorized share capital of the Company be increased from US$50,000 divided into 45,000,000 Class A Ordinary Shares
with a par value of US$0.001 each and 5,000,000 Class B Ordinary Shares with a par value of US$0.001 each to US$500,000 divided into 450,000,000
Class A Ordinary Shares with a par value of US$0.001 each and 50,000,000 Class B Ordinary Shares with a par value of US$0.001 each (the
&ldquo;Share Capital Increase&rdquo;); and (c) subject to the Share Consolidation and the Share Capital Increase being approved and effected,
the Company adopt an amended and restated memorandum and articles of association in substitution for, and to the exclusion of, the Company&rsquo;s
existing memorandum and articles of association, to reflect corrected typographical corrections, the Share Consolidation and the Share
Capital Increase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Share Consolidation and
the Share Capital Increase were subsequently effected, and the Company&rsquo;s memorandum and articles of association were amended and restated,
on February 29, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Beginning with the opening
of trading on February 29, 2024, the Company&rsquo;s Class A Ordinary Shares began trading on a post-Share Consolidation basis on the
Nasdaq Capital Market under the same symbol &ldquo;ZCMD,&rdquo; but under a new CUSIP number of G9897X115.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Contractual Arrangements between the Zhongchao
WFOE and Zhongchao Shanghai</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Zhongchao Inc. (the &ldquo;Company&rdquo;
or &ldquo;Zhongchao Cayman&rdquo;) is an offshore holding company incorporated in the Cayman Islands as an exempted company with limited
liability. As a holding company with no material operations of our own, we, through the contractual arrangements (the &ldquo;Contractual
Arrangements&rdquo;), between Beijing Zhongchao Zhongxing Technology Limited (&ldquo;Zhongchao WFOE&rdquo;), a wholly subsidiary of Zhongchao
Cayman incorporated in the PRC, and a variable interest entity (the &ldquo;VIE&rdquo;), Zhongchao Medical Technology (Shanghai) Co., Ltd.
(&ldquo;Zhongchao Shanghai&rdquo;) and its subsidiaries or collectively &ldquo;the PRC operating entities&rdquo;, consolidate the financial
results of the PRC operating entities. Due to the restrictions imposed by PRC laws and regulations on foreign ownership of companies engaged
in value-added telecommunication services and certain other businesses, we operate our businesses in which foreign investment is restricted
or prohibited in the PRC through certain PRC domestic companies. Accordingly, the Contractual Arrangements are designed to allow Zhongchao
Cayman to consolidate Zhongchao Shanghai&rsquo;s operations and financial results in Zhongchao Cayman&rsquo;s financial statements in
accordance with U.S. GAAP as the primary beneficiary. Neither we nor our subsidiaries own any equity interests in the PRC operating entities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As we chose such VIE structure,
we are subject to certain unique risks and uncertainties that may not otherwise exist if we had direct equity ownership in the PRC operating
entities. Because we do not directly hold equity interests in the VIE and its subsidiaries, our Contractual Arrangements may not be effective
in providing control over Zhongchao Shanghai. Further, we are subject to risks due to uncertainty of the interpretation and the application
of the PRC laws and regulations, including but not limited to limitations on foreign ownership and regulatory review of overseas listing
of PRC companies through a special purpose vehicle, and the validity and enforcement of the Contractual Arrangements. We are also subject
to the risks of uncertainty about any future actions of the PRC government in this regard that could disallow the VIE structure, which
would likely result in a material change in the PRC operating entities&rsquo; operations and cause the value of our securities to decrease
significantly or become worthless. However, as of the date of this prospectus supplement, the agreements under the Contractual Arrangements
have not been tested in any courts of law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P></DIV>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 98%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following charts summarize
our corporate legal structure and identify our subsidiaries, our VIE and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 750px; width: 648px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Permission Required from the PRC Authorities
to Issue Our Securities to Foreign Investors</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this prospectus
supplement, in the opinion of our PRC legal counsel, Han Kun Law Offices, although we are required to complete the filing procedure in
connection with our offerings under the Trial Administrative Measures of the Overseas Securities Offering and Listing by Domestic Companies,
or the Trial Measures, no relevant PRC laws or regulations in effect require that we or the PRC operating entities obtain permission from
any PRC authorities to issue securities to foreign investors in connection with a potential offering made pursuant to this prospectus
supplement as of the date of this prospectus supplement, and neither we nor the PRC operating entities have received any inquiry, notice,
warning, sanction, or any regulatory objection to the offerings in connection with this registration statement from the China Securities
Regulatory Commission (the &ldquo;CSRC&rdquo;), Cyberspace Administration of China (the &ldquo;CAC&rdquo;), or any other PRC authorities
that have jurisdiction over our operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">PRC laws and regulations governing
our current business operations are sometimes vague and uncertain, and therefore, these risks may result in a material change in the PRC
operating entities&rsquo; operations, significant depreciation of the value of our securities, or a complete hindrance of our ability
to offer or continue to offer our securities to investors and cause the value of such securities to significantly decline or be worthless.
The Chinese government may intervene or influence the operations of the PRC operating entities at any time and may exert more control
over offerings conducted overseas and/or foreign investment in China-based issuers, which could result in a material change in the operations
of the PRC operating entities and/or the value of our securities. Further, any actions by the Chinese government to exert more oversight
and control over offerings that are conducted overseas and/or foreign investment in China-based issuers could significantly limit or completely
hinder our ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline
or be worthless. Recently, the PRC government initiated a series of regulatory actions and statements to regulate business operations
in China with little advance notice, including cracking down on illegal activities in the securities market, enhancing supervision over
the use of variable interest entities for overseas listing, adopting new measures to extend the scope of cybersecurity reviews, and expanding
the efforts in anti-monopoly enforcement. On February 17, 2023, the CSRC promulgated the Trial Administrative Measures of the Overseas
Securities Offering and Listing by Domestic Companies, or the Trial Measures, and five supporting guidelines, which became effective on
March 31, 2023. According to the Trial Measures, among other requirements, (1) domestic companies that seek to offer or list securities
overseas, both directly and indirectly, should fulfil the filing procedures with the CSRC; if a domestic company fails to complete the
filing procedure or conceals any material fact or falsifies any major content in its filing documents, such domestic company may be subject
to administrative penalties; (2) if the issuer meets both of the following conditions, the overseas offering and listing shall be determined
as an indirect overseas offering and listing by a domestic company: (i) any of the total assets, net assets, revenues or profits of the
domestic operating entities of the issuer in the most recent accounting year accounts for more than 50% of the corresponding figure in
the issuer&rsquo;s audited consolidated financial statements for the same period; (ii) its major operational activities are carried out
in China or its main places of business are located in China, or the senior managers in charge of operation and management of the issuer
are mostly Chinese citizens or are domiciled in China; (3) where a domestic company seeks to indirectly offer and list securities in an
overseas market, the issuer shall designate a major domestic operating entity responsible for all filing procedures with the CSRC, and
such filings shall be submitted to the CSRC within three business days after the submission of the overseas offering and listing application;
and (4) if the issuer issues securities in the same overseas market after the initial issuance and listing, it shall submit filings with
the CSRC within three business days after the completion of the issuance. Further, at the press conference held for the Trial Measures
on February 17, 2023, officials from the CSRC clarified that the PRC domestic companies that have already been listed overseas on or before
the effective date of the Trial Measures, March 31, 2023, shall be deemed as existing issuers, or the Existing Issuers. Existing Issuers
are not required to complete the filing procedures immediately but shall carry out filing procedures as required if they conduct refinancing
or are involved in other circumstances that require filing with the CSRC. Therefore, in the opinion of our PRC legal counsel, Han Kun
Law Offices, we are required to go through filing procedures with the CSRC within three business days after the completion of the offerings
in connection with this registration statement and for our future offerings and listing of our securities in an overseas market under
the Trial Measures. We will begin the process of preparing a report and other required materials in connection with the CSRC filing, which
will be submitted to the CSRC in due course. If we fail to complete such filing requirement, Chinese regulatory authorities may impose
fines and penalties upon the PRC operating entities&rsquo; operations in China, limit the PRC operating entities&rsquo; operating privileges
in China, delay or restrict the repatriation of the proceeds from the offerings in connection with this registration statement into China,
or take other actions that could have a material adverse effect upon the PRC operating entities&rsquo; business, financial condition,
results of operations, reputation and prospects, as well as the trading price of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The officials from the CSRC
have also confirmed that for the PRC domestic companies that seek to list overseas with VIE structure, the CSRC will solicit opinions
from relevant regulatory authorities and complete the filing of the overseas listing of companies with VIE structure which meet the compliance
requirements. As the Trial Measures were newly published, there are substantial uncertainties as to the implementation and interpretation,
and how they will affect our current listing, and future offering or financing. If we are required by the Trial Measures for any future
offering or any other financing activities to file with the CSRC, we cannot assure you that we will be able to complete such filings in
a timely manner, or even at all. Any failure of us to fully comply with new regulatory requirements may significantly limit or completely
hinder our ability to continue to offer our securities, cause significant disruption to our business operations, severely damage our reputation,
materially and adversely affect our financial condition and results of operations and cause our securities to significantly decline in
value or become worthless.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the opinion of our PRC
counsel, Han Kun Law Offices, neither we nor the PRC operating entities are subject to cybersecurity review with the CAC under the Cybersecurity
Review Measures which became effective on February 15, 2022, since we or the PRC operating entities have not been notified by the regulatory
authorities as critical information infrastructure operators, and we or the PRC operating entities and neither we nor the PRC operating
entities currently have over one million users&rsquo; personal information and do not anticipate that we will be collecting over one million
users&rsquo; personal information in the foreseeable future, which we understand might otherwise subject us to the Cybersecurity Review
Measures. On November 14, 2021, the CAC released the Regulations on the Network Data Security Management (Draft for Comments), or the
Data Security Management Regulations Draft, to solicit public opinion and comments. Pursuant to the Data Security Management Regulations
Draft, data processor holding more than one million users/users&rsquo; individual information shall be subject to cybersecurity review
before listing abroad. Data processing activities refers to activities such as the collection, retention, use, processing, transmission,
provision, disclosure, or deletion of data. As of the date of this prospectus supplement, the MDMOOC online platform has more than 194,370
registered users, and we currently do not hold more than one million users/users&rsquo; individual information. However, we or the PRC
operating entities may be deemed as a data processor under the Data Security Management Regulations Draft. As of the date of this prospectus
supplement, neither we nor the PRC operating entities have been informed by any PRC governmental authority of any requirement that we
or the PRC operating entities file for a cybersecurity review. However, if we or the PRC operating entities are deemed to be a critical
information infrastructure operator or a company that is engaged in data processing and holds personal information of more than one million
users, we or the PRC operating entities could be subject to PRC cybersecurity review.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Permission Required from the PRC Authorities
for Our and PRC Operating Entities&rsquo; Operation in China</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this prospectus
supplement, except as disclosed in this prospectus and our most recent annual report on Form 20-F on April 30, 2024, we, or the PRC operating
entities are not required to obtain any other permission or approval from the PRC authorities for the PRC operating entities&rsquo; operations
in China, nor have we, or the PRC operating entities, received any denial for our operation in China. Given the uncertainties of interpretation
and implementation of relevant laws and regulations and the enforcement practice by relevant government authorities, we may be required
to obtain additional licenses, permits, filings or approvals in the future. If any of the PRC operating entities is found to be in violation
of any existing or future PRC laws or regulations, or fail to obtain or maintain any of the requisite licenses and permits, the relevant
PRC regulatory authorities would have broad discretion to take action in dealing with such violations or failures. In addition, if any
of the PRC operating entities had inadvertently concluded that such licenses, permits, registrations or filings were not required, or
if applicable laws, regulations or interpretations change in a way that requires any of the PRC operating entities to obtain such licenses,
permits, registrations or filings in the future, the relevant PRC operating entities may be unable to obtain such necessary licenses,
permits, registrations or filings in a timely manner, or at all, and such licenses, permits, registrations or filings may be rescinded
even if obtained. Any such circumstance may subject the relevant PRC operating entities to fines and other regulatory, civil or criminal
liabilities, and the relevant PRC operating entities may be ordered by the competent government authorities to suspend relevant operations,
which will materially and adversely affect our business operations. See <I>&ldquo;&mdash; Risks Related to Doing Business in China&mdash;The
PRC operating entities&rsquo; failure to obtain, maintain or renew other licenses, approvals, permits, registrations or filings necessary
to conduct their operations in China could have a material adverse impact on our business, financial conditions and results of operations</I>.&rdquo;
in our most recent annual report on&nbsp;Form 20-F filed on April 30, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the opinion of our PRC
legal counsel, Han Kun Law Offices, based on their understanding of the current PRC laws, rules and regulations, that (i) the structure
for operating our business in China (including our corporate structure and VIE Arrangements with Zhongchao Shanghai, Zhongchao Shanghai
and their shareholders), as of the date of this prospectus supplement, do not result in any violation of PRC laws or regulations currently
in effect; and (ii) the Contractual Arrangements among Zhongchao WFOE and Zhongchao Shanghai and their shareholders governed by PRC law
are valid, binding and enforceable in accordance with the terms of each of the VIE Arrangements, and do not result in any violation of
PRC laws or regulations currently in effect. However, there are substantial uncertainties regarding the interpretation and application
of current or future PRC laws and regulations concerning foreign investment in the PRC, and their application to and effect on the legality,
binding effect and enforceability of the Contractual Arrangements. In particular, we cannot rule out the possibility that PRC regulatory
authorities, courts or arbitral tribunals may in the future adopt a different or contrary interpretation or take a view that is inconsistent
with the opinion of our PRC legal counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Dividend Distributions or Transfers of Cash
among the Holding Company, Its Subsidiaries, and the Consolidated VIE</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the year ended December
31, 2023, Zhongchao Cayman made cash transfer of $0.1 million to Zhongchao USA. For the year ended December 31, 2022, Zhongchao Cayman
made cash transfer of $1.5 million to Zhongchao USA. Except as otherwise disclosed above, for the years ended December 31, 2023 and 2022,
no other cash transfer or transfer of other assets have occurred between Zhongchao Cayman, its subsidiaries, the consolidated VIE and
the subsidiaries of the VIE. For the years ended December 31, 2023 and 2022, none of our subsidiaries, the consolidated VIE, or the subsidiaries
of the VIE have made any dividends or distributions to Zhongchao Cayman. For the years ended December 31, 2023 and 2022, no dividends
or distributions have been made to any U.S. investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We intend to keep any future
earnings to re-invest in and finance the expansion of the business of the PRC operating entities, and we do not anticipate that any cash
dividends will be paid in the foreseeable future. Under Cayman Islands law, a Cayman Islands company may pay a dividend on its shares
out of either profit or share premium amount, provided that in no circumstances may a dividend be paid if this would result in the Company
being unable to pay its debts due in the ordinary course of business. Cash proceeds raised from overseas financing activities, including
the cash proceeds from this offering, may be transferred by Zhongchao Cayman to Zhongchao HK, and then transferred to Zhongchao WFOE via
capital contribution or shareholder loans, as the case may be. Cash proceeds may flow to the VIE from Zhongchao WFOE pursuant to certain
contractual agreements between Zhongchao WFOE and the VIE as permitted by the applicable PRC regulations. The process for sending such
proceeds back to the mainland China may be time-consuming after the closing of this offering. We may be unable to use these proceeds to
grow the business of the PRC operating entities until the PRC operating entities receive such proceeds in mainland China. Any transfer
of funds by us to our PRC subsidiaries, either as a shareholder loan or as an increase in registered capital, are subject to PRC regulations.
Capital contributions to our PRC subsidiaries are subject to the report to the Ministry of Commerce of the People&rsquo;s Republic of
China, or the MOFCOM, in its local branches and registration with a local bank authorized by the China&rsquo;s State Administration of
Foreign Exchange, or the SAFE. Any foreign loan procured by our PRC subsidiaries is required to be registered or filed with the SAFE or
its local branches or satisfy relevant requirements as provided by the SAFE. Any medium- or long-term loan to be provided by us to the
VIEs must be registered with the National Development and Reform Commission, or the NDRC, and the SAFE or its local branches. We may not
be able to obtain these government approvals or complete such registrations on a timely basis, if at all, with respect to future capital
contributions or foreign loans by us to our PRC subsidiaries. If we fail to receive such approvals or complete such registration or filing,
our ability to use the proceeds of our financing activities and to capitalize our PRC operations may be negatively affected, which could
adversely affect our liquidity and our ability to fund and expand our business. See &ldquo;Item 3. Key Information&mdash;D. Risk Factors&mdash;
Risks Related to Doing Business in China&mdash;<I>PRC regulation of loans and direct investment by offshore holding companies to PRC entities
may delay or prevent us from using the proceeds of the initial public offering or any subsequent offerings to make loans or additional
capital contributions to our PRC subsidiary, which could materially and adversely affect our liquidity and our ability to fund and expand
our business</I>&rdquo; in the Annual Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under our current corporate
structure, we rely on dividend payments from Zhongchao HK and Zhongchao WFOE to fund any cash and financing requirements we may have,
including the funds necessary to pay dividends and other cash distributions to our shareholders or to pay any debt we may incur:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">Zhongchao WFOE&rsquo;s ability to distribute dividends is based upon its distributable earnings. Current
mainland China regulations permit Zhongchao WFOE to pay dividends to Zhongchao HK in accordance with applicable PRC laws and regulations
under which Zhongchao WFOE can only pay dividends to Zhongchao HK out of its accumulated profits, if any, determined in accordance with
Chinese accounting standards and regulations. Furthermore, Zhongchao WFOE could make payments to Zhongchao HK pursuant to the relevant
agreements between them as permitted by the applicable PRC regulations. In addition, Zhongchao WFOE is required to set aside certain after-tax
profit to fund a statutory reserve as described below in this section.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">Based on the Hong Kong laws and regulations, as of the date of this prospectus supplement, there is no
restriction imposed by the Hong Kong government on the transfer of capital within, into and out of Hong Kong (including funds from Hong
Kong to mainland China), except transfer of funds involving money laundering and criminal activities and some tax restrictions between
Hong Kong and mainland China as discussed herein below in this section. As a result, Zhongchao HK may further distribute any dividends
or payments (if any) received from Zhongchao WFOE to Zhongchao Cayman as dividends.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">Under Cayman Islands law, a Cayman Islands company may pay a dividend on its shares out of either profit
or share premium amount, provided that in no circumstances may a dividend be paid if this would result in the company being unable to
pay its debts due in the ordinary course of business. If we determine to pay dividends on any of our Ordinary Shares in the future, as
a holding company, unless we receive proceeds from future offerings, we will be dependent on receipt of funds from Zhongchao HK, which
will be dependent on receipt of dividends or payments (if any) from Zhongchao WFOE, which will be dependent on payments from the VIE in
accordance with the laws and regulations of the PRC and the Contractual Arrangements between them.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">Cash dividends, if any, on our Class A Ordinary Shares will be paid in U.S. dollars. The PRC government
also imposes controls on the conversion of RMB into foreign currencies and the remittance of currencies out of the PRC. Therefore, we
may experience difficulties in completing the administrative procedures necessary to obtain and remit foreign currency for the payment
of dividends from our profits, if any. Cash in mainland China may not be available to fund operations or for other use outside of the
PRC due to interventions in or the imposition of restrictions and limitations on the ability of the Company, it subsidiaries and the PRC
operating entities by the PRC government to transfer cash or assets. Furthermore, if Zhongchao WFOE, Zhongchao HK or the VIE incurs debt
on its own in the future, the instruments governing the debt may restrict their ability to pay dividends or make other payments. If either
Zhongchao WFOE, Zhongchao HK or the VIE is unable to distribute dividends or make payments directly or indirectly to Zhongchao Cayman,
we may be unable to pay dividends on our Ordinary Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The transfer of funds among
the PRC operating entities are subject to the Provisions of the Supreme People&rsquo;s Court on Several Issues Concerning the Application
of Law in the Trial of Private Lending Cases (2020 Second Amendment Revision, the &ldquo;Provisions on Private Lending Cases&rdquo;),
which was implemented on January 1, 2021 to regulate the financing activities between natural persons, legal persons and unincorporated
organizations. In the opinion of our PRC counsel, Han Kun Law Offices, the Provisions on Private Lending Cases does not prohibit using
cash generated from one PRC operating entity to fund another affiliated PRC operating entity&rsquo;s operations. We or the PRC operating
entities have not been notified of any other restriction which could limit the PRC operating entities&rsquo; ability to transfer cash
among each other. In the future, cash proceeds from overseas financing activities, including this offering, may be transferred by Zhongchao
Cayman to Zhongchao HK, and then transferred to Zhongchao WFOE via capital contribution or shareholder loans, as the case may be. Cash
proceeds may flow to Zhongchao Shandong from Zhongchao WFOE pursuant to the Contractual Arrangements between Zhongchao WFOE and Zhongchao
Shandong as permitted by the applicable PRC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We plan to distribute earnings
or settle amounts owed under the Contractual Arrangements with the VIE when required in the future. As of the date of this prospectus
supplement, none of Zhongchao HK, Zhongchao WFOE and the PRC operating entities have made any dividends to Zhongchao Cayman. As of the
date of this prospectus supplement, we have not made any dividends or distributions to any U.S. investors. As of the date of this prospectus
supplement, Zhongchao Cayman and its subsidiaries, as well as the PRC operating entities have not adopted or maintained any other cash
management policies and procedures, and each entity needs to comply with applicable law or regulations with respect to transfer of funds,
dividends and distributions with other entities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the mainland
China government imposes controls on the convertibility of the Renminbi into foreign currencies and, in certain cases, the remittance
of currency out of mainland China. Therefore, we may experience difficulties in completing the administrative procedures necessary to
obtain and remit foreign currency for the payment of dividends from our profits, if any. If the foreign exchange control system prevents
us from obtaining sufficient foreign currencies to satisfy our foreign currency demands, we may not be able to transfer cash out of mainland
China and pay dividends in foreign currencies to our shareholders. Cash in mainland China may not be available to fund operations or for
other use outside of the PRC due to interventions in or the imposition of restrictions and limitations on the ability of the Company,
it subsidiaries and the PRC operating entities by the PRC government to transfer cash or assets. There can be no assurance that the PRC
government will not intervene or impose restrictions on our ability to transfer or distribute cash within our organization or to foreign
investors, which could result in an inability or prohibition on making transfers or distributions outside of mainland China and may adversely
affect our business, financial condition and results of operations. See &ldquo;Item 3. Key Information&mdash;D. Risk Factor &mdash; <I>Governmental
control of currency conversion may limit our ability to use our revenues effectively and the ability of our PRC subsidiaries to obtain
financing</I>&rdquo; in the Annual Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, each of our subsidiaries
in China is required to set aside at least 10% of its after-tax profits each year, if any, to fund a statutory reserve until such reserve
reaches 50% of its registered capital. Each of such entity in China may also set aside a portion of its after-tax profits to fund an optional
employee welfare fund, although the amount to be set aside, if any, is determined at the discretion of its board of shareholders. Although
the statutory reserves can be used, among other ways, to increase the registered capital and eliminate future losses in excess of retained
earnings of the respective companies, the reserve funds are not distributable as cash dividends except in the event of liquidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cash dividends, if any, on
our Class A Ordinary Shares will be paid in U.S. dollars. If we are considered a PRC tax resident enterprise for tax purposes, any dividends
we pay to our overseas shareholders may be regarded as China-sourced income and as a result may be subject to PRC withholding tax at a
rate of up to 10.0%. Certain payments from the VIE, Zhongchao Shanghai, to Zhongchao WFOE are subject to PRC taxes, including business
taxes and value added tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Arrangement
between Mainland China and the Hong Kong Special Administrative Region for the Avoidance of Double Taxation and Tax Evasion on Income,
or the Double Tax Avoidance Arrangement, the 10% withholding tax rate may be lowered to 5% if a Hong Kong resident enterprise owns no
less than 25% of a PRC project. However, the 5% withholding tax rate does not automatically apply and certain requirements must be satisfied,
including without limitation that (a) the Hong Kong project must be the beneficial owner of the relevant dividends; and (b) the Hong Kong
project must directly hold no less than 25% share ownership in the PRC project during the 12 consecutive months preceding its receipt
of the dividends. In current practice, a Hong Kong project must obtain a tax resident certificate from the Hong Kong tax authority to
apply for the 5% lower PRC withholding tax rate. As the Hong Kong tax authority will issue such a tax resident certificate on a case-by-case
basis, we cannot assure you that we will be able to obtain the tax resident certificate from the relevant Hong Kong tax authority and
enjoy the preferential withholding tax rate of 5% under the Double Taxation Arrangement with respect to dividends to be paid by our PRC
subsidiary to its immediate holding company, Zhongchao HK. As of the date of this prospectus supplement, we have not applied and have
no plan to apply for the tax resident certificate from the relevant Hong Kong tax authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Business Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our Company</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are not a Chinese operating
company, but an offshore holding company incorporated in the Cayman Islands as an exempted company with limited liability. As a holding
company with no material operations of our own, we consolidate the financial results, through a series of the Contractual Arrangements,
with Zhongchao Shanghai and its subsidiaries, or collectively, &ldquo;the PRC operating entities.&rdquo; Neither we nor our subsidiaries
own any equity interests in the PRC operating entities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Class A Ordinary Shares
currently trading on Nasdaq are the shares of the offshore holding company, Zhongchao Cayman. You are not investing in the PRC operating
entities. &nbsp;&nbsp;Instead, we consolidate financial results of Zhongchao Shanghai as primary beneficiary through the Contractual Arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Zhongchao Shanghai, together
with its subsidiaries, is a platform-based internet technology company offering services to patients with oncology and other major diseases
in China. The PRC operating entities address the needs along the patient journey of symptoms occurrence, medical consultations, medication
prescriptions, medication management, and treatment consultations. The PRC operating entities provide online healthcare information, professional
training and educational services to healthcare professionals, patient management services in the professional field of tumor and rare
diseases, internet healthcare services, and pharmaceutical services and operate an online information platform to general public.&nbsp;The
PRC operating entities also engage in sales of patent drug in China.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PRC operating entities
provide the healthcare information, education, and training services to the healthcare professionals under their &ldquo;MDMOOC&rdquo;
brand, which we believe is one of the leading consumer brands in China&rsquo;s healthcare training and education sector, as evidenced
by the Securities Research Report on online medical care industry by Essence Securities Co., Ltd., a company provides securities services
throughout China, where the PRC operating entities are considered as one of the main and typical public company proving medical training
with doctor interactive and online training platform and leading the Internet medical education industry. &nbsp;The PRC operating entities
provide focused patient management services, via their &ldquo;Zhongxun&rdquo; IT system and WeChat mini program and Zhongxin Health WeChat
mini program, to their pharmaceutical enterprises and NFP customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PRC operating entities
established Chongqing Xinjiang Pharmaceutical Co., Ltd., a PRC company (&ldquo;Xinjiang Pharmaceutical&rdquo;), aiming at realizing medications
accessibility and affordability for patients. Xinjiang Pharmaceutical cooperates with Zhixun Internet Hospital and other internet hospitals
to build a 2B2C (to business and to customer) pharmaceutical procurement platform and streamline the delivery of medications from pharmaceutical
factories to retail ends.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B><I>MDMOOC-Healthcare Information, Education, and Training for Professionals</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><I>The MDMOOC Online Platform of the PRC Operating Entities</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The MDMOOC online platform
of the PRC operating entities&rsquo; is realized through various products, including MDMOOC mobile App, MOOC Medical WeChat subscription
account, and MDMOOC website, where users can access our rich media content and engaging Community of Practice Share (COPS) on MDMOOC website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.5in"><B><I>MOOC Mobile App</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The MOOC Medical mobile app
of the PRC operating entities serves as a one-stop destination where they offer users relevant healthcare knowledge and study insights,
assist them along their journey to obtain the knowledge and information they are searching for in a supportive community, and allow them
to review and test their understanding of courses by participating in the Practice Improvement (PI) system. The PRC operating entities
designed the interface of their platform in simple white and sky blue, signaling health and learning respectively, and creating a soft
and welcoming texture to their platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">When users open the MOOC Medical
mobile app, they will immediately see the featured banners that display academic courses, open classes, case library, and practice improvement
courses. As users scroll down, courses that are most popular among the healthcare professionals, courses recommended by the PRC operating
entities&rsquo; medical editors, and the latest healthcare news appear. Users can also explore various medical courses by medical specialty
and subject areas.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Opening Course is a collection
of video courses of various medical fields and topics. The courses are often presented by medical experts. Most of the courses are free
to users.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Commencing from the fourth
quarter of 2018, in addition to providing training and education courses through the platforms, the PRC operating entities have been engaged
by certain customers on a project basis to establish individual columns on the MDMOOC online platform to provide training and knowledge
of certain drug treatment for healthcare professionals and patients. Most of the drug treatments are cancer-related or rare disease-related.
The PRC operating entities also plug in supplemental features, to manage the drug treatment including reviewing patients&rsquo; applications,
tracking their usage of drugs, and collecting related information (such programs with new plug-in features are hereinafter referred as
the &ldquo;patient-aid projects&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this prospectus
supplement, we have established nearly 22 courses for cancer-related drug treatment, including drug treatment for lung cancer, liver cancer,
and extended blood cancer, and 7 columns for drug treatment of rare diseases, including drug treatment for pulmonary fibrosis, multiple
sclerosis, systemic lupus erythematosus, Crohn&rsquo;s disease and skin diseases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B><I>MDMOOC WeChat Subscription Account</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WeChat Subscription Account
provides a new means to propagate information for the media and individuals, building better communication with readers with a better
management. It also facilitates discovery and consumption of services and products. It is useful for discovery and quick actions, and
complements full-function native apps by increasing their traffic.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PRC operating entities&rsquo;
MDMOOC WeChat subscription account features similar interfaces and functions as their mobile app. It serves as additional access points
to the PRC operating entities&rsquo; platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B><I>MDMOOC Website</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Users can access online healthcare
information, education and training content and the services through the PRC operating entities&rsquo; website MDMOOC.org. As more internet
users shift to mobile ends, the PRC operating entities&rsquo; website mainly serves a comprehensive knowledge base targeting users who
are in the process of researching for specific medical courses, articles, or news.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PRC operating entities
designed their professional website to meet the needs of their users in a personalized and easy-to-use manner. The PRC operating entities
plan to expand into new medical specialty areas that appeal to their current users base and attract new users. The PRC operating entities&rsquo;
objective is to be the category leader in each of their medical specialty areas by delivering the highest quality specialty-based content
and selectively acquiring other high-quality medical specialty Websites. As part of this strategy, the PRC operating entities will (1)
work with more medical associations to produce programs and courses to meet the need of healthcare professionals; (2) expand their R&amp;D
team and provide more support to their self-developed courses; (3) cooperate with international continuing medical education providers
to improve the quality and diversity of their courses; and (4) expand their new media team to create and provide high-quality online courses
for mobile users.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I><U>The MDMOOC Onsite Activities of the PRC Operating Entities</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to their online
presence, the PRC operating entities also hold onsite activities to provide healthcare information and education services from time to
time under their &ldquo;MDMOOC&rdquo; brand. The PRC operating entities&rsquo; onsite activities not only provide their healthcare professionals
with medical knowledge and clinical skills but also another career path which enhance their professional competitiveness. Also, many of
their onsite activities were accompanied with live steaming, which will be uploaded to the MDMOOC online platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PRC operating entities
cooperate with Beijing Chronic Disease Prevention and Health Education Research Association and Professor Yixin Zhang from the Ninth
People&rsquo;s Hospital of Shanghai Jiao Tong University School of Medicine to create courses titled &ldquo;Essential Course for Wound
Care Management&rdquo; and &ldquo;Advanced Course for Surgical Wound Treatment&rdquo;. These courses have been certified and authorized
by the European Wound Management Association (EWMA), a European not-for-profit umbrella organization, linking national wound management
organizations, individuals and groups with interest in wound care. The PRC operating entities have successfully held four (4) training
programs for Essential Course for Wound Care Management and two (2) training programs for Advanced Course for Surgical Wound Treatment.
Each program accepted no more than twenty (20) applicants who shall hold academic credential above undergraduate. The PRC operating entities
also required all applicants to have more than six-year working experience in the field of wound repair. The PRC operating entities have
issued a certificate to each of the applicant upon completion of the training as their proof of achievement and ability in the wound
management and treatment. The PRC operating entities believe that after attending these programs, the participants would acquire the
basic capacity to lead a wound-management department in a hospital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PRC operating entities
believe the combination of online and onsite services would provide their end-users the greatest convenience. With more choices of the
forms of healthcare education, the PRC operating entities enrich the learning experience of their end-users.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>New Plug-in to Certain Programs-
Assistance in Patient-Aid Projects</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PRC operating entities
have been engaged by certain customers on a project basis to establish individual columns on the MDMOOC online platform to provide training
and knowledge of certain drug treatment for healthcare professionals and patients. Most of the drug treatments are cancer-related or rare
disease-related. The PRC operating entities establish online columns to facilitate qualified patients to obtain free drug treatment from
not-for-profit organizations (&ldquo;NFPs&rdquo;) till the earlier of the expiration of contract period or the free drugs are completely
delivered. For each column, the PRC operating entities plug in features to manage the drug treatment including reviewing patients&rsquo;
applications, tracking their usage of drugs, and collecting related information (such programs with new plug-in features are hereinafter
referred as the &ldquo;patient-aid projects&rdquo;). Those customers are existing customers of us. They provide those drugs sponsored
by pharmaceutical companies without charge to qualified patients and the PRC operating entities charge those customers on the services
in connection with the online columns and related training and management. In this way, the PRC operating entities believe not only can
they facilitate the clinical application of those drugs, but also benefit patients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this prospectus
supplement, we have established nearly 22 columns for cancer-related drug treatment, including drug treatment for lung cancer, liver cancer,
and extended blood cancer, and 7 columns for drug treatment of rare diseases, including drug treatment for pulmonary fibrosis, multiple
sclerosis, systemic lupus erythematosus, Crohn&rsquo;s disease, and skin diseases. The total number of patients covered under these patient-aid
projects has reached nearly 125,970 by the end of 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Sunshine Health Forums-Healthcare Information
and Education for the Public</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PRC operating entities&rsquo;
goal is not only provide continuing education and training to healthcare professionals but to promote healthy lifestyle and provide healthcare
knowledge to the public. In order to achieve that, the PRC operating entities develop and operate the Sunshine Health Forums, online education-for-all
platforms that disseminate articles and features related to healthcare and wellness education, medical behavior intervention, and newly
developed health technology and application. The PRC operating entities developed Sunshine Health Forum, a WeChat subscription account,
and Sunshine Health Forum.org, the official website providing portals to leading we-media the PRC operating entities have strategic relationships
to improve the efficiency and effectiveness of the information acquisition for the PRC operating entities&rsquo; users. The PRC operating
entities establish one school for each disease to make it easier for the public to obtain information they would like to know. We have
established their partnership with the following we-media platforms, including but not limited Toutiao.com, WeChat official accounts platforms,
Yidianzixun.com, Douyin.com, CN-Healthcare.com, iQiyi, Youku, and Huoshan.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Zhongxin Health Patient Management Services in Patient-aid Projects</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PRC operating entities
utilize its self-developed patient management system, branded as &ldquo;Zhongxin Health&rdquo; to provide patient management services
to their pharmaceutical enterprises and NFPs customers to assist their patient management for patients with cancer, rare disease or other
major diseases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During cancer treatment processes,
patients face various changes using one or more anti-tumor medications, including, among others, dosing punctuality, incorrect dosage,
missed dose, taking with other drugs and adverse reaction management. If such challenges cannot be solved, the treatment process will
be negatively affected, and patients&rsquo; confidence in treatment could be undermined, ultimately affecting the curative effects. In
order to resolve medication-related challenges in a timely manner and promote the continuity of treatment, the PRC operating entities
developed and designed the Zhongxin Health mini program with several functions. The program can automatically remind patients to take
medications and precautions based on different types of cancers and medication consumption time. It can also provide general self-treatment
information based on the adverse reactions that patients might have taking such medications and timely provide corresponding self-treatment
information for such adverse reactions specifically encountered by patients during the medication administration process. Additionally,
the program could improve patients&rsquo; self-management ability through various illustrations and video courses. Utilizing the program,
patients can customize and self-manage their medication process based on different cancers and medication consumption time, and such system
could help improve patients&rsquo; confidence in their treatment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Xinjiang Pharmaceutical Drug Retail Services</I></B><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Xinjiang Pharmaceutical was
established aiming at realizing medications accessibility and affordability for patients. Xinjiang Pharmaceutical has cooperates with
Zhixun Internet Hospital and other internet hospitals to build a 2B2C (to business and to customer) pharmaceutical procurement platform
and streamline the delivery of medications from pharmaceutical factories to retail ends. This approach enables Xinjiang Pharmaceutical
to supply domestic and international high-quality and cost-effective drugs, improving drug accessibility and lowering medication cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since the beginning of 2022,
embracing the development opportunity of a series of investment promotion of pharmaceutical industry initiated by the Chongqing government,
Xinjiang Pharmaceutical has been able to develop rapidly. Xinjiang Pharmaceutical has obtained Pharmaceutical Trade License, Medical Device
Trade License, Qualification Certificate for Drug Information Service over the Internet and other related licenses. Xinjiang Pharmaceutical
plans to engage in pharmaceutical import and export trade, OME (original equipment manufacturer) production, medical consumables operation,
and pharmaceutical internet services, aiming to continuously expand the industry chain and supply chain of the pharmaceutical market in
China. Meanwhile, it remains committed to becoming a competitive technology-based pharmaceutical service enterprise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Holding Foreign Company Accountable Act</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Holding Foreign
Companies Accountable Act (the &ldquo;HFCAA&rdquo;), if the Public Company Accounting Oversight Board, or the PCAOB, is unable to inspect
an issuer&rsquo;s auditors for three consecutive years, the issuer&rsquo;s securities are prohibited to trade on a U.S. stock exchange.
Furthermore, on June 22, 2021, the U.S. Senate passed the Accelerating Holding Foreign Companies Accountable Act (&ldquo;AHFCAA&rdquo;),
which, if signed into law, would amend the HFCA Act and require the SEC to prohibit an issuer&rsquo;s securities from trading on any U.S.
stock exchanges if its auditor is not subject to PCAOB inspections for two consecutive years instead of three consecutive years. Pursuant
to the HFCA Act, the PCAOB issued a Determination Report on December 16, 2021 which found that the PCAOB is unable to inspect or investigate
completely registered public accounting firms headquartered in: (1) mainland China of the PRC, and (2) Hong Kong. In addition, the PCAOB&rsquo;s
report identified the specific registered public accounting firms which are subject to these determinations. On August 26, 2022, the CSRC,
the Ministry of Finance of the PRC, and PCAOB signed a Statement of Protocol, or the Protocol, governing inspections and investigations
of audit firms based in China and Hong Kong. Pursuant to the Protocol, the PCAOB has independent discretion to select any issuer audits
for inspection or investigation and has the unfettered ability to transfer information to the SEC. Under the PCAOB&rsquo;s rules, a reassessment
of a determination under the HFCA Act may result in the PCAOB reaffirming, modifying or vacating the determination. On December 15, 2022,
the PCAOB Board determined that the PCAOB was able to secure complete access to inspect and investigate registered public accounting firms
headquartered in mainland China and Hong Kong and voted to vacate its previous determinations to the contrary. However, whether the PCAOB
will continue to be able to satisfactorily conduct inspections of PCAOB-registered public accounting firms headquartered in mainland China
and Hong Kong is subject to uncertainty and depends on a number of factors out of our, and our auditor&rsquo;s, control. The PCAOB is
continuing to demand complete access in mainland China and Hong Kong moving forward, as well as to continue pursuing ongoing investigations
and initiate new investigations as needed. The PCAOB has indicated that it will act immediately to consider the need to issue new determinations
with the HFCA Act if needed and does not have to wait another year to reassess its determinations. In the future, if there is any regulatory
change or step taken by PRC regulators that does not permit our auditor to provide audit documentations located in China or Hong Kong
to the PCAOB for inspection or investigation, or the PCAOB expands the scope of the Determination so that we are subject to the HFCA Act,
as the same may be amended, you may be deprived of the benefits of such inspection which could result in limitation or restriction to
our access to the U.S. capital markets and trading of our securities, including trading on the national exchange and trading on &ldquo;over-the-counter&rdquo;
markets, may be prohibited under the HFCA Act. On December 29, 2022, a legislation entitled &ldquo;Consolidated Appropriations Act, 2023&rdquo;
(the &ldquo;Consolidated Appropriations Act&rdquo;), was signed into law by President Biden. The Consolidated Appropriations Act contained,
among other things, an identical provision to AHFCAA, which reduces the number of consecutive non-inspection years required for triggering
the prohibitions under the Holding Foreign Companies Accountable Act from three years to two.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Marcum Asia CPAs LLP (&ldquo;MarcumAsia&rdquo;
formerly known as &ldquo;Marcum Bernstein &amp; Pinchuk LLP&rdquo;) was our auditor for the financial statements for the fiscal year ended
December 31, 2021. The Company then appointed Prager Metis CPAs, LLC (&ldquo;Prager Metis&rdquo;) as the independent registered public
accounting firm. Prager Metis replaced MarcumAsia, which the Company dismissed effective as of September 27, 2022. Both MarcumAsia and
Prager Metis are headquartered in New York, New York, registered with PCAOB and subject to laws in the United States pursuant to which
the PCAOB conducts regular inspections to assess its compliance with the applicable professional standards. Neither our former auditor,
MarcumAsia, nor our current auditor, Prager Metis, was/is headquartered in mainland China or Hong Kong or was identified in the Determination
Report as a firm subject to the PCAOB&rsquo;s determination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">Our principal executive office
is located at Nanxi Creative Center, Suite 216, 841 Yan&rsquo;an Middle Road, Jing&rsquo;An District, Shanghai, China 200040. Our telephone
number is 021-32205987. We maintain a website at <I>http://izcmd.com</I> that contains information about our company, though no information
contained on our website is part of this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B>&nbsp;</P>

</DIV>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">THE
OFFERING</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 23%">Class A Ordinary Shares offered by us</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 75%">3,094,000 shares</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">Class A Ordinary Shares to be outstanding after this offering</TD>
    <TD>&nbsp;</TD>
    <TD>5,065,124 shares</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">Use of Proceeds</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">We intend to use the net proceeds of this offering of our Class A Ordinary Shares, after deducting our offering expenses, for general corporate purposes.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">Nasdaq Symbol</TD>
    <TD>&nbsp;</TD>
    <TD>ZCMD</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Risk Factors</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">An investment in our common shares involves risks. You should carefully
consider each of the factors described or referred to under &ldquo;Risk Factors&rdquo; beginning on page S-13 of this prospectus supplement,
page 37 of the accompanying prospectus and in the documents incorporated by reference into this prospectus supplement and accompanying
prospectus before you make an investment in our Class A Ordinary Shares.</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
number of our Class A Ordinary Shares to be outstanding after this offering is based on 1,971,124 of Class A Ordinary Shares outstanding
as of June 30, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Unless
otherwise indicated, all information in this prospectus supplement assumes no exercise of outstanding options or warrants to purchase
shares of Class A Ordinary Shares.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

</DIV>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white"><A NAME="z_005"></A>RISK
FACTORS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">An
investment in our Class A Ordinary Shares involves a high degree of risk. The following risk factors are risks of which we are aware and
that we consider to be material to this offering of our Class A Ordinary Shares. You should also consider the risks, uncertainties and
assumptions discussed under the heading &ldquo;Risk Factors&rdquo; included in our most recent Annual Report on&nbsp;Form&nbsp;20-F&nbsp;and
other reports that we file with the SEC, which are on file with the SEC and are incorporated herein by reference, and which may be amended,
supplemented or superseded from time to time by other reports we file with the SEC in the future. If any of the following risks and uncertainties
develops into actual events, our business, financial condition or results of operations and cash flows could be materially adversely affected.
In that case, the trading price of our Class A Ordinary Shares could decline and you could lose all or part of your investment. Additionally,
we cannot be certain or give any assurance that any actions taken to reduce known risks and uncertainties will be effective. Before investing
in our Class A Ordinary Shares, you should carefully consider the risks described below, together with all of the other information contained
in this prospectus supplement and the accompanying prospectus and incorporated by reference herein and therein, including from our most
recent Annual Report on&nbsp;Form&nbsp;20-F&nbsp;and Reports on Form 6-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Risks Related to This
Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>The price of our
Class A Ordinary Shares may be volatile, and you could lose all or part of your investment in our Class A Ordinary Shares.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
price of our Class A Ordinary Shares may fluctuate as a result of changes in our operating performance or prospects and other factors.
Some specific factors that may have a significant effect on the price of our Class A Ordinary Shares include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">the public&rsquo;s reaction to our public disclosures;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">actual or anticipated changes in our operating results or future prospects;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">strategic actions by us or our competitors, such as acquisitions or restructurings;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">impact of acquisitions on our liquidity and financial performance;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">new laws or regulations or new interpretations of existing laws or regulations applicable to our business;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">changes in accounting standards, policies, guidance, interpretations or principles applicable to us;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">conditions of the industry as a result of changes in financial markets or general economic or political
conditions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">the failure of securities analysts to cover our Class A Ordinary Shares in the future, or changes in financial
estimates by analysts;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">changes in analyst recommendations or earnings estimates regarding us, other comparable companies or the
industry generally, and our ability to meet those estimates;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">changes in the amount of dividends paid, if any;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">changes in our financing strategy or capital structure;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">future issuances of our Class A Ordinary Shares or the perception that future sales could occur; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">volatility in the equity securities market.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B><I>&nbsp;</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B><I>A substantial number of our Class A
Ordinary Shares will be sold in this offering, which could cause the price of our Class A Ordinary Shares to decline.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
this offering we will sell 3,094,000 Class A Ordinary Shares, which represent approximately 61% of our outstanding Class A Ordinary Shares
as of June 30, 2024, after giving effect to the sale of the Class A Ordinary Shares. This sale and any future sales of a substantial number
of our Class A Ordinary Shares in the public market, or the perception that such sales may occur, could adversely affect the price of
our Class A Ordinary Shares on the Nasdaq Capital Market. We cannot predict the effect, if any, that market sales of those Class A Ordinary
Shares or the availability of those Class A Ordinary Shares for sale will have on the market price of our Class A Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Because we do not
expect to pay cash dividends for the foreseeable future, you must rely on appreciation of our Class A Ordinary Shares price for any return
on your investment. Even if we change that policy, we may be restricted from paying dividends on our Class A Ordinary Shares.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
do not intend to pay cash dividends on Class A Ordinary Shares for the foreseeable future. Accordingly, you will have to rely on capital
appreciation, if any, to earn a return on your investment in our Class A Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to Doing Business in China</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We conduct our business through Zhongchao
Shanghai and its subsidiaries by means of VIE Arrangements. If the PRC courts or administrative authorities determine that these VIE Arrangements
do not comply with applicable regulations, we could be subject to severe penalties and our business could be adversely affected, and our
securities may decline in value or become worthless. In addition, changes in such PRC laws and regulations may materially and adversely
affect our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are uncertainties regarding
the interpretation and application of PRC laws, rules and regulations, including the laws, rules and regulations governing the validity
and enforcement of the VIE Arrangements between Zhongchao WFOE and Zhongchao Shanghai. In the opinion of our PRC legal counsel, Han Kun
Law Offices, based on their understanding of the current PRC laws, rules and regulations, that (i) as of the date of this prospectus supplement,
the structure for operating the PRC operating entities&rsquo; business in China (including our corporate structure and VIE Arrangements
with Zhongchao Shanghai, Zhongchao Shanghai and their shareholders) do not result in any violation of PRC laws or regulations currently
in effect; and (ii) the VIE Arrangements among Zhongchao WFOE and Zhongchao Shanghai and their shareholders governed by PRC law are valid,
binding and enforceable in accordance with the terms of each of the VIE Arrangements, and do not result in any violation of PRC laws or
regulations currently in effect. However, there are substantial uncertainties regarding the interpretation and application of current
or future PRC laws and regulations concerning foreign investment in the PRC, and their application to and effect on the legality, binding
effect and enforceability of the VIE Arrangements. In particular, we cannot rule out the possibility that PRC regulatory authorities,
courts or arbitral tribunals may in the future adopt a different or contrary interpretation or take a view that is inconsistent with the
opinion of our PRC legal counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any of our PRC entities
or the PRC operating entities or their ownership structure or the VIE Arrangements are determined the PRC courts or administrative authorities
to be in violation of any existing or future PRC laws, rules or regulations, or any of our PRC entities or the PRC operating entities
fail to obtain or maintain any of the required governmental permits or approvals, the relevant PRC regulatory authorities would have broad
discretion in dealing with such violations, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify">revoking the business and operating licenses;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify">discontinuing or restricting the operations;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify">imposing conditions or requirements with which the PRC entities may not be able to comply;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify">requiring us and the PRC operating entities to restructure the relevant ownership structure or operations;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify">restricting or prohibiting our use of the proceeds from this offering to finance our business and operations in China; or</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify">imposing fines.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The imposition of any of these
penalties would severely disrupt the PRC operating entities&rsquo; ability to conduct business and have a material adverse effect on our
financial condition, results of operations and prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, if the PRC courts
or administrative authorities determine that these VIE Arrangements do not comply with applicable regulations, the securities we are registering
may decline in value or become worthless if the determinations, changes, or interpretations result in our inability to assert contractual
control over the assets of our PRC subsidiaries or the PRC operating entities that conduct substantially all of the operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>China&rsquo;s economic, political and social
conditions, as well as changes in any government policies, laws and regulations may be quick with little advance notice and could have
a material adverse effect on the PRC operating entities&rsquo; business and the value of our securities.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The majority of the PRC operating
entities&rsquo; business are conducted in China. Accordingly, our business, financial condition, results of operations, prospects and
certain transactions we may undertake may be subject, to a significant extent, to economic, political and legal developments in China.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">China&rsquo;s economy differs
from the economies of most developed countries in many respects, including the amount of government involvement, level of development,
growth rate, control of foreign exchange and allocation of resources. While the PRC economy has experienced significant growth in the
past two to three decades, growth has been uneven, both geographically and among various sectors of the economy. Demand for the products
of the PRC operating entities depends, in large part, on economic conditions in China. Any slowdown in China&rsquo;s economic growth may
cause the potential customers of the PRC operating entities to delay or cancel their plans to purchase the PRC operating entities&rsquo;
products, which in turn could reduce our net revenues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although China&rsquo;s economy
has been transitioning from a planned economy to a more market oriented economy since the late 1970s, the PRC government continues to
play a significant role in regulating industry development by imposing industrial policies. The PRC government also exercises significant
control over China&rsquo;s economic growth through allocating resources, controlling the incurrence and payment of foreign currency-denominated
obligations, setting monetary policy and providing preferential treatment to particular industries or companies. Changes in any of these
policies, laws and regulations may be quick with little advance notice and could adversely affect the economy in China and could have
a material adverse effect on our business and the value of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PRC government has implemented
various measures to encourage foreign investment and sustainable economic growth and to guide the allocation of financial and other resources.
However, we cannot assure you that the PRC government will not repeal or alter these measures or introduce new measures that will have
a negative effect on us, or more specifically, we cannot assure you that the PRC government will not initiate possible governmental actions
or scrutiny to us, which could substantially affect our operation and the value of our Ordinary Shares may depreciate quickly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Chinese government exerts substantial
influence over the manner in which the PRC operating entities must conduct their business activities. We are currently not required to
obtain approval from Chinese authorities to list or continue to list on U.S. exchanges nor for the execution of VIE agreements, however,
if the VIE or the holding company were required to obtain approval and were denied permission from Chinese authorities to list or continue
to list on U.S. exchanges, we will not be able to continue listing on U.S. exchange or continue to offer securities to investors, which
could materially affect the interest of the investors and cause the value of our securities to significantly decline or be worthless.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Chinese government exerts
substantial influence over the manner in which the PRC operating entities must conduct their business activities. China&rsquo;s business
operations are comprehensively regulated. The PRC operating entities could be subject to regulation by various political and regulatory
entities, including various local and municipal agencies and government sub-divisions. The PRC operating entities may incur increased
costs necessary to comply with existing and newly adopted laws and regulations or penalties for any failure to comply. In the event that
the PRC operating entities are not able to substantially comply with any existing or newly adopted laws and regulations, the business
operations of the PRC operating entities may be materially adversely affected and the value of our Ordinary Shares may significantly decrease
or become worthless.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 17, 2023, the
CSRC promulgated the Interim Administrative Measures on Overseas Securities Offering and Listing by Domestic Enterprises (CSRC Announcement
[2022] No. 43) (&ldquo;Trial Measures&rdquo;), and five supporting guidelines, together with five supporting guidelines, which took effect
on March 31, 2023. As the Trial Measures were newly published, there are substantial uncertainties as to the implementation and interpretation,
and how they will affect our current listing, and future offering or financing. If we are required by the Trial Measures for any future
offering or any other financing activities to file with the CSRC, we cannot assure you that we will be able to complete such filings in
a timely manner, or even at all. Any failure of us or the PRC operating entities to fully comply with new regulatory requirements may
significantly limit or completely hinder our ability to continue to offer our securities, cause significant disruption to our business
operations, severely damage our reputation, materially and adversely affect our financial condition and results of operations and cause
our securities to significantly decline in value or become worthless.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, the PRC government
authorities may strengthen oversight and control over offerings that are conducted overseas and/or foreign investment in China-based issuers
like us. Such actions taken by the PRC government authorities may intervene or influence the operations of the PRC operating entities
at any time, which are beyond our control. Therefore, any such action may adversely affect the operations of the PRC operating entities
and significantly limit or hinder our ability to offer or continue to offer securities to you and cause the value of such securities to
significantly decline or be worthless.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Chinese government may
intervene or influence our operations at any time, which actions may impact our operations materially and adversely, significantly limit
or completely hinder our ability to offer or continue to offer securities to investors, and cause the value of our securities to significantly
decline or be worthless.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Chinese government has
exercised, and continues to exercise, substantial control over virtually every sector of the Chinese economy through regulation and state
ownership. Our ability to operate in China may be harmed by changes in its laws and regulations, including those relating to online transmission
of audio-visual program, internet live streaming services, online publishing, private education, internet information security, privacy
protection and other matters. The central or local governments of these jurisdictions may impose new, stricter regulations or interpretations
of existing regulations that would require additional expenditures and efforts on our part to ensure our compliance with such regulations
or interpretations. Accordingly, government actions in the future, including any decision not to continue to support recent economic reforms
and to return to a more centrally planned economy or regional or local variations in the implementation of economic policies, could have
a significant effect on economic conditions in China or particular regions thereof, and could require us to divest ourselves of any interest
we then hold in Chinese properties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PRC operating entities&rsquo;
business is subject to various government and regulatory interference. The PRC operating entities could be subject to regulation by various
political and regulatory entities, including various local and municipal agencies and government sub-divisions. The PRC operating entities
may incur increased costs necessary to comply with existing and newly adopted laws and regulations or penalties for any failure to comply.
Our operations could be adversely affected, directly or indirectly, by existing or future laws and regulations relating to our business
or industry, which could result in further material changes in our operations and could adversely impact the value of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, given recent
statements by the Chinese government indicating an intent to exert more oversight and control over offerings that are conducted overseas,
including but not limited to the newly promulgated Trial Measures, although we are currently not required to obtain permission from any
of the PRC federal or local government, if we are required by the Trial Measures for any future offering or any other financing activities
to file with the CSRC we cannot assure you that we will be able to complete such filings in a timely manner, or even at all. Any failure
of us to fully comply with new regulatory requirements may significantly limit or completely hinder our ability to continue to offer our
securities, cause significant disruption to our business operations, severely damage our reputation, materially and adversely affect our
financial condition and results of operations and cause our securities to significantly decline in value or become worthless.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We are required to complete filing procedures
with the CSRC in connection with the offerings in connection with this prospectus supplement, it is uncertain whether such filing can
be completed or how long it will take to complete such filing.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 17, 2023, the
CSRC published the promulgated the Trial Administrative Measures of the Overseas Securities Offering and Listing by Domestic Companies,
or the Trial Measures, and five supporting guidelines, which became effective on March 31, 2023. According to the Trial Measures, among
other requirements, (1) domestic companies that seek to offer or list securities overseas, both directly and indirectly, should fulfil
the filing procedures with the CSRC; if a domestic company fails to complete the filing procedure or conceals any material fact or falsifies
any major content in its filing documents, such domestic company may be subject to administrative penalties; (2) if the issuer meets both
of the following conditions, the overseas offering and listing shall be determined as an indirect overseas offering and listing by a domestic
company: (i) any of the total assets, net assets, revenues or profits of the domestic operating entities of the issuer in the most recent
accounting year accounts for more than 50% of the corresponding figure in the issuer&rsquo;s audited consolidated financial statements
for the same period; (ii) its major operational activities are carried out in China or its main places of business are located in China,
or the senior managers in charge of operation and management of the issuer are mostly Chinese citizens or are domiciled in China; (3)
where a domestic company seeks to indirectly offer and list securities in an overseas market, the issuer shall designate a major domestic
operating entity responsible for all filing procedures with the CSRC, and such filings shall be submitted to the CSRC within three business
days after the submission of the overseas offering and listing application; and (4) if the issuer issues securities in the same overseas
market after the initial issuance and listing, it shall submit filings with the CSRC within three business days after the completion of
the issuance. Further, at the press conference held for the Trial Measures on February 17, 2023, officials from the CSRC clarified that
the PRC domestic companies that have already been listed overseas on or before the effective date of the Trial Measures, March 31, 2023,
shall be deemed as existing issuers, or the Existing Issuers. Existing Issuers are not required to complete the filing procedures immediately
but shall carry out filing procedures as required if they conduct refinancing or are involved in other circumstances that require filing
with the CSRC. Therefore, in the opinion of our PRC legal counsel, Han Kun Law Offices, we are required to go through filing procedures
with the CSRC within three business days after the completion of the offerings under this prospectus supplement and for our future offerings
and listing of our securities in an overseas market under the Trial Measures. We will begin the process of preparing a report and other
required materials in connection with the CSRC filing, which will be submitted to the CSRC in due course. If we fail to complete such
filing requirement, Chinese regulatory authorities may impose fines and penalties upon the PRC operating entities&rsquo; operations in
China, limit the PRC operating entities&rsquo; operating privileges in China, delay or restrict the repatriation of the proceeds from
the offerings in connection with this registration statement into China, or take other actions that could have a material adverse effect
upon the PRC operating entities&rsquo; business, financial condition, results of operations, reputation and prospects, as well as the
trading price of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>An active trading market for our Class A
Ordinary Shares may not continue and the trading price for our Class A Ordinary Shares may fluctuate significantly.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot assure you that
a liquid public market for our Class A Ordinary Shares will develop or continue. If an active public market for our Class A Ordinary Shares
does not continue following the completion of the offerings in connection with this registration statement, the market price and liquidity
of our Class A Ordinary Shares may be materially and adversely affected. The public offering price for our securities would be determined
based upon several factors, and we can provide no assurance that the trading price of our Class A Ordinary Shares after the offerings
in connection with this registration statement will not decline below the public offering price. As a result, investors in the offerings
in connection with this registration statement may experience a significant decrease in the value of their securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>You may experience difficulties in effecting
service of legal process, enforcing foreign judgments or bringing original actions in mainland China against us based on Hong&nbsp;Kong
or other foreign laws, and the ability of U.S.&nbsp;authorities to bring actions in China may also be limited.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We are an exempted company
with limited liability incorporated under the laws of the Cayman Islands. The majority of the operations of the PRC operating entities
conducted outside of the U.S., and the majority of our assets are located in mainland China. In addition, our management consists of five
officers who are all located in China and three independent directors, among which two (Mr. John C. General and Mr. Kevin Dean Vassily)
are located in the United States and one (Ms. Dan Li) is located in China. As a result, it may be difficult for our shareholders to effect
service of process upon us or those persons inside mainland China. In addition, our PRC legal counsel has advised us that China does not
have any treaties or other form of reciprocity with the United States or the Cayman Islands that provide for the reciprocal recognition
and enforcement of foreign judgments. Therefore, recognition and enforcement in mainland China of judgments of a court in any of these
non-PRC&nbsp;jurisdictions in relation to any matter not subject to a binding arbitration provision may be difficult or impossible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">On July&nbsp;14, 2006, Hong&nbsp;Kong
and the PRC entered into the Arrangement on Reciprocal Recognition and Enforcement of Judgments in Civil and Commercial Matters by the
Courts of the PRC and of the Hong&nbsp;Kong Special Administrative Region Pursuant to Choice of Court Agreements Between Parties Concerned,
or the 2006 Arrangement, pursuant to which a party with a final court judgment rendered by a Hong&nbsp;Kong court requiring payment of
money in a civil and commercial case pursuant to a choice of court agreement in writing may apply for recognition and enforcement of the
judgment in mainland China.&nbsp;Similarly, a party with a final judgment rendered by a mainland China court requiring payment of money
in a civil and commercial case pursuant to a choice of court agreement in writing may apply for recognition and enforcement of the judgment
in Hong&nbsp;Kong. A choice of court agreement in writing is defined as any agreement in writing entered into between parties after the
effective date of the 2006 Arrangement in which a Hong&nbsp;Kong court or a mainland China court is expressly designated as the court
having sole jurisdiction for the dispute. Therefore, it is not possible to enforce a judgment rendered by a Hong&nbsp;Kong court in mainland
China if the parties in dispute have not agreed to enter into a choice of court agreement in writing. The 2006 Arrangement became effective
on August&nbsp;1, 2008.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Subsequently on January&nbsp;18,
2019, Hong&nbsp;Kong and mainland China entered into the Arrangement on Reciprocal Recognition and Enforcement of Judgments in Civil and
Commercial Matters between the Courts of the Mainland and of the Hong&nbsp;Kong Special Administrative Region, or the Arrangement, pursuant
to which, among other things, the scope of application was widened to cover both monetary and non-monetary&nbsp;judgments in most civil
and commercial matters, including effective judgments on civil compensation in criminal cases. In addition, the requirement of a choice
of court agreement in writing has been removed. It is no longer necessary for parties to agree to enter into a choice of court agreement
in writing, as long as it can be shown that there is a connection between the dispute and the requesting place, such as place of the defendant&rsquo;s
residence, place of the defendant&rsquo;s business or place of performance of the contract or tort. The 2019 Arrangement shall apply to
judgments in civil and commercial matters made on or after its effective date by the courts of both sides. The 2006 Arrangement shall
be terminated on the same&nbsp;day when the 2019 Arrangement comes into effect. If a &ldquo;written choice of court agreement&rdquo; has
been signed by parties according to the 2006 Arrangement prior to the effective date of the 2019 Arrangement, the 2006 Arrangement shall
still apply. Although the 2019 Arrangement has been signed, its effective date has yet to be announced. Therefore, there are still uncertainties
about the outcomes and effectiveness of enforcement or recognition of judgments under the 2019 Arrangement.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Furthermore, shareholder claims
that are common in the U.S., including securities law class actions and fraud claims, generally are difficult to pursue as a matter of
law or practicality in China. For example, in China, there are significant legal and other obstacles to obtaining information needed for
shareholder investigations or litigation outside China or otherwise with respect to foreign entities. Although the local authorities in
China may establish a regulatory cooperation mechanism with the securities regulatory authorities of another country or region to implement
cross-border&nbsp;supervision and administration, such regulatory cooperation with the securities regulatory authorities in the U.S.&nbsp;have
not been efficient in the absence of mutual and practical cooperation mechanism. According to Article&nbsp;177 of the PRC Securities Law
which became effective in March&nbsp;2020, no overseas securities regulator is allowed to directly conduct investigation or evidence collection
activities within the territory of the PRC.&nbsp;Accordingly, without the consent of the competent PRC securities regulators and relevant
authorities, no organization or individual may provide the documents and materials relating to securities business activities to overseas
parties. See also &ldquo;Risk Factors <B><I>&mdash;&nbsp;You may face difficulties in protecting your interests, and your ability to protect
your rights through U.S.&nbsp;courts may be limited, because we are incorporated under Cayman Islands law</I></B><I>&rdquo;&nbsp;</I>for
risks associated with investing in us as a Cayman Islands company<I>.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>You may face difficulties in protecting
your interests, and your ability to protect your rights through U.S.&nbsp;courts may be limited, because we are incorporated under Cayman
Islands law.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We are an exempted company
with limited liability incorporated under the laws of the Cayman Islands. Our corporate affairs are governed by our amended and restated
memorandum and articles of association, as amended, the Companies Act (Revised) of the Cayman Islands, which we refer to as the Companies
Act below, and the common law of the Cayman Islands. The rights of shareholders to take actions against the directors, actions by minority
shareholders and the fiduciary responsibilities of our directors to us under Cayman Islands law are to a large extent governed by the
common law of the Cayman Islands. The common law of the Cayman Islands is derived in part from comparatively limited judicial precedent
in the Cayman Islands as well as from the common law of England, the decisions of whose courts are of persuasive authority, but are not
binding, on a court in the Cayman Islands. The rights of our shareholders and the fiduciary responsibilities of our directors under Cayman
Islands law are not as clearly established as they would be under statutes or judicial precedent in some jurisdictions in the U.S.&nbsp;In
particular, the Cayman Islands has a less developed body of securities laws than the U.S.&nbsp;Some U.S.&nbsp;states, such as Delaware,
have more fully developed and judicially interpreted bodies of corporate law than the Cayman Islands. In addition, Cayman Islands companies
may not have standing to initiate a shareholder derivative action in a federal court of the U.S.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Shareholders of Cayman Islands
exempted companies like us have no general rights under Cayman Islands law to inspect corporate records or to obtain copies of lists of
shareholders of these companies (other than copies of our amended and restated memorandum and articles of association and register of
mortgages and charges, and any special resolutions passed by our shareholders). Under Cayman Islands law, the names of our current directors
can be obtained from a search conducted at the Registrar of Companies. Our directors have discretion under our amended and restated memorandum
and articles of association to determine whether or not, and under what conditions, our corporate records may be inspected by our shareholders,
but are not obliged to make them available to our shareholders. This may make it more difficult for you to obtain the information needed
to establish any facts necessary for a shareholder motion or to solicit proxies from other shareholders in connection with a proxy contest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">As a company incorporated in
the Cayman Islands, we are permitted to adopt certain home country practices in relation to corporate governance matters that differ significantly
from the Nasdaq corporate governance requirements; these practices may afford less protection to shareholders than they otherwise would
under rules and regulations applicable to U.S.&nbsp;domestic issuers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">As a result of all of the above,
our public shareholders may have more difficulties in protecting their interests in the face of actions taken by management, members of
the board of directors or controlling shareholders than they would as public shareholders of a company incorporated in the U.S.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white"><A NAME="z_006"></A>USE
OF PROCEEDS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
intend to use the net proceeds of this offering of our Class A Ordinary Shares, after deducting our offering expenses, for general corporate
purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
cannot specify with certainty all of the particular uses of the net proceeds that we will receive from this offering and have not quantified
or allocated any specific portion of the net proceeds or range of net proceeds to any particular purpose. Accordingly, we will have broad
discretion in using these proceeds.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white"><A NAME="z_007"></A>DILUTION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Dilution
in net tangible book value per share to new investors is the amount by which the offering price paid by the purchasers of the Class A
Ordinary Shares sold in the offering exceeds the pro forma net tangible book value per Class A Ordinary Shares after the offering. Net
tangible book value per share is determined at any date by subtracting our total liabilities from the total book value of our tangible
assets and dividing the difference by the number of Class A Ordinary Shares deemed to be outstanding at that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
net tangible book value of our Class A Ordinary Shares as of December 31, 2023 was approximately $21.0 million, or $10.24 per share,
based on 2,054,943 both Class A and Class B Ordinary Shares outstanding as of that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">After
giving effect to the sale of our Class A Ordinary Shares in the aggregate amount of $928,200 at an offering price of $0.30 per
share, and after deducting estimated aggregate offering expenses payable by us, our pro forma as adjusted net tangible book value as
of December 31, 2023 would have been approximately $21.9 million, or $4.26 per outstanding Ordinary Share. This represents an
immediate decrease in the net tangible book value of approximately $5.98 per share to our existing shareholders and an immediate
dilution in net tangible book value of $(3.96) per share to investors purchasing shares in this offering. The following table
illustrates this per share dilution:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The following table illustrates
this dilution on a per share basis:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%">Assumed public offering price per share</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">0.30</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Net tangible book value per share as of December 31, 2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">10.24</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: left">Decrease in net tangible book value per share attributable to this offering</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5.98</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">As adjusted net tangible book value per share as of December 31, 2023, after giving effect to this offering</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4.26</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Dilution per share to investors purchasing shares in this offering</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(3.96</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The table above is based
on 1,971,124 Class A Ordinary Shares outstanding as of December 31, 2023</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B>&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center; background-color: white"><A NAME="z_008"></A>PLAN
OF DISTRIBUTION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
are selling an aggregate of 3,094,000 Class A Ordinary Shares directly to specified purchasers (collectively, the &ldquo;Purchasers&rdquo;).
We have entered into that certain Share Purchase Agreements (the &ldquo;Share Purchase Agreements&rdquo;), each dated as of October 1,
2024, with each of such Purchasers relating to the sale of Class A Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Subject
to the terms and conditions of the Share Purchase Agreements, on the closing date, we will issue an aggregate of 3,094,000 Class A Ordinary
Shares to such Purchasers with each purchaser to receive such number of Class A Ordinary Shares as specified in the Share Purchase Agreements,
respectively, and we will receive gross proceeds in the amount of $928,200. <FONT>We estimate that the
expenses of this offering payable by us will be approximately <FONT>$45,000</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Class A Ordinary Shares were offered directly to the Purchasers without a placement agent, underwriter, broker or dealer. We currently
anticipate that the closing of the sale of such Class A Ordinary Shares will take place on or about October 2, 2024.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center; background-color: white"><A NAME="z_009"></A>LEGAL
MATTERS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
validity of the issuance of the Class A Ordinary Shares offered to the Purchasers pursuant to the Share Purchase Agreements will be opined
on by Ogier (Cayman) LLP.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center; background-color: white"><A NAME="z_010"></A>EXPERTS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
financial statements in this prospectus as of December 31, 2023 and 2022 and for the years ended December 31, 2023 and 2022 , incorporated
by reference from the Company&rsquo;s Annual Report on Form 20-F for the year ended December 31, 2023 have been audited by Prager Metis
CPAs, LLC, an independent registered public accounting firm, as set forth in their report, which is incorporated herein by reference,
and are included in reliance upon such report given on the authority of such firm as experts in accounting and auditing. The office of
Prager Metis CPAs, LLC is located at 401 Hackensack Avenue, 4<SUP>th</SUP>&nbsp;Floor, Hackensack, New Jersey 07601.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
financial statements in this prospectus for the year ended December 31, 2021, incorporated by reference from the Company&rsquo;s Annual
Report on Form 20-F for the year ended December 31, 2023 have been audited by Marcum Asia CPAs LLP (Formerly known as &ldquo;Marcum Bernstein
&amp; Pinchuk LLP&rdquo;), an independent registered public accounting firm, as set forth in their report, which is incorporated herein
by reference, and are included in reliance upon such report given on the authority of such firm as experts in accounting and auditing.
The office of Marcum Asia CPAs LLP is located at 7 Pennsylvania Plaza Suite 830, New York, NY 10001.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in; background-color: white"><A NAME="z_011"></A>WHERE
YOU CAN FIND MORE INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As permitted by SEC rules,
this prospectus omits certain information and exhibits that are included in the registration statement of which this prospectus supplement
forms a part. Since this prospectus supplement may not contain all of the information that you may find important, you should review the
full text of these documents. If we have filed a contract, agreement or other document as an exhibit to the registration statement of
which this prospectus forms a part, you should read the exhibit for a more complete understanding of the document or matter involved.
Each statement in this prospectus, including statements incorporated by reference as discussed above, regarding a contract, agreement
or other document is qualified in its entirety by reference to the actual document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to the information
reporting requirements of the&nbsp;Exchange Act that are applicable to foreign private issuers, and, in accordance with these requirements,
we file annual and current reports and other information with the SEC. You may inspect, read (without charge) and copy the reports and
other information we file with the SEC at the SEC&rsquo;s Public Reference Room located at 100 F Street, N.E., Washington, D.C. 20549.
You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also maintains
an internet website at&nbsp;<I>www.sec.gov</I>&nbsp;that contains our filed reports and other information that we file electronically
with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We maintain a corporate website
at http://izcmd.com. Information contained on, or that can be accessed through, our website does not constitute a part of this prospectus
supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 55.1pt; background-color: white">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B>&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center; background-color: white"><A NAME="z_012"></A>INCORPORATION
OF CERTAIN INFORMATION BY REFERENCE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
SEC allows us to incorporate by reference the information and reports we file with it, which means that we can disclose important information
to you by referring you to these documents. The information incorporated by reference is an important part of this prospectus supplement
and the accompanying prospectus, and information that we file later with the SEC will automatically update and supersede the information
already incorporated by reference. We are incorporating by reference the documents listed below, which we have already filed with the
SEC, and any future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, of 1934, as amended, including
all filings made after the date of the filing of this registration statement and prior to the effectiveness of this registration statement,
except as to any portion of any future report or document that is not deemed filed under such provisions, after the date of this prospectus
supplement and prior to the termination of this offering:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">The Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390024037934/ea0204387-20f_zhongchao.htm">Form 20-F</A> for the year ended March 31, 2024 filed with the SEC on April 30, 2024;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.1pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">The Reports on Form 6-K filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390024000426/ea191051-6k_zhongchao.htm">January 3, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390024003107/f6k0124_zhongchao.htm">January 12, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390024015290/ea0200269-6k_zhongchao.htm">February 20, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390024017147/ea0200607-6k_zhongchao.htm">February 27, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390024018474/ea0200948-6k_zhongchaoinc.htm">February 29, 2024</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390024023204/ea0201983-6k_zhongchao.htm">March 18, 2024</A>;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.1pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">The description of our Class A Ordinary Shares contained in our registration statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390020003473/f8a12b021320_zhongchao.htm">Form 8-A</A> filed with the SEC on February 13, 2020, including any amendments or reports filed for the purposes of updating this description.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">All
documents that we file with the SEC pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act (and in the case of a Current Report
on Form 6-K, so long as they state that they are incorporated by reference into this prospectus, and other than Current Reports on Form
6-K, or portions thereof, furnished under Form 6-K) (i) after the initial filing date of the registration statement of which this prospectus
forms a part and prior to the effectiveness of such registration statement and (ii) after the date of this prospectus and prior to the
termination of the offering shall be deemed to be incorporated by reference in this prospectus from the date of filing of the documents,
unless we specifically provide otherwise. Information that we file with the SEC will automatically update and may replace information
previously filed with the SEC. To the extent that any information contained in any Current Report on Form 6-K or any exhibit thereto,
was or is furnished to, rather than filed with the SEC, such information or exhibit is specifically not incorporated by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Upon
request, we will provide, without charge, to each person who receives this prospectus, a copy of any or all of the documents incorporated
by reference (other than exhibits to the documents that are not specifically incorporated by reference in the documents). Please direct
written requests for copies to us at 841 Yan&rsquo;an Middle Road, Jing&rsquo;An District, Shanghai, China 200040, Attention: Weiguang
Yang, 021-32205987.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Red"><B>The information in
this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the
Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an
offer to buy these securities in any state where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Red"><B>SUBJECT TO COMPLETION,
DATED MAY 17, 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROSPECTUS</B>&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Zhongchao Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>$45,000,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Ordinary Shares, Preferred Shares, Debt Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Warrants, Units and Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may, from time to time
in one or more offerings, offer and sell up to $45,000,000 in the aggregate of Ordinary Shares, preferred shares, warrants to purchase
Ordinary Shares or preferred shares, debt securities, rights or any combination of the foregoing, either individually or as units comprised
of one or more of the other securities. The prospectus supplement for each offering of securities will describe in detail the plan of
distribution for that offering. For general information about the distribution of securities offered, please see &ldquo;Plan of Distribution&rdquo;
in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus provides a
general description of the securities we may offer. We will provide the specific terms of the securities offered in one or more supplements
to this prospectus. We may also authorize one or more free writing prospectuses to be provided to you in connection with these offerings.
The prospectus supplement and any related free writing prospectus may add, update or change information contained in this prospectus.
You should read carefully this prospectus, the applicable prospectus supplement and any related free writing prospectus, as well as the
documents incorporated or deemed to be incorporated by reference, before you invest in any of our securities.&nbsp;<B>This prospectus
may not be used to offer or sell any securities unless accompanied by the applicable prospectus supplement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to General Instruction
I.B.5. of Form F-3, in no event will we sell the securities covered hereby in a public primary offering with a value exceeding more than
one-third of the aggregate market value of our Ordinary Shares in any 12-month period so long as the aggregate market value of our outstanding
Ordinary Shares held by non-affiliates remains below $75,000,000. The aggregate market value of our outstanding voting and non-voting
common equity held by non-affiliates is approximately $42.97 million based on the closing price of $2.66 per ordinary share on March
17, 2021 and 16,154,819 ordinary shares held by non-affiliates. During the 12 calendar months prior to and including the date of this
prospectus, we have not offered or sold any securities pursuant to General Instruction I.B.5 of Form F-3.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Ordinary Shares are listed
on the Nasdaq Capital Market under the symbol &ldquo;ZCMD.&rdquo; The applicable prospectus supplement will contain information, where
applicable, as to other listings, if any, on the Nasdaq Capital Market or other securities exchange of the securities covered by the prospectus
supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Investing in our securities
involves a high degree of risk. See &ldquo;Risk Factors&rdquo; on page 11 of&nbsp;this prospectus and in the documents incorporated by
reference in this prospectus, as updated in the applicable prospectus supplement, any related free writing prospectus and other future
filings we make with the Securities and Exchange Commission that are incorporated by reference into this prospectus, for a discussion
of the factors you should consider carefully before deciding to purchase our securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may sell these securities
directly to investors, through agents designated from time to time or to or through underwriters or dealers. For additional information
on the methods of sale, you should refer to the section entitled &ldquo;Plan of Distribution&rdquo; in this prospectus. If any underwriters
are involved in the sale of any securities with respect to which this prospectus is being delivered, the names of such underwriters and
any applicable commissions or discounts will be set forth in a prospectus supplement. The price to the public of such securities and the
net proceeds we expect to receive from such sale will also be set forth in a prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Neither the Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus
is truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The date of this prospectus is May 17, 2021.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 63 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 90%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 10%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT><FONT STYLE="font-size: 10pt">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">About this Prospectus</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><A HREF="#a_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commonly Used Defined Terms</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><A HREF="#a_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note Regarding Forward-Looking Statements</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_004">Our Business</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_005">Risk Factors</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_006">Use of Proceeds</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">12</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_007">Dilution</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">12</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_008">Description of Share Capital</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_017">Description of Debt Securities</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_018">Description of Warrants</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">23</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_020">Description of Units</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_009">Plan of Distribution</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_010">Legal Matters</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_011">Experts</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_012">Financial Information</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_013">Information Incorporated by Reference</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_014">Where You Can Find More Information</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_015">Enforceability of Civil Liabilities</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">30</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_016">Indemnification for Securities Act Liabilities</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 64; Options: NewSection; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_001"></A>ABOUT THIS PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus is part of
a registration statement that we filed with the Securities and Exchange Commission, or the SEC, under the Securities Act of 1933, as amended,
or the Securities Act, using a &ldquo;shelf&rdquo; registration process. Under this shelf registration process, we may from time to time
sell Ordinary Shares, preferred shares, warrants to purchase Ordinary Shares or preferred shares, debt securities or any combination of
the foregoing, either individually or as units comprised of one or more of the other securities, in one or more offerings up to a total
dollar amount of $45,000,000. We have provided to you in this prospectus a general description of the securities we may offer. Each time
we sell securities under this shelf registration, we will, to the extent required by law, provide a prospectus supplement that will contain
specific information about the terms of that offering. We may also authorize one or more free writing prospectuses to be provided to you
that may contain material information relating to these offerings. The prospectus supplement and any related free writing prospectus that
we may authorize to be provided to you may also add, update or change information contained in this prospectus or in any documents that
we have incorporated by reference into this prospectus. To the extent there is a conflict between the information contained in this prospectus
and the prospectus supplement or any related free writing prospectus, you should rely on the information in the prospectus supplement
or the related free writing prospectus; provided that if any statement in one of these documents is inconsistent with a statement in another
document having a later date &ndash; for example, a document filed after the date of this prospectus and incorporated by reference into
this prospectus or any prospectus supplement or any related free writing prospectus &ndash; the statement in the document having the later
date modifies or supersedes the earlier statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have not authorized any
dealer, agent or other person to give any information or to make any representation other than those contained or incorporated by reference
in this prospectus and any accompanying prospectus supplement, or any related free writing prospectus that we may authorize to be provided
to you. You must not rely upon any information or representation not contained or incorporated by reference in this prospectus or an accompanying
prospectus supplement, or any related free writing prospectus that we may authorize to be provided to you. This prospectus and the accompanying
prospectus supplement, if any, do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the
registered securities to which they relate, nor do this prospectus and the accompanying prospectus supplement constitute an offer to sell
or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation
in such jurisdiction. You should not assume that the information contained in this prospectus, any applicable prospectus supplement or
any related free writing prospectus is accurate on any date subsequent to the date set forth on the front of the document or that any
information we have incorporated by reference is correct on any date subsequent to the date of the document incorporated by reference
(as our business, financial condition, results of operations and prospects may have changed since that date), even though this prospectus,
any applicable prospectus supplement or any related free writing prospectus is delivered or securities are sold on a later date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As permitted by SEC rules
and regulations, the registration statement of which this prospectus forms a part includes additional information not contained in this
prospectus. You may read the registration statement and the other reports we file with the SEC at its website or at its offices described
below under &ldquo;Where You Can Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the context otherwise
requires, all references in this prospectus to &ldquo;Zhongchao,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo; &ldquo;the
Company,&rdquo; &ldquo;the &ldquo;Registrant&rdquo; or similar words refer to Zhongchao Inc., together with our subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 65; Options: NewSection; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_002"></A>COMMONLY USED DEFINED TERMS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
references to &ldquo;RMB,&rdquo; &ldquo;yuan&rdquo; and &ldquo;Renminbi&rdquo; are to the legal currency of China, all references to
&ldquo;HKD&rdquo; is to the legal currency of Hong Kong, and all references to &ldquo;USD,&rdquo; and &ldquo;U.S. dollars&rdquo; are
to the legal currency of the United States;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;China&rdquo; and &ldquo;PRC&rdquo; refer to the People&rsquo;s Republic of China, excluding, for the purposes of this prospectus only, Macau, Taiwan and Hong Kong;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Class A Ordinary Shares&rdquo; refers to our Class A ordinary shares, $0.0001 par value per share;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Class B Ordinary Shares&rdquo; refers to our Class B ordinary shares, $0.0001 par value per share;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.25pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Controlling Shareholder&rdquo; refers to Mr. Weiguang Yang, the CEO of the Company;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depending on the context, the terms &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our company,&rdquo; &ldquo;our&rdquo;, &ldquo;Zhongchao&rdquo; and &ldquo;Zhongchao Cayman&rdquo; refer to Zhongchao Inc., a Cayman Islands company, and its subsidiaries and affiliated companies;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Horgos Zhongchao Medical&rdquo; refers to Horgos Zhongchao Medical Technology Co., Ltd., a PRC company, which cancelled its registration on May 11, 2020;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Horgos Zhongchao Zhongxing&rdquo; refers to Horgos Zhongchao Zhongxing Medical Technology Co., Ltd., a PRC company, which cancelled its registration on September 16, 2020;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;mobile MAUs&rdquo; are the number of unique IP address that various mobile devices having access to our MDMOOC mobile app or Sunshine Health Forums from mobile end at least once during a month. The numbers of our mobile MAUs are calculated using internal company data that has not been independently verified, and we treat each distinguishable device IP address as a separate user for purposes of calculating mobile MAUs, although inaccuracy may result from the possibility that one mobile device may have more than one IP addresses;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;monthly UVs&rdquo; of MDMOOC website, MDMOOC.org, or the website of our Sunshine Health Forums, ygjkclass.com, are to the number of unique IP address that various internet browsers apply to access our websites, from either PC end or mobile end, at least once during a month. The numbers of our monthly UVs of our websites&nbsp;are calculated using internal company data that has not been independently verified, and we treat each distinguishable IP address as a separate user for purposes of calculating monthly UVs, although inaccuracy may result from the possibility that some individuals may have more than one IP address and/or share the same IP address with other individuals to access our platform;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;NFP(s)&rdquo; refers to not-for-profit organizations;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;SAIC&rdquo; refers to State Administration for Industry and Commerce in China and currently known as State Administration for Market Regulation;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Shanghai Huijing&rdquo; refers to Shanghai Huijing Information Technology Co., Ltd., a PRC company;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Shanghai Jingyi&rdquo; or &ldquo;Shanghai Zhongxin&rdquo; refers to Shanghai Zhongxin Medical Technology Co., Ltd, a PRC company, which was formerly known as Shanghai Jingyi, or Shanghai Jingyi Medical Technology Co., Ltd., a PRC company and changed to its current name as Shanghai Zhongxin on November 16, 2020.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Shanghai Maidemu&rdquo; refers to Shanghai Maidemu Cultural Communication Corp., a PRC company;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Shanghai Xingzhong&rdquo; refers to Shanghai Xingzhong Investment Management LP, a PRC company;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Shanghai Zhongxun&rdquo; refers to Shanghai Zhongxun Medical Technology Co., Ltd., a PRC company;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Zhongchao BVI&rdquo; refers to Zhongchao Group Inc., a British Virgin Island company;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Zhongchao HK&rdquo; refers to Zhongchao Group Limited, a Hong Kong company;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Zhongchao Shanghai&rdquo; refers to Zhongchao Medical Technology (Shanghai) Co., Ltd., a PRC company;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Zhongchao WFOE&rdquo; refers to Beijing Zhongchao Zhongxing Technology Limited, a PRC company;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Beijing Boya&rdquo; refers to Beijing Zhongchao Boya Medical Technology Co., Ltd., a PRC company;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Liaoning Zhixun&rdquo; refers to Zhixun Internet Hospital (Liaoning) Co., Ltd., a PRC company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_003"></A>NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus and our SEC
filings that are incorporated by reference into this prospectus contain or incorporate by reference forward-looking statements within
the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. All statements other than statements of historical
fact are &ldquo;forward-looking statements,&rdquo; including any projections of earnings, revenue or other financial items, any statements
of the plans, strategies and objectives of management for future operations, any statements concerning proposed new projects or other
developments, any statements regarding future economic conditions or performance, any statements of management&rsquo;s beliefs, goals,
strategies, intentions and objectives, and any statements of assumptions underlying any of the foregoing. The words &ldquo;believe,&rdquo;
&ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo; &ldquo;plan,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;may,&rdquo; &ldquo;could,&rdquo;
&ldquo;should,&rdquo; &ldquo;potential,&rdquo; &ldquo;likely,&rdquo; &ldquo;projects,&rdquo; &ldquo;continue,&rdquo; &ldquo;will,&rdquo;
and &ldquo;would&rdquo; and similar expressions are intended to identify forward-looking statements, although not all forward-looking
statements contain these identifying words. Forward-looking statements reflect our current views with respect to future events, are based
on assumptions and are subject to risks and uncertainties. We cannot guarantee that we actually will achieve the plans, intentions or
expectations expressed in our forward-looking statements and you should not place undue reliance on these statements. There are a number
of important factors that could cause our actual results to differ materially from those indicated or implied by forward-looking statements.
These important factors include those discussed under the heading &ldquo;Risk Factors&rdquo; contained or incorporated by reference in
this prospectus and in the applicable prospectus supplement and any free writing prospectus we may authorize for use in connection with
a specific offering. These factors and the other cautionary statements made in this prospectus should be read as being applicable to all
related forward-looking statements whenever they appear in this prospectus. Except as required by law, we undertake no obligation to update
publicly any forward-looking statements, whether as a result of new information, future events or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_004"></A>OUR BUSINESS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>History and Development of the Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our Corporate History and Structure</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a holding company incorporated
on April 16, 2019, under the laws of the Cayman Islands, or Zhongchao Cayman. We have no substantive operations other than holding all
of the issued and outstanding shares of Zhongchao Group Inc., or Zhongchao BVI, established under the laws of the British Virgin Islands
on April 23, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Zhongchao BVI is also a holding
company holding all of the outstanding equity of Zhongchao Group Limited, or Zhongchao HK, which was established in Hong Kong on May 14,
2019. Zhongchao HK is also a holding company holding all of the outstanding equity of Beijing Zhongchao Zhongxing Technology Limited,
or Zhongchao WFOE, which was established on May 29, 2019 under the laws of the PRC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We conduct our business
through our variable interest entity, or VIE, Zhongchao Medical Technology (Shanghai) Corp., or Zhongchao Shanghai, a PRC company,
and through its wholly owned subsidiaries, including Shanghai Maidemu Cultural Communication Corp., or Shanghai Maidemu, Shanghai
Zhongxun Medical Technology Co., Ltd., or Shanghai Zhongxun, Horgos Zhongchao Zhongxing Medical Technology Co., Ltd., or Horgos
Zhongchao Zhongxing, Horgos Zhongchao Medical Technology Co., Ltd., or Horgos Zhongchao, Shanghai Zhongxin Medical Technology Co.,
Ltd (formerly known as &ldquo;Shanghai Jingyi Medical Technology Co., Ltd.&rdquo;, or &ldquo;Shanghai Jingyi&rdquo;), or Shanghai
Zhongxin, Beijing Zhongchao Boya Medical Technology Co., Ltd., or Beijing Boya, and Zhixun Internet Hospital (Liaoning) Co., Ltd.,
or Liaoning Zhixun, each a PRC company. We commenced our operations under the name Zhongchao Medical Consulting (Shanghai) Limited,
or Shanghai Zhongchao Limited, a limited liability company established under the laws of the PRC, to provide medical online and
offline training services. Zhongchao Shanghai was incorporated on August 17, 2012 by Juru Guo and Baorong Xue, who held 60% and 40%
equity interests in Zhongchao Shanghai respectively. On May 25, 2015, the two shareholders transferred all equity interests to
Weiguang Yang who held 100% equity interests in Zhongchao Shanghai after the transfer. On January 15, 2016, the name was changed to
Zhongchao Medical Technology (Shanghai) Co., Ltd. On February 5, 2016, the management completed its registration with the State
Administration for Industry and Commerce, or SAIC, to convert Shanghai Zhongchao Limited into a company limited by shares, or
Zhongchao Shanghai. Through direct ownership, Zhongchao Shanghai has established subsidiaries and branch offices in various cities
in PRC, including Beijing, Shanghai, and Tianjin. In October 2020, we also established an office in Tokyo, Japan and will pursue
potential market opportunities there.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 27, 2016, Zhongchao
Shanghai was listed on the National Equities Exchange and Quotations Co., Ltd., or the NEEQ. At the time of listing, Weiguang Yang directly
held 54.60% equity interests in Zhongchao Shanghai and Shanghai Xingzhong Investment Management LP. Ltd., a limited partnership incorporated
under the PRC laws (&ldquo;Shanghai Xingzhong&rdquo;), directly held 17.90% equity interests in Zhongchao Shanghai. Shanghai Xingzhong
was incorporated on September 22, 2015 by management of Zhongchao Shanghai as a platform for certain officers and employees holding founder
shares. Pursuant to its partner agreement, Weiguan Yang is the general partner of Shanghai Xingzhong; and manages and operates Shanghai
Xingzhong. He has the right, among others, to possess, manage, maintain and dispose the assets of Shanghai Xingzhong including its equity
interest in Zhongchao Shanghai. As a result, Weiguang Yang controlled 72.50% equity interests in Zhongchao Shanghai upon listing on NEEQ.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To facilitate our initial
public offering in the United States, Zhongchao Shanghai was delisted from NEEQ in February 2019. At the time of delisting, Weiguang Yang
controlled 57.29% equity interests in Zhongchao Shanghai (43.41% of which was directly held and 13.88% of which was controlled through
Shanghai Xingzhong). After the delisting, a minority shareholder of Zhongchao Shanghai transferred his shares to Mr. Yang. At the time
of our restructure in August 2019, Mr. Yang controlled 58.78% equity interests in Zhongchao Shanghai (44.90% of which was directly held
and 13.88% of which was controlled through Shanghai Xingzhong). To conclude, Zhongchao Shanghai has been under the control of Weiguan
Yang since its initial listing on NEEQ in June 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 24, 2019, Zhongchao
Shanghai changed its name to Zhongchao Medical Technology (Shanghai) Limited. Zhongchao Shanghai engages in technology development, technology
transfer, and technical services in the field of medical technology, technical consulting in the field of network technology, and medical
information consulting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 12, 2015, Zhongchao
Shanghai established its wholly owned subsidiary, Shanghai Maidemu. Shanghai Maidemu engages in planning for cultural and artistic exchanges,
designing, producing, acting for and publishing various kinds of advertisements, and medical consultation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 27, 2017, Zhongchao
Shanghai established its wholly owned subsidiary, Shanghai Zhongxun. Shanghai Zhongxun engages in technology development, transfer, service
and consulting in the fields of medical technology and computer technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 12, 2017, Zhongchao
Shanghai established its wholly owned subsidiary, Horgos Zhongchao Medical. Horgos Zhongchao Medical engages in technology development,
transfer, service and consulting in the fields of medical technology and computer technology. On March 26, 2020, due to business adjustment,
Horgos Zhongchao Medical started its dissolution and intends to apply to the registration authority for cancellation registration. It
is now in the liquidation announcement period, which will end on May 10, 2020. Horgos Zhongchao Zhongxing will take over the business
of Horgos Zhongchao Medical after it completes its dissolution registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 28, 2016, Shanghai
Maidemu formed a joint venture with Ms. Hongxia Zhang and Ms. Shuhua Gao, contributing a 55% equity interest in Shanghai Huijing Information
Technology Co., Ltd., or Shanghai Huijing, a PRC company. On January 21, 2019, Shanghai Huijing was 100% owned by Shanghai Maidemu. Shanghai
Huijing engages in technology development, transfer, service and consulting in the fields of computer technology, graphic designing, website
page designing, planning cultural and artistic exchanges.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 16, 2019,
Zhongchao Cayman was incorporated in the Cayman Islands and issued 5,497,715 Class B Ordinary Shares at 0.0001 par value as founder
shares to More Healthy Holding Limited, representing 80.94% of total voting power of the Company, on converted basis, given that
each Class B Ordinary Share is entitled to 15 votes and each Class A Ordinary Share is entitled to 1 vote and assuming the exercise
of the HF Warrant. More Healthy Holding Limited is a BVI company 100% owned by Weiguang Yang (&ldquo;More Healthy&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 68; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 29, 2019, Zhongchao
Shanghai established its wholly owned subsidiary, Horgos Zhongchao Zhongxing. Horgos Zhongchao Zhongxing engages in technology development,
transfer, service and consulting in the fields of medical technology and computer technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 14, 2019, Zhongchao
Cayman completed a reorganization of entities under common control of Weiguang Yang, who owned a majority of the voting power of Zhongchao
Cayman prior to the reorganization. Zhongchao Cayman, Zhongchao BVI, and Zhongchao HK were established as the holding companies of Zhongchao
WFOE. Zhongchao WFOE is the primary beneficiary of Zhongchao Shanghai and its subsidiaries, and all of these entities included in Zhongchao
Cayman are under common control which results in the consolidation of Zhongchao Shanghai and subsidiaries which have been accounted for
as a reorganization of entities under common control at carrying value. The consolidated financial statements are prepared on the basis
as if the reorganization became effective as of the beginning of the first period presented in the consolidated financial statements.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As part of the Company&rsquo;s
organization for the purpose of the initial public offering and listing on Nasdaq, on August 1, 2019, the Company and HF Capital Management
Delta, Inc., a company incorporated under the laws of the Cayman Islands (&ldquo;HF Capital&rdquo;) entered into a certain warrant agreement
to purchase Class A Ordinary Shares of the Company (the &ldquo;HF Warrant&rdquo;). At the issuance of the HF Warrant, Yantai Hanfujingfei
Investment Centre (LP), a limited partnership incorporated under PRC laws (&ldquo;Yantai HF&rdquo;, whose managing partner, Hanfor Capital
Management Co., Ltd., is the sole member of HF Capital, and together with &ldquo;HF Capital&rdquo; hereinafter collectively referred to
as &ldquo;HF&rdquo;) was a 6.25 % shareholder of Zhongchao Shanghai (which represented 1,350,068 shares in Zhongchao Shanghai, among which
675,068 shares were issued by Zhongchao Shanghai and the remaining 675,000 shares were purchased from two pre-existing shareholders) and
planned to withdraw its capital contribution in Zhongchao Shanghai but to contribute the same amount of capital to Zhongchao Cayman directly
via HF Capital. As HF Capital needs to complete necessary administrative registration required under Chinese regulations of outbound direct
investments (ODI) to hold equity interest in Zhongchao Cayman, the HF Warrant entitles HF Capital to purchase 1,350,068 Class A Ordinary
Shares, representing 6.25% economic beneficial interest, or 1.37% of the voting ownership interest of the Company as of December 31, 2019,
or 5.42% economic beneficial interest, or 1.33% of the voting ownership interest of the Company as of the date of this prospectus, from
the Company, if the following conditions are met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
PRC governmental consent and approval required for HF Capital to exercise the warrant and payment of the capital contribution have been
obtained, including without limitation, any approval or filing with respect to HF Capital&rsquo;s investment into the Company, and payment
by HF Capital of the capital contribution to the Company, and reasonable evidence thereof shall have been provided to the Company;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HF
Capital has fully paid the capital contribution to Zhongchao Cayman; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company released the paid-in capital of Yantai HF from Zhongchao Shanghai.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The HF Warrant was issued
in connection with a framework agreement among Zhongchao Shanghai, Mr. Weigang Yang, and Yantai HF dated August 1, 2019 (the &ldquo;Framework
Agreement&rdquo;), pursuant to which Zhongchao Shanghai has agreed to complete Yantai HF&rsquo;s withdrawal of capital contribution in
Zhongchao Shanghai no later than one month following the completion of HF Capital&rsquo;s ODI and HF has agreed to invest the same amount
of fund in U.S. dollars in Zhongchao Cayman upon the completion of its ODI registration. In addition, the parties have agreed to, once
the ODI registration of HF Capital is completed, deposit Yantai HF&rsquo;s capital contribution into a bank account mutually controlled
by Zhongchao Shanghai and Yantai HF, to be used as HF Capital&rsquo;s capital contribution in Zhongchao Cayman.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 69; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this
prospectus, the registration of Yantai HF&rsquo;s withdrawal of its capital contribution in Zhongchao Shanghai has been completed
with local State Administration for Industry and Commerce. The paid-in capital of Yantai HF in an amount of RMB20 million
(approximately US$2.9 million) is currently being held in the corporate bank account of Zhongchao Shanghai and is to be deposited in
a designated bank account mutually controlled by Zhongchao Shanghai and Yantai HF after the completion of HF Capital&rsquo;s ODI
procedures and to be released as HF Capital&rsquo;s capital contribution in Zhongchao Cayman as provided in the Framework Agreement.
According to the Administrative Measures for the Outbound Investment by Enterprises promulgated by the NDRC on December 26, 2017
which became effective on March 1, 2018, the Administrative Measures on Outbound Investments promulgated by the MOFCOM on September
6, 2014 which became effective on October 6, 2014, and the Notice of the SAFE on Further Simplifying and Improving the Foreign
Exchange Management Policies for Direct Investment promulgated by the SAFE on 13 February 2015 which became effective on June 1,
2015, the procedures of ODI include obtaining the Filing Notice of Outbound Direct Investment Projects issued by the competent
branch of the NDRC, the Certificate of Outbound Direct Investment of Enterprises issued by the competent branch of the MOFCOM, and
completing the foreign exchange registration of outbound direct investments. HF Capital is currently in the process of completing
its ODI procedures. HF has further committed that in any event if it cannot complete its ODI procedures, HF shall make such capital
contribution to Zhongchao Shanghai in an amount of RMB20 million (approximately US$2.9 million) or to Zhongchao Cayman in the same
amount of fund in U.S. dollars, subject to certain condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 26, 2020, the board
of Horgos Zhongchao Medical, one of the wholly-owned subsidiaries of the Company, approved its dissolution. The application for cancellation
registration was approved by the registration authority on May 11, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 1, 2020, all shareholders
of Zhongchao Shanghai, except Mr. Yang and Shanghai Xingzhong, decided to withdraw their capital contribution from Zhongchao Shanghai
(the &ldquo;Capital Reduction&rdquo;). Given the effect of the Capital Reduction, Mr. Yang became the 76.4% shareholder of Zhongchao Shanghai
with the remaining equity interests held by Shanghai Xingzhong. The Company was advised by its PRC counsel that the VIE arrangements consisting
of a series of six agreements with Zhongchao Shanghai (the &ldquo;Original VIE Arrangements&rdquo;) shall be terminated, except for the
Master Exclusive Service Agreement by and between Zhongchao WFOE and Zhongchao Shanghai dated as of August 14, 2019, to reflect the Capital
Reduction. On September 10, 2020, Zhongchao WFOE, and Zhongchao Shanghai, and its shareholders signed a confirmation agreement to confirm
that the Original&nbsp;VIE&nbsp;Agreements have been terminated because of the Capital Reduction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Accordingly, on September
10, 2020, to clarify the legal effect of the Capital Reduction and to sustain the effective control over Zhongchao Shanghai by the Company,
Mr. Yang and Shanghai Xingzhong, as the shareholders of Zhongchao Shanghai, signed a series of&nbsp;VIE&nbsp;agreements with Zhongchao
WFOE, the terms of which are substantially the same as those of the Original VIE Arrangements except the number of shareholders of Zhongchao
Shanghai reduced to two (the &ldquo;New&nbsp;VIE&nbsp;Agreements&rdquo;). Upon entry into the New VIE Agreements, the Original VIE Agreements,
except for the Master Exclusive Service Agreement, were expired.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The board of directors of
the Company approved and ratified the New VIE Agreements. The Company does not expect any negative impact of these&nbsp;New VIE Agreements
on its operation. The New VIE&nbsp;Agreements enable Zhongchao WFOE and the Company to keep the effective control over Zhongchao Shanghai.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November 16, 2020, Shanghai
Jingyi, a subsidiary of the Company changed its name to Shanghai Zhongxin Medical Technology Co., Ltd. (&ldquo;Shanghai Zhongxin&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 16, 2020, Horgos
Zhongchao Zhongxing, one of the wholly-owned subsidiaries of the Company, cancelled its registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In September 2020, we established
an office in Tianjin as the offices for medical service staff and technic staff. In October 2020, we established an office in Japan and
will pursue potential market opportunities there.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, on April 27,
2020, Beijing Boya was incorporated under the PRC laws, of which 70% of its equity was owned by Zhongchao Shanghai and 30% of its equity
was entrusted to Zhongchao Shanghai by the other shareholder Zhengbo Ma through a certain share entrustment agreement on April 27, 2020.
Beijing Boya is primarily engaged in online hospital services, medical services, elderly nursing services, remote healthcare management
services, healthcare consultation services, sales of medical appliances and other medical products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 12, 2020, two
shareholders of Shanghai Jingyi, Li Dai and Hegang Ma, transferred their shares to Mr. Weiguang Yang. As a result, Mr. Weiguang Yang
holds 49% of Shanghai Jingyi&rsquo;s equity and Zhongchao Shanghai holds 51% of its equity. Through a certain entrustment agreement
on November 1, 2020, Mr. Weiguang Yang agreed to hold his equity interest of Shanghai Zhongxin on behalf of Shanghai Zhongxun.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 70; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 23, 2020, Shanghai
Jingyi changed its name to Shanghai Zhongxin Medical Technology Co., Ltd., or Shanghai Zhongxin.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 16, 2020, Mr.
Weiguang Yang transferred certain parts of his shares to Zhongchao Yixin and Zhongren Yixin, As a result, Mr. Weiguang Yang, Zhongchao
Yixin, and Zhongren Yixin holds 19%, 20% and 10% of the equity interest of Shanghai Jingyi, respectively.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following charts summarize
our corporate legal structure and identify our subsidiaries, our VIE and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 552px; width: 780px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notes: All percentages reflect the voting ownership
interests instead of the equity interests held by each one of the shareholder of the Company given that each Class B Ordinary Share will
be entitled to 15 votes as compared to Class A Ordinary Share, each one of which will be entitled to 1 vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
5,497,715 Class B Ordinary Shares held by Mr. Weiguang Yang (&ldquo;Yang&rdquo;), the 100% owner of More Healthy Holding Limited (&ldquo;More
Healthy&rdquo;).</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
an aggregate of 10,988,809 Class A Ordinary Shares including 9,638,741 Class A Ordinary Shares held by 11 shareholders of Company, each
one of which holds less than 5% voting ownership interests of the Company, as of the date of this prospectus and 1,350,068 Class A Ordinary
Shares to be issued upon exercise of the HF Warrant. See footnote 3 below.</FONT></TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 71; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to directly hold equity interest in the Company, HF Capital Management Delta, Inc. (&ldquo;HF Capital&rdquo;) has to complete certain
registration and obtain approval with local governmental authority in PRC. As a part of reorganization and due to the aforementioned
factor, HF Capital was granted a warrant to purchase 1,350,068 Class A Ordinary Shares of the Company at a price $0.0001 per share or
such other amount agreed by the Company and HF Capital at a grant price of RMB 20,000,000 (approximately USD$2.9 million) conditioned
upon (i) HF Capital completes necessary registration and obtains approval with local governmental authority in PRC for its direct investment
in the Company and (ii) Zhongchao Shanghai shall have paid HF Capital RMB 20,000,000 as returned capital contribution in Zhongchao Shanghai.
The above chart assumes that HF Capital has not exercised such warrant.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
RMB 2.74 million (approximately USD$0.4 million) subscribed capital contribution to Zhongchao Shanghai, as of the date of this prospectus.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
RMB 9.70 million (approximately USD$1.4 million) subscribed capital contribution to Zhongchao Shanghai, as of the date of this prospectus.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
RMB 1.35 million (approximately USD$0.2 million) subscribed capital contribution to Zhongchao Shanghai, as of the date of this prospectus.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
RMB 3.00 million (approximately USD$0.4 million) subscribed capital contribution to Zhongchao Shanghai, as of the date of this prospectus.
Shanghai Xingzhong Investment Management LP. Ltd., a limited partnership incorporated under the PRC laws (&ldquo;Shanghai Xingzhong&rdquo;),
the general partner of which is Weiguang Yang. As the general partner of Shanghai Xingzhong, Weiguang Yang exercises the voting rights
with respect to the shares held by Shanghai Xingzhong.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
RMB 1.35 million (approximately USD$0.2 million) subscribed capital contribution to Zhongchao Shanghai, as of the date of this prospectus.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beijing
Boya was incorporated under the PRC laws on April 27, 2020, of which 70% of its equity was owned by Zhongchao Shanghai and 30% of its
equity was entrusted to Zhongchao Shanghai by the other shareholder Zhengbo Ma through a certain share entrustment agreement on April
27, 2020.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shanghai
Zhongxin, a PRC company, which was formerly known as Shanghai Jingyi, or Shanghai Jingyi Medical Technology Co., Ltd., a PRC company
and changed to its current name as Shanghai Zhongxin on November 16, 2020. On October 12, 2020, two shareholders of Shanghai Jingyi,
Li Dai and Hegang Ma, transferred their shares to Mr. Weiguang Yang. As a result, Mr. Weiguang Yang holds 49% of Shanghai Jingyi&rsquo;s
equity and Zhongchao Shanghai holds 51% of its equity. On November 1, 2020, Mr. Weiguang Yang transferred certain parts of his shares
to Zhongchao Yixin and Zhongren Yixin. As a result, Mr. Weiguang Yang, Zhongchao Yixin, and Zhongren Yixin hold 19%, 20% and 10% of the
equity interest of Shanghai Jingyi, respectively. Through certain entrustment agreements, Mr. Weiguang Yang, Zhongchao Yixin and Zhongren
Yixin hold 19%, 20% and 10% of the equity interest of Shanghai Jingyi on behalf of Shanghai Zhongxun, respectively.&nbsp;&nbsp;As a result,
Shanghai Zhongxun owns 100% of Shanghai Zhongxin&rsquo;s equity interest.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Business Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our Company</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a provider of healthcare
information, education, and training services to healthcare professionals and the public in China. We offer a wide range of online and
onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical
practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education
courses, and articles and short videos with educational healthcare content to healthcare professionals as well as the public. The services,
programs, and products that we provide:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">make
it easier for healthcare professionals to access healthcare reference sources, stay abreast of the latest medical information, learn
about new treatment options, earn continuing medical education credits and communicate with peers; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">enable
the public to obtain health information on a particular disease or condition, offer content on topics of individual interest, improve
public health consciousness, and promote people&rsquo;s lifestyle.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 72; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We provide our healthcare
information, education, and training services to the healthcare professionals under our &ldquo;MDMOOC&rdquo; brand, which we believe is
one of the leading consumer brands in China&rsquo;s healthcare training and education sector, as evidenced by the Securities Research
Report on online medical care industry by Essence Securities Co., Ltd., a company provides securities services throughout China, where
we are considered as one of the main and typical public company proving medical training with doctor interactive and online training platform
and leading the Internet medical education industry. We provide our healthcare educational content to the public via our &ldquo;Sunshine
Health Forums&rdquo;, which, based on the amount of the registered users and daily review volume, we believe is one of the largest platform
in China, for general healthcare knowledge and information to the public.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We commenced our operation,
through Zhongchao Shanghai, in August 2012 with a vision to offer a wide range of accessible and immediate healthcare information and
continuous learning and training opportunities for Chinese healthcare professionals. Since our inception, we have focused on developing
our information, education, and training programs to address the needs in the healthcare industry in China; and developing online platforms
and onsite activities to deliver our information services, education programs and training products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>MDMOOC-Healthcare Information, Education, and Training for Professionals</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B>Online Platforms</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We launched our first online
platform in a form of website, www.mdmooc.org, under our &ldquo;MDMOOC&rdquo; brand in 2013 to provide information, education, and training
services to physicians and allied healthcare professionals, such as pharmacists and nurses primarily located in China, via Internet-Plus
solutions. Internet Plus refers to the applications of the internet and other information technology in conventional industries, such
as manufacturing, education and healthcare. It is an incomplete equation where various internet (mobile, cloud computing, big data or
Internet of Things) can be added to other traditional fields. We further launched our MDMOOC Wechat subscription account and MDMOOC mobile
App in 2015 and 2016, respectively (together with the website, the &ldquo;MDMOOC online platform&rdquo;). Healthcare professionals in
China can apply for registration with their healthcare qualification to get access to our MDMOOC online platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The programs available on
our MDMOOC online platform enable our users to timely obtain extension knowledge of precedents, treatments, and first-hand experiences
of various disease and other healthcare related matters. In addition, our MDMOOC online platform offers these professional users what
we believe is one of the largest online libraries of continuing medical education programs in China that are produced in association with
entities accredited by the National Health Commission of the PRC, such as Chinese Medical Association and Chinese Journal of Continuing
Medical Education. From the convenience of their home or office computer and mobile App, our professional users can access a variety of
accredited editorial resources and programs including online journal articles, medical conferences, and open classes and obtain continuing
medical education credits which are required for the healthcare qualification of doctors, nurses, and pharmacists.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe MDMOOC online platform
helps healthcare professionals improve their clinical knowledge and practice of medicine. Since launching in 2013, we have been continuously
developing our MDMOOC online platform with new forms of Internet-based education solutions. There are currently approximately 2,976 education
and training programs available on our MDMOOC online platform and free to our registered users. About 95% of all our programs are self-developed
by our research and development team. The original content of these programs, including daily medical thesis, commentary, conference coverage,
expert columns, and activities are written by our research and development team and authors from widely respected academic institutions,
and edited and managed by our in-house editorial staff. The remaining 5% of programs are created under the purchase orders of our corporate
or institution customers, where we develop customized programs with designated healthcare topics. Such 5% of programs are only available
to certain registered users with program passcodes provided by our corporate or institution customers. Our revenues are mainly sourced
from these 5% of programs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently provide our proprietary
interactive programs via Practice Improvement (PI), a problem-based and case-based form of healthcare course, which integrates state-of-the-art
treatment information and clinical cases for particular diseases into interactive practice modules; Community of Practice Share (COPS),
an online and live clinical experience sharing platform that creates the most effective discussion in a particular healthcare domain or
medical area due to the common interests of the users; Continuing Professional Development (CPD), a section of our platform that provides
discussions and articles focusing on the future development and the differences between Continuing Medical Education (CME) and Continuing
Professional Development (CPD), and other general information of physician competency framework and Meta-analysis. Our original, exclusive
and proprietary content includes innovative features such as after-class quiz, key point summary and highlight during the courses, and
peer-review and comments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that our ability
to create, source, edit and organize online healthcare-related content, interactive education services, and training programs has made
MDMOOC online platform one of the leading health destinations and most recognized information platform in healthcare sector in China.
As of the date of this prospectus, our MDMOOC online platform has more than 680,000 registered users and a database of more than 2 million
healthcare experts including over 700,000 physicians, and 1,300,000 allied healthcare professionals in medical academics, associations,
and leading hospitals who constantly collaborate with us to develop training programs on needed basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B>Onsite Education Activities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to healthcare
information, education, and training via Internet-Plus, we organize onsite healthcare and medical training sessions and academic conferences
from time to time under our &ldquo;MDMOOC&rdquo; brand. For instance, in January 2019, we launched EWMA-certified (defined as below) wound-management
collaboration training programs, covering the topics including but not limited to basic concepts of acute and chronic wounds, management
of different levels of surgical and non-surgical wounds, the construction of different levels of wound centers, and medical staff collaboration
in the process of wound management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cooperate with Beijing
Chronic Disease Prevention and Health Education Research Association and Professor Yixin Zhang from the Ninth People&rsquo;s Hospital
of Shanghai Jiao Tong University School of Medicine to create courses titled &ldquo;Essential Course for Wound Care Management&rdquo;
and &ldquo;Advanced Course for Surgical Wound Treatment&rdquo;. These courses have been certified and authorized by the European Wound
Management Association (EWMA), a European not-for-profit umbrella organization, linking national wound management organizations, individuals
and groups with interest in wound care. We plan to hold four (4) training programs for Essential Course for Wound Care Management and
two (2) training programs for Advanced Course for Surgical Wound Treatment. Each program will accept no more than twenty (20) applicants
who shall hold academic credential above undergraduate. We also require all applicants to have more than six-year working experience in
the field of wound repair. We will issue a certificate to each of the applicant upon completion of the training as their proof of achievement
and ability in the wound management and treatment</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this prospectus,
we have successfully held the first short-term training program for Essential Course for Wound Care Management in Fujian, China from March
28, 2019 to April 4, 2019 and our first training program for Advanced Course for Surgical Wound Treatment from June 23, 2019 to June 29,
2019 in Jiangsu, China. We further held the second and third training programs for Essential Course for Wound Care Management in Zhejiang,
China from August 25, 2019 to August 31, 2019 and our second and third training programs for Advanced Course for Surgical Wound Treatment
from December 1, 2019 to December 7, 2019 in Jilin, China. As a result of the outbreak of COVID-19 and pandemic, we postponed our original
plan to hold our future training programs in the 1<SUP>st</SUP>&nbsp;quarter of 2020 in Zhengzhou, Henan Province. However, we successfully
held the postponed Essential Courses for Wound Care Management and the Advanced Courses for Wound Treatment in Xi&rsquo;an from September
10, 2020 to September 18 2020, and in Hangzhou from December 18, 202 to December 26, 2020, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe the combination
of online and onsite services would provide our end-users the greatest convenience. With more choices of the forms of healthcare education,
we enrich the learning experience of our end-users.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 74; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B>New Plug-in to Certain
Programs- Assistance in Patient-Aid Projects</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Commencing from the fourth
quarter of 2018, in addition to providing training and education courses through our platforms, we have been engaged by certain customers
on a project basis to establish individual columns on our MDMOOC online platform to provide training and knowledge of certain drug treatment
for healthcare professionals and patients. Most of the drug treatments are cancer-related or rare disease-related. We establish online
columns to facilitate qualified patients to obtain free drug treatment from not-for-profit organizations (&ldquo;NFPs&rdquo;) till the
earlier of the expiration of contract period or the free drugs are completely delivered. For each column, we plug in features to manage
the drug treatment including reviewing patients&rsquo; applications, tracking their usage of drugs, and collecting related information
(such programs with new plug-in features are hereinafter referred as the &ldquo;patient-aid projects&rdquo;). Those customers are existing
customers of us. They provide those drugs sponsored by pharmaceutical companies without charge to qualified patients and we charge those
customers on our services in connection with the online columns and related training and management. In this way, we believe not only
can we facilitate the clinical application of those drugs, but also benefit patients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this prospectus,
we have established nearly 20 columns for cancer-related drug treatment, including drug treatment for lung cancer, liver cancer, and extended
blood cancer, and 4 columns for drug treatment of rare diseases, including drug treatment for pulmonary fibrosis, multiple sclerosis,
and systemic lupus erythematosus. The total number of patients covered under these patient-aid projects has reached nearly 45,000 by the
end of 2020. We have launched another 3 or 4 columns for the treatment of rare diseases, including Fabry disease and Gaucher disease in
mid-2020. We expect the numbers of columns for both cancer-related treatment and treatment of rare diseases double by the end of 2021,
coving an aggregate of nearly 65,000 patients.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Sunshine Health Forums-Healthcare Information
and Education for the Public</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our goal is not only to provide continuing education
and training to healthcare professionals but to promote healthy lifestyle and provide healthcare knowledge to the public. In order to
achieve that, we develop and operate the Sunshine Health Forums, online education-for-all platforms that disseminate articles and features
related to healthcare and wellness education, medical behavior intervention, and newly developed health technology and application. We
launched our Sunshine Health Forums in a form of website, www.ygjkclass.com, in May 2016 followed by WeChat subscription account in August
2016, and mobile App in 2017. We establish one forum for each category of diseases for the convenience of the public. We cooperate with
certain well-known we-media platforms in China, including but not limited Toutiao.com, Yidianzixun.com, Douyin.com, CN-Healthcare.com,
iQiyi, Youku, and Huoshan.com to streamline our articles co-produced by healthcare professionals and us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Corporate Information</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">Our principal executive office
is located on the 841 Yan&rsquo;an Middle Road, Jing&rsquo;An District, Shanghai, China 200040. Our telephone number is 021-32205987.
We maintain a website at http://izcmd.com that contains information about our Company, though no information contained on our website
is part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_005"></A>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Investing in our securities
involves a high degree of risk. You should carefully consider the risk factors set forth under &ldquo;Risk Factors&rdquo; described in
our most recent annual report on&nbsp;Form 20-F, filed on April 30, 2021, as supplemented and updated by subsequent current reports on
Form 6-K that we have filed with the SEC, together with all other information contained or incorporated by reference in this prospectus
and any applicable prospectus supplement and in any related free writing prospectus in connection with a specific offering, before making
an investment decision. Each of the risk factors could materially and adversely affect our business, operating results, financial condition
and prospects, as well as the value of an investment in our securities, and the occurrence of any of these risks might cause you to lose
all or part of your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_006"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as described in any
prospectus supplement and any free writing prospectus in connection with a specific offering, we currently intend to use the net proceeds
from the sale of the securities offered under this prospectus to fund the development and commercialization of our projects and the growth
of our business, primarily working capital, and for general corporate purposes. We may also use a portion of the net proceeds to acquire
or invest in technologies, products and/or businesses that we believe will enhance the value of our Company, although we have no current
commitments or agreements with respect to any such transactions as of the date of this prospectus. We have not determined the amount of
net proceeds to be used specifically for the foregoing purposes. As a result, our management will have broad discretion in the allocation
of the net proceeds and investors will be relying on the judgment of our management regarding the application of the proceeds of any sale
of the securities. If a material part of the net proceeds is to be used to repay indebtedness, we will set forth the interest rate and
maturity of such indebtedness in a prospectus supplement. Pending use of the net proceeds will be deposited in interest bearing bank accounts.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_007"></A>DILUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If required, we will set forth
in a prospectus supplement the following information regarding any material dilution of the equity interests of investors purchasing securities
in an offering under this prospectus:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
net tangible book value per share of our equity securities before and after the offering;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
amount of the increase in such net tangible book value per share attributable to the cash payments made by purchasers in the offering;
and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
amount of the immediate dilution from the public offering price which will be absorbed by such purchasers.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_008"></A>DESCRIPTION OF SHARE CAPITAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following description
of our capital stock (which includes a description of securities we may offer pursuant to the registration statement of which this prospectus,
as the same may be supplemented, forms a part) does not purport to be complete and is subject to and qualified in its entirety by our
Amended and Restated Memorandum and Articles of Association (&ldquo;M&amp;A&rdquo;) and by the applicable provisions of Cayman Islands
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our authorized capital stock consists
of 450,000,000 Class A Ordinary Shares and 50,000,000 Class B Ordinary Shares. As of May 13, 2021, there were 18,085,355 Class A Ordinary
Shares and 5,497,715 Class B Ordinary Shares outstanding.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following description of
our capital stock is intended as a summary only and is qualified in its entirety by reference to our M&amp;A, which have been filed previously
with the SEC, and applicable provisions of Cayman Islands law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We, directly or through agents,
dealers or underwriters designated from time to time, may offer, issue and sell, together or separately, up to $45,000,000 in the aggregate
of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
shares;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">preferred
shares;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">secured
or unsecured debt securities consisting of notes, debentures or other evidences of indebtedness which may be senior debt securities,
senior subordinated debt securities or subordinated debt securities, each of which may be convertible into equity securities;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants
to purchase our securities;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">rights
to purchase our securities; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">units
comprised of, or other combinations of, the foregoing securities.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our authorized capital stock
consists of 450,000,000 Class A Ordinary Shares and 50,000,000 Class B Ordinary Shares. As of May 13, 2021, there were 18,085,355 Class
A Ordinary Shares and 5,497,715 Class B Ordinary Shares outstanding (not including 1,350,068 Class A Ordinary Shares to be issued upon
exercise of the HF Warrant issued to HF Capital. For more details regarding the HF Warrant, please see &ldquo;Our Corporate History and
Structure&rdquo;).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 76; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue the debt securities
as exchangeable for or convertible into Ordinary Shares, preferred shares or other securities. The preferred shares may also be exchangeable
for and/or convertible into Ordinary Shares, another series of preferred shares or other securities. The debt securities, the preferred
shares, the Ordinary Shares and the warrants are collectively referred to in this prospectus as the &ldquo;securities.&rdquo; When a particular
series of securities is offered, a supplement to this prospectus will be delivered with this prospectus, which will set forth the terms
of the offering and sale of the offered securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Ordinary Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The following are summaries of material provisions of our M&amp;A,
corporate governance policies and the Companies Act (Revised) of the Cayman Islands (&ldquo;Companies Act&rdquo;) insofar as they relate
to the material terms of our Class A Ordinary Shares and Class B Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Objects of Our Company</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Under
our M&amp;A, the objects of our Company are unrestricted and we have the full power and authority to carry out any object not prohibited
by the law of the Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Share Capital</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
authorized share capital is divided into Class A Ordinary Shares and Class B Ordinary Shares. Holders of our Class A Ordinary Shares and
Class B Ordinary Shares will have the same rights except for voting rights and conversion rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
holders of Class A Ordinary Shares are entitled to 1 vote for each such share held and shall be entitled to notice of any shareholders&rsquo;
meeting, and, subject to the terms of M&amp;A, to vote thereat. The Class A Ordinary Shares are not redeemable at the option of the holder
and are not convertible into shares of any other class.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
holders of Class B Ordinary Shares shall have the right to 15 votes for each such share held, and shall be entitled to notice of any shareholders&rsquo;
meeting and, subject to the terms of the M&amp;A, to vote thereat. The Class B Ordinary Shares are not redeemable at the option of the
holder but are convertible into Class A Ordinary Shares at any time after issue at the option of the holder on a one to one basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Dividends</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The holders of our Class A Ordinary Shares and Class B Ordinary Shares
are entitled to such dividends as may be declared by our Board of Directors subject to the Companies Act and to our M&amp;A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Voting Rights</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
respect of all matters subject to a shareholders&rsquo; vote, each Class B Ordinary Share is entitled to 15 votes, and each Class A Ordinary
Share is entitled to 1 vote, voting together as one class. At any general meeting a resolution put to the vote of the meeting shall be
decided on a poll which shall be taken at such time and in such manner as the Chairman of the meeting directs and the result of the poll
shall be deemed to be the resolution of the meeting</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">No
business shall be transacted at any general meeting unless a quorum of members is present at the time when the meeting proceeds to business;
one or more members holding Ordinary Shares which carry in aggregate (or representing by proxy) not less than one-third of all votes attaching
to all Ordinary Shares in issue and entitled to vote at such general meeting, present in person or by proxy or, if a corporation or other
non-natural person, by its duly authorised representative, shall be a quorum for all purposes provided always that if the Company has
one (1) member of record, the quorum shall be that one (1) member present in person or by proxy. To avoid confusion for the purpose, when
counting the quorum, each issued and outstanding Class A Ordinary Share has one (1) vote and each issued and outstanding Class B Ordinary
Share has fifteen (15) votes. An ordinary resolution to be passed at a general meeting requires the affirmative vote of a simple majority
of the votes cast, while a special resolution requires the affirmative vote of at least two-thirds of votes cast at a general meeting.
A special resolution will be required for important matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 77; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Conversion</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Class
A Ordinary Shares are not convertible. Each Class B Ordinary Share shall be convertible, at the option of the holder thereof, into such
number of fully paid and non-assessable Class A Ordinary Shares on the basis that one Class B Ordinary Share shall be converted into one
Class A Ordinary Share (being a 1:1 ratio and hereafter referred to as the &ldquo;Conversion Rate&rdquo;), subject to adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Transfer of Ordinary Shares</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Subject
to the restrictions set out below, any of our shareholders may transfer all or any of his, its or her Class A Ordinary Shares or Class
B Ordinary Shares by an instrument of transfer in the usual or common form or any other form approved by our Board of Directors or in
a form prescribed by the stock exchange on which our shares are then listed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
Board of Directors may, in its sole discretion, decline to register any transfer of any Class A Ordinary Shares or Class B Ordinary Shares
whether or not it is fully paid up to the total consideration paid for such shares. Our directors may also decline to register any transfer
of any Class A Ordinary Shares or Class B Ordinary Shares if (a) the instrument of transfer is not accompanied by the certificate covering
the shares to which it relates or any other evidence as our Board of Directors may reasonably require to prove the title of the transferor
to, or his/her right to transfer the shares; or (b) the instrument of transfer is in respect of more than one class of shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
our directors refuse to register a transfer, they shall, within two months after the date on which the instrument of transfer was lodged,
send to the transferee notice of such refusal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
registration of transfers may be suspended and the register closed at such times and for such periods as our Board of Directors may from
time to time determine, provided, however, that the registration of transfers shall not be suspended nor the register closed for more
than 30 days in any year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Winding-Up/Liquidation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
a return of capital on winding up or otherwise (other than on conversion, redemption or purchase of shares), a liquidator may be appointed
to determine how to distribute the assets among the holders of the Class A Ordinary Shares and Class B Ordinary Shares. If our assets
available for distribution are insufficient to repay all of the paid-up capital, the assets will be distributed so that the losses are
borne by our shareholders proportionately; a similar basis will be employed if the assets are more than sufficient to repay the whole
of the capital at the commencement of the winding up.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Calls on Ordinary Shares and Forfeiture of
Ordinary Shares</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
Board of Directors may from time to time make calls upon shareholders for any amounts unpaid on their Class A Ordinary Shares or Class
B Ordinary Shares in a notice served to such shareholders at least 14 days prior to the specified time and place of payment. The shares
that have been called upon and remain unpaid on the specified time are subject to forfeiture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Redemption of Shares</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
may issue shares on terms that are subject to redemption, at our option or at the option of the holders, on such terms and in such manner
as may be determined by our Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Variations of Rights of Shares</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">All
or any of the special rights attached to any class of shares may, be varied with the resolution of at least two thirds of the issued shares
of that class or a resolution passed at a general meeting of the holders of the shares of that class present in person or by proxy or
with the consent in writing of the holders of at least two-thirds of the issued shares of that class.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 78; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>Inspection of Books
and Records</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Directors shall from time to time determine whether and to what extent
and at what times and places and under what conditions or regulations the accounts and books of the Company or any of them shall be open
to the inspection of members not being Directors and no member (not being a Director) shall have any right of inspecting any account or
book or document of the Company except as conferred by Companies Act or authorized by the Directors or by the Company in a general meeting.
However, the Directors shall from time to time cause to be prepared and to be laid before the Company in a general meeting, profit and
loss accounts, balance sheets, group accounts (if any) and such other reports and accounts as may be required by Companies Act. (See &ldquo;Where
You Can Find More Information&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Issuance of Additional Shares</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
M&amp;A authorize our Board of Directors to issue additional Class A Ordinary Shares or Class B Ordinary Shares from time to time as our
Board of Directors shall determine, to the extent there are available authorized but unissued shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
Board of Directors may, issue preferred shares without action by our shareholders to the extent there are authorized but unissued shares
available. Issuance of additional shares may dilute the voting power of holders of Class A Ordinary Shares and Class B Ordinary Shares.
However, our Memorandum of Association provides for authorized share capital comprising Class A Ordinary Shares and Class B Ordinary Shares
and to the extent the rights attached to any class may be varied, the Company must comply with the provisions in the M&amp;A relating
to variations to rights of shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Anti-Takeover Provisions</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Some
provisions of our M&amp;A may discourage, delay or prevent a change of control of our Company or management that shareholders may consider
favorable, including provisions that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">authorize
our Board of Directors to issue preferred shares in one or more series and to designate the price, rights, preferences, privileges and
restrictions of such preferred shares without any further vote or action by our shareholders (subject to variation of rights of shares
provisions in our M&amp;A); and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limit
the ability of shareholders to requisition and convene general meetings of shareholders. Our M&amp;A allow our shareholders holding shares
representing in aggregate not less than ten percent of our paid up share capital (as to the total consideration paid for such shares)
in issue to requisition an extraordinary general meeting of our shareholders, in which case our directors are obliged to call such meeting
and to put the resolutions so requisitioned to a vote at such meeting.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">However,
under Cayman Islands law, our directors may only exercise the rights and powers granted to them under our M&amp;A for a proper purpose
and for what they believe in good faith to be in the best interests of our Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 79; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>General Meetings of Shareholders and Shareholder Proposals</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
shareholders&rsquo; general meetings may be held in such place within or outside the Cayman Islands as our Board of Directors considers
appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">As a Cayman Islands exempted company, we are not obliged by the Companies
Act to call shareholders&rsquo; annual general meetings. However, our M&amp;A provide that we shall hold a general meeting in each year
as our annual general meeting other than the year in which the M&amp;A were adopted at such time and place as determined by the directors.
The directors may, whenever they think fit, convene an extraordinary general meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Shareholders&rsquo;
annual general meetings and any other general meetings of our shareholders may be convened by a majority of our Board of Directors. Our
Board of Directors shall give not less than seven days&rsquo; written notice of a shareholders&rsquo; meeting to those persons whose names
appear as members in our register of members on the date the notice is given (or on any other date determined by our directors to be the
record date for such meeting) and who are entitled to vote at the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Cayman
Islands law provides shareholders with only limited rights to requisition a general meeting, and does not provide shareholders with any
right to put any proposal before a general meeting. However, these rights may be provided in a company&rsquo;s articles of association.
Our M&amp;A allow our shareholders holding shares representing in aggregate not less than ten percent of our paid up share capital (as
to the total consideration paid for such shares) in issue to requisition an extraordinary general meeting of our shareholders, in which
case our directors are obliged to call such meeting and to put the resolutions so requisitioned to a vote at such meeting; otherwise,
our M&amp;A do not provide our shareholders with any right to put any proposals before annual general meetings or extraordinary general
meetings not called by such shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Exempted Company</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We are an exempted company with limited liability under the Companies
Act. The Companies Act distinguishes between ordinary resident companies and exempted companies. A Cayman Islands exempted company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
a company that conducts its business mainly outside of the Cayman Islands;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is exempted from certain requirements of the Companies Act, including
the filing an annual return of its shareholders with the Registrar of Companies or the Immigration Board;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
not have to make its register of members open for inspection;</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
not have to hold an annual general meeting;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may issue negotiable or bearer shares or shares with no par value (subject
to the provisions of the Companies Act);</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for 20 years in the first instance);
and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&ldquo;Limited
liability&rdquo; means that the liability of each shareholder is limited to the amount unpaid by the shareholder on the shares of the
company (except in exceptional circumstances, such as involving fraud, the establishment of an agency relationship or an illegal or improper
purpose or other circumstances in which a court may be prepared to pierce or lift the corporate veil).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Register of Members</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Under
Cayman Islands law, we must keep a register of members and there should be entered therein:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
names and addresses of the members, a statement of the shares held by each member, and of the amount paid or agreed to be considered
as paid, on the shares of each member;</FONT></TD>
</TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 80; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
date on which the name of any person was entered on the register as a member; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
date on which any person ceased to be a member.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Under
Cayman Islands law, the register of members of our Company is prima facie evidence of the matters set out therein (i.e. the register of
members will raise a presumption of fact on the matters referred to above unless rebutted) and a member registered in the register of
members is deemed as a matter of Cayman Islands law to have legal title to the shares as set against its name in the register of members.
Once our register of members has been updated, the shareholders recorded in the register of members are deemed to have legal title to
the shares set against their name.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
the name of any person is incorrectly entered in, or omitted from, our register of members, or if there is any default or unnecessary
delay in entering on the register the fact of any person having ceased to be a member of our Company, the person or member aggrieved (or
any member of our Company or our Company itself) may apply to the Cayman Islands Grand Court for an order that the register be rectified,
and the Court may either refuse such application or it may, if satisfied of the justice of the case, make an order for the rectification
of the register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Indemnification of Directors and Executive
Officers and Limitation of Liability</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Cayman Islands law does not limit the extent to which a company&rsquo;s
M&amp;A may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands
courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime.
Our M&amp;A require us to indemnify our officers and directors for actions, proceedings, claims, losses, damages, costs, liabilities and
expenses (&ldquo;Indemnified Losses&rdquo;) incurred in their capacities as such unless such Indemnified Losses arise from dishonesty
of such directors or officers. This standard of conduct is generally the same as permitted under the Delaware General Corporation Law
for a Delaware corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling
us under the foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against public policy
as expressed in the Securities Act and is therefore unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Preferred Shares</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">As
all the current authorized share capital is designated as Ordinary Shares, shareholders&rsquo; special resolution will be needed to amend
the Company&rsquo;s M&amp;A to alter its authorized share capital if the Company decides to issue preferred shares. After such resolution
and amendment, the Board is empowered to allot and/or issue (with or without rights of renunciation), grant options over, offer or otherwise
deal with or dispose of any unissued shares of the Company (whether forming part of the original or any increased share capital), either
at a premium or at par, with or without preferred, deferred or other special rights or restrictions, whether in regard to dividend, voting,
return of capital or otherwise and to such persons, on such terms and conditions, and at such times as the Board may decide and they may
allot or otherwise dispose of them to such persons (including any director of the Board) on such terms and conditions and at such time
as the Board may determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">You
should refer to the prospectus supplement relating to the series of preferred shares being offered for the specific terms of that series,
including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">title
of the series and the number of shares in the series;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
price at which the preferred shares will be offered;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
dividend rate or rates or method of calculating the rates, the dates on which the dividends will be payable, whether or not dividends
will be cumulative or noncumulative and, if cumulative, the dates from which dividends on the preferred shares being offered will cumulate;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 81; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
voting rights, if any, of the holders of preferred shares being offered;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
provisions for a sinking fund, if any, and the provisions for redemption, if applicable, of the preferred shares being offered, including
any restrictions on the foregoing as a result of arrearage in the payment of dividends or sinking fund installments;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
liquidation preference per share;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
terms and conditions, if applicable, upon which the preferred shares being offered will be convertible into our Ordinary Shares, including
the conversion price, or the manner of calculating the conversion price, and the conversion period;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
terms and conditions, if applicable, upon which the preferred shares being offered will be exchangeable for debt securities, including
the exchange price, or the manner of calculating the exchange price, and the exchange period;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
listing of the preferred shares being offered on any securities exchange;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
discussion of any material federal income tax considerations applicable to the preferred shares being offered;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
preemptive rights;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
relative ranking and preferences of the preferred shares being offered as to dividend rights and rights upon liquidation, dissolution
or the winding up of our affairs;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
limitations on the issuance of any class or series of preferred shares ranking senior or equal to the series of preferred shares being
offered as to dividend rights and rights upon liquidation, dissolution or the winding up of our affairs; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
additional rights, preferences, qualifications, limitations and restrictions of the series.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Upon
issuance, the preferred shares will be fully paid and nonassessable, which means that its holders will have paid their purchase price
in full and we may not require them to pay additional funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Any
preferred share terms selected by the Board could decrease the amount of earnings and assets available for distribution to holders of
our Ordinary Shares or adversely affect the rights and power, including voting rights, of the holders of our Ordinary Shares without any
further vote or action by the stockholders. The rights of holders of our Ordinary Shares will be subject to, and may be adversely affected
by, the rights of the holders of any preferred shares that may be issued by us in the future. The issuance of preferred shares could also
have the effect of delaying or preventing a change in control of our company or make removal of management more difficult.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_017"></A>Description of Debt Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As used in this prospectus,
the term &ldquo;debt securities&rdquo; means the debentures, notes, bonds and other evidences of indebtedness that we may issue from time
to time. The debt securities will either be senior debt securities, senior subordinated debt or subordinated debt securities. We may also
issue convertible debt securities. Debt securities issued under an indenture (which we refer to herein as an Indenture) will be entered
into between us and a trustee to be named therein. It is likely that convertible debt securities will not be issued under an Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture or forms of
Indentures, if any, will be filed as exhibits to the registration statement of which this prospectus is a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>As you read this section,
please remember that for each series of debt securities, the specific terms of your debt security as described in the applicable prospectus
supplement will supplement and, if applicable, may modify or replace the general terms described in the summary below. The statement we
make in this section may not apply to your debt security.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 82; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Events of Default Under the Indenture</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless we provide otherwise
in the prospectus supplement or free writing prospectus applicable to a particular series of debt securities, the following are events
of default under the indentures with respect to any series of debt securities that we may issue:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
we fail to pay the principal or premium, if any, when due and payable at maturity, upon redemption or repurchase or otherwise;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
we fail to pay interest when due and payable and our failure continues for certain days;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
we fail to observe or perform any other covenant contained in the Securities of a Series or in this Indenture, and our failure continues
for certain days after we receive written notice from the trustee or holders of at least certain percentage in aggregate principal amount
of the outstanding debt securities of the applicable series. The written notice must specify the Default, demand that it be remedied
and state that the notice is a &ldquo;Notice of Default&rdquo;;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
specified events of bankruptcy, insolvency or reorganization occur; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
any other event of default provided with respect to securities of that series, which is specified in a Board Resolution, a supplemental
indenture hereto or an Officers&rsquo; Certificate as defined in the Form of Indenture.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We covenant in the Form of
Indenture to deliver a certificate to the trustee annually, within certain days after the close of the fiscal year, to show that we are
in compliance with the terms of the indenture and that we have not defaulted under the indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nonetheless, if we issue debt
securities, the terms of the debt securities and the final form of indenture will be provided in a prospectus supplement. Please refer
to the prospectus supplement and the form of indenture attached thereto for the terms and conditions of the offered debt securities. The
terms and conditions may or may not include whether or not we must furnish periodic evidence showing that an event of default does not
exist or that we are in compliance with the terms of the indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The statements and descriptions
in this prospectus or in any prospectus supplement regarding provisions of the Indentures and debt securities are summaries thereof, do
not purport to be complete and are subject to, and are qualified in their entirety by reference to, all of the provisions of the Indentures
(and any amendments or supplements we may enter into from time to time which are permitted under each Indenture) and the debt securities,
including the definitions therein of certain terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">General</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise specified
in a prospectus supplement, the debt securities will be direct secured or unsecured obligations of our company. The senior debt securities
will rank equally with any of our other unsecured senior and unsubordinated debt. The subordinated debt securities will be subordinate
and junior in right of payment to any senior indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue debt securities
from time to time in one or more series, in each case with the same or various maturities, at par or at a discount. Unless indicated in
a prospectus supplement, we may issue additional debt securities of a particular series without the consent of the holders of the debt
securities of such series outstanding at the time of the issuance. Any such additional debt securities, together with all other outstanding
debt securities of that series, will constitute a single series of debt securities under the applicable Indenture and will be equal in
ranking.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 83; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Should an indenture relate
to unsecured indebtedness, in the event of a bankruptcy or other liquidation event involving a distribution of assets to satisfy our outstanding
indebtedness or an event of default under a loan agreement relating to secured indebtedness of our company or its subsidiaries, the holders
of such secured indebtedness, if any, would be entitled to receive payment of principal and interest prior to payments on the senior indebtedness
issued under an Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prospectus Supplement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each prospectus supplement
will describe the terms relating to the specific series of debt securities being offered. These terms will include some or all of the
following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
title of debt securities and whether they are subordinated, senior subordinated or senior debt securities;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
limit on the aggregate principal amount of debt securities of such series;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
percentage of the principal amount at which the debt securities of any series will be issued;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
ability to issue additional debt securities of the same series;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
purchase price for the debt securities and the denominations of the debt securities;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
specific designation of the series of debt securities being offered;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
maturity date or dates of the debt securities and the date or dates upon which the debt securities are payable and the rate or rates
at which the debt securities of the series shall bear interest, if any, which may be fixed or variable, or the method by which such rate
shall be determined;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
basis for calculating interest if other than 360-day year or twelve 30-day months;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
date or dates from which any interest will accrue or the method by which such date or dates will be determined;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
duration of any deferral period, including the maximum consecutive period during which interest payment periods may be extended;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
the amount of payments of principal of (and premium, if any) or interest on the debt securities may be determined with reference to any
index, formula or other method, such as one or more currencies, commodities, equity indices or other indices, and the manner of determining
the amount of such payments;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
dates on which we will pay interest on the debt securities and the regular record date for determining who is entitled to the interest
payable on any interest payment date;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
place or places where the principal of (and premium, if any) and interest on the debt securities will be payable, where any securities
may be surrendered for registration of transfer, exchange or conversion, as applicable, and notices and demands may be delivered to or
upon us pursuant to the applicable Indenture;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
rate or rates of amortization of the debt securities;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
we possess the option to do so, the periods within which and the prices at which we may redeem the debt securities, in whole or in part,
pursuant to optional redemption provisions, and the other terms and conditions of any such provisions;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
obligation or discretion, if any, to redeem, repay or purchase debt securities by making periodic payments to a sinking fund or through
an analogous provision or at the option of holders of the debt securities, and the period or periods within which and the price or prices
at which we will redeem, repay or purchase the debt securities, in whole or in part, pursuant to such obligation, and the other terms
and conditions of such obligation;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 84; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
terms and conditions, if any, regarding the option or mandatory conversion or exchange of debt securities;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
period or periods within which, the price or prices at which and the terms and conditions upon which any debt securities of the series
may be redeemed, in whole or in part at our option and, if other than by a board resolution, the manner in which any election by us to
redeem the debt securities shall be evidenced;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
restriction or condition on the transferability of the debt securities of a particular series;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
portion, or methods of determining the portion, of the principal amount of the debt securities which we must pay upon the acceleration
of the maturity of the debt securities in connection with any event of default if other than the full principal amount;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
currency or currencies in which the debt securities will be denominated and in which principal, any premium and any interest will or
may be payable or a description of any units based on or relating to a currency or currencies in which the debt securities will be denominated;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provisions,
if any, granting special rights to holders of the debt securities upon the occurrence of specified events;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
deletions from, modifications of or additions to the events of default or our covenants with respect to the applicable series of debt
securities, and whether or not such events of default or covenants are consistent with those contained in the applicable Indenture;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
limitation on our ability to incur debt, redeem stock, sell our assets or other restrictions;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
application, if any, of the terms of the applicable Indenture relating to defeasance and covenant defeasance (which terms are described
below) to the debt securities;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">what
subordination provisions will apply to the debt securities;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
terms, if any, upon which the holders may convert or exchange the debt securities into or for our Ordinary Shares, preferred shares or
other securities or property;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
we are issuing the debt securities in whole or in part in global form;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
change in the right of the trustee or the requisite holders of debt securities to declare the principal amount thereof due and payable
because of an event of default;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
depositary for global or certificated debt securities, if any;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
material federal income tax consequences applicable to the debt securities, including any debt securities denominated and made payable,
as described in the prospectus supplements, in foreign currencies, or units based on or related to foreign currencies;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
right we may have to satisfy, discharge and defease our obligations under the debt securities, or terminate or eliminate restrictive
covenants or events of default in the Indentures, by depositing money or U.S. government obligations with the trustee of the Indentures;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
names of any trustees, depositories, authenticating or paying agents, transfer agents or registrars or other agents with respect to the
debt securities;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
whom any interest on any debt security shall be payable, if other than the person in whose name the security is registered, on the record
date for such interest, the extent to which, or the manner in which, any interest payable on a temporary global debt security will be
paid if other than in the manner provided in the applicable Indenture;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 85; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
the principal of or any premium or interest on any debt securities is to be payable in one or more currencies or currency units other
than as stated, the currency, currencies or currency units in which it shall be paid and the periods within and terms and conditions
upon which such election is to be made and the amounts payable (or the manner in which such amount shall be determined);</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
portion of the principal amount of any debt securities which shall be payable upon declaration of acceleration of the maturity of the
debt securities pursuant to the applicable Indenture if other than the entire principal amount;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
the principal amount payable at the stated maturity of any debt security of the series will not be determinable as of any one or more
dates prior to the stated maturity, the amount which shall be deemed to be the principal amount of such debt securities as of any such
date for any purpose, including the principal amount thereof which shall be due and payable upon any maturity other than the stated maturity
or which shall be deemed to be outstanding as of any date prior to the stated maturity (or, in any such case, the manner in which such
amount deemed to be the principal amount shall be determined); and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
other specific terms of the debt securities, including any modifications to the events of default under the debt securities and any other
terms which may be required by or advisable under applicable laws or regulations.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise specified
in the applicable prospectus supplement, the debt securities will not be listed on any securities exchange. Holders of the debt securities
may present registered debt securities for exchange or transfer in the manner described in the applicable prospectus supplement. Except
as limited by the applicable Indenture, we will provide these services without charge, other than any tax or other governmental charge
payable in connection with the exchange or transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Debt securities may bear interest
at a fixed rate or a variable rate as specified in the prospectus supplement. In addition, if specified in the prospectus supplement,
we may sell debt securities bearing no interest or interest at a rate that at the time of issuance is below the prevailing market rate,
or at a discount below their stated principal amount. We will describe in the applicable prospectus supplement any special federal income
tax considerations applicable to these discounted debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue debt securities
with the principal amount payable on any principal payment date, or the amount of interest payable on any interest payment date, to be
determined by referring to one or more currency exchange rates, commodity prices, equity indices or other factors. Holders of such debt
securities may receive a principal amount on any principal payment date, or interest payments on any interest payment date, that are greater
or less than the amount of principal or interest otherwise payable on such dates, depending upon the value on such dates of applicable
currency, commodity, equity index or other factors. The applicable prospectus supplement will contain information as to how we will determine
the amount of principal or interest payable on any date, as well as the currencies, commodities, equity indices or other factors to which
the amount payable on that date relates and certain additional tax considerations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 86; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_018"></A>Description of Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue warrants to
purchase our Ordinary Shares or preferred shares. Warrants may be issued independently or together with any other securities that may
be sold by us pursuant to this prospectus or any combination of the foregoing and may be attached to, or separate from, such securities.
To the extent warrants that we issue are to be publicly-traded, each series of such warrants will be issued under a separate warrant
agreement to be entered into between us and a warrant agent. While the terms we have summarized below will apply generally to any warrants
that we may offer under this prospectus, we will describe in particular the terms of any series of warrants that we may offer in more
detail in the applicable prospectus supplement and any applicable free writing prospectus. The terms of any warrants offered under a
prospectus supplement may differ from the terms described below.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will file as exhibits to
the registration statement of which this prospectus is a part, or will incorporate by reference from another report that we file with
the SEC, the form of the warrant and/or warrant agreement, if any, which may include a form of warrant certificate, as applicable that
describes the terms of the particular series of warrants we may offer before the issuance of the related series of warrants. We may issue
the warrants under a warrant agreement that we will enter into with a warrant agent to be selected by us. The warrant agent will act solely
as our agent in connection with the warrants and will not assume any obligation or relationship of agency or trust for or with any registered
holders of warrants or beneficial owners of warrants. The following summary of material provisions of the warrants and warrant agreements
is subject to, and qualified in its entirety by reference to, all the provisions of the form of warrant and/or warrant agreement and warrant
certificate applicable to a particular series of warrants. We urge you to read the applicable prospectus supplement and any related free
writing prospectus, as well as the complete form of warrant and/or the warrant agreement and warrant certificate, as applicable, that
contain the terms of the warrants.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The particular terms of any
issue of warrants will be described in the prospectus supplement relating to the issue. Those terms may include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
title of the warrants;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
price or prices at which the warrants will be issued;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
designation, amount and terms of the securities or other rights for which the warrants are exercisable;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
designation and terms of the other securities, if any, with which the warrants are to be issued and the number of warrants issued with
each other security;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
aggregate number of warrants;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
provisions for adjustment of the number or amount of securities receivable upon exercise of the warrants or the exercise price of the
warrants;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
price or prices at which the securities or other rights purchasable upon exercise of the warrants may be purchased;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
applicable, the date on and after which the warrants and the securities or other rights purchasable upon exercise of the warrants will
be separately transferable;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
discussion of any material U.S. federal income tax considerations applicable to the exercise of the warrants;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
date on which the right to exercise the warrants will commence, and the date on which the right will expire;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
maximum or minimum number of warrants that may be exercised at any time;</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">information
with respect to book-entry procedures, if any; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
other terms of the warrants, including terms, procedures and limitations relating to the exchange and exercise of the warrants.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 87; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Exercise of Warrants</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each warrant will entitle
the holder of warrants to purchase the number of Ordinary Shares or preferred shares of the relevant class or series at the exercise price
stated or determinable in the prospectus supplement for the warrants. Warrants may be exercised at any time up to the close of business
on the expiration date shown in the applicable prospectus supplement, unless otherwise specified in such prospectus supplement. After
the close of business on the expiration date, if applicable, unexercised warrants will become void. Warrants may be exercised in the manner
described in the applicable prospectus supplement. When the warrant holder makes the payment and properly completes and signs the warrant
certificate at the corporate trust office of the warrant agent, if any, or any other office indicated in the prospectus supplement, we
will, as soon as possible, forward the securities or other rights that the warrant holder has purchased. If the warrant holder exercises
less than all of the warrants represented by the warrant certificate, we will issue a new warrant certificate for the remaining warrants.
If we so indicate in the applicable prospectus supplement, holders of the warrants may surrender securities as all or part of the exercise
price for warrants.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to the exercise of any
warrants to purchase Ordinary Shares or preferred shares of the relevant class or series, holders of the warrants will not have any of
the rights of holders of Ordinary Shares or preferred shares purchasable upon exercise, including the right to vote or to receive any
payments of dividends or payments upon our liquidation, dissolution or winding up on the Ordinary Shares or preferred shares purchasable
upon exercise, if any.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Outstanding Warrants</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this prospectus, there is an outstanding warrant
to purchase 1,350,068 Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I><A NAME="a_019"></A>Description of Rights</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue rights to purchase
our securities. The rights may or may not be transferable by the persons purchasing or receiving the rights. In connection with any rights
offering, we may enter into a standby underwriting or other arrangement with one or more underwriters or other persons pursuant to which
such underwriters or other persons would purchase any offered securities remaining unsubscribed for after such rights offering. Each series
of rights will be issued under a separate rights agent agreement to be entered into between us and one or more banks, trust companies
or other financial institutions, as rights agent, that we will name in the applicable prospectus supplement. The rights agent will act
solely as our agent in connection with the rights and will not assume any obligation or relationship of agency or trust for or with any
holders of rights certificates or beneficial owners of rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The prospectus supplement
relating to any rights that we offer will include specific terms relating to the offering, including, among other matters:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> the date of
    determining the security holders entitled to the rights distribution;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
aggregate number of rights issued and the aggregate amount of securities purchasable upon exercise of the rights;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
exercise price;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
conditions to completion of the rights offering;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
date on which the right to exercise the rights will commence and the date on which the rights will expire; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
applicable federal income tax considerations.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each right would entitle the
holder of the rights to purchase for cash the principal amount of securities at the exercise price set forth in the applicable prospectus
supplement. Rights may be exercised at any time up to the close of business on the expiration date for the rights provided in the applicable
prospectus supplement. After the close of business on the expiration date, all unexercised rights will become void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 88; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If less than all of the rights
issued in any rights offering are exercised, we may offer any unsubscribed securities directly to persons other than our security holders,
to or through agents, underwriters or dealers or through a combination of such methods, including pursuant to standby arrangements, as
described in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I><A NAME="a_020"></A>Description of Units</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following description,
together with the additional information we may include in any applicable prospectus supplement, summarizes the material terms and provisions
of the units that we may offer under this prospectus. While the terms we have summarized below will apply generally to any units that
we may offer under this prospectus, we will describe the particular terms of any series of units in more detail in the applicable prospectus
supplement and any related free writing prospectus. The terms of any units offered under a prospectus supplement may differ from the terms
described below. However, no prospectus supplement will fundamentally change the terms that are set forth in this prospectus or offer
a security that is not registered and described in this prospectus at the time of its effectiveness.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will file as an exhibit
to the registration statement of which this prospectus is a part, or will incorporate by reference from another report we file with the
SEC, the form of unit agreement that describes the terms of the series of units we may offer under this prospectus, and any supplemental
agreements, before the issuance of the related series of units. The following summaries of material terms and provisions of the units
are subject to, and qualified in their entirety by reference to, all the provisions of the unit agreement and any supplemental agreements
applicable to a particular series of units. We urge you to read the applicable prospectus supplement and any related free writing prospectus,
as well as the complete unit agreement and any supplemental agreements that contain the terms of the units.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue units consisting
of any combination of the other types of securities offered under this prospectus in one or more series. We may evidence each series of
units by unit certificates that we may issue under a separate agreement. We may enter into unit agreements with a unit agent. Each unit
agent, if any, may be a bank or trust company that we select. We will indicate the name and address of the unit agent, if any, in the
applicable prospectus supplement relating to a particular series of units. Specific unit agreements, if any, will contain additional important
terms and provisions. We will file as an exhibit to the registration statement of which this prospectus is a part, or will incorporate
by reference from a current report that we file with the SEC, the form of unit and the form of each unit agreement, if any, relating to
units offered under this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we offer any units, certain
terms of that series of units will be described in the applicable prospectus supplement, including, without limitation, the following,
as applicable</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
title of the series of units;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identification
and description of the separate constituent securities comprising the units;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
price or prices at which the units will be issued;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
date, if any, on and after which the constituent securities comprising the units will be separately transferable;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
discussion of certain United States federal income tax considerations applicable to the units; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
other material terms of the units and their constituent securities.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The provisions described in
this section, as well as those described under &ldquo;Description of Share Capital - Ordinary Shares and Preferred Shares&rdquo; and &ldquo;Description
of Warrants&rdquo; will apply to each unit and to any Ordinary Shares, preferred shares or warrant included in each unit, respectively.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 89; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Issuance in Series&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">We may issue units in such amounts and in numerous
distinct series as we determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Transfer Agent and Registrar</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The transfer agent and registrar
for our Ordinary Shares is Transhare Corporation, located in Clearwater, Florida. Their mailing address is 2849 Executive Drive, Suite
2800, Clearwater, FL 33762. Their phone number is (303) 662-1112.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NASDAQ Capital Market Listing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Ordinary Shares are listed on the NASDAQ Capital
Market under the symbol &ldquo;ZCMD.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_009"></A>PLAN OF DISTRIBUTION&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may sell the securities
offered through this prospectus (i) to or through underwriters or dealers, (ii) directly to purchasers, including our affiliates, (iii)
through agents, or (iv) through a combination of any these methods. The securities may be distributed at a fixed price or prices, which
may be changed, market prices prevailing at the time of sale, prices related to the prevailing market prices, or negotiated prices. The
prospectus supplement will include the following information:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
terms of the offering;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
names of any underwriters or agents;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
name or names of any managing underwriter or underwriters;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
purchase price of the securities;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
over-allotment options under which underwriters may purchase additional securities from us;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
net proceeds from the sale of the securities;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
delayed delivery arrangements;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
underwriting discounts, commissions and other items constituting underwriters&rsquo; compensation;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
initial public offering price;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
discounts or concessions allowed or reallowed or paid to dealers;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
commissions paid to agents; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
securities exchange or market on which the securities may be listed.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Sale Through Underwriters or Dealers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Only underwriters named in
the prospectus supplement are underwriters of the securities offered by the prospectus supplement. If underwriters are used in the sale,
the underwriters will acquire the securities for their own account, including through underwriting, purchase, security lending or repurchase
agreements with us. The underwriters may resell the securities from time to time in one or more transactions, including negotiated transactions.
Underwriters may sell the securities in order to facilitate transactions in any of our other securities (described in this prospectus
or otherwise), including other public or private transactions and short sales. Underwriters may offer securities to the public either
through underwriting syndicates represented by one or more managing underwriters or directly by one or more firms acting as underwriters.
Unless otherwise indicated in the prospectus supplement, the obligations of the underwriters to purchase the securities will be subject
to certain conditions, and the underwriters will be obligated to purchase all the offered securities if they purchase any of them. The
underwriters may change from time to time any public offering price and any discounts or concessions allowed or reallowed or paid to dealers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 90; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If dealers are used in the
sale of securities offered through this prospectus, we will sell the securities to them as principals. They may then resell those securities
to the public at varying prices determined by the dealers at the time of resale. The prospectus supplement will include the names of the
dealers and the terms of the transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will provide in the applicable
prospectus supplement any compensation we will pay to underwriters, dealers or agents in connection with the offering of the securities,
and any discounts, concessions or commissions allowed by underwriters to participating dealers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Direct Sales and Sales Through Agents</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may sell the securities
offered through this prospectus directly. In this case, no underwriters or agents would be involved. Such securities may also be sold
through agents designated from time to time. The prospectus supplement will name any agent involved in the offer or sale of the offered
securities and will describe any commissions payable to the agent. Unless otherwise indicated in the prospectus supplement, any agent
will agree to use its reasonable best efforts to solicit purchases for the period of its appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may sell the securities
directly to institutional investors or others who may be deemed to be underwriters within the meaning of the Securities Act with respect
to any sale of those securities. The terms of any such sales will be described in the prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Delayed Delivery Contracts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the prospectus supplement
indicates, we may authorize agents, underwriters or dealers to solicit offers from certain types of institutions to purchase securities
at the public offering price under delayed delivery contracts. These contracts would provide for payment and delivery on a specified date
in the future. The contracts would be subject only to those conditions described in the prospectus supplement. The applicable prospectus
supplement will describe the commission payable for solicitation of those contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Market Making, Stabilization and Other Transactions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the applicable prospectus
supplement states otherwise, other than our Ordinary Shares, all securities we offer under this prospectus will be a new issue and will
have no established trading market. We may elect to list offered securities on an exchange or in the over-the-counter market. Any underwriters
that we use in the sale of offered securities may make a market in such securities, but may discontinue such market making at any time
without notice. Therefore, we cannot assure you that the securities will have a liquid trading market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any underwriter may also engage
in stabilizing transactions, syndicate covering transactions and penalty bids in accordance with Rule 104 under the Securities Exchange
Act. Stabilizing transactions involve bids to purchase the underlying security in the open market for the purpose of pegging, fixing or
maintaining the price of the securities. Syndicate covering transactions involve purchases of the securities in the open market after
the distribution has been completed in order to cover syndicate short positions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Penalty bids permit the underwriters
to reclaim a selling concession from a syndicate member when the securities originally sold by the syndicate member are purchased in a
syndicate covering transaction to cover syndicate short positions. Stabilizing transactions, syndicate covering transactions and penalty
bids may cause the price of the securities to be higher than it would be in the absence of the transactions. The underwriters may, if
they commence these transactions, discontinue them at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>General Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Agents, underwriters, and
dealers may be entitled, under agreements entered into with us, to indemnification by us against certain liabilities, including liabilities
under the Securities Act. Our agents, underwriters, and dealers, or their affiliates, may be customers of, engage in transactions with
or perform services for us, in the ordinary course of business.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 91; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_010"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as otherwise set forth in the applicable prospectus supplement,
certain legal matters in connection with the securities offered pursuant to this prospectus will be passed upon for us by Hunter Taubman
Fischer &amp; Li LLC to the extent governed by the laws of the State of New York, and by Ogier to the extent governed by the laws of the
Cayman Islands. If legal matters in connection with offerings made pursuant to this prospectus are passed upon by counsel to underwriters,
dealers or agents, such counsel will be named in the applicable prospectus supplement relating to any such offering. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_011"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The financial statements in
this prospectus as of December 31, 2020 and 2019 and for the years ended December 31, 2020, 2019 and 2018, incorporated by reference from
the Company&rsquo;s Annual Report on Form 20-F for the year ended December 31, 2020 have been audited by Marcum Bernstein &amp; Pinchuk
LLP, an independent registered public accounting firm, as set forth in their report, which is incorporated herein by reference, and are
included in reliance upon such report given on the authority of such firm as experts in accounting and auditing. The office of Marcum
Bernstein &amp; Pinchuk LLP is located at Suite 830, 7 Penn Plaza, New York, New York, 10001.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_012"></A>FINANCIAL INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The financial statements
as of December 31, 2020 and 2019 for the years ended December 31, 2020, 2019 and 2018 are included in our Annual Report on Form
20-F, which are incorporated by reference into this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 92; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_013"></A>INFORMATION INCORPORATED BY REFERENCE&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SEC allows us to &ldquo;incorporate
by reference&rdquo; into this prospectus the information we file with the SEC. This means that we can disclose important information to
you by referring you to those documents. Any statement contained in a document incorporated by reference in this prospectus shall be deemed
to be modified or superseded for purposes of this prospectus to the extent that a statement contained herein, or in any subsequently filed
document, which also is incorporated by reference herein, modifies or supersedes such earlier statement. Any such statement so modified
or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We hereby incorporate by reference
into this prospectus the following documents that we have filed with the SEC under the Exchange Act:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Company&rsquo;s Annual Report on&nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390021023712/f20f2020_zhongchao.htm">Form
20-F</A>&nbsp;for the fiscal year ended December 31, 2020, filed with the SEC on April 30, 2021;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Company&rsquo;s Current Reports on Form 6-K, filed with the SEC on&nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390021001874/ea133240-6k_zhongchao.htm">January
13, 2021,</A>&nbsp; <A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390021015925/ea137868-6k_zhongchaoinc.htm">March 17, 2021</A>
and <A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390021024835/ea140442-6k_zhongchao.htm">May 6, 2021</A>; and</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
description of our Ordinary Shares incorporated by reference in our registration statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390020003473/f8a12b021320_zhongchao.htm">Form
8-A</A>, as amended (File No. 001-39229) filed with the Commission on February 13, 2020, including any amendment and report subsequently
filed for the purpose of updating that description; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All documents that we file
with the SEC pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act (and in the case of a Current Report on Form 6-K, so long
as&nbsp;<FONT STYLE="background-color: white">they state that they are incorporated by reference into this prospectus, and</FONT>&nbsp;other
than Current Reports on Form 6-K, or portions thereof, furnished under Form 6-K) (i) after the initial filing date of the registration
statement of which this prospectus forms a part and prior to the effectiveness of such registration statement and (ii) after the date
of this prospectus and prior to the termination of the offering shall be deemed to be incorporated by reference in this prospectus from
the date of filing of the documents, unless we specifically provide otherwise. Information that we file with the SEC will automatically
update and may replace information previously filed with the SEC. To the extent that any information contained in any Current Report on
Form 6-K or any exhibit thereto, was or is furnished to, rather than filed with the SEC, such information or exhibit is specifically not
incorporated by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon request, we will provide,
without charge, to each person who receives this prospectus, a copy of any or all of the documents incorporated by reference (other than
exhibits to the documents that are not specifically incorporated by reference in the documents). Please direct written or oral requests
for copies to us at 841 Yan&rsquo;an Middle Road, Jing&rsquo;An District, Shanghai, China 200040, Attention: Weiguang Yang, 021-32205987.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_014"></A>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As permitted by SEC rules,
this prospectus omits certain information and exhibits that are included in the registration statement of which this prospectus forms
a part. Since this prospectus may not contain all of the information that you may find important, you should review the full text of these
documents. If we have filed a contract, agreement or other document as an exhibit to the registration statement of which this prospectus
forms a part, you should read the exhibit for a more complete understanding of the document or matter involved. Each statement in this
prospectus, including statements incorporated by reference as discussed above, regarding a contract, agreement or other document is qualified
in its entirety by reference to the actual document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to the information
reporting requirements of the&nbsp;Exchange Act that are applicable to foreign private issuers, and, in accordance with these requirements,
we file annual and current reports and other information with the SEC. You may inspect, read (without charge) and copy the reports and
other information we file with the SEC at the SEC&rsquo;s Public Reference Room located at 100 F Street, N.E., Washington, D.C. 20549.
You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also maintains
an internet website at&nbsp;<I>www.sec.gov</I>&nbsp;that contains our filed reports and other information that we file electronically
with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We maintain a corporate website
at http://izcmd.com. Information contained on, or that can be accessed through, our website does not constitute a part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 93; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_015"></A>ENFORCEABILITY OF CIVIL LIABILITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are incorporated under
the laws of the Cayman Islands as an exempted company with limited liability. We incorporated in the Cayman Islands because of certain
benefits associated with being a Cayman Islands exempted company, such as political and economic stability, an effective judicial system,
a favorable tax system, the absence of foreign exchange control or currency restrictions and the availability of professional and support
services. However, the Cayman Islands have a less developed body of securities laws that provide significantly less protection to investors
as compared to the securities laws of the United States. In addition, Cayman Islands companies may not have standing to sue before the
federal courts of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of our assets are located
in China. In addition, some of our directors and officers are residents of jurisdictions other than the United States and all or a substantial
portion of their assets are located outside the United States. As a result, it may be difficult for investors to effect service of process
within the United States upon us or our directors and officers, or to enforce against us or them judgments obtained in United States courts,
including judgments predicated upon the civil liability provisions of the securities laws of the United States or any state in the United
States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">According to our local Cayman
Islands&rsquo; counsel, there is uncertainty with regard to Cayman Islands law relating to whether a judgment obtained from the United
States or Hong Kong courts under civil liability provisions of the securities laws will be determined by the courts of the Cayman Islands
as penal or punitive in nature. If such a determination is made, the courts of the Cayman Islands will not recognize or enforce the judgment
against a Cayman Islands&rsquo; company. The courts of the Cayman Islands in the past determined that disgorgement proceedings brought
at the instance of the Securities and Exchange Commission are penal or punitive in nature and such judgments would not be enforceable
in the Cayman Islands. Other civil liability provisions of the securities laws may be characterized as remedial, and therefore enforceable
but the Cayman Islands&rsquo; Courts have not yet ruled in this regard. Our Cayman Islands&rsquo; counsel has further advised us that
a final and conclusive judgment in the federal or state courts of the United States under which a sum of money is payable other than a
sum payable in respect of taxes, fines, penalties or similar charges, may be subject to enforcement proceedings as a debt in the courts
of the Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date hereof, no
treaty or other form of reciprocity exists between the Cayman Islands and Hong Kong governing the recognition and enforcement of judgments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cayman Islands&rsquo; counsel
further advised that although there is no statutory enforcement in the Cayman Islands of judgments obtained in the United States or Hong
Kong, a judgment obtained in such jurisdictions will be recognized and enforced in the courts of the Cayman Islands at common law, without
any re-examination of the merits of the underlying dispute, by an action commenced on the foreign judgment debt in the Grand Court of
the Cayman Islands, provided such judgment (1) is given by a foreign court of competent jurisdiction, (2) imposes on the judgment debtor
a liability to pay a liquidated sum for which the judgment has been given, (3) is final, (4) is not in respect of taxes, a fine or a penalty,
and (5) was not obtained in a manner and is of a kind the enforcement of which is contrary to natural justice or the public policy of
the Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_016"></A>INDEMNIFICATION FOR&nbsp;SECURITIES ACT&nbsp;LIABILITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Insofar as indemnification
for liabilities arising under the&nbsp;Securities Act&nbsp;may be permitted to our directors, officers and controlling persons pursuant
to the foregoing provisions, or otherwise, we have been informed that in the opinion of the SEC such indemnification is against public
policy as expressed in the&nbsp;Securities Act&nbsp;and is, therefore, unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 94; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "  7D# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<0O#(,HX*D5E6H*<7;<&>+DDG)Y)YHK1UC1[C2+QXY4/E$_NY,<,/\:SP,D
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M5959F959DPK%>H!J_52J5&K28HP@G>*,W5]!T[6E1;^V$A3[K D$?B*RO^$
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*1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" -^ P0# 2(  A$! Q$!_\0
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M6[\.#X:?#)/%MO96&DW&NWC2^$)-'3Q0ES;Z3:RWKV#:0+_RVMU6V,MW:QS
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MX7_\'/C+_P":6@#[>\WV7_OO_P"QH\WV7_OO_P"QKXA_X=K_ +#O_1O?A?\
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M_M(/^T7_ .DO@6OT)K\]O^"?O^N_;A_[2#_M%_\ I+X%K]": "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /@?
M]H/_ )/9_P"">?\ V&OVJO\ U1K5]\5^<_[7M]XU\'_M"?L;?&'0_@]\5/BW
MX6^%_B3XZ6WC&Q^$&@:=XK\2Z/%X^^%%SX>T#4+O1]1UKP^%TZ;5H4M))X+N
MYDCDF1W@6']Z>K_X;DO?^C+?VZ__  R7AS_YY% 'W+=1B6)D*EAG=@9SN0%H
MSA<,<2!"-I4J0'##;FOS5T__ ()[Z3H&EV=GHOCK5!J*66BZ'J]W>Z'?'2/%
M/@_P_=_"J^L/!7B/1-(\7:09/"K:G\/=4UF?3-'U71);J\\=^*FE="'M-=]%
M_P"&Y+W_ *,M_;K_ /#)>'/_ )Y%'_#<E[_T9;^W7_X9+PY_\\B@#P[Q-_P3
M<EUUO%VI7'Q/O?$7B35%FDT.;Q1IGBF'2W\1ZE\0-'U_6OB/XQ&E>-0?$OQ'
MU/P/!JOPUU;5]*M/".DZGX4_L?3].TOPT+2[O;VKJ?\ P3,;Q'K>CW6M_'/Q
MG-X>T^\^%ES=^'K;2==LH]2\+?#!_AG,/A')<KX_:.W^%6I7_P /[[4=.\)S
MV&I7^FZCXLUBZO?%?B"P2/3K[WO_ (;DO?\ HRW]NO\ \,EX<_\ GD4?\-R7
MO_1EO[=?_ADO#G_SR* /DRV_X),:7'H7AVWO?BYJ^J>(-$7Q#IE]XAN?!5YI
MMYJ?A#Q'XUT'XA7/@JT;0OB#::QHWAA_'&EZQXWO]'TSQ EI)XPU^UUO2(]$
M.CS:?>_3*?L3R+_PO26+QW(+OXWP^&(M3OK_ ,/>(;K4Y=.\/?$?Q-X^D\/>
M.=27XAF_\9Z?K6A^*)?A9K::3?>"7G^&^FVVAC4Y-5N)==AVO^&Y+W_HRW]N
MO_PR7AS_ .>14%S^W7<VMM<74O[%_P"W0D5M!-<2O)\%?#B(L4$;2R,S'XCG
M "(QP S$C:JLQ (!YWX+_P"">VI>!O#_ ,1M.\/?M!_$#2_$'Q)^&7B;X9:E
MXIM=+O;J\TBPU[3_  'H^CZAH%GKWB;5;;37^'>D>&/$&F^ ;9&DETB+Q9<7
M-Q?7]S97,VK^1^'/^"6^I>%/B%XSG\/_ !Q\9:1\&-2^%FI^ O 7A%I_$]_X
MQ\'OXWE_:#N?'FD/J%EK.BZ!!X2N=>^-MCXFT^STK3UU);[P5X)TNTU3P]H/
M@73'U3Z7TG]O?^V]+T[6=-_8U_;FN]-U:QM-3TZZA^"OAUXKG3]0MX[RRN%)
M^(ZLHGM9HI2CJK(7*D$ ,VA_PW)>_P#1EO[=?_ADO#G_ ,\B@#SSQ1_P3ST7
M6OA#^T5\(='^*GC[P9HGQ\6YLTNO">B>%9KWP?HECXM\>>*M(\*PQ^,M/\46
M>M^$X%\:+H<^FWMO8W.IZ/HEI:P:EI2ZE>"/NO'G[+'Q4^(^K^ K_P 1?&_3
M;C3?AK/;ZUX3T:Z^%TTSMXZ\.^*_M_A#XA^(KW1/&OA72M8\1IX1LK#P3XFM
MK?PQH&B:AH>N>/O^$8TWP9<>)K2;0;/_  W)>_\ 1EO[=?\ X9+PY_\ /(H_
MX;DO?^C+?VZ__#)>'/\ YY% '&']A:[M_"/B7PC;>/+":/Q#X<M;"'7#X,\4
M:9XGT'Q/<Z_\=?$/BCQ/HVJ^'OBQX>A3[9'\?_&GAWP]H5_#?Z1I6AKI.GZ\
MWC:UBU6.\_0G0=,@T?2;#3+9'C@LK2UM(DD=W<1VEM#:QAV=4W.(X$$CJB+-
M(&G*EY79OBG_ (;DO?\ HRW]NO\ \,EX<_\ GD4?\-R7O_1EO[=?_ADO#G_S
MR* /NVO@7X%D?\-[?M]\CCPI^QN#ST/_  A/Q6.#Z<<_3GI5X?MQWI_YLN_;
MK'_=$?#Q_P#0?B.3^F*XW]DR^\:>,_VF_P!LCXTZY\'/BU\(_"/Q&T[]F[1/
M!MI\8?#FE^$_$6O7/P\\(>.K#Q5=V&CZ?K_B!CIEC-X@TR**ZNKBTGNKEKB*
M*T,,*74P!^CU%%% 'B?[2G_)O'QX'<_!?XI@#N3_ ,(/KG '>L+]DH$?LM_L
MSY!&/V>O@PISQAA\.?#H*G/0@@@@\@@BN^^,7A>]\<_"WXD>!M,FM[?4O&GP
M^\9^%-/N+Q)WM(+WQ!X<U+2;.>[^SJ\QMH+J[AEN$MUDN9(%E\F-G0 _GQ\*
M(/\ @J#\+?A?\.?AK;_ O]A_6[?X?> _"'@B'5I_VH_C783:I'X5\/V&A+J4
MM@/V7[M+)[Y;$7362WET+-I# MU<!/-< _5'(]1^8HR/4?F*_.W_ (3;_@J/
M_P!&[?L-?^)6_&K_ .A9H_X3;_@J/_T;M^PU_P")6_&K_P"A9H _1+(]1^8H
MR/4?F*_.W_A-O^"H_P#T;M^PU_XE;\:O_H6:/^$V_P""H_\ T;M^PU_XE;\:
MO_H6: /T2R/4?G2U^=G_  FO_!49N/\ AG?]AOD@?+^U=\:P>O8C]E@G\._2
MN6LOBW_P4ZO_ !7XA\)0_LX?L2?;?#FE>&-6NIV_:P^-7D3P^*7UZ*TA@"?L
MKM)Y\$GAZ^,X=5C,302)(2TB1@'Z>9 ZG%)D>H_,5^=@\:?\%11R/V=_V'#_
M +W[5_QK8?E_PRQU]Z7_ (3;_@J/_P!&[?L-?^)6_&K_ .A9H _1+(]1^8HR
M/4?F*_.W_A-O^"H__1NW[#7_ (E;\:O_ *%FC_A-O^"H_P#T;M^PU_XE;\:O
M_H6: /T2R/4?F*0LHQEE&2 ,D#)/0#GDGL.M?G=_PFW_  5'_P"C=OV&O_$K
M?C5_]"S3'\;?\%1L+_QCU^P[&P8%?+_:H^-$S,0"2HC;]EGYSLW.JKEF954#
MDT 9W_!)C_DS#2_^SB?VVO\ UM'X^C^?%?I/7QC^P!\"OB!^SE^S#X8^&'Q3
MN_"-WX^3QY\<?'WB;_A!-5U77/"=CJ'Q?^-_Q#^+3:-HNKZWI6A:GJ-KH,?C
M9-$-_=Z-I4E]+I\EX=-L/M'V.#[.H **** /SQ^$O'_!3+]L@G@-^S!^QH%)
MX!/_  FW[5C8'J=H+8'.WGI7Z'5^8?Q ^&O[9?@+]L/XK_'G]G[P+^SU\1/!
MWQ<^#7P5^'^H:?\ %GXM>//A;XC\/ZW\)/$?QBU*>>R7PI\'?B7;:UI.K6_Q
M'MEB:;4=-GLY+ DV]Q'=YM>G_P"$Z_X*??\ 1N/[%G_B6GQJ_P#H5* /T5HK
M\ZO^$Z_X*??]&X_L6?\ B6GQJ_\ H5*/^$Z_X*??]&X_L6?^):?&K_Z%2@#]
M%2,^OYD?RHK\ZO\ A.O^"GW_ $;C^Q9_XEI\:O\ Z%2FOX[_ ."H 4E/V;OV
M+9'Q\J+^UI\:068\ 9/[*G SC<0&(7)"L0%(!^BV,^OYD?R-+7Y@Z3\9/^"F
M^K:SXGT2+]F3]C6"Z\*W^E6-Z\_[6GQH2&<ZQI5GK-G):L/V4RSC['>Q+.CJ
MKPW*3PMD1K(_4_\ "=?\%/O^C<?V+/\ Q+3XU?\ T*E 'Z*8[\_F?Y9Q2U^=
M7_"=?\%/O^C<?V+/_$M/C5_]"I1_PG7_  4^_P"C<?V+/_$M/C5_]"I0!^BM
M%?G5_P )U_P4^_Z-Q_8L_P#$M/C5_P#0J4?\)U_P4_[?LX?L5_C^UM\:1_[Z
MI0!:_P""?;H\O[<)1U<?\/!_VBCE6##!M? N#D$]>U?H77P]^PU\(/C!\)?"
M7QDO?CG;_#W3?'WQC_:0^*OQONM"^&7B'6_%OA7P[I_CH:)#IVB6_B+Q#X3\
M%ZIJ-W;6VB+/>ROX>T^*.>Y:V59&A,TWW#0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 SRX]Q;8FXXRVU=QQ
MMQDXR<;5QD_PKZ##L#T'Y"EHH 3 ]!^0HP/0?D*6B@!,#T'Y"C ]!^0I:* $
MP/0?D*QO$:K_ ,(_KGRC_D$:CV':TF(_6MJL7Q(<>'M=/_4(U'_TDFH \E^'
M.MW&C?"#X,+9Z5=ZQ=:IX&\#:?:V-I/96I:8>"8-3DDDN+]XK=%2UTZY*J9
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M\2_$4JQ&J> P4P'+Z5KX5#@L0Y;Q @4[%9P&D!V#S,LG)_-SQI^SA^V5K/P
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MY^'VBPK?2SP6<+:A\.]!5;B4VMM<SOY)B"I%"J,QD(+J""/4#=>-B%S%X0&
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M97XV_$1N!N^&7P:(((!*GQ?\<0P_'Y01W 'H*\R_X;,^ 7_0V>)__#._&?\
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M /SOZ /JJBOE7_AM']GK_H;O$G_AHOC/_P#._H_X;1_9Z_Z&[Q)_X:+XS_\
MSOZ /JJBOE7_ (;1_9Z_Z&[Q)_X:+XS_ /SOZ/\ AM']GK_H;O$G_AHOC/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7P2(\_\%.'*D+_ ,8(Q@Y4MG_B_P!@9&X(< <97(YP>>/O:O@Z/_E)
MN_\ V8E'_P"K^H ^Z_*;NR_]^E'^-'E'^\O_ 'Z2IJ* //OBCK\W@_X;^/\
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M88-X;T!E.0=%TL@X(R#8P$8R!V/X'(/((H VMH_R%_\ B:-H_P A?_B:=10
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MYC_X);KM_P"">?[(HR3_ ,67\,'GU*3YQZ#.=JC 5<*. *^^*^"/^"6[!O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\'1_\I-W_P"S$H__
M %?U?>-?!T?_ "DW?_LQ*/\ ]7]0!]XG.#@9..!TR?3-?/'Q>^*/Q&\(^(/"
M?A#X;>"_#_C;Q5XA\+^//%ITS6_$$OAF"YL/ VJ>!-&N+'3]0>WN[6'4+NX\
M>V5^AU!XK:/3])U'=*'DCDB^ACG!QC.#C/3/;..<>M?._P ?-6T#X8^&K+XS
MW_AIO$.L_#VXL]%T?R=7O-+N!8_$37_"W@[5K63[-!<V]_9S[M(U&XTZ_L[N
MT:?1;6]C,-Y9V[. ?GN_[>Z/\7M1TS]H3X4?"JW^'WP[U#XGVNF?$_X1?$;5
M?C4FCZ[X0N_A]\,/&R^*="U#X=> -3\-7&DWOQ>?P%XJTCPVWQ*M?[837]-%
MS>7GA*_-GV%K^V1^P]+=ZKX:N/!%QIX\.:-8+JLR?##0X=+T.V'A_P <?%[P
MWH$VIZ)>RVL\6IZ%\-?$GB32].T^ZU#PO#+9Z99:_<Z9X@U233Z[K2/VF/V2
M=/O?$EWIOPSO=#U+_A&]1^)?BBYC^#UMHM]>^&[JVT?Q98>+M=DM+2.XUB7Q
ME=ZCIMQX:G:/4];U#6(5N-4CTEY&O9>9U+]HW]BOQ[H%W\/Y?AKX@F\&^([K
M6OAYK$^F?"I_#_ARRU"+1]0B\;>'KN_LVTW[#>>"]-\4:I_PDW]G3"VMFU^]
MN=%NM1N]3OX;@ P/$7[?GP"U"*PNM"^%^J>)/#=AXSU/P;\7CK7@S0HM;\&:
M9:_ OQ5^T5=:AIFC?VC/'XQM3X430M;GO=*N[GPYJVG^+KA?#.OZ_KT-UI:;
M>C?\%!OV)[GQ)?\ @?P],G]K>'O%DWPKURW\/_#^RFT>T2XO_@KX>DC6\M+B
M:QU7PKJEQ\9_A%ISV7AN76]7BMM21M7\.:;'X6U-=*H_#K]J#]B3PEX5T_P[
MX1\$:Q#X=T'X<+XPL]6U/P%!]B;X<7VK0:?HWB'4?&WCG4K=)]*\6:G\0=0L
MO#MOXEU>VU:^CUC6[*ZTK38+BYCO]FV_;4_8QL8+'6+SP9-X<CFN_&WCWPU>
MS?#OP[/>WUOX7DN[63XG:7;:#>ZEK'F^)IK1;+0[V\M]-\331O,?$-KIL+7K
M, >?Z5^VI^S[I6@ZYXO^)OPG^&O@;X;V_P <V^%/PCM?#.K^&O'GQ5UGQCX?
M^)'C;X=7MSXO^#__  BNA7_PVOAX_P!*U6\\.6NA:SX]UR31_$\NJ7X\*ZI#
MJ6FZ;JZM^W_^P7<6MD;C2-2\3>&O[/U1['Q8/A+#J_A&*SMO"/C76_$L$$5P
MUL8_[(\)?"7QR?$VEQZ/'*+?P-_PB][9W&J2^%-'ONR\'_M3_LY:[\/_ (<?
M$WXC_#;1O#&M_&#Q7XJEBCM? 5KXBO+*^\%?%Z?X'>%O$7BO5H-+;4K#7M1U
M[5_#F@VLDD,VJZ-?:[=A?L^D:!JNHV?&ZQ^U?^R!\%?@+\(_&'AKX=:=_P *
M^\3^+;?PW96/C3P_%X7U#PMX'N_"T_Q)\=?$W7KOQ1#J=U?:=I/PK\2ZOXM6
MROK^35/%MSXQL/"B7EIJ7BBXB4 [+P;^V=\!FUKXF?#C]F/PIIM[\4T\2IX>
MO;*32$T3X>O\0H]%\(>&_!3^*/%6AW&H2CPWJNFZOX$TC2;OP[IFLWEEHD=O
M!-I>GO;RB/[:^&7Q#\2^*M3\3>&_%^A:5H?B;PI_PB U6#1-1GU?2M_B+P1I
M.O7T4&H306Q>2P\13ZSI$ ,7^EV&FPWX"R33PVWQ_;?M??LR:1=0KX-\"ZI)
MK&K>,].TU!I7PRBT]KN74K^UEL_&-UJNE6%RAT:[<27.F:U>%M0U/5K73+06
MOVB]TZ\?ZY^!]]8>+?!VF?%&/1;/1=8^*-CH7BWQ#!:7<MXC:C#X>L_#]F%N
M)54/%!HFEZ=;K' D-LLD<DT:323SW4X![97P=_PM+P1\.OVV_CDGCGQ!:Z!)
MJ_[,?[*S:<+BWNW2Y2P^)O[7PN3%)!'.289KS:P=(\JT>W.UF;[QKY.\%(5_
M;<_:&)Q@_LS?LF$8ST;XH?ME8[?[)S^% '0WOQ^_9QU&<W-_XO\ #5[,42,O
M=Z3<7#E$)9$\R;2WDVH2Q4;\*7? &>(/^%X_LUM_J->\&.1][=H=PN!VY31I
M#U[$#ZU]+T4 ?-/_  N[]G';_P AOPB&]?\ A'KTQ]?^>@T7)&.X7KVI%^-W
M[.!SNUKP@WIY7AR^D _WB=#7!]!S7TO10!^-/[<7[8/P*\(_LX?M1^'O&T7A
M30=!\5?"+XD^"?AAXYT+3K[58]=\3>,/AMXETSPYH&MZ/'H%AKOAG7[SQ/'<
M:?I5_9)KGA6Y@BAO[WQ)H][NT@?KMX58OX=T5BAC#:98%4*E<+]DAQMS@LG]
MQRD19<'RUZGXQ_;1^%'AN#]G+]L/XD7*7FK^*+G]E[XY6NG7>N:E?ZO:^%[>
M+X3^)89+3P=H][++H_A5+Y(R=3O]$LK/5M4)']IWEZ5B:'[4\-J%\/Z(% "_
MV3IVT#(POV.':O+,WRC"@L[$@ EN<  VJ^*?VNOVE_B5\ )/AA8_#/X>_"_X
MCZ]\0?&W_"-MX;^('QBU/X3ZN^A6>GQZSXE\2^$39?#3XA6/B(>#]"CU37?$
M%EJ]WX3MHK6PL]-M-4NM>\1>']+O_M:N'\4_#CP/XUN+*Y\7^#O"GBR73)_M
M6E-XHT#2]?\ [)NML"M<Z4-6L[U-.N9#;V[R7-HL4KM:VV\N$& #X:T#_@I!
M\+T^$OA'XC>/=#\4^&=3U3X:^'/'_B[PS8Z&-4N?"@US2/ MY';(\>KA]=@U
M*_\ B#X=M-%70$U;4X;?4K2\\3Z=X=1-2&G=+<_\%$/@A9>*H/!=W:>-$\2O
MKUQX1NM)7P]:K_9/C6T\4>)O"LW@W6M6NM<M=#TG69KOP5XPO=/U"]U"+PEJ
MEAX=U :7XFO]3CCTR7ZYN/AKX-O?L)O?"OA:[?33<BP:[\/Z7=FQBO=/M-*N
MX; 2V86RBN=.LK33KN.V6**ZTVSMM.:./3XX;2#S.?\ 9=^#%S\2?$OQ8N?A
M]X=O/&GC'P_#X9\47]^+N_L]:TJ/4-.U1TN]"N7;P_\ ;9;[2--N9-7CTI-6
M::VFF6\BGU"^FE /E*Q_X*B? W0M.\.1?%F6[\ ^*O%'Q!\2^!=*T""VBU]K
MN'2OBYJOPDT7Q/9PZ?J3ZY>^'=9\0VFGZ1/=V>AW%YI.N:@(+[38[3[%<7_H
M^M?MU^#;;PE<>,M$T5+K2K;1_BVSIXDUJS\-3/XP^%GP^TOXA+X.MKJV7Q!I
M&IW7BG2=2CDTZ^T34]62SMQ=O-:W%_HNLZ9:_5LGPN\#3SV=U<^#?"=S=:7/
M)=Z/>76A:;=7NE7DUV]]-=Z;>2V7VK3;R6\EEO7N[*:.;[:YNLF2GGX7^ SI
M&F^'SX)\&G0=&U"+6-'T0>&M%CTG1]8MY);F#5M)T]=/-EI>J0WDTMS#J6G6
M]K?17,DET)WD;: #\Y]5_P""FMAX4\5Z]X9\9^ ] TD^%?CA<>"_&5S9>,-?
MU)O /P*M5T^UF_:#\92KX!B\.PV$6I:_X5N+[POX9\3>)],T3P_XB^VZUXZL
M=;\/>)_#FD=K\2/^"B_A+X7WGCK^VO"2:SIW@#P3^U9XVU>+PYXDM+[Q/-#^
MR_K?@O3)M%M?#LMK"AU'QQ8^+7U>UFN=5MK;0+#3I+JY_M&!KAK3[DA^&G@J
MV34[>V\'^#X+36WU!]9AA\-:/ -8;6O)&MOJJQ6034I-46UM5U)[P3'5%BB%
M^)3;0,,\_![X;OKC^)6^'O@ >(GNI+Z3Q&GA#0UU^6^E@^RR7S:HMBEX+V2T
M)L6N6GEF&GAK%9!;SR* #"^ ?Q*\5?%3X=:)XN\8:+\/=!U[4+C4X-0TOX8?
M$W_A<'A&T:QN6BA6Q\=KX5\%QZC<-$%_M&V_L"V;3+S=9^9=X,X]MKF?#7A/
M0O"-C;Z3X:T71_#NCVHE^SZ/H&GVVE:5;&9VDE-MIUE#!9P-+(QFFDA@BEN)
M6+W,D[@.>FH ^ O^"J37*_\ !.+]M0V<44UT?V=OB8+>*>22&&2X_P"$=O/L
MT<TT4%S+#!)<>5%//';W#VT#R7"6UR\2V\MS3_$/[?\ >V6GW-W^SE^QC,5L
M;9%0_M>_&6[3R5BC:!C+)^PS!(7,3>8T0S##)//$K7 43O%_P5*_Y1T?MH?]
MF\_$C_TPW-?<^E_\@VP_Z\K3_P!)HJ /C-/$'[=I)\S]FC]CG&./)_:Q^+3G
M/^T)?V*( ![@L<]AUJPOB']N $>;^S3^R9C/S>1^U+\2WQR?NF?]D"VW<8].
M_'K]IT4 ?&B^(_VT!GS/V:?V8">,>1^TSX\D&.?O&3]E: @^@ 88[CI7RO\
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M>)\'?_!OJ'_RLH_X>W_\$V?^CQ/@[_X-]0_^5E 'Z+45^=/_  ]O_P"";/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5\L?&G]C;]G?\ :'\6Z'XY^+GPUB\2>+?#FA7OA?1_$MIXI\8^
M$M;M?#M]J(U:YT1[WP7XBT&:\TM]31+Z.TOY;N*.<><B1S#-?4]% 'P0O_!,
MK]BX#GX4:WG/_19?C@?3_JHU._X=E_L6_P#1*-;_ /#R?'#_ .>-7WK10!\%
M?\.R_P!BW_HE&M_^'D^.'_SQJ/\ AV7^Q;_T2C6__#R?'#_YXU?>M% 'P5_P
M[+_8M_Z)1K?_ (>3XX?_ #QJ\OM_^"<G[(3_ !<\6Z$/AEXA?2;+X=?#;5[>
MP/QD^-K00W^I^*?BE::A=Q!_B3&R2W5IHVGQ3[9$$Z6=NK;_ "E _3^>3R87
MDRH*@8+_ '<DA0#@@DDD #(R2!FOSF\!_MZ?LC^./VX?B?\ LS^%OCY\/M:_
M:#TKP7X/\,WWPCLKRZ;QKIVL^ =>^+&L>,M-OM*: /%/X>T_6-+O]6>22W@A
ML=0L9[:2\CO;26< P-+_ .";7[+6J_VM=0?#V"PM;77-8TJ"WN_B/^T1J,@B
MTS4;BUCFEO$^.>GHT\Y*H8H;&&+<JI&#^[6M(?\ !-']EQ6>,^"+',;,KC_A
M,/VBG;*LROM+?'DM(%92"5W!>.=I7/V;X>UO28+3Q#:3ZWH]C>1>+_&+&.ZU
M*TAE@C;4KW][-#)*LBA4=K@$+D+&>!AI$_+3X;? GXKGP]X;N=;B\.0WD?PV
M^&GA[XDZ1XI^*]W#)\4/&'PY^.FH^+?&.GWND"VU/1=%T/Q]I4^LW^G:S$KV
M^M1W5GINM6<NG7+K; 'O[?\ !-/]ED!2/!FFL&(7CQG^T(VW)V[G"_'LE$!^
M_(^U$#(SLJNA9D7_  3._9=N)3'%X*T^1P?F1?&G[1:[=PD8 L/C]A<"-MW
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M&OBG7?$EO<_$>Z\<7::/#X6O-:NIK6T_LCPV-:M/$%AHHBBM[.\\&Q7Z?Z1
MK?9L(A"HL84; (U R "JL-HSV ##\/4"@">OS;_9 _Y/4_X*L_\ 9?OV<_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS2*!^TC\!<*[!E=@#XF."^]C(?\ EH6._<.*N+^T+^V,@VK_ ,$^/%F,L?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4W>F0-ZY)P!N&21G( SR1M/Y'T-.KX6\<6'Q
M,^)'[6'BOX9Z)\>_BA\)/!GA#]GOX3^.[;2_AOH_P;O9]6\4>.OB+\;-!UJ^
MU>_^*7PH^)=X\$6D_#SP_!8V&E-IT4$D=S-LE>YER ?=&1ZC\Q1D>H_,5\(7
M'PUU&TUV7PQ=?\%!OCS;>(HETXS:%/-^QA!K41U?4;'2--2319OV8H=71[W4
M]4TFPM=^GJMU>ZKIUG;-/<W4<1[+_AG3XCG./VUOVHCC);&A?LB_* >,_P#&
M*O5AR /N_P#+0QC)H ^O<CU'YBC(]1^8KXKUCX'^-/#UA-JNN?MR?M*:1ID$
MME#+J&IV/['6GV4<VH74=C90R7=Y^RU!;)-=WTT-C:Q&8O<WEQ;6T >695&L
MG[.GQ'>/S/\ AM;]J$ ]/^)'^R*P)*J5&Y?V5&49=MAW%=N5+ ,=H /K:[E\
MNWED4ME &_=H9'P&!.R-5=G;&=H6.1B<8BD/R-^-O[-G_!53]G;]H7_@I'^T
MM^Q9X$\+_'*S^,_PFT"#0O'TWB+X:)IO@CP\?@[XG\8Z9K=[=>*8M>O(4T[Q
M+<>+]'D\#W3VQ;Q-9:G;W-M#"8G ^O[GX+^*;?6[/PQ/^WG^T5:^(]2M[B]T
MG19;;]CJ+6K^ULG83ZAI^EM^RQ]ON;>TDC999H;:18IT"D%")*\G\!_\$V?"
MWPU^+WQI^/7@;]I?]H#PU\7/VAF\!M\9_&MCX:_9/&J^/9OAEH4WA[P1/JWV
MG]EV6",Z+I,PMH4L(;19T2.2^^U:C;V]_  ?=*6_B;2]>\175MHT.IV&L3Z?
M=VUPNJPV4T+V6E06(BFM9[-V'EO:HZR),_F A6C<M@_,?B_]E+P_X_U77]2\
M7Z-XOOK;6[KX@&#2=(^*&L>%;/3=/^)EMX(/BBV)T(P37VH)X@\#Z7XBT#Q&
M&L-<\-W\5K/I,\;V@N)NAN?V??'MDUL+O]N/]IR$WEP;2U2?2?V0HVN+E;>>
M\:WMHY/V5$>XN4M+6ZNFMX5>46UM<S% D+D5C\"?&R6#ZF_[<G[2@T^.WENY
M-033OV/7L$M8(WFEN3=?\,L*K6R0QO,TR*X6%3*RA.: .2\._L5?"/PWJ]YK
M-G\+M6OY]1EOKS5K+7?BMXBU?1]=UO5-0\+7WB?Q1K.AZBTNE:AXJ\<W'@KP
M]'X[UV[B>Y\6VB:A;Z@;FTUO6'GZ[X'_ +-WA_\ 9^\1:[K7PZ\$3:=8ZQX;
MT'PTNC77B^34A80Z/XF^(/BR>[M[_4+9YY9-9U/XAWTEW"=MK:QZ;8HD!O)+
MJY>>']GWXAW,*7%O^VO^T_/!)DQR1Z/^R"RLH+@,&/[*PBP_EL8U\SS-N#(D
M7(!I/P!\<:YI]CJND_MR?M+ZCINI6L%[8:AI^E?L?WMC>6=S%YMO<VMY;?LL
M2VUS!,F'AFMY9(98V66*1T920#WW57\5ZP^DQ2>'H-/MK36]+U*XN&UN&[:.
M'3KI;N8I:V^FF2:65(Q;PJ) I:9V908U:O1DFBD+".6.0J<,$=6*G"MA@I)!
MVLIY[,IZ$9^3_P#AFKXD?]'L?M1?^"#]D7_Z%:O+OV#/'WQ0\7:K^VCX0^)_
MQ*\0?%5_@5^V7XQ^#/@7Q1XKT?P-H_B3_A [#X)_ 'Q_9:?K2_#OPEX&\-:A
M=6OB'X@^)7AU&+PW:7;64]M:7$LZVD3T ?H+1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !7Q]HR2R?MT_%Q8NI_9+_ &= PW*NY#\7?VI@5RT<
MHP21D%>1W7K7V#7R-X=_Y/N^+G_9I7[.?_JW_P!J2@#A/B?^R1XL^*OQ2^)7
MBWQ%X[L(?#7B[3?AQI7A"/1M&U?1_&'@?1_ 7BOP5X[U+P];^(M-\960N;+Q
MUXM\*2:GXEUBQM-)\12Q6G@33%U!](\'2:?JWD6H_L$_&[59K>ZNOVN?B1_:
MFE6.H266L07'CG2Y=9\42-JDGAWQ1XETS3_BW)H%_+X/&IQ:7I.CV.B:1H=U
MHNF6C:MINHZYY>KVOZHT4 ?C/\//V#/VA?%WA2\T_P"//Q3U"RFO/$-[=ZSI
M:>+/&?BV+4E^V?#G7!XAT!]$\>>$M/\ #EYJ5YX0NO#=Y::S9^,57357QGIM
MOH7C/6=4)[74OV%?CGJGB'Q3?VG[9GCRTTS5/#7P^\-VGA.PTGQG9Z= _@?P
MM?\ A6#7=<N[;XPPZ_=:Y)+>)XACU#3-5T>34-=T30[G6SKFFO<:?)^KDLB@
M.F2#M(R%;(RO4,#P>>HZ'Z5^<?Q?_9C^)_Q8^(?Q-U31_&^K_#"UU+^V9M'\
M2Z#>:;+-XETKQ#\ K'X;:9X5O[&]TCQ$MMI/A7Q=:ZQK>J&.UTS4F?Q,]QX5
MUNSU:$36X!5^,7[&'C[XI?$V#QCX>_:%U[P/I&JIX+M_'MM9^%HI?'/BS2O!
M.B^)_#B:7I/Q$T;Q-X5U/P?I&HGQ=<:_>S>$DMM9L_$,NMPV&KVND^*]2TJ"
M/5OV2OC%=:MXIU'PE^TOXC\,MKZ>.M/M])\OQMKFFVVF>-8?&*Z5K3R7?Q2C
MN#X^\&6>M^'M%\&:[I\FC:)::=X#TO49?"M_J,CM:W]5^#G[9L_BCQQXDTKX
M_6ZV.G:QXAUGP'X3C;3Y])UO49O&'AG4?#T.NV^J> H/[)\,2> X=?\ A]/X
M8TO4]7TNUUEH/&+>*9M2OM0CT3RB']FO]J7XO_!#]F:Z^+'CR\\(_%OX9>,_
M''C/XA:!XG\10>(M/^)7V_5]:F\-^#?%=Q\,=2TBTB\%RS2:5MTFQUG6WTK3
M-.T)?$9\3SV6L^&-9 /7OAM^S9\9/#'PR^%5AK_Q@T>]^(?@OX@>&OBQJFH>
M(K+QEX[T"UNS\"O^%0>)_#.B7'B/XEWOB5FU?5=1\1>-E\17'B V9\2>(;N>
MST**TN186WF</_!._P :P>![GPY:?M0_$6/7[_P%/X$BURVU7X@S:3!=7/A[
M7/#EUJ]CX1O?BB?#&]_#^L6]O%"]HV]-(@O&<W+)=672ZE\(OV[-)^'L=QHG
M[05EJ/Q$\.#QCK>GZ',VEZGI?BF^U#2O 5IH^BW^N>(/ >@Q7,.I76B_$?4M
M'TZ[CT*Q\$7WCWP[HL>IZUH?AW2]8DZ7]@OX8_M(^"&^)OBC]HV?5(M<\8KX
M,MK;3M;\5>&_&&JW&J>'+SQC+J7B=]5\+75Y9PZ==>'=<\&^#-$TN>_U35+#
M1_ ]D=9U;6;J>ZU:[ /.?"7_  3Q^)G@J;3X-(_:.\83>&M%\/VNB:;X)DE\
M5:5X4NXH?B)_PF6LVVM6NC?$.VU2:W\<6!-GXFN-/U>PNK?4I[RYTO;I'V?0
MQ^BWP<^'\GPK^%OP\^&[ZB-7;P)X-\->$FU=;>XLDU7_ (1_1K;2VU!;&[U7
M7+NS^V/ 9_LUWK6L7,._RY]5U&1#>3>EJZOG;GC&<CUS_A3J "OS7_X)\?\
M)1O^"FW_ &D@\>?^LO?LEU^E%?FO_P $^/\ DHW_  4V_P"TD'CS_P!9>_9+
MH _2BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OD;P[_R?=\7
M/^S2OV<__5O_ +4E?7-?(WAW_D^[XN?]FE?LY_\ JW_VI* /KFHWE5,9SSGI
M@XQDG//'RAF^BD?>*AI*\Q^*.@>)?$&@V%IX5OVTO4[7QM\-/$%S=&:]@2?0
M?"GQ*\)>)_%&ELVGQS7DAUCPWI&JZ<MI"@2_^T&QN94M[F0. ?/WQZ^#]Q\8
M?C1\(K/Q#I>M:O\ "!/ 7QAT;QM:Z/XDU[PO+8^*M3OOA=J_@O5+K4?"NM:'
MKJPRZ=X9\6:1&;"^<3C5/LEY#+IUS<;?G;PC^R_^TSH_B_5O'&F>-=#^&_B5
M_$_Q0FL;/0O&>N?$#P/<^#O%_P 0?@M/X8\,_P#"*^-/"DDFC:7I'PN^&^OV
MWBB#2;S2[W7/'OB.+5M+UC1; V<?AS=LOA#_ ,%"-*BU+3[G]HI?%H;P)I]K
MH>KZGI_PRTF\B\:ZW#IMUX]O=:M])^!"6$]QX<O9;VP^!5[IZVNA>'M/CFN?
MBIX?^*=V+>Q.1?\ @#_@HKIOC;P 5^-8UO37)UGQ9:VVA_#2U^'=I9>$=+^
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MX;\%>)K+Q;!/83WGQ;^,^N:%I%S=_P!H3Z-X4UWXK>,=4\-VAU!WDN;RWO\
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M!_X^+FYG_P"NUQ/+]^:1F +0^(/@S&\^+?"PB!">:?$.D"-G,376%;[85/\
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M/]G5!\4? P;SOMD&GF(H?$&X/%?7,-K*" 1*'4JIP*CF_:G_ &<HQ'Y?Q_\
M@;(TDMM"$_X6UX 0^9=2210(-_B-0SSRQ2P01INEDGADCBBF<;*]B'ACP\O*
MZ)I"G>T@*Z99J1(\PN&D!$0P[3@3L_WC,!*3O :@>&?#ZG<NBZ:I^7D6%D#\
MK.R\B'/RM)(R^C.Y&"S$@'A2?M?_ +,+Q17 _:&^ YMY_)$$T?QF^&D\<[7/
MAS_A+;:.$V_BF832S>'2NL1Q6YFDETQAJL*2Z,R:H]ZX_:Q_9EMLB;]H?X&I
MA)I"S?%?P&L:I ]LLFYV\0*JD"^LV )Y$V>F*]G/AK02H7^QM-P %4&PLB%
MB^S@ >5@ 0?N  .(?W8^3Y:?_P (]HH.3I=@QP1N^Q6@.&V;AGRLX;RHMPZ'
MRX\YV+@ \/E_:U_9EB3S3^T5\!S'YUA S?\ "V_ ($<NIZB=+L8Y&/B,('NK
M]+BQ@4'S);NVFAMXYYQ';R06W[7O[,%S;PW"_M'? ,QW*0FW8?&#X=GSC-;K
M=QE##XGN8Y$DM?-N(C%+(9(H7>(2)Y;R>[KX=T-2Q72-+#.4+D:?:AF,<TMQ
M&7(C^8QW$\TZ$D[9II95P\CL9!H6D @C3+(%0%4I:6R[55'C4+\F0%CDD0 8
M 1W4#:S @'SR?VR?V5=L[)^TW^SM(+>PN]3E,?QE^'3F+3[&UMKJZOY%_P"$
MI4+96\%Y9W$MPTBVR07UI-)<1VL\-W-Y]\3/CK^PU\9O _BCX:?$?X^_L[^(
MO"GC.!]"UO07^-?@NSO)&AU&.*V^Q7^B^*X=6TO6M.UO3;&]TS4M*O+76-*U
MG3]/OK*2TU&R@\K[&_L+2-I3^S+/8R/$5^RVNTQR!1)&5\O!20(@="-K!%#
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M%A\>?@G9:1J/@K4/A[!X8N/VK0WA:0/\._#_ .S#X@\0V'A:?XA-H4'Q$O/
M&G:-\'_$'C+3]-B\42&:WT6:^M_$.JSO?>R^$OB+^P7X3^(WBSXJ^&OVD?A/
MH^M^-[V#5/%NE:?^TMH4?@'7O% TW2?AU;>*M1\ 6_CZ7P;+XO;P[X#T7PR/
M$+Z5'JCVNCB0RMK$5Y):_H2=)L" /LL  Z*8(2._3Y"!]X_F?4T?V5I^ /L=
MO@%2 T$)4%6WJ0 O#*_SJ>S988/- 'S+!^VE^R=':S/#^TM\ 'LM/24W-Z_Q
MD^';I;K!I4&MS"\,'B$0V=Q#I5W!J<T-P]NJV#QW8\JVGB<:UO\ MB_LKSN8
MT_:0^ [R .WEQ_%CP,S[8G5)B!_;I!\MI(4;D8:50?F)1?H,Z18%=GV6W\O&
MWRA;PB,KY?E%=I3&#'^[QTV'9]WBG?V78;B_V2+>=P+>5#N(8H6!;;D[C&A;
M)Y*(3]T8 /G2#]L;]E^ZG:WM/VB_@3>2BZM;01P?%3P.S>?>ZC>:9:0$)XAD
M)FFO;.:R1%5I9KJ">&U@N+F.:TMX+']M']E:]BLI!^T7\"D;4;.TO[.)?BOX
M(G:>TOK.6_M;B%H-<D6>&6WMKIDFA+Q2^43"[H-Q^D?[)T\$,+* ,I4J?)@R
M"CM(A!VY!61W=<?==F889B2HTRQ'(M(@>.1%#_"CQK_#VCD=!Z([J/E8@@'@
M$W[7_P"RW")"_P"T5\#U$,3SRLWQ/\(E(X(WA1Y'*:JQ5 ;B'+%=J[\L0.D4
MW[7_ .S/"8\_'KX-N)KA[:)E^(_A=5>6'5_[!N8E,FHINFMM7*Z;-$!E-0W6
M+$7.V-OH4Z;9')-M&205.8XCE25)4Y7D$JI(Z$JN>@P#3;($$6L8(W8(CB!&
M\DO@[?XR26_O$DG)- 'S^W[7G[,BF(?\+Y^$@$QVJQ^(/A(@,([V8[L:SD#R
M].O3P"<QCT(I)/VO/V9HX6N?^%\?"1[>,7#2RI\0/"S*JVUHM]*RG^UN0MJZ
M/V.2>,"OH+^SK/C_ $9/E.5^2+@XD7(XX.V:4<=I9!T=LM.EV1!!MXBK;MR&
M&$A@Z")P05P=\0$;9^]& ARH H \('[6/[-[9*?'+X42*EQ%:RM#XZ\/3".:
M:6.WC1_+OR4+3S0J!ALALYY&'Q?M7?LX3L4@^.7PJDD ;*#QOH(?[TL:G:;[
MH9()006W?+C&<U[L=/M&(+6Z,0P8$I$2&5@ZL"1D,'57!ZAE# Y -+_9]KC
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M3>/_  +X T"Y^%]SH?A?49SK.GZ%IL#?9]?\;MJU[#(?A]HVEZB >O'X4?\
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M3^U5C+;TVCJ=RX!W#+E^%'_!2,G_ )/5_9T?/0#]BC7HNF"3E_VIF#<$<#D
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M$O3?"OAD3:B=7XK:W_P4^A^,DME\.O"9UGX7^#;30X[+Q+%#\%;<?$_Q//\
M!OQU:12#3=?U>76_#/@6V^*NJ>!M0\<0V<VE>*K"/2]<B\+7NI^'I?(U']B?
MLJ8(WR#KCYE^7/'&4/08'.<@#=GDE3;1X(!9201N&UF&00#EU<-@DL X9<D@
MJ4)4@'YE_#N__;<\3_%/X>:AX_\ "=_I?P^L?A;XUU*[T[5KSPAX?LW\<ZG=
MZE9^$M#^)D/ACQ9KNI7'BK3+.TAN-3'A?0[SP6FGZO9ZSI6H:3JS7NA)L? W
M4_V\M7U#PKJOQK\.:'H&A-JVFZ?XA\.6VG^#+?Q%J.F7UO\ $NWU_7M>N]&\
M5Z_I_A[4/#FN:?\ #R7P=I?AK5=;CU7P3J\&K>(GD\2W6L:!X6_1T6Z!MVZ0
M\,,%S@Y.<_WN!Q@-AL*[AI$1U%MHEZ _Q=\<M@9 4 +@#@)M .6P6)8@'X>1
MC_@JMX.TCP^L'AKQ1X]F\'G4YKBYD\3?!A==\?I\3;75=:>TO[2^O-.TJS3]
MG_4X;'PMX9D6Z$OB/0]46]>'4;VVN9XO?)/&_P"W+>_"/]H?4O%?PDN/$7C/
MPKX7^%_ASP!\._A3JFF>#_%GC'XF^)]%T'QC\2O$.C^+]:\9:/H5OX*\!3^.
M-&\$2V=IXO75=;E^%WQ DL]:GU'6O#P;]1S;1$8P0.^TA<\ <D 'J _!'S*.
MW!C:RC=@QDFQNRR>9\CJ4DC*-E2V") 6=665O+B1I#&GED _(/P?JG[;G@#1
M_B_<^,?!7QL^-4>I>&=,T;X=>&;:Z^%WPV^(GB;QM#9^./%6I>*?[6T?XM:I
MX'^'_A_2M.B\%?"6VN-+U31IM<UV6PUVVT,7Z:SJVH\QJTG_  4)T[1=2U6S
MT7]H775LO@]X3:VT+1-7_9\TWQGK_CW4=%^ 46F6.GZ/J7CV7PUI^L>"_%&@
M_'_4OBT[^+;2QU+PKXR\+6GAWQ#X\O\ ^ST\.?M*ULC$$/*N,?=8?>!R'.5.
M7SMY.1\@&,%PPMK&N-I< *B  KT3'?;GY@"& (4$LZ!)3OH ^._V=+#]I)_B
M7^T'K?Q6O];3X8ZGXHL$^#>A>)T\/PZ]80_VOXOU?7+J.+P]XC\26L7ABVT;
M7/!?@[0S<7>G7^J'P1?Z_?>'-*U#7+R>^^S:9'&(UVJ21G/.!S@#@*%51@#A
M5 [XR22^@ HHHH 0]/Q7^8KX!_X)^_\ ((_:\_[/[_:J_P#4OL:^_CT_%?YB
MO@'_ ()^_P#((_:\_P"S^_VJO_4OL: /O^BBB@ HHHH **** "BBB@ HHHH
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M7NDW=E<Z;=V<FG>,[6"\LKF^^#.HW*75KI>G:?8_\3"\^ 'POFO8H+6*W/\
M8L\8CD@U/4XKO'D_9>_9..AS>'(_#>OIIUWX:O\ PO=7EJ?B%HNJ_P!E7D>J
M1+LN]#TRSD&KVXU2=[;74DBU.WG\J_-W<WMLSWH!]2_#[7_@M\5=(N]?^'9\
M!>,-$LM=UOPW/JN@6VC:GIRZUX=NY+#6M/%Y:VLENUSI5^@L-3A$A?3K\36-
MV(KNVFA7T?\ X0OPC_T+'A__ ,$VF_\ R-7AWPUTSX2?"JUUZU\)W'B:%?$W
MBO6/&>MRZGI/BW59;S7M?_LX:E=*USI++:QRPZ5:Q&ULX[>"*1IIXEDDE>0^
MM?\ "S/!W_/]J?\ X3'BG_Y2T 8'BGPUX>TS5O UU8:)I5E=/XUTR-+BSTZR
MM)HQ_96MEAYL$"2LC)&$:/S A^]C(P?7*\<USQ7HOB36?!-IHTM_=SVWB^PO
M;A7T36[.."UCTS6(GEEGOM.MH$"R7,*[6D#DN,*0K%?8Z "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBFLVU6;!;:I;:N-S8!.%R0,GH,D#/4B@!U%?!=_^WYX977_%
MVC>&/V:_VQ_B+8>#O&WC3P!>>+_A]\"+GQ#X-U;Q!\/_ !5K'@KQ2/#VM'Q#
M9G5=/T_Q-H.KZ4NHQVL=O<7%C<I"SM#*$B_X;VC_ .C-/V^?_$;[G_YJJ /O
MFBO@;_AO:/\ Z,T_;Y_\1ON?_FJH_P"&]H_^C-/V^?\ Q&^Y_P#FJH ^^:*^
M!O\ AO:/_HS3]OG_ ,1ON?\ YJJ/^&]H_P#HS3]OG_Q&^Y_^:J@#[YHKX&_X
M;VC_ .C-/V^?_$;[G_YJJ/\ AO:/_HS3]OG_ ,1ON?\ YJJ /OFBO@;_ (;V
MC_Z,T_;Y_P#$;[G_ .:JC_AO:/\ Z,T_;Y_\1ON?_FJH ^^:*^!O^&]H_P#H
MS3]OG_Q&^Y_^:JC_ (;VC_Z,T_;Y_P#$;[G_ .:J@#[YHKX&_P"&]H_^C-/V
M^?\ Q&^Y_P#FJH_X;VC_ .C-/V^?_$;[G_YJJ /OFBO@;_AO:/\ Z,T_;Y_\
M1ON?_FJH_P"&]H_^C-/V^?\ Q&^Y_P#FJH ^^:*_.KQ/_P %&_#O@SPWK_B_
MQ3^R1^W?HGAGPMH>K>)/$.LWO[.-VEII.AZ%87&J:OJ5T4\4/*+;3].M;B\N
M#''(PAB<JK,-M?=_A?Q;HOB_PUX>\5Z3/(NE>)]"TGQ%I?VV(VET=-UJQAU"
MR-Q;R$M#/Y$RK/"69H9EDB<[T(H Z:BJ_P!KM?\ GXA_[^)_C1]KM?\ GXA_
M[^)_C0!8HJO]KM1_R\0_]_%/\C6)J/BSP_I,T<.I:KIUB\I/E"\U'3K,RJOD
MEWA6[NX))D19)'<Q(^/L\L>/.>VBN #HZ*YA/&W@R0D)XM\-.0 3LUS3&P#T
MSBZ.,]J#XU\(@D?\)/X?..XUS2OZW@/Y@4 =/17+_P#";>$?^AF\/_\ @\TG
M_P"3:<?&?A$ '_A*/#QSC@:WI>>?<W8'Y'Z9H Z:BN:7QGX189_X2CP\/8ZW
MIA_]!NF'ZTO_  F7A'_H:?#O_@ZTW_Y)H Z2BN8/C7PB"1_PD_AXX[C6]* _
M6\!_,"E7QIX1;/\ Q4_AX8]=;TLY_P"^;MOUQ[4 =-7C!MX8OCMKES%X+UF.
MZU/X3>$+.\^(1GD?P]?6FF>+_'36?@R.S(6&/6M);7=3U^:Z242OI^JQQ.AC
MB7/HG_"8^$>O_"4>'L>O]M:=_P#)-?->H>/O B?M8:7I*>*M8?5=2_9ZUB^\
MN/6]%/PU33M'^)&B6SR7(;45N!X[DFUXC3\6S0/X?AU-6F$@6,@'U@;>,XSG
M@8&W:F <?W%4] !@G&%'&<DGV>/_ &_^_C_XUSW_  FWA'_H9O#_ /X/-)_^
M3:/^$V\(_P#0S>'_ /P>:3_\FT =#]GC_P!O_OX_^-'V>/\ V_\ OX_^-8"^
M-/"+9_XJ?P\,>NMZ6<_]\W;?KCVH/C3P@ ?^*I\.DCL-;TS/ZW0'YD4 ;_V>
M/_;_ ._C_P"-'V>/_;_[^/\ XUSW_";>$?\ H9O#_P#X/-)_^3:?_P )GX0/
M3Q5X</\ W&]-_P#DF@#>^SQ_[?\ W\?_ !H^SQ_[?_?Q_P#&L(^,O"(!/_"4
M^'>/^HUIO];D#\ZC_P"$V\(_]#-X?_\ !YI/_P FT = +6)7#@R;E.1F1B,Y
MST)Y_N\_P\58KE_^$V\(_P#0S>'_ /P>:3_\FU/;^*M O6:+3M5T[5+@*SBU
MT[4M-N[A@JNY*QQWAP,(1N<J@)7<P!R #H:*0$, P.00"#Z@C(/Y4-T/!/!X
M'4\=!R.?3D?6@!:*_-?5/^"A^MCQ=X[\.^!/V%/VVOBYHG@7QWXS^'DWC_X=
M>&/@7-X+\1Z[X"\07?A?Q-<>&Y_%OQ\\)^)+K3K'7;"\T[[3?^'].+36\@,"
MG86C_P"'@GQ0_P"D9/\ P40_\)/]FO\ ^B>H _2RBOS3_P"'@GQ0_P"D9/\
MP40_\)/]FO\ ^B>H_P"'@GQ0_P"D9/\ P40_\)/]FO\ ^B>H _2RBOS3_P"'
M@GQ0_P"D9/\ P40_\)/]FO\ ^B>H_P"'@GQ0_P"D9/\ P40_\)/]FO\ ^B>H
M _2RBOS3_P"'@GQ0_P"D9/\ P40_\)/]FO\ ^B>H_P"'@GQ0_P"D9/\ P40_
M\)/]FO\ ^B>H _2RBOS3_P"'@GQ0_P"D9/\ P40_\)/]FO\ ^B>H_P"'@GQ0
M_P"D9/\ P40_\)/]FO\ ^B>H _2RBOS3_P"'@GQ0_P"D9/\ P40_\)/]FO\
M^B>H_P"'@GQ0_P"D9/\ P40_\)/]FO\ ^B>H _2RBOS3_P"'@GQ0_P"D9/\
MP40_\)/]FO\ ^B>H_P"'@GQ0_P"D9/\ P40_\)/]FO\ ^B>H _2RBOS3_P"'
M@GQ0_P"D9/\ P40_\)/]FO\ ^B>H_P"'@GQ0_P"D9/\ P40_\)/]FO\ ^B>H
M _2RBOS3_P"'@GQ0_P"D9/\ P40_\)/]FO\ ^B>H_P"'@GQ0_P"D9/\ P40_
M\)/]FO\ ^B>H _2RBOS3_P"'@GQ0_P"D9/\ P40_\)/]FO\ ^B>H_P"'@GQ0
M_P"D9/\ P40_\)/]FO\ ^B>H _2RBOS3_P"'@GQ0_P"D9/\ P40_\)/]FO\
M^B>H_P"'@GQ0_P"D9/\ P40_\)/]FO\ ^B>H _2RBOS3_P"'@GQ0_P"D9/\
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M[XC^)+Z^BM[NXEM+/QF)[B.*RUB]T*[<Q1M(S+9ZQIU_I5VRDBTO[.2SN,7
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M,NFK#>WGC/PRT;_@I+H6E7%GXGU#P;JGB%W\0SKK'B&Y\.Z[H;Z'IV@ZQ/\
M#C0HM*T3Q=X8OT\7ZM;:1X'\+_%#Q/<31Z.?B%K?Q'\8>&X-=\##PM#I !^L
M>4'!89XXW_WCM'?NWRCU/ YHRG]\=OX_[QPO?^(\#U/ K\4_A;\</V]_BI\7
MO'GB72O >FV_@CP1XE\2>%-&\$ZGX//AZ.3PW-XLT&#3+G7=>\7_ !6T"TO?
M&)TCP_XIU/3;O0-(OKJS6ZT31_&7A_P;HWC"+Q,/HSPQJO[?.NP177BWPM\-
M?#L=QX6UW2;[2-"NK1_$=CXJNO"?Q>O=#\5:9KEUX[OM'@CL?$.A?!O3)M#N
M-!U" W'CS7]7&NQ:5X9N96 /T?WQ_P#/1>H'^L[G&!][J=RX'^T/44I:,'!<
M \\%\'@J#W[%E!]"R@]1G\>_#VD_\%'O"O@7PUX1\*KH:_8_ 'AI=;\8?$%X
M?&OQ)N?B-?77Q5U7QG-9-XL^.GC6QNM)L!X?^&OAKP_HM]XCN;*_E^)6IZCI
M-[X0MM!CL8/4+_Q__P %"K&'Q;K/B'P1\)-"T73[S5[+PS8>%]-;XC^(_$ZZ
MWX\\$>&? NV!?'GA&RLI+3PUJOBSQ7JOVR>&QFN+/3K6]UK1+**YNIP#],C+
M"#M,J [6;!E .U?O-C=G:O\ $>@[D4N^+_GHO5E_UG\2;MZ_>ZIL?<.J[&SC
M:<?D_P"&]:_X*?2>(M)\1>-?!/PG_LQ;>]L[OPCX7N-#@MI(I-:_9[G35=3?
M4?B-JC7VLWVF3_'.'2%M)M-TWP>N@0V^H+XF&N:-?ZEUNO0?\% O&'PQTO67
MT_P%\.OBYX.^.EIXMB\)^%-9T74?#/CGX2>&O >K:A<_#GQ1J>O2^5+!\1/&
M,D/@VP\0Z<=+U+07U#0/&EU!$?#K6]R ?IF7C&<NHPH8YDQA22 Q^;A200">
M"00#D&G?+_>]?XCV.#W['@^_%?DC\+Y?^"F7A"\C\"^(]/\  WB[3[B#Q9J6
MH?%OQCJ7AS6I+77O$/QEMKK3QH>@:+XQ\.WLWA3PM\--0U6;2?#6KV^C7BV^
MD:#HS:OJ%W8ZL]CPWB/]IS_@HO\ #_Q1\*M*^*GP8\&^&=!\67'PWA\2>(/!
M6C3?$B:SO[5/!8^,&DZ7X5\,>.[_ %65KNZ\0ZO%\/HI6F\1^5HU[J$>BZEI
M.CWVH$ _:8M&!DNH&X+DO@;F;:JYW?>+?*!U+<#GB@L@ZN!]7]MWK_=!;Z#/
M2OR\L-9_X*=:LFHW][X3_9R\)M:K=/I^GV]O=^+YM4$^B?$W48+6;4C\1?#<
M5BPU;0OAKX7:6YTZ8W-EXP;Q%=I;KX8U*&US=4\3?\%0-6M?'J6'P^^!7@]T
MUKQ)8^#D&L)XGOYM#O?%VC^'-"U2ZGNO%?A[1=.FTOPIJ.L_$BYNKK1M0DU/
M4O#I\,7NCK>W^EVMV ?JJ"AR X)!*G#YPP."#@\$'@CJ#UHW( "7 !&0=_!'
M)R#G&, \^QK\HM<\&?\ !076/&_PW^(NG^+I]-MO!/[-7A&7QGX"DF\+0:1\
M3/C[]C^)]MXY\'S^$=,\8KX/T^'5+V\\!7X\52>,[32O#EOX=B@\)^(&CUW4
MV%C2M3_X*=ZOH.F:YJFD?!GPSKDOC'6--E\":5HUEK6ER>%9_AE9_P!E^(/$
M'B/4OB="]RY^*=WJ4T^G^%_[#U&WAM-,TVXC;3Y]1N80#]52T8ZN!TZOCKMQ
MU;OO7'^\O]X93?'G'F+GT\SG^'MN_P!M/^^U_O#/YHZ!XA_X*.ZUXXL-&UGP
M?\#O"7@.UO7M[_QQ$UWXDU/7M/T"PN#!JMKX0L_'&DW^@3_$;4[0V9M)=?UZ
M+PGINIZ5?_:-;6'76M?,;S7?^"C7@CP3\8OB)K'AKP1J>L3:5=>+]*\#V<^G
M:U=:+KW@7PA\+6>7P^++QWJ$%[X1\?'P_P#$);KP/I5EI_BF>_>2\&N)>ZC)
M<2 'Z^AD()#@A1EB'R ",@GG@$<Y/;GI2%XE)!D4$ $@R $ XP2"V0#D8]<C
MUK\U_'NO_M:)9_LY7$N@ZRWB1_C#X@OO'ND^"8/#FB7NO>%- \1RWN@:7K&G
MZGXTU?P-X:7Q-\&[7QM>:AI6I_$J^\-KX_L]+M8M;@UVYTRUTWGTU+_@I<+_
M ,7/I7A[X9Q>&7\7_%>]\-:+XK31[SQG<^%7\<17GP[L/^$BT;Q_8:+H,U]X
M+UC5--MX)M&UV3PY)X=LGGU#Q&EY%,0#]2LIQ\PYZ?.>>0..>>2!]2!3=\1.
M!(I.0N/,YW$%@N-W4J"P'7 )Z U^4NG:K_P5#\/2C39O!WP7\=:9)JGCN]EU
M[7-4\.Z#J]MI4FEZ,/A_X8TV#0O$*PZP;.7[=:W^MZPVFZIJVO)<VU[)I?AU
M+'6KWH)?A_\ MI:K-\*M?C\7:AH=YX4O/VB?&'B_3Y]5TS3SXIN-1^..B>(_
MA5X%N_!-GXPUOPS>Q^(OA7%KO@^/^U?'=_H7PZ75&U+3]5M=8TC3WC /T[RG
M'S#YL%?G^\#C!'/.<C&.N11N3&=XQ@G._C"_>/7H,C/IGFORST77?^"E>I:1
MJ.M^*?#WPL\'ZGIGQ TFRT3P;H.E:!XEG\1^"9?ACXE74;_Q)K=W\4%LM,@E
M^+.H^$X;NST>/2-6TWP_HVJ7]BFL0R 13:?XB_X*>OX_T_PUJ/@[X :1\.X]
M=M-+U+XH*]YJFL:IHD'CC5S=>(H?AY;_ ! BOM)N9_AY;Z*T.C7/BC4;>UOM
M9GU6XNI[B.;0(P#]1/,BPQ\U,("7/F#" 9R6.["@8.2< 8-.#(Q(5P2#M(#Y
M(;D[2 >#@$X//!]*_(/1X/\ @I9:_%?4?$>I^&?!<WA/QG?_  Z\-^(M!MO$
MFDV4/@_2_"DWQ:O]>^(/@(MX^N+2QBUJW3X<>%]6\.WEE?:KJX\7#59-2M[K
MPJ9K?UO]DOQQ^U1XU^*=AK'QO\.)X;T/7?@+I7B*^TJRL;K2=+T_5=7\0:7?
M^!S+HD_B'QA::%XON([[XJ:?XETJR\27&H-X=T#X?:OX@L=,U+5GTZT /8?V
M_5_XPM_:FY./^%&?$ XPIR3X?U!3DE2Q&TLN"VTAV!!!X^O84"J&'5ECW'C)
MPB@$\=AQQ@8[5\B?M^_\F6?M3?\ 9#/'_P#Z8-0KZ]B_U:_[J?\ H"T 2444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!\I?L<_\DO\ '7_9TO[:G_K8'QRKZM_S^5?*7['/_)+_ !U_V=+^VI_ZV!\<
MJ^K: (6MX7?>\:LX# ,<DJ'4J^SGY"ZG:Y7!=0H8D*N(Q8V:L[+;1(TLOGRE
M$"&2?=N$SE<;Y5<*ZR-EU=(V5@T:%;5% $!MH"=QC&[(.X%@V025.X$-\K$L
MO/RL2PPW-1M863B)7M+9Q"Z20AH8V\IXP1$\>5.QX@3Y;+@Q_P !6K=% %8V
M=L26\E-[;=S@$.2A8HQ<$.71G=D<G>C22LK RR%F?V?9#@6\878\6P ^68Y"
M-\9CSY9C< (R%2IB AQY0""Y10! +6 %R(P#(P:0@L#(P?>#(01OVM]T/D*N
M4 "$K4JJJ#:HP,DXYZL2S$D\DEB22>I)-.HH **** "BBB@ HHHH ^;?VP=3
MU3P]^RO^T?XKT+4+O2?$'@[X&?%?QGX;U:PF-O?:1XF\)> ]>U_P[J]E/E8X
M[K2M8T^SO[;SCY0GMT,G[O.*GPHU73[WX3?"76_$]SXYU77?$/PP\!>(M3U*
MS/Q,U:6[U'6?#.FWU_=O/X<CNK&VEN+R:9S%"T>%.0-I(5W[:_\ R9K^UM_V
M;)\>O4?\TK\5^F#^1!KLOV>H%?X"_!(M@D_"#X9<;5"@GP3HF=H !&>,@EN@
MQCG(*5TGRI-]$RR)_!4O_+E\1LO\V3H_QG7D_,26>Q1>?=AD\#)P"CMX248C
MT[XC2 \[ET[XJ+@^F+F)7Z8Y V\\$G<!ZUY*)R ./0$>W4'-,*J3DJI^NXG_
M -#JDTNE_73\GL9<DIZRDX/:T4K6[^]=WU/G#1_$VGS^,K3P;J>E>,9;K58+
MJZL-1@O/'MM;V<,0213XCL]3O!>Z$;J,L;"_N+J^AU&X^T++]DFMXK2+Q[X2
MZOXAU_\ ;"_;#^'6K>(O$M]X)\ >"_V6-1\'^'&\1:W]CT6[\<Z-\5YO%D]N
M!J$5P\VKRZ%IES,9II$#V2(B!$"-]L:;H&EZ1]I_LZRM;4W<S7%RT<)$EQ,[
M%WENIO,\^[<NS,'N9)7&0-Q"J!\1? M=O[?G[>@SG'P^_8MY]<^'_CH?ZTYU
M(3TBK==[^7^0J$<13AR5:T:T5JG9*5_^W=+6O?3>Q]XZ?9P:=:6VGVL1AM+*
MV@M;9"S/L@MHD@ACWR2R2-LB15&\YP!R:O445!N%%%4]0OH--L[B_NG6*UM(
M9;BZG=D2.WMH(WEGN)&D>-%B@C1I9F9U"1([D_+@@%L]#CK@X_+VP?R->$?$
M;]HCX7?"K6])\/>,_$5W:ZYKMSX>L]*T72?#_B+Q-JU]=>*YO$<7A^VM]-\,
MZ1J]\9=3_P"$/\426B)!,T\.A:DZ-N@*GT;1/'7A7Q/H^E:WX>\1:-K.F:_I
MNCZMHM_IUY#<V>IZ9XCM!>Z!?V<R3XGM=8LR;S39$)-]:I));JVTD>9W'@O0
MKCXA^+/B(GB-[&Y\:?#3PCX U V@M!<:7;^ /$7Q'U?2=:LY;J2X@LK^UN/B
MCXBM[W[5:SQQR7&DV[1M.R1R &5\./VJ?@I\5?$7B/PQX/\ &4DFN^$]SZ_H
MOB3PUXP\"ZMI[6]_XJTO4+=]&\=:%X<UEIM,O_"'B"/5%_LY8]/ATF:ZG9;<
MM*GL,_C_ ,&VL<LMSXJ\-V\4&EV^N7$DVM:?%';Z)=M$EIK5P[W"K!H]V\\"
M6FJ3%+"Y>>!(+B1IH@_P[I?[ G[.=EHEIX?U?6?&_BN2RTRRT:P\2^(?$6CP
M^)M/L%M_BM':Z?%K.@:+H(NWU>X^-'CC5]9O-3AU._\ &VL7-EK/B"]UQM*N
MI9O-_BO_ ,$__P!GCXB?#K5?A/\ #KQU:^!?$\&M>'?$7B/6$U>T\6ZY>V=_
M/X2F&F^*M+GU;3[I]%\8WOP[M;JVT@BVT9M1M]=L="TJ+3M]GIP![9\0O!WP
M,^)?[0FBZA/\4=2TKXJGP9IY\)VO@#QJOA_Q##I7@[4?$C:]!9ZG9:@VFZE;
M>)-,^+8&L>%]7LK^6XT_3M-\2::MG<:=;W<.9-^R)^RIXB^(_A;XAS :CXPT
M#P3XHT/06L?B \T,GAR_U2XU?7+RXTBWN3!J#0:E?3E]3 >.T,$0<_:)H11X
M6_9B_9]?QCXKO-6\1:AXC\>>$]2\.ZUK>I3ZCI>C'PKK/B+QOX>^*T^HZ-)H
M^DZ;!X=C\8>-/!JZA?:9;:OJ-E:6$VH^%]+FTO0KNWT>#9^$_P"QM\"?@KJF
M@^+/"_B'QE=WGP]TSQ"US?\ BWQH?$%PUWJY^(5WJ'B3Q'?W=M_:1U.VLOB)
MXR@CC:_LM%>VN8+UM'DN].L;NW /%?@G\.OV3!^T++\5_AY\3_&=YXV?P/H/
MQ1U2P^(NI>-(+;4/AOJ=A\7_  5\.-:\/Q_$&VTE-)\#Z-%KGQ9N=(M]#M;R
MUO;2\TK58+NWT!=#%Q^C3^/O!EA9ZA)<^+_#$,6CV%OJ>JW-QX@TN&&PL-0F
M\JQU*_N)[H16=EJ$[A+.[NF2WN7;$3R8('YZ^%OV"OV1O$/@Z'Q1X2\5^,+G
M2_'/AG2=0TSXB>'/B%:Z3>3^&]1_X65K>D7WAV_\.V&DZ/I6A:XGQ@\87UUH
M^EZ;9:'K)O+>/5]/NKB(B?D_C-_P3'^!OC;X)^'/A)X&\5W?@73M'M].TL:_
MXBDL?'8\5>%;'P'X6\ 6WAOQ;<:MJ-E/XCLD\/>#O"#LE_J=SI^L10:SI%Y:
M/I?BK7W8 _1+1_C/\-]:\'S>.;'QIH\OAJUCU0W.H?:XS-!+HEI?:AJEM+IT
M?G:A_:5K86MS?MI45M<7[V5O'<K;>7(N><^&_P"T;\,OB=XDL_"_AG6-4EU?
M4]/\2:SI-OK'AKQ#X>_M?2O")\(P>(;O2GUG3["*_@T^3QWX1F:>V5XKFWUN
M&ZM<P*WE_#7C[]DO]BBS\#>'O!WBOX@ZMI6C^,-$G^(5CI/@3X@OI*_$FR\"
M^!H+;7/&>C^'/"%OJ5UXBLH-#-CJ]U+H6G7_ )4[VL]C+(UTMG?^MZ5\0/V9
MQXL_9W^/%C\<_"UEX#TWP?\ $?X$?".SU"\%EIWBCQ1XA\2?#_P]K27NNZS<
M6#6VM:%JGPPM_!4-CJ\5BQ\2:QJ-G<2KJ,EO9( ?H72$ ]:^<=(_:O\ @%XA
MTP:KH'Q:\ ZU;R>'/%'C""+3=<6[U&X\)^"9M/A\4^(K;1[:.?5KK3;$:G8W
M-A-#9F/7;"]T_4-&EO+*^M[A_7_ WCGPQ\2/"^@>-_!6NZ/XH\(>*M'L]>\.
M>(M!OX=4TC6M(U"-+BQU+3=0MV:"[L;NVFADAE3:0PD1U5U9$ .O  Z4M%%
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M7'"D;L;0?NXW-C& ,G&*3[-!@*(D &< # YZG P,GN3U/)S4U% %46-H&5Q
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M=PWQ)KW_  3^_9\N=;U7Q9X>T/4_"_C'Q#J2S:[XCM]<\1ZNUYH6I?%KPO\
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M3/10!4-A9-@&U@(""/;Y:[#$L<T2PLF-K0JES<!86!B4SS,$#2.3,(8E*$(
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M,*C_ (4Y_P %7O\ H^?]DS_Q _QC_P#1A4 ?IC17YG?\*<_X*O?]'S_LF?\
MB!_C'_Z,*C_A3G_!5[_H^?\ 9,_\0/\ &/\ ]&%0!^F-%?F=_P *<_X*O?\
M1\_[)G_B!_C'_P"C"H_X4Y_P5>_Z/G_9,_\ $#_&/_T85 'Z8T5^9W_"G/\
M@J]_T?/^R9_X@?XQ_P#HPJ/^%.?\%7O^CY_V3/\ Q _QC_\ 1A4 ?IC17YG?
M\*<_X*O?]'S_ +)G_B!_C'_Z,*C_ (4Y_P %7O\ H^?]DS_Q _QC_P#1A4 ?
MIC17YG?\*<_X*O?]'S_LF?\ B!_C'_Z,*C_A3G_!5[_H^?\ 9,_\0/\ &/\
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M4,FR2"%E,:@&_1110 4444 %%%% 'Q]^W[_R99^U-_V0SQ__ .F#4*^O8O\
M5K_NI_Z M?(7[?O_ "99^U-_V0SQ_P#^F#4*^O8O]6O^ZG_H"T 24444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?&GQ._8?\
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M ,,%>#/^CB?VYO\ Q-+X_P#_ ,V-'_#!7@S_ *.)_;F_\32^/_\ \V-?=%%
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M?]!7XM_^'[^./_SRZ /7:*\B_P"%,>$O^@K\6_\ P_?QQ_\ GET?\*8\)?\
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M+_A%_"/_ $6_X[_^%/XA_P#F<I?^$6\)?]%N^/'_ (4WB+_YG* /JRBOE/\
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MH ]UHKPK_A2#_P#17/C?_P"' D_^5U(WP18 D_%KXX,,8('Q!E'!X/(L48
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^<_VL/\
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MM52%5349RW^B2$@D#&2:],4;55?[H YZ\#'/ _D/H* %HHHH **** "BBB@
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M\4 =FB#:,<=3CKR22<%@6QG.,\@<<=*Y3Q"BC7/!#8R5US4@,@<;O"VO G@
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M[OY?MFT?>M?'O[/7_)P7[>G_ &<%\+O_ %CW]G&@"L?#O_!01<;OC7^QP,D
M9_9?^-@R20H S^U[U+,JCU) ZD5&NA_M_2*KI\;_ -C1T< HT?[,7QI8.&W;
M2C?\-?%6!V/C&<A6Q]TX] _:H\)>./'/PCUGPS\.3JQ\77EWHMYID>E>+9?!
M)N1H_B#1]6N;'4M?C1'CT+4K6SFTWQ!86NHZ)JNJZ%>:EIVDZUIEY<+=Q_%?
MA_X<?\%!?A_\*?$&C>$?%/@#4/B!K7Q(U3QOID&NZL-<T+PSI7B+Q;\8M?U[
MP[9ZCXFTFY\0W_A*>TNO@WI^G:?K.JR^*-+L=5\6PV.M>5H-GH\@!])G0OV_
MU"EOC=^QN S;%)_9C^,X#/N"[%)_:]P6W$+M&3N(&,T_^P/^"@(;:?C;^QMN
MX^7_ (9@^->[EM@X_P"&OL\O\@_VOEZ\5\C?'>']N2:R\&?!&#6?$.IK\5_!
M?Q@TO7OB)X'\)Z5-8Z/X@NO@WX'@T?3_ !AXJT[P_9Z=\,O#UC\5-4^(<GAG
M7H'T[6]1\*:)X;T[09/%.NC4M-D]_M=%_;:N/B%X0TV;6? =_P#"W3M1NCXE
MUR>YL]*\5:_INE?M#OJGA2^2+0M T.WT[79_@!9>'K#Q5INEQ?\ "*:QXIU/
M6[4:5I$MD(;L A^)?P/_ &N_C-X(\5_"_P"*?CW]ACQ]X!\;:;/HWC#P9XD_
M94^,VIZ'XATN40">QU;39OVOC#<P$);;DE0[3Y9XW#/:6OA3]O;38(H+7XS_
M +&EI;*D$,$2_LP_&E($C41VUK# G_#7P2.-%\JWMXHP$5!%#&H58T'SOXQ^
M$O\ P4!\(W?C#Q1\*/B'X=\8ZO>^&_CW9>"_"?CKQ.;3P]I&L>,/B?\ %+Q)
M\)+Z:Z&D7+3)X;TK6_AK)J5WJ?F:C8Z#H_B#P?HK.ER;B?'\.>$?V][GQ#J6
MGZ5K^FZ'=>'-3_LKQ-XEURZUZ^\.ZO#XA3Q5XHA7P#:>,;/4- \3P:=::WX'
MT76=8MM$DL-.G35?#.D7RW/AF&PTX ^J?[$_;]^4_P#"\?V,\.JNA_X9C^-/
MS(^=CK_QE_\ ,K8.UAD-@X)P:5=#_;_=(Y$^-_[&C)*5$3K^S%\:620OG8(V
M'[7Y#EL';M)W8.,X->!?#;5_VQ?B[X,^/^B^.[?7/ WQ,\/?&/P?I7@;[5X8
M'@7P#_8/A;QQH>I:]-X(\9?9+?7_ !WX>U[P]IE^USK,]A?Z1=P:W;:59ZYJ
M":CJOAWPMRVD_"/_ (* KXFM?'7C[QKX6U7Q#X=\":=X1\.:=X7OO!&EV5W=
M>(=*^%&M?$'6I;+Q!X$UK08-9T7Q;:_%'PUX<UK4K2>&3X<Z=HEGJEKJ'B/5
M!KDX!]2G1/V_E57;XX?L9JC;2K']F/XTA6#*SJ58_M?X.Y%9EP3E59AD D..
M@_\ !0 ':?C=^QJ&+B,*?V8?C4"7(4A,']K[.\AU(7J0RG&&&?)-+\'_ +?\
MVDZI<>(?BIX"L=:DN-;DTG3M$T7PA/HX@6U^+7]DV[2:OX%U+6(M/@NK7X*7
M%RMU=W6I00ZAX]AEEDGL--O(>'F\&_\ !1CQ+>W=YK7B;P/HEAI_C/QJ?#^@
M^&O$&DVVF3>#;_1[N#PG;^,[J#PI:ZYX@T?P]KFG:'.L>CW?A/Q=*NNZS')J
M>MP:3!<ZP ?2"Z+^WXZR,GQQ_8R98E5I67]F/XTLL2N@D1I"/VOR$5XR'4M@
M,A##*D&E&A_M_$,1\</V,R%+!B/V8OC20I0D.&(_:_X*$$,#@J0<XP:\^^%N
MA?MUN/"TWQ,\7>!+:2PUO0'\0:1I<7AO4W\06%[>?"&P\917?B&S\&Z;Y-K:
M6J?'C6/ ,FDC2O$8@_X5TOC'4-9OYM6BD\\'P,_:R^'.K_&#6_@I\0+&U;XF
M?'SQ%XYC7X@:QXD^,8TKX;O\._#-KX-\/6'ASQ]XVTK2_!WAZ+X@0>+;OQ9H
MGA'4;35H-%UJUN?#?VFZALK  'T*-"_;_)=1\;_V-"T?,BC]F+XU$QCD9<#]
MK_*<J1\V.A]#1_8?[?VUF_X7A^QGM0L';_AF+XT[5*;PX8_\-?X4J8Y-P.-N
MQ\XVMCY[7X<_MTGQ%-XM\,^.].\/-XLU+X$:!XST[Q3?^#M=GTCP?H'B/5O^
M%J^)?#7V#P%8^&O^$VN?#-U'IOA>UT^V@\-:FM]+<:OH]]K-MI^LR\A=^"_^
M"GOB+X::)+XEU?X.6/QK\-)X0\1V9TW6K>#X;7GC32O#,]MJ-II]IIGAZV\0
M)H5QK]UJ:^(-+\27&MV.I:E)H^I>&+33/#^GZOH=X ?6AT'_ (* !0Q^-O[&
MX4G:&_X9A^- 4MDC:"W[7O+9!& >H(QD&@:#_P % "2!\;OV-F("L0O[,7QI
MR%92ZDY_:^.%9 6![J"P. 37PEXQ^)__  4NTKXRZKX \.^%+JZMM)\!^&I?
M!5YJ'PWT[5OA3XB\0>.?B1I/AA=<^+'Q=T/P[;0Z5J?PV\':]?:UXFT#X<QZ
M9?:EJ?ANZUJV\"Z-\/\ ^SM2U?Z$^)7PQ_:RTWXWZYX[\ W2^)=*E\,_"_0_
M"WB#4/B_?>%K/PUH6F7EPOQETFQ^"U[X?UCX<ZS\1/&:7<VM>$?'OBRR\10V
M=U=Z7IEW:Z3;>'+2'5P#VI/#W_!0-U5T^-?['3HX#(Z_LP?&ED96&58,O[7F
M&4@@@J>1R#7E'QP\??MV? +X;ZM\6O$?Q(_9+\6>'_"NJ>$4UOPYH_[/?QC\
M,:IJFE^(/&7A_P ,WJ:?XAO/VG?%5KI%]!;ZQ)<6E[=>'M7M4N(HUNK&6%W9
M/J7X/^)OC$=.\,>%OBUX1TE_$%CX.TJ?Q9\1/"^MV;>$=6\7/;Z)%?Z?H>AW
M"1:\N_4KO6V:Y: :8EAIEA?K<H^OV^F6'D/_  49_P"3./B[_P!=?AS_ .K8
M\"4 8T?C[]KGXE?&G]H7P;\*/&G[//@?P7\$?'7@KP!:1?$?X,?$CXA>)M>O
M?$7P2^&/Q8O]7N=9\,?'KX9Z9:0177Q"DTBTTZ/PVSI!I:W$]]++=*B]:V@?
MM]Q@F3XX_L<(%R27_9?^-(P I8DD_M?*  JLQR.%5F)P#A_[.PS^T%^WW_V<
M7\+C^7[&G[,YKCOVT?A1\=/B7KWP*O/@KXGU/PZO@CQCJGB3Q8+'QEJOA*RO
M5%OIK^&CK]IIEU:_\)9X?M-0T^]_M;0'^VWDME=3'2]-ENI&OM. .N/A_P#;
M[&S/QQ_8X'FX,>?V7OC2/,!*@%/^,P/GR70#;G)90/O#(/#_ .WV6VCXX_L<
M%B&8*/V7OC3N*JVUFQ_PV!G"M\K'& W!YKX5^*'AC_@I%?Z1\.O#][XDT#6/
MB)XON_BO;ZOJ_@K2/$'@?X8^"(D^$6NW&@7LWC#PYXMU8#P@?'AL5\.ZYXKB
MT'Q_)#?VFG/I>NMH>KZS;=IK?C;]OOP-\9_V=O 7BR#5?$G@/Q?XX2X\?^,O
MA=\+[3Q>+72F\-?!M]0\/>+]:30K3PKX.\+1>+=2^,EI'XFU2XT6_A\"V>BW
MMOX@UCQ7I_\ 8NM 'UK_ &#^WS@M_P +R_8WVC.6_P"&7_C3@;4\QLG_ (;
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MP:=( >HKH'[?3?=^./['#=?N_LO_ !I/W3M;I^V >C<'T/!YI/["_;XS(/\
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MTGYF02*O'[8'5HR'4=2A##Y3FD&@?M]$(P^.7[&Y$N/+(_9?^-)$F[&W8?\
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M/NP'4B@>'OV_&SM^-_['+8)!Q^R[\:C@AF0@X_:_X(='4^C*R]5(&-\1+?\
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M\(+^QQD,5(_X6]\:LA@&)4_\62X8!6)'7"L<<&D&N?M^%58>!?V."K;=K?\
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M0$?7_P!OF,[9/!'[&R'DXD^,/QH4\&('@_!%> 9H0>.#-&#_ *Q,_*UUJ_\
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MH,W*^$OV-F'RG:/B)\:B<-]WI\,>C#E3W'0GK3!KO_!0$E%'A/\ 8T+2[O+
M^(_QI)DVMM;8/^%99?:WRMMSAN#S7B9US_@IA'HZ7C^!O@G!J5Y!!YND:9<V
M=U<>'[V'X3:/+"MMJ&O>,X+;6XYOC5=:OI.M7U[)-J>G_#C2HM1TRRUSQ!?K
MI[_/'BWXA?\ !2C]F_X26DS^"/!WCK4(_'OBQ=5U#4M2O?&36/AWQM\6+F\T
M6XB\2V.MWNN6E_X>T?Q ]E'H^J^&[KPII'@O1=#L1J5]K-IJ-G: 'WO_ &Q_
MP4%(!'A#]C<AMNT_\+$^->&W8VX/_"L>=VY=N.NX8ZBD_MG_ (*#':1X0_8V
MPYVIGXC?&H;FY.%_XMC\QP#P,G@^AKP"^NOVT/BEH7Q0TNZ1=,\-:'\3/@_I
M6C_\*\63X1_%SQU\,M1?3_'_ ,4-0TG7O&>O2:3X/\0Z9X:\8^&_AW86$-_I
M5[<^*/ _CR./Q9H9U[3+K1?6/#/C']ICP%J'B9?&/PKUOQI\/=$L)[/P=9^'
M]2\':_\ $K5H8= \+S^&H]:U2[^(5LOB+Q+?:P/%VC^-KS^S=-L+*[/A[5-!
MN;W0CXIU[3P#IAK?_!0,AR/"7[&Q$>1(1\1OC40A4$L'/_"LOEP%8G., $G@
M&AM9_P""@N60>$?V.!(!]T?$3XUEP6#;3L_X5@6).QRHVG=L; .#7'?$$?M?
MZ=\1?'%U\.-'O+_PUJ'B_2/$'A*34K[X>7/A9O#T/P$\2>&IO".HVVK>+=.\
M4:3'+\<H_"WBG6KK2-/ADO="@U631]:N;F"&WU?TW]E73?C)X<\"WVC_ !MT
M_69O$ES\1/BQXLM->U/5_#^IL_ASQE\9/'>L>!/#YM=%\1>(DTVXT+P)/X4)
ML+&]O/#^CVEY_8^EZE(-+\F@#C_@!^T#\<?%WQ_^/?[/GQK\'?#/0-?^#WP^
M^"GQ*TOQ%\+_ !/XE\0:+XCTSXQWWQ8TI-$N[3Q;X5\-ZCIM[X?N_A?)/]JA
M6[@U&UUF *\3VDIF^Y@<@'U //7GUZ?R%?G-\)VW?\%+?VTN,8_9?_8?_P#4
MJ_:QK]&5Z#Z#^5 "T444 %%%% !1110 4444 %%%% !1110 4444 %?'O[/7
M_)P7[>G_ &<%\+O_ %CW]G&OL*OCW]GK_DX+]O3_ +."^%W_ *Q[^SC0!]?O
M''( )$1P,D!U5@"5*DC<#C*L5..JD@\$THC0=$0=.BCMNQV[;FQ_O-ZFG44
M1F&$]8HSP5Y1?NL$#+TZ$1Q@CH0B _=&%$48P1&@(S@A%&,DDXP.,DDG'4DD
M\DT^B@"(V\#%6:&)F3.QC&A*YSG:2N5SDYQC.3GJ:!!"!@0Q ?,<"- ,OG><
M ?QY.[^]DYSFI:* &>7'R?+3DY8[%Y(S@GCDC)Y/3)JC<BWC>'"QJY)" !55
MF81Q*N-K*S?ZLJ-K.$C;8IVX%]_NGTQD_0<D?B,BOSN_:HE^.I^+7@^V^'VD
M_%OQ#X17X?7>J:QX5^%?B6U\%:GK\4/BW3;#7K#2O%NLZMH7AC1O%MI?ZCX#
MU*T.NZOI][?^$;?QA9^%[N*];4K>] /F34?#O_!0O4?@]XE\(V%C\2;#7]4^
M%.G?#*_T_4?%WP=O]0N/$UIX0^/6CZQ\0?"?BF[UJ35M'D\0>+M3^!DVHZMJ
MGB%-7'@B3Q%<^'-,\/\ BW3;"X/ZY>"-4U74M%^U>)?#MYX4U#^U?$%K_8^K
M7VE:E=&PM-;O+72]3DNM)O=0L3'KVFPV&NPP"XCFM8=1@MKFRTV:$Z?:_FWH
M%G_P4,\*:AJ]K9:?X0\0Z3=>/?B9KGAG4/'^I7&M:EX<\&>)/B[XAC\+Z%XA
M33OB'H]IXF@\'_#.70]9T6UTYO#MG8'5$T*UC%QIXNIX;[QK^W?J'QL^!NF>
M+_AP_A/P';?$OX7MK>K_  ZN+G4-'U%;WX/_ ! N/B_9?$$6OBS78XO -MJ5
MY93>%X?$6BZ1<V'C>#P/IFDWWB&>]S:@'ZQ"*')811Y;&6V+DXZ9.,G';/2E
M\J+G]W'R #\B\@$D \= 68@= 6)[FA"2J^Z_RP*?0!%Y$&,>3%C<SX\M,;V(
M+-]W[S$ LW4D D\"D:VMW8,\$+LN"K-$C,I!4@@E21@JI&.A52.@Q-10!&(8
MAC$48VDE<(HVD]2.."<G..O>@0PJ JQ1!57:H$:@!0 H4 # 7:JK@<84#& *
MDHH B,$+,&,,196#*QC0LK+G:P)&0RY.".1DX/-?$_\ P49_Y,X^+O\ UU^'
M/_JV/ E?;M?$7_!1G_DSCXN_]=?AS_ZMCP)0!K_L[?\ )P7[??\ V<5\+O\
MUC3]FBOL1D1@0RJP. 0R@@@'(!!!Z$ CT(SUKX[_ &=O^3@OV^_^SBOA=_ZQ
MI^S17V-0!$+>!3N6&)6#;@1&@.[).[(7.[))SUR3S3C%$0%,<948PI12!C.,
M#&!C<V,=,GU-/HH B\B'_GC%Z?ZM.F5;'3U1#]54]5&%6&%0%6*-57;M58U
M7;]W  P-N!MQTQQ4E% $7D0;=ODQ;<@[?+3;D#:#C&,A?E!QP.!Q3'CM85:1
MXX8T57#/Y: *C_-+N(7A&QNDSA3C+],U8JEJ$;RVSK&RJ_52Z%TSM8#<%!9<
M$@JP#!6"ETD3<C $4ESIH!C9K?<V5$>Q=Y8%.-A0X(E6)"67"SB*)OWNQ*^*
M_P!JOP]\4?$FLZ=8?#O3_&^J6<O@+7%UW3O!'BV^\ ZCK>F6OQ@^ ^I^*_">
MD>.(+[2X/"OC7Q/X'T_Q58>%-4.L:'J6W^W+?1==T.[NY-2B^)/$/PU_;FU7
MX&_ SQQX,\=_&UOC7K_B74;/XX^"M>\6:+:^%_#MW;> /BIH=^VB^']<U3PQ
MY/A^V^,T'A/5Y+T:SXN@C\)1OJ-AX4\3>&5N?"NK^Q>+?B/^WM:WWB_3-5^&
MWAW3;K4?%WB?P=\'Y?!UOX@N+'4(C>:O>^%M7USQ)8>-[U8-"F\(:'/K>K>)
M?%N@?#^TTG4S>:6]K)-=Z):4 9WBSP-^W7HVH6LOP0M+C2/!VM7FEZW%X6^(
M_C72O%?BCP+<>'?@;\+/"?AZVO/%-QXKO[KQC)>^*XO'I\8Z=K>N^(-)U36-
M$TO6;>7SM:U#7=5VO$-W^V_=>*?!VB^+/#Z3^ ;"/X8_VYXD\.R^&F?4O%]E
M^T!X0EL-673?"\EOXHTV"7P-8W3_ ! M;BVNOAX?#<NJ7<]OIIDOM.M^._X7
MU_P4&\*_$/\ 9S\#_$#X8>#8M*^(^O-/\0?&O@GX8_$;QO8^#?#UAXFT#2_^
M$<U'4?#WCCQ#I&F:[JGAB_O=5N/'NM:E;Z5;3:CJ&K6_AO\ L/0[]!F:;%_P
M4L\(?';XOZOI.DV'C+X6ZYX^UNU\,6'CS5='O])T'P]<^+?'-]X(U;P=9:?\
M4]-U.2QD\-W/A?P[X_O;RQ\&7_@G3;"].D^#?C#K'GW'AP _8J*2T2%/.^S1
MR&)6GRJ*H81Q"4LQ+C:O[M2S2. /+4NWRYG62T8Y4Q%H\+D*-T>Z,N%/&4S&
MI.#C*X]1G\R/"_B#]N[XB>*M$\%>/O"/A#P[\+?%FJ?%CP7XW^(W@3^U_"/C
MOP[X<\'P:MX0T#QYX5?6/%FIZC87OQ%\7^&;7QYX;TZ/0-8L=&\ _$K2]-FU
M:ZUOPW'K6I>[?LRZ=\1M"\6?M*>'/%FK?$;6OA[X:^*O@?P[\&];^)E[J&JZ
MMJ_AW2?V??A'8>-+[2M5U18[_6-&OOB3:>+;B[U.=%ANO&\OC%M.5;$6Z@ ^
MQ#;VYSF"$Y()S$G)#,X)^7DAV9P>S,S#DDTJPPKG;#$N3D[8T&3D-DX')RJG
M)YRH/4"I:* (O(@.<PQ'=D-^[3Y@0%(/'.0 #GJ !TIWE1 DB.,$]3L7)P"H
MR<9.%)'T)'0T^B@"!;6U4 +;0* P<!88P X4*& "C#!550W4*  < "G"W@ P
M((0,J<"- ,JJJIP%QE5554]E50.  ):* *&I@#3-0   %C=X & /]'DZ 5^7
M4G_*$E_^T6,__K);U^HVJ?\ (-U'_KQN_P#TGDK\N9/^4)+_ /:+&?\ ]9+>
M@#],?!W_ "*7A?\ [%[11^ TZVP/PKH61'X=58=<,H;G!&>0>Q(^A([FN>\'
M_P#(I>%_^Q>T;_TW6U='0!'Y462?*CRP 8[%R0,@ \<@ G /3)QUIJV]NBJB
M00JB;=B+$BJNT*%VJ% 7:$0+@# 10.%&)J* (_)B&[$4?S9W?(OS9"J=W'.5
M1 <]0J@\*,+Y:8(V)@\$;1@@9P",=LG\SZT^B@"&00 #S$CZL5!0-U!5B!@X
MRKE6/]UB"<$TP-:G"XC^9AM4Q@;F!$@V@J-S KO&W)#(Q',;;?(OCSK^N^&?
MAWJ.J^&[S^S]5;5?".DKJ(AAG;2M/U_QSX6T77-;BBN,P--H.@7VJ:RGFJR*
M+%F8HH9A^;WQX\4_M]?!/2/%'A;X5V_B;X_:[KWP+O[+P+\2+3X6^&$@\!_&
MR2[^+_C%-9U_0K+4X[:3PUHO@;P3X>\'6^C)J5\VJ_$OQ7\/;66:TL_&.K:C
MHP!^N\C66S*" $*RC:B@B/(AD"X7.S*I$X'RDA$/\(K\5X?&/[;7B[PSK+^#
M]:^+T'C27XN? )_!EG<> _#]Y\)4\!7OQ9^&1^.]YXL\0VFAVGCF?5_ NJGX
MP^ M2\(VWCGPI8/\*/#V@ZAX>\.:['J%UXBN^UUW]JG]MC42EKI7[*_CCPUI
MZ6?QB\.76N:MX;U2]N+75O#NA^!)_AQXT@\+^'M/\27\T?B'7KOQGH7AZWL;
MQ;&2WBM/$^MM9>']*U:[TKU3P_\ M#?M?WC>/[:3]E:#3SX.U74K#PWJVO>(
MM5O7^(ECHVC^.=2_MFQDT+P]J%B!XHU'PYX8@LEM]16+PSJ'C=M$UK3;231O
MM5\ <!I?[1'[?C?#;2OB#JO[,EW8ZU=:3)K/B?X<1Z1=Z[XJT74+_P  2W]O
MHGAN.#7/"]K?6.A^.+=[>]@U"[U/6]0M-3@M(/$$5Q:BZM/H#]B'XE_&CXE6
M7QHO?C;X9U#PIJ.F>.?!$6D:#J=A]@A\-76I_!/X9ZQXP\):1'*]Q-+I6B^,
M;W6+Z%Y+V^?3[G7+O0)+J671)6.9I?QU_:*\12_'+P9K7P#OO >H^#_"OQE;
MX=^/X6N-;\,^.]2\+6GAK3?AIJ6B6M_H7V)KCXA:OJ'C#4K#PI?SWE_9Z3X4
MLWOX[J'78&/B6C?M*?MT> I=;M_&W[*FI?$:**S\<^)(]:\ HZVZ0>'/A;X%
MUGPMX$\-Z1_9FG76N:[XO\97_BBQTK4=8N--L);RTN?#D&H!K&S< 'ZSE[?[
MI,?S;EVLH&X#Y#P0,J=H4'[K * 2"N8RUD).?LXD#.V2J;]QW"0@XSN/E.7(
M.2(G8\(2/R7C^-_[=OCGPOX9UJP^#]_\,M:\4_%30H;SPGX@T35-9U'PIX4T
MCQ;^S1I&K$ZG:VBV5IX3\0>$M4^.?BN\NM3T^348H-/N+#2];@G@L9[STW3/
M&'[0]G\6/V:_&GB'5?$5CI_[1&NP:#XU_9UOM T,:/\ !BPT#X$_$?Q?XKU>
M'Q6VEIXOU6\7QWHWA.UN#K$^F6RMJL-C::8'O[EI@#]'Q;6P8.+> ..CB*,,
M/N=&"Y'^KCZ'_EFG]U</\F(<"*/&<XV+UR3GIUR2<]<DGN:DHH C$40SB.,;
MB&;"*,L#D,<#D@@$$\@C-(8(2"##$01@@QH0026(((Y!+,<'C))ZDU+10!&L
M,*+L2*-5' 58U50"&!&  .0S#IT9AW.9*** /S/\/?\ *8#XO_\ :.W]G;_U
MH[]I6M]_^4K6B?\ :/SQG_ZT=X#K \/?\I@/B_\ ]H[?V=O_ %H[]I6M]_\
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MJQ!."418U;!Y!9$1CDG:Q*$[D:@";[/!DMY,66W9/EID[E"MD[<G<H"MGJH
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MDG[4?[:\?B?XB:5X!^"UW\53X#\8_&G0=<L=?N;62TTL^%/A9I?Q/^'&A_\
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M8 ?E#X@^//\ P4&\.7-_KEY\'/ UGX!T3PCXGO=0O9/ 6JZMXMO_ (@R^*_
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MOP]\4I_'_AS3[RXN'+0Z1Y=HJ:7'IY?Z]J*&"*!=L2*B\#"JJCY1@9VJ,D#
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M7_XJC</\E?\ XJOSO_X=_P"O?]'^?\%"O_#R?#;_ .<Q1_P[_P!>_P"C_/\
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M_A@?V6?_ )U='_#+7[7_ /TDJ^,7_A@?V6?_ )U= 'Z!45^?8_9=_:])"_\
M#RSXP[B,A3\ OV60V!_LGX6;OTIW_#+7[7__ $DJ^,7_ (8']EG_ .=70!^@
M5%?G[_PRU^U__P!)*OC%_P"&!_99_P#G5T?\,M?M?_\ 22KXQ?\ A@?V6?\
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M=N[AAC>H=>H&<JP((SU]: )**** "BBB@ HHHH **** "BBB@ HHHH ****
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MDTO_ ./UE_\ "C_@K_T2#X7?^&_\)_\ RIH_X4?\%?\ HD'PN_\ #?\ A/\
M^5- &I_PM'X<_P#0]^#O_"DTO_X_1_PM'X<_]#WX._\ "DTO_P"/UE_\*/\
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M\EUR'_#/'P _Z(;\'O\ PV?@K_Y24?\ #/'P _Z(;\'O_#9^"O\ Y24 =?\
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M2>.O#5S=WVH>#O#'A'Q-H7A_6&@\+&WO)M3;Q/:6GWA\*O$?B_7_  ?H4_Q
M\-GPUXT&CZ*/$UG;+;MHXU^Z\.:;J>M1Z*]OJ^MR6]EIVI7]QHDUG?WK3P:G
MI6HP6T^IV=M'JEV <[^S1\7/$WQO^$6E^/O&G@BP^''B\>+?BEX'\4^"M*\5
M#QMINA^(OA3\4O&?PLUJ/3_%?]B^'#K=A>ZEX-N=2L;QM"TN0VE[!%+:))&[
M-[U7R?\ L7D?\*8UX_\ 5Q_[97Z?M??')3^JG\,5]84 %%%% !1110 4444
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MQT3PI\.]:T#6(H)_"$<VK:S/<_%#3(K[P;(-"EO)?#WB;0+#Q)?Z_-I&F:H
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MXJVFHZ(@M-=T_7M2UWXEV.N> [-($\.Z:D%E-$R:AJ-M?7,H!]2_\-1^(/\
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MUBXG\,W'BG0?%_B+P[X8N_ _A[Q'J^A:3;ZOK-K9W6OOY]\?$.F7GAG2+_\
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MU?5KJ\\%7OC'7M8M],71Q=WVI:K9:%9W%NFJ2:MI8!RGPB_X*50^,?AAX?\
M$?B?X+>.)?B/J&C:?+K?@KPLN@F[U/Q!?6GA#6K-=#@UWQ/;Z4GAN_\ #'B6
MTUF&\UOQC!K=BD&I6%YH"7EJS#U?X0?MW^$_C7^T!X;^%?@/0+N7P[+<>/-!
M\1ZUK%SI3ZM#XG\/:%9^+_#=WI\7A[7-5M5TB\LK?QK8>(;#6HK/7O#NMVV@
MVU];0'6TB:SH7_!2']D?7[2RU/PUX\U37[.\L/!FI6,^B_#[QY?RCP[XU\">
M-?B7HFN36]KX4N[VQT^Q\$_#SQ7KOB WZV/_  CL.@W\&J1VEQ)ID>K:5Y^U
M]^R5#<:)\:O%-W>Z)+X6N6\!^&?%WB_X<^,] U;2K3XG^*=4\+WEOI,6JZ-'
M?C1M8\5?"75[+Q)JEA8K:Z8OA&T.HB*RN]/NK\ ^]_[,L=C1_9U\ME9'0-($
M=&,K-&ZA\/&WGS HX*%9I4*[)'4CZ;92!A) )%?[Z.\CQO\ ,')>-G,;$LJ,
MQ926,4)8DPQ;/CV?]O?]G:QUO1_#FJZ[XDTG6]?\,:#XRTJPU#P)XW@>7PQX
MMU+5M.\'ZU=2'P]Y>G6'BK^QK^_T>>^:W1M/MYIKTV<BQ0SZ6D_ML_!O7KW7
M(-(B\:7EEH^L3^';+58_!^MR6WBS7H-1^%^B_P!E^#K2VM;G5]?N#KGQ=\':
M4YM].18IKF[O'/\ 9=G/?J ?6D=E;1-O2-E?!!?S9BY#.)6!=I"Q#2YD8$X:
M1I)&R\CEHO[+L.<VRDL &8M(7.)OM )D+ERRW&)U8MN6<"8$2 -7PQ!^W%I?
MQ)UG4O#'[,O@?_A>GB;0[GQ5I_B33KCQ9'\,K'P_>>%)_A>]TUWJ?BCP]<&]
ML;W1OBIH6LV5SI%GJ-Q(I2P-DMU)>#3?I_X*?%*R^,?P]TWQS9:=+I)GU;Q;
MX;U/2Y;H7ITWQ%X$\8:]X$\46$5Z+>T6^M;3Q%X;U.*RU%+:WCU&S$%[%#''
M.JT =O#X4\-6VJ7NMP:'IL.KZC9V6GWVI1VL2WMU9:;<7EWIUK-<!?->"QN]
M1O[JTC+;;>YO+F>()+-(S:8T^R7<! N)/]8"7(E_=B',H+'S3Y(6',FX^2D<
M.?+C15NT4 ,2-8QM0$#W9F/XEB23[DYK\_\ _@H/_P B[^RG_P!G]_LB?^K*
MLZ_0.OS\_P""@_\ R+O[*?\ V?W^R)_ZLJSH _0.BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :W0?[R
M?^AK7Q[^PA_R;K#_ -ER_:W_ /6M/C?7V$W0?[R?^AK7Q[^PA_R;K#_V7+]K
M?_UK3XWT ?8E%%>8_&?QKJWPY^$GQ/\ B!H6E1:]K/@?X>^-?&&E:#(MP_\
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M2&2W=)!++)YLJNK+(T<2NICB1 Q_"7AYW60Z3IX=7FDWK86(=FN+:*QGW/\
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M/: ?G!X)_;W^''B?P1\'_B5'\*?$^C:-\6M \6W^KRZW=_#71]>\+:]X9N?
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MU?Z9H.J6MWI6AR:!;Z)IS:2-$M=/6SO(Y]3B U.^OKRYT)_V;/@%<S6US/\
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M!U^?G_!0?_D7?V4_^S^_V1/_ %95G0!^@=%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!'*P0*3G!=%R.
M<$L,<?>.X@* H8[F!("AF7X[_83E1/V=XE)R1\<?VM3GA?O?M9_&YAPY5AP>
MZCVR,$_7UWYFR,QL582CG:67!1U)<#&%C#>;DR1#<BC?R%;XS\&?LF^-/A[I
M6HZ!X!_:X_: \(>%K[QG\1?&UEX8L_"W[+NN6&AWGQ+^('B;XCZYIVFZGXE_
M9WUK7KC3+?7O%>IIIB:KJVI7EK8?9[22]N/($C 'VAYZ>O\ X\G_ ,51YZ>O
M_CR?_%5\O_\ "A/C)_T>W^T-_P"$'^R'_P#0QT?\*$^,G_1[?[0W_A!_LA__
M $,= 'U!YZ>O_CR?_%5SM]H>DZE<:==ZCINGZC=Z->RZEHEU>1PS3Z/J$]IJ
M&G27VFR31SO9W1TW5M1L?-A=6^RS-!D)(S)X#_PH3XR?]'M_M#?^$'^R'_\
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M_P!'M_M#?^$'^R'_ /0QT?\ "A/C)_T>W^T-_P"$'^R'_P#0QT ?4'GIZ_\
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M"//&"1^S)X"?(.<$8X(!+@_>4+\U=S_PHKX^_P#1Z'Q8_P##2_LX?_.KK9^
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MG#_Q"SQS_P#1E4?\*Z_;Q_Z.N_9P_P#$+/'/_P!&50!]ET5\:?\ "NOV\?\
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M0 4444 %%%% !1110 4444 %%%% !2$[06/0 D_@,]\#\S2TUSA'(X(5B#]
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MHVDV&FB;P] \JV=ND D:/5WVLVP#+*6/S=3GDD8KT&@ HHHH **** "BBB@
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M#/6/BQH_A_3/#5QH5O;W/B"]\*Z#K4]XT>JGP_X:NM(UB/Q3X@T6WT75;NT
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MNC\_^SV&_P"%"_!$MR3\)OAR23CG_BC=)SG  ZGL /0 <5\[_$KPYX>\1?\
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MIUU\)CH<L-UXPDNXK2WN&U[PWI:P3Z5<VJZ=K^G$/J6C:CJ%I97%B]W+%:R
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MVF7W@>'43:Z[9^.O"6K:7,+8M?:%X@L-9A5M-DDN(P#V"Y_;@_9.:)A!\?\
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MI-MK6C-<7=TL4 ?4(8ED,TL,<GU8@ ! & &( '0#CBOSO^.( _X*'_\ !/[
M W?#/]M0'@<@:'\%  ?4 < 'H.!0!='_  4.\)A06_9<_;U)*A_E_8Z^+I #
M#<$)CTN9-Z*0DFV1L2*P(4@JJK_P4/\ "+9_XQ;_ &]QC'7]CKXO]\^NCCTK
M2_;!_:3^(_[.6H>%-2\)_#R7QSX6U;PC\0+S7YM.T7Q3XAU30O$ECK/PF\(_
M#=CI7AFWD$GA_5O%GQ$BTOQ.)'75K31II_$]K+8Z!X5\171\/O?^"B5SX:\
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MX0^)>OZ1 A\ :AXG3QCH6LWO@2Q7^U;-?#D/ARSU&VT?QWJ7A?QEKF@^%W]
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M[7Q(/#$FN6-EJFGVNOSZ;$YN]8TWR/$EJ-2TF""T^B-;_9Q^"WB/1-+T#6?
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M\% $"?L'_MI %C_QBC^T/]XYP/\ A4GB\X]^23DY8YP20 !]?U\A_P#!0/\
MY,0_;2_[-1_:&_\ 51^+Z /7/V?/^2"_!'_LDOPY_P#4.TBO#O&//_!0CX #
MU_8^_:Q_]7/^QG7N/[/G_)!?@C_V27X<_P#J':17AWC'_E(3^S__ -F??M8_
M^KH_8SH ^EOB-\,O OQ;\,7G@OXB^'K3Q3X7U"2WDOM%OI;J*TNS;2B5([C[
M'<6TLUO(-\%W:22-:WUG-<65[#<6=Q/!)X?=?L/_ +)MW?>&]3G^ _P^>_\
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M6_#N#4/$-OH&C:Q!X%L;;QGX.U+1[F[\77FF6\8N-/O6D6UO89'WK#_@H/\
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M:7J%EXNU=A_87A_PQJ7BRP.F^'_!'B/Q'JMUJ^@Z?I^EZ5IET-5NK"_@EL5
M/-_VG?CI\"_V8_%O@S^U_@WHVN>)/$VG>)_B):ZYHOASP?8W6EWMI\0/A#\,
M%U.]UW4+:UDM]1\1>-_BOX#L-4\0W&I65IH/AV'6O$^O7=Y:Z#;:5?\ D&E?
M'3]ECX,:%\0]#\5? "'PC:>#?B-X\\6ZT]OX:MOB#HGB7Q'-'I'Q'^(WC'0_
M$,NFW4_B37-#U?XIO#!I\L5O<:9_:Z:!H,R6\&H:;I'I_B;]HC]A'XQ>/= T
MG7M?TGQOXTT'0/B%X/CT:?P%\2==AC\->,/#>@W7Q*\#>(8+?PA<Z#=6NK:9
M%X7L]>\,>(4O8G\0VEKH3Z>GBRWMX;/G=+^/7[ VE^';;PK#X$@T_P )V^I#
MPUX5TRR_9L\=W7A[Q+%K_A/X8>(VE\(Q^'/AOJFES:7J4'C[P#H\_G&R==;N
M].T;5;>#49;=IP#>B_:K_9PUK4[^VL?AO+/XLT"PM=*\2:3K?@C0=(US3-'T
M#XL>'/@YXI\.WSM!-/:7WP]UCQ;:F30[V"RTK4H+NV@\.:E)]KDB;[>;X4_#
MJ6*>-_ WA$1WDLEU=QQ^'M,@CN;Z:^M-5DU&:*"UBC?4_P"U+*TU--2*"_AU
M"WBO89X[E!)7Y]WW[0/_  3HNO%-]=RW'@Z7Q5XRE\.:WK7BSP]\*/'Z6VN;
M]9\*_%J&?6O%NA^"##=:'#J&G>'?%?C235]5DTG3$LHH?&\MA-8"TKWK6_VR
M_#>F:7\'M5T/X=?$+Q-8_%GQYXB\!6L,6DRZ-KNAR^$-=ET#Q!J]SX;UJ&UU
MG4[&S-EJ6L1/I=M/!<Z#IMSJJ78MIK%KP ]R\8_ GX1_$"VT.S\9?#_PQKUI
MX:UG1M?TBUO-)MS;P:AX?:231A/#$L<>HV%A)(7AT;4EO-&,D=N\EA(]K;&'
MM_"WA/0/!EA<:5X<TY--L;O5]<\03Q+)<3&75?$NL7NNZS<O+=2SRYNM4O[J
M=(!(+>SB>*SLH;>RM[:VA^*K[_@I/^RY':6]_H7B7Q?XPM!X]\#?#S5[SPI\
M*?BSJ>G>'-<^(/BA_"N@-K6I2^!+6SM()KF"\U58VE-Y>>'[.77=*M=0TJ>P
MN[S4T+_@HW^R7XC^S)I7Q'O;FZNO!T?CQ--3X=_%EM8B\,7'AN[\86-_>:''
M\/WUG3GUSPM8S:_X3M-2T^SN_&>F3Z?<>$H=:-_"E 'W/17Q#<?M]? N/Q9X
MA\*1WVN)/X=L]9AO;G5/!WQ%T VGB[0-.UG6]1\%ZW;ZUX&L_P#A%]5ET/2/
M[3T:?Q'/IMKKZW'V;1VO+B$I)8\)_MH>'OBL8-0^!OA"\^)WA/3M+\3WOCGQ
M1<:CJ/P^A\'7>AZIK&@:9:0Z=XX\+Z3>>+[#Q!XB\)^.O#]OXC\*?VEH%GK7
M@S6M-GOWO8C;H ?:U?)_[9?_ "2;PA_V=!^Q-_ZV/\"J^C_"OB2R\7>&O#OB
MC35D73_$NB:5KMDDRE)H[35K"&_@6=&52DB1S*CC'WP>!BOG#]LO_DDWA#_L
MZ#]B;_UL?X%4 ?6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7S_ /M8_P#)K/[2G_9 _C!_ZKWQ#7T!7C_[0GA?6O''P'^,
M_@?PW;1WOB+QI\*OB#X1T&UFNH+*&XUGQ+X3U?1M,BFN[ET@MHGO;V!99Y6$
M<,9:1R$5B "]\#?^2*_"#_LE_@'_ -132:]2K\^/AQ\:_P!J3PE\/? OA2__
M & _B_-J'A?P=X8\.W\MI\:OV5)+1[[1=$L=-NVM9;CXU6DTULUQ;2&":2UM
MVEB*.T,3,8U[3_AHO]IG_I']\9__  ]'[)W_ ,_*@#ZZ\1:4NO:#K6AO))#'
MK&E:AI4LL102Q1ZA9S6DDD9D22/>BS%D\R.1-P&Z-URI_*C0/^"1OP:\+>(-
M/\5Z)XM\61:S!KMUKVN"ZT?P-=6OBV]EUOXB:OH^J:U#+H9W>+? L?Q(U&Q^
M&_C2*1->\!RZ-H6KZ'<"XM);.X^G?^&B_P!IG_I']\9__#T?LG?_ #\J/^&B
M_P!IG_I']\9__#T?LG?_ #\J /D_P]_P21^&O@3P1XD\.>%M<MO$>N^)-2^!
MEK=ZO\1O _@#5_#]OX0^%7Q&^$?BOQ7HEIX*T_0(="G7XK:/\*=-E^)D=S!;
MQ_$?QK-=>*/$K6]_?SWL?H7P[_X)=?!CP _AQ;BZN/%\?A631;[2I=>\)_#Y
M[J]\1>&/#GC31/"7C#Q=,OA\Q^,_%W@B\\:R7_PZ\1:M:Q7/P[T[PYX?\.>&
MK1-,MF5_;O\ AHO]IG_I']\9_P#P]'[)W_S\J/\ AHO]IG_I']\9_P#P]'[)
MW_S\J /D#P5_P1M^!W@C5HM<AUS5=?NF\2>&O$U_:ZMHVE:=%<7G@_Q!\7=>
M\-6MEJ/@R^\(>(['2_#DGQ:O8O"5H_B&Y?PG-X9\+ZEI,L<L>K65][7HW_!.
M3P+HGP,U3X(0>+=9O-'U'XMZ+\7)I]:\*_#W7;#6=8\.^$_#?@RUMO'GA6ZT
M.V\*_$=-<T_PY;>(O%E[XJTNYO\ Q%\0W/C.XGM-0AMO*]4_X:+_ &F?^D?W
MQG_\/1^R=_\ /RI#^T9^TR 2/^"?WQFX!//QI_9.4<#N?^%XG ]3@X'.#0!Q
MO@+_ ()^_#[X9>!_%O@'P5KVO:+IOCB;X=S>+]32R\*RZQXJN_ GQ>\<?%B;
M6]=OCHJ'4O%'B>/QQ+X#UWQ5J4.H:JOA;PWX8DL46[L(X[;Q[QG_ ,$R9-<\
M2^$?%6D?%_Q#'K.@ZOX7\/7M]J.D>&XBOP+L4\/:7XU^&5C::?I:1ZI=>.?
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:1JJHH554(H'0*H 4#V   KX\_;!^]^RU_V>!\'O_3?XRH ^QJ*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "OB#]K_P#Y#G[&W_9[OPX_]5]\7Z^WZ^(/VO\
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M/A]ID'P[\)0V'@?5?&2A/%VH^$[./2%MO#U[XH3>GB&XTJ*UEUE9)/[1:Y+
MCK]8^!_PEU_Q9%X]UGP#X9U#QS%:>'-._P"$SGTNU'BN72O"'B_3_'WAC2+G
MQ''&FLW>D:'XTTK3O%%AIES>RV4>N6<&IO ]XIF;U6B@#Y\U+]D[]F76=?\
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MM 'CI^$'[73!2O[8MH,C)'_#._P_&#Z?-K3'W[8SWIO_  I_]KS_ */&M/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@#T&.52N23T5N-[?>17X."<98X!Y P  ,"N8\.R))K'C,JV_;K6F*6&2,?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "' ;L# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH *JWU[9Z;97FHZC=6]CI^GVMQ>WU[=S);VMG9VD3SW-U<SRLL4-O;P1O-
M--(RI'&C.[!5)%JORW_X*=_'P>"OA0GPL\.7[)K_ (\U&WL?$$MK*4>Q\/VT
M1U*?3VEC96CN-3D2R:YB!8'2O,MKR'[/J\);XSQ#XTP'A[P9Q#QAF,56I9+E
MU?$8?">T5.>88^25'+\OIRM*498O&UL-2G.,)NCA_K-?E?L4I<^*Q$<+AZV(
MDKJE3E/EVYI:*,;].:4HJ_1-OH?+_P"U#_P4Y\7ZMK&I>$/V?YAX9\-V4\MG
M-XWN+.*;Q#KC12!'GTN&]CEAT339U600_P"C?VV8VBN&N],N#+80?G/=_M'?
M'V]O9M0G^-'Q1-U/,\[NGCSQ1&H=V+'9&FJ!$4$X154"-<*FT  >+T5_C3QA
MXM^(O'&;U\XSWBW._:5:TZF'P&6YIF6593EM.4W*GALNR[+LPP-"A2HQ<:<:
ME18K%U>3VN)Q=:M.;7YWB,PQF)J.I4Q%75W4(3G"G!7T4(0E%)+9-\TG:[DV
MV?IK^S]_P4Q^+WP^U:STSXKWEQ\3?!4TR1W<E_Y \6:5$[1*]UIVM,(Y=0>)
M1+*UKKLMXEPVR"*\TN-FN8_Z"O!/C3PU\1/"FA^-?"&IP:QX<\16$>H:7?P9
M DB<LDD,T;8DM[RTG26TOK294GL[R">UG1)HG0?Q@5^T/_!*KX]KILOBOX)^
M)=19--N9K/Q#X1ENICY%EJ5TZZ;?Z<KR,1##JA33EMHP8K>._A5(TDNM5D8?
MU%]%KQ^XF7%>!\.^-<ZQ>=Y-GD*V'R',LXQ,\7F&3YO1HSKX?!2S'$SGB<3E
MN94Z-;#0I8W$8B>"QL<-.AB50Q-6A'W,CS2O*O'!XBI*K"HI*E.;<IPG&+DH
M<SNY0E&,DE)MQDE9V;2_<>BBBO\ 2<^P"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HKR+XU?&WP-\!_!ESXR\;WS1P[FMM(
MTBT\M]6U[4MA=+#3H)'120,/<W4SQVUI&5,LGFRV\,WXD_$W_@I'\=_%VH3#
MP5<:;\.M#69C:VFEV-GJ>HR0]$%_JNKVES+-,I^;S;"#28G! >TX(K^<O&KZ
M4OA/X%8BAE/%689AFW$^)P]/&4^%>&<)1S'-Z.$K<WL,7F=2OB\'EV3X?$J$
MWA?[0Q:Q6+A"5;#8">'C]9E^Q>&O@9Q]XI4JN/R'!X3 9)1K2P]3/L[Q%3!9
M=4Q%/E]KA\%&EA\3C,QK4>:*K_4\/*CAY2C3K8J%9^PC_0G5._U'3]*M)K_5
M+ZTTZRMU+SWE]<PVEM"H!):6>=XXD& >685_-3I_[=O[4%B</\2;O4(227AU
M"PT^3<#U47$%O!>1?[+17*%/X<  5W^A_M":[\79##XCUS56\00*TYL+_5+R
M_BD18Q'+/I%Q>32S)$$_X^+-61HU);;+'OD'Y?P5].[PJX_QM/),FROB#)^(
ML4W#+\NXJ_LW 8?'U;2<:.$S#+<7F.'Q&)DHN4,$WA,37491P[K5%[)^UXB?
M1P\1_#K*JV?8NAEO$&1X2*GC\QX>Q&(Q$\MIMQB\1C\NQF$PN/HX.,I153&T
M88O#4.:,L4\-3E[:/ZD_&#]K?1]&@N]#^'+#5-696A?Q!+%BQLB=Z.;"VG3=
M<W"$92YNXEM4)CEBMM1A<LGXM?M5-J_BC0+'Q3J%Q<7]W9>(7FU*XFDDED\O
M5X9(1-(\A=RHNQ&'D=B[2W&^5W>1F/N]9^K:58:YIE_H^IP+<Z?J5K+:7<)X
M+12C!9&ZI+&P66&0?-'*B.O*BN3Q,QF;^)629QE>98N-/ZY@JU'+Z%-2IX#
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M'D_ZQX#GY>3$<E[>T]G&V^_)[3GMUVO;IT/Z:**^7/V8/VK/ /[3GAF6_P!
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M20Q"2>=Y)IG$:*'EFD>61LO([.Q8_P YG_!;#]IWXN>"?B/\-?@WX!\4>-/
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M3_H[#3/_  \OQA_^9BOF_P#B'?!/_1Y.$?\ PUY]_P#*#W?]>.+?^C6\2_\
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MGGFO]&/H+9CFE7*O$/*:LJL\EP689!CL&IN3HX?,\PPN8T<PIT+WC!XG"8'
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M=.A1I3J346I2]V*:<DS[X_X?P_"#_HA7Q'_\'FB?_(E2P?\ !=[X/2SPQ/\
M OXE*DDL<;M'K.@R2*CNJL8XY(K>.20*2422>"-VPKS1*3(OZQ?\,K?LP_\
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ME>(I580QV$RW&1JUZ."E[>]+$X;"UXXJ&&4ITZM"C5]A&I.C"E"E^0!(49)
M'J2 /S-?H-^PW^RKJ'Q;\=6/C3QIILMI\//"TEOJSVM] T;^*KJ.4&QTZ.WE
M"O\ V3<S1N;N[=#%=VMM>VMJPF9;B'UG2/A/\-=#G2ZTSP3H$-U&P:.XFM#>
MRQL""&C^WR7*HP(R&50P[,*_4/\ 9QTJ*R\!-?+AI-4U*9RPQ\L-G##;) ,
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M6FB:+9R3"WADN[R0(KW%PRLMO;0)NGNKAU*6]O%+,XV1L:^Z/^"7_P 9[O\
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M0I4I4*-*=7%TZT85,UA3JU:594EA<"Z-:;ITIRJ7E2<J<4W+X>_X?P_M)?\
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M_"?P!>_!V7Q,)['Q=XH?Q8==UV?P]-#Y<^B:&\/A_0?['_M4.\6IZD'N+MK
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M&H>(]'DUO3+_ %*VUQM+N;%+W2[8V,T317T=A=7&J(L@99+33;U@08P#N_\
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M;D^%H4Z48PBIU,35<74Q-6<_]M?"_A_+.&/#S@W*,HITH82GP[D^,G4IJ/\
MM>-S3+<!FF88ZK**_>5L7C,PK5)U).3<:=&FFH4:<(%>N? [XN>(O@G\2/#W
MCSP[<.DFGWD4>J6)F>*TUG1Y7"W^E:@%RKVMU 70LZ2-:R%+RV"7=O;RQ^1T
M5^>9/G&:</9MEF?9)CL1EF<9+F&#S7*\PPLW3Q&"S# 8BEBL)B:4DU[U.M1B
MY0ES4ZM.5:A5A4H8BO2J?89CEV!SC 8W*<SPM+'9=F>$Q& QV#K14Z6)PF+I
M3H5Z,XM/XZ=1\LE:=.I&E5IRA5HTIP_K_P#"?BC1O&WAG0_%OAZ[6]T7Q#IE
MKJNG7"XRUO=1+((Y4!)BN;=RUO=6[XDM[F*6"55DC91T-?S^?L??MBW_ ,#)
MH?!7C1;S6/AOJ4\4K+"XFOO"]Y<!%GU+3$D95FM)?EEU/3/,C6;:U[9E-0%Q
M#JO[N^$?&?A7Q[H=KXD\':]IWB+1+P'R;_3;A9HUD7'F6]Q&=L]G=PD[;BSN
MXH+NW?,<\,;@K7_5G1R3/\/PKP9Q)FN J4</Q9P?PCQ)"O3I5%AZ.(XBX5X<
MS_$Y=5YHMX;%8+$9SB,,\/7=.<Z=&E5I>UC*:I?X'4.(,CS#/>)\CR[&TZF*
MX;XDXDR*MAYU(>WJT<CXASS)J.844I)8G"8RCE=#$1KT/:0A.M.E5]E.,'5Z
M:BBBN(]4***S]5U;2]"TZ\U?6M1LM)TK3X'N;[4M2NH;*QL[>,9>:YNKAXX8
M8U[L[J,D <D"JC&4Y1A",ISG)1A"$93G.4FHQC&,8RE*4I-1C&,92DVE&+;2
M<RE&$93G*,(0BY3G.480A&*<I2E*4HQC&,4Y2E*48Q2;E))-JW//#;0S7-S-
M%;V]O%)////(D4,$,2&26::60JD<4:*SR2.RHB*68@ FOXEO^"C?[6NM?M3?
MM!>)KFSU6XD^%_@/4=1\)_#724DD2Q_LG3[K[->>(VM]Y1M1\57EK_:UQ.\4
M=U'8MI>DW&Y='MRO[A?ME_MOQ>-]+UGX4_!^YG3P]=QW-AXB\6>7);S:^@1D
M.FZ9#*(Y[?17E^6[>XCCNM6"^0\4&E>;'J_\H$ZRI/<)/N\])YTFWDEQ*LKK
M(')R=X<,&R<[LYYK^Q/ 3P[K9++&<3Y[A51S6MAH8?*L'7@OK&783$.4L1BJ
ML9)NAC,9"$*$:>E;#X15(U'3J8F=*'\K^,''^&SQT>'<CQ+KY9AJSKYEC*,W
M]7S#%TO=HX>C)-*OA,')SJRJZT:^*<)4E4I8>%6<5%%%?TT?A)^@7_!.']JS
M7OV8?VB?"D\NISK\-O'VJ:9X0^)&D22M]@?1]1NQ;6OB$PLXB2_\*75U_;-M
M<*AN&M(]3TN)XX=7N]_]MU?YS^DV]S=ZG86MG%+/=7%W!#;PP F:6:2152.(
M*03([$*H!!)( YK_ $2/#T%W:Z!H=M?[OMUOH^F07N]M[_:X;*".YW-D[F\Y
M7W-D[CDY.<U_'WTF,HP.'S3AK.J$*=+'YGALPP>.Y%&,L3#+982>$Q%5))SJ
M4J>+J83VDDY2I1I0E)^R@H_T[X!YGC*^ S_*:LYU,'E]?!8O!\SE*-">/6)C
MB:%-NZC"I/#4\3[--)5)5)J*]I-RV*\X^+7PF\ ?''X?^(/AA\3M B\2^#/$
MT-O%JFER7-W92&2RNX-0L+NTOK">VO;*]L+^UMKRTN;:>.2.:%0V^)I(W]'H
MK^9L/B*^$KT<5A:U7#8G#5:=?#XBA4G2K4*U*<:E*K2JTW&=.I3G&,X3C)2C
M))I[I_OU>A1Q-&KA\12IU\/7ISHUZ%:$:E*M2JQ<*E*K3FI0G3G"3C*,DU)-
MIKM^7W_#GG]A7_HGGBG_ ,.+XP'\M3Q^5=!X7_X)-?L,>%M;LM=A^$MWK<]A
M()8;#Q+XR\6ZUHTD@(*F]TFXU866H1 CYK6_BN;.92R3V\L;,A_2&BOJY^(?
M'E2$Z<^,N)90J1E"<?[9QL>:,DU)7A.G)73:O&<'9NTEN?.0X(X.IRC.'"V0
M1E"2E%_V7A7:46FG:49Q=FD[2A)::Q>Q6LK*STZSM-/T^TMK"PL+:"RL;&R@
MBM;.RL[6)(+:TM+:!(X;>VMX42&""%$BAB1(XT5% $[HDBLCJKHZLCHZAE=&
M!#*RD$,K D,I!!!((Q3J*^/;;;DVW)MR<FVY.3;;DY-MN3;;;;;;;;;;;?TZ
M2222222222222222222222222222222_,B^_X)"?L,7][=WTOPX\0PR7ES-<
MO#:>/O%EK:PM-(TABMK:+4EC@@CW;(8D&$C55R<9/:?#?_@EY^Q1\,/$]CXO
MT/X1KJ^LZ7-#=:;_ ,)AXD\1^*M,L[NWE6:"[&AZOJ4^C74\,J+)$U_8W:Q2
M*DL:)+''(GZ!T5];6X_XXKT*F&K<7\25*%6FZ-2E+.,:HSI2CR2IRY:E.;C*
M'N22J1YHMQ<FG+F^:I<&<(T:L*]+AC(H5J<U5A465X1RA44N=3CS0G%24_>3
MY':23232L5Q7Q&^'OA3XK^!/%7PW\<Z;_:_A+QGHUWH6O:>)Y[22>QO$VLUO
M=VKQ7-G=V\@CN;.\MI([BTNH8;B!TEB5AVM%?*T:U7#UJ6(P]6I1KT*M.O0K
M4IRIU:-:C4A5I5:<XM2A4IU*<*D)Q:E&<(R3NCZ*K2I5Z52A6IPJT:U.I2K4
MJD5.G5I582IU*=2$DXSA4ISG"<9)J49235F?E]_PYX_85_Z)YXI_\.+XP'Z#
M4\?AC'M7W5\%O@E\-OV?/ &F?#/X4^'QX<\):7/=WD5FU[>ZE=7-]?R"2\O[
M_4=1GN;V\NYRL<?F33,L-O#;VEND-K;P0Q^KT5[N:\6\49YAHX/.>(<YS3"1
MJQKQPV/S#$8F@J\(SC"K[*HU!U(1G-0DU)PYY<O*Y-OR,NX:X>RBN\5E6297
MEV)E3E1>(P>"H4*SI3<93I^T@G-0DX0<HII2Y8\UTDE^=_Q _P""6'[%OQ*\
M:>)?'WB+X;ZK%X@\7:O>:]KAT;QIXITG3[G5]2F>ZU*]ATVUU,6MF]]>237E
MQ#:I#;"XFE>&&)7VCDH?^"/O["D,T4Q^''B6812)(89OB+XS,4H1@WERB/5H
MY#&^-KA)$<J2%=3S7Z>T5W4O$#CJA2IT*/&'$E.C1I0HTJ<,WQBA3I4J<:5.
MG!<S:A3IPA""YFXQA%*7NQ:XZG!7"%6K4K5>&,BJ5:M2=6I4EEF&<IU*DY5)
MSEHDY3G.4Y/E7-*4FU[SOR_@OP5X4^'7A70_!'@?0=.\,>$_#=C'INB:%I4/
MD65A:1LSE(U):226::26YNKJ>26ZO+N:>[NYIKF>65_!_P!H_P#8]^!?[5W_
M  B8^-'A[5=>'@D:R/#XTWQ'K&@"V&OG2SJ?G#2KJW%T93H]@8S/N,/E.(RH
MED#?4%%>!@\VS3+\P6;8',<;A,TC4K55F-#$U88U5<2JD<14^L\TZSJ5U6JJ
MM.4Y3J>UJ<\I.<F_:Q66Y?C<$\MQ>!PF)R^4*5-X&M0ISPGLZ#@Z-/ZORQI*
M%%TJ;IPC&,8>SARQ2BD?GCX _P""6'[$OPZ\4Z7XPTCX3RZMJVBW$=WIT'BO
MQ5XE\2Z-%=PNLD-Q/H>I:E+I.HM$Z*R1:E:7EL&&XP%@"/T.Z=***VS;/L[S
MZK2K9WF^99M5H0=.A4S'&5\7*C3E)2E"E[:;C2C.24IJG"#G))S<W&/+EEN3
MY3DU.I2RG+,!EM.M-5*L,#A:.&56<5RQE4]E%2J.,6XQ<YRY4VHJ*;O\R_M#
M_L??L^_M31:-_P +G\"1>(=0\/))#HVNV&J:KH&O65I-(9I=/_M31KRSGN].
M>9GF6PO_ +5:P3RS3VT4,T\TDGRQ_P .>?V%?^B>>*?_  XWC#_Y9U^H-%>A
ME_&G%^4X2E@,LXGSW 8*AS>QPF$S/%4</1YY.<U2I*<H4XRG*4W&')#FE*2@
MG*3EQ8WA3AG,L34QF8</Y/C<75Y?:XG$Y?AZM>KR14(NI4<8RJ.,8QBI3YI<
ML8Q<FHQ4?F3]G/\ 8_\ @'^RI!XEC^"_@^;P_<>+I+%O$&I:CK>L:_J5]#I@
MN/[/LQ=:O>71M;*U>[NIE@M$@66:=I;DS.D)C^FZ**\;,,QS#-L76Q^:8W%9
MACJ_(ZV+QM>IB<15]G"-.'/5JN4Y*%.$806D80BHQC%*S]7!8'!9;AJ6"R_"
M8? X2CS>RPV%HPH4*?/.52?)3II13G.4IR>KE)N4I-ZKX'^*O_!,K]C/XP^+
M=0\<>*?A0+'Q'J\\]WK%UX3\1>(?"MIJE]<RM-<W]WI.CZC;Z2+ZYF>2:ZNK
M:RMYKN>26XNFFGEDD;S;_ASS^PK_ -$\\4_^'&\8?_+.OU!HKZ'#\?<<86A2
MPV'XOXCHX>A3C2HT89OC.2E2A%1A3@I3J-0A&,8PCSR48QC&-HQC&/B5N#.$
M<16J5Z_#.15:U:<JE6K/+,+SU*DVY3G-QA!.<Y-RE+E3E)RD[RE)O\OO^'//
M["O_ $3SQ3_X<;QA_P#+.C_ASS^PK_T3SQ3_ .'&\8?_ "SK]0:*U_XB-Q]_
MT6?$O_AXQ9E_J-P9_P!$KD'_ (;,.?E]_P .>?V%?^B>>*?_  XWC#_Y9T?\
M.>?V%?\ HGGBG_PXWC#_ .6=?J#11_Q$;C[_ *+/B7_P\8L/]1N#/^B5R#_P
MV8<_+[_ASS^PK_T3SQ3_ .'&\8?_ "SJ:W_X(_?L*V\\$X^'/B:4P31S".7X
MB^,S&YC<.$?R]6CDV-C:QCDC< DHZ-AA^G=%'_$1>/O^BSXF_P##QBU^*::W
MW336Z::31_J-P9_T2N0?^&S#/\'=/T::[IJZ>=I&DZ9H&DZ7H6BV5OINCZ+I
MUEI.DZ=:((K73],TVVBL["RMHQQ';VMK#%!"@X2.-5'2M&BBOC92E.4ISE*4
MIRE*4I-RE*4I2E*4I2;E*4I2E*4FVY2E*3;;;?U,8QC&,8I1C%*,8Q248QBE
M&,8I))1C&,8Q22244DDDDOD#]H?]A/\ 9I_:B\2Z1XQ^+_@>ZU?Q1HVD+H-M
MK6D^(M=\/W<^CQ7-Q>6MA?KI5];V]Y'975Y>RVDLT)N8?M<\8F,++&OS[_PY
MY_85_P"B>>*?_#C>,/\ Y9U^H-%?48+CCC++<)0P&7\4Y_@L%A8>SPV$PV:8
MJEAZ%/FE/V=&DI.-."E.<E"+44Y2Y8Q3:/GL7PCPMC\36QF-X=R;%8O$3]I7
MQ-?+\/4K5I\L8\]6HTG.;C"*<I7DU&-VVDS\OO\ ASS^PK_T3SQ3_P"'&\8?
M_+.C_ASS^PK_ -$\\4_^'&\8?_+.OU!HKJ_XB-Q]_P!%GQ+_ .'C%G/_ *C<
M&?\ 1*Y!_P"&S#GYL>'O^"2?["_AW6;#6H_A5J6K2Z=.MQ#8:]XX\7ZGI,TJ
M<H+[3GU>."^@!Y>TNQ+:3C*7$$T19#^CMC8V6F65GINFV=KI^G:?:V]C86%C
M;Q6EE8V5I$D%K9V=K D<%M:VT$<<-O;PQI%#$B1QHJ*JBU17BYOQ%GV?NC+/
M,ZS3-WAE-8?^T<=B,6J"J6]I[*%6;A3<^6*G*%-3FHQ4IRC&,5ZV6Y)DV3*J
MLHRK+\L5=Q=;ZCA*&&=;DOR>UE3ASS4+ODC*;C%MN,$VY,HHHKQCU#\7/^"C
M_P"S+K)UZ7X]^#=,DOM+U"UM;?Q_;6<;23Z7J%C##8VFNO$@/_$MOK*&VM[J
M551;34+9Y[F2635X_*_(,@@D$$$$@@C!!'!!!Y!!X(/2O[&YH8KB*6WN(HYX
M)XWAFAF198IHI5*212QN&22.1&9'1U*NI*L""17PU\3/^">?[/GQ"U"75K#3
M]7\ ZA<2F6Y3PA=6L&E3NR[3_P 2G4+.]@LD7"F.#2GTZU0@_P"CMNX_R^^D
MU]!//>->,<W\1/"'&9-#%\28JIF?$?!^=XS^R*3SFORO&YKD.:O#8G PAFE6
M*Q>.RO,:6'5+,*F*Q."QKHXRMA:7]P^"7TI<KX9X=R_@_P 0L-F4L-DU"&"R
M;B++,/\ VA4CEM*ZPV S7 *O0Q4Y8&$G0PN.P=2JYX2%"ABL-[3#4J]3^<BK
MUE:F9Q(X(@C;+$\;V&"(U]2>YZ*,D\X!_<Y?^"6'PF2!@/'OC-[O+%)9;?3&
MME'\(>UC6*5\'!8B\CW<C"@\>&?$;_@F3\0-&MY[WX=^+=%\90P[GCTB]MW\
M,ZL8EBRL-HEQ=:AI5U,TJG<]SK&F+M<;8Y'4A^/Z+O[-W&YKQWDN>?2/XGX8
MX7X+R;,L+C\1P1EF98C.\YXRG@\11Q%')\PSK 8"AD'#V08VK1ITLVQ$L=B\
MWQ>7RQ6 P%+ 3QM7,L)C](#Z:3RK@_-<K\$.&^(.(>*<SP.(PE'BO&8/#99E
MG"T<50JT:N:8+*<5C:N=9YG6$IU:E3+*$<)ALMPV-CAL;C*F-CA*6 Q/Y?DE
MB2>I)/Y^GM7IWPU^,GQ(^$>JC5_ /BK5-!G;8MS!;S"6PO8D8,L-]IURD^GW
MT2D'RXKVUN(HF9I(XUD.^N;\8^!_%O@#6;KP_P",=!U+P_J]HVV:SU*TFM90
M"SJDJ"9$,D$WENUO.@,5Q&IE@>2(ASXO\3/&B^ O!^IZ^BI)?_N[#1X)!N27
M5+S<MNTB_P <-LJRW<R\!XX#&2-XK_I=AA,%F6%I8.%#!8S 8JE1H4<.J>%K
MY?5PSA3IT*=.G&%7"/#0I4Z4:2IQ]E2I4::H^SC1IJG_ (.JOC<#BWB%6QF$
MS##UJDY5O:8G#XZCB>><JLIU'*EBH8AU)U'5=22J3G4J.JINI/VGZGR?\%D'
M^&5K:V?Q4\&Z'XFU9HPPM?"][=Z+K4T)/[JZN;1H=<L8_,7.Z61-(MY6!:WA
MVY0<5<?\%]O#:ZBL=K^S7JTNE;E#7,_Q/MH;[8<;RMJG@6:$,/FVJ;H@\989
M)K^;6_O[W5+VZU+4;J:]O[Z=[F[N[AS)-//(<N[L?R51A44*B!54 5*Y/^('
M^&]23JXCA^,JTTW-8?'YG@\/&4M6Z6'H8SDIV;?*U+:WN)6BOK*7BQQ]0IQI
M0S^I.$+<L\1@LNQ-9I;*=>KA%4FK;\UY/K-N[?\ 438_\%K]$\?;])\!_#G3
M_"WB*:)ELX/&NMW6JF>X9<*+2"PM/#]M>,ARXB74_M#X"BU9<M7S#\6OVC/B
MW\:+HR>-O%=_=:='*9+30;-ET_0[)L( 8-,LU@M6F380MY/'-J!1WCDNY$8K
M7X*JS(RNC,DD;*\<B,R/&Z$,CHZD,CHP#*ZD,K %2" :_0WX&_$"Y\<^%9(-
M6F,^O^'98;'4+AB/,O[29&;3]0D  _?.D4MM=/C$D\'G'#3$5K0\-.$^%)1Q
M^19+A:%2+47B*_M,;C:#G>*E2Q>,G7J4XR;Y6Z4:%2-TG4<)-'EYKQSQ3Q%3
M>&S?.L7B,/+5X2FZ>$P<[:VJ8;!T\/3JV:32K.O&ZOR72:]K!(((X(.0?0BO
M@3X\_#:[\+^(;SQ1IUL\GAGQ!=/=O+$I9-)U6X8O=65SM&(8;F8O<V,K8C<2
M26^1)$ WZ':-HFK^(M1M-(T/3;W5M3OIEM[.PT^VFN[NYG<,R0P6\"2333.J
M.4BB1Y9-K!$8C%??WP]_X)I_%7QQIWF_$&\T#P1I&H6ZK+I>K1'7M6FAEW%D
MNM#M<68A>/83#>ZO97L;DK+9Q.F:,9Q?DW"+CB\XS/!X&G5BXJA7J_O\3!.[
M]AAJ4:V)J2A+:<*#IQDW&=1<S2Y,JX;SOB.I*ADV68O,)TVO:3H4K4*#DM/;
MXFK*EAJ/,M5&==3:]Z-)I7/Y=:*_JNU#_@A9^S[J.^8?$GQYI%W(2SKH-EIM
MMI:N3DF'3M6N-;F@3TBCU (HX0* !7HOPL_X(K?LE^ M8M]:\5WGC[XJ26DL
M$\.D>)]7L=+\/-+"XD#W-EX<T[3=3NE,BC-O+K1M)(]T-S;W",17DXCZ0/AO
M1H5*E+&9OBZL(MPPU#)<5"I5DD[1C5Q-:AAXINR]I4E&*3YG%I6?V.'\%N/*
MU2G"K@\NPD)M<]:OFV%G&E%M7<J>&IUZLFE=\E-2;:LI*]U^0W_!*/\ 8A\2
M?'7XO^'_ (T>,-%N+/X-?"W7+77#?7T$D,'C+Q?I$T=YHWAS2_,"K>VUGJ$=
MMJ/B215FM8M.@_LJY\N?6+5A_7M6-X=\.>'_  CH>E^&?"NB:5X<\.Z):16&
MCZ'HEA;:7I.F64((BM;&PLXH;:V@3)(CAC12S,Q!9F)V:_DGQ%X]QWB#GW]J
M8BC]2P.$HO!Y3ERJ>U^J83VCJSE6JI1C6QF*JM5L55A"--.-*C12HT(.I_2W
M W!F$X*R?^SZ-7ZUC,356*S+'.'L_K.)]FJ<8TJ;<I4\+AZ=Z6'IRE*;3J5:
MK=6M)0*KWDK06EU.F-\-M/*FX97='$SKN ()&0,@$9'<58J"YA^T6UQ;[MGG
MP2P[L9V^;&R;L9&<;LXR,XQD5\%&W-&^W-&_I=7_  N?9.]G;>SMZV=OQL?S
MC7/_  6)^)47[-EQXC75OA>?VB8OCE_PC:>$&\&>*/[&/PG'A*:\;6RHU86)
MU(>*ECT_?_PD N/LIS_994_:1_1O93/<6=I/)@//;03/M!"[Y(E=MH)) RQP
M"20.YK\8Y_\ @D5!-^S'/\!?^%J>'%\3R_'$_%D?$S_A6<)U-=&/A&7PS_PA
MQA_X2(:BUN;EUUCSCK7V-;E2BZ;EC*?V>M8?LUK;6Y;>;>"&$OC;O\J-4W;<
MG;NVYQDXSC)K]1\1L7P!BH8+_4G#T:$HYSQ%/&^SH5J3J8*I#(O[*E1]I1I<
MF YJ>9?4L)4]IB\*_K;Q56?UC#\GY[P+AN-,//%_ZVUJM:,LJR..$YZU.IR8
MN$\X_M&-7DJU>?&\L\!];Q,/9X;$+ZM]7IP="OS?S_\ @?\ X*&_M4?$GXV>
M-_AKIGQ/_90\!#1/C/>?#+PMX>^(7A7XI1>)?% F\57?A_18=.OO#5MXAT(W
M5S*EEI[3ZI?:*)=0NXO+A2)S)'_0/7X\>#O^"<'[0GPO^(7CWQA\*OVN-!\'
M:3\0/B1J7Q"U;1)O@'X2\37R3WNLWNI6]M;>(?$NJ:IJ-A/9V]]);"YTIM.2
M24"Y^SHX7;^N.O6NJ7NAZU9:'J$6DZU=Z3J-KH^JSVQO8=,U2XLYHM/U":S$
ML!NXK*[>&YDMA/"9TC,0ECW[QAXBXGA'%XO)5PB\FHX)8.G3Q:P&"Q.$K4\5
M*AE4*U3'NM@Z,ZL566-G32JXZ:<<1.-2,*M&@M>!Z'$V&PV:_P"LRS2KBWBI
MSPSQN+P^)I5,.JV92I4\$J6*JPIMTGA(SO3PD&I4(2A*=.K6/R$^'G_!1'XC
M^)_V[)/@[K&B>'[7]G+Q9X^^(GPF^&WBR/1[NWU35/&GPZTW3H[Z8:Y+JLEO
MJ5I?:_/:6T"1:5;HT/BK1A%))]GDEE_8:_G>VL;VYC"F2WM+F>,,"5+Q0O(H
M8 @E=RC(!!(S@CK7XRVW_!'?POX>\,?"75O!7Q;U?1?CQ\.?']MX\U;XHZE8
MZQK6C^([JVU6ZUF*WM_!DGBBV@T6:WNXO#ZIJ$&HSS7<>CRG48[J6^,EO^S=
MW;M=V5S:LX1[FUFMVD5251IH6C+A202%+;@I.2!@GO6/'\^"*V)R2KP95@\/
M0P,\KS2DL#BL#*OB,KQ-*A0SF<,14K*J\ZPDZN)J5(5*<YU*=ZN"P4N6B]N#
M(<74Z&;T^*J<U7K8N.89=4>,P^+C1H9AAZE6KE<)4(4G3658F-.A"$J<X1A.
MU/%8M)U5\&_\$YOVE_B-^U3\$/$7Q#^)L'AN#7M+^)>N^$K5/"^F76E:>=*T
M[0O#&I6YEMKO4=4E:Z^TZQ=J\PN%5XE@'E*RLS^N_M?^+/CIX ^!WBGQ[\ 9
M?A]'XI\#VFI^+_$*_$>WU6ZTFX\$^'/#VMZMKEOI<&D/%-)X@EFM=/&G1W$T
M%I*@N8I9X7DBD7Y _98_8%_:(_9=UK0].\.?M=QWOPBA\:MXO\5?#*W^$VE6
MD?B:2YAL+34K<^(+W7-6U+3I-0LM+L;66:U*I&D/F0PQR$L?T>^+'@=_B9\+
MOB-\.8]171W\>^!O%?@Y-6:V-ZNF/XET.^T==0:S$UL;I;,W@N#;BX@,PC,8
MFCW;Q'$=3A?!\=0S+(:^2YEPSB,VP^,IX"GE^8_4<#ESQ&!H5\!C<%CZ.#G4
M:PZQV)Y,+6K4K.DXUG6BJ3>1PXAQ7!\L!G%'-L!G]#+:V%GC)XW _6\9CE0Q
M=6EC,)B\'5Q4*:E7^IT.?$4J532HI4E2;J+Y,_X)]?%W]H[X]?!X?%[X\/\
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M=?:'TE=0%DUZ&B%X8C.+:W#^6L7Q?^%4OQ2?X5/'K::+_P *V^,7@WXJR![
MWW]L1>%+?68&T12+JV^Q/?'5@POS]H$'D$&UE\S*_33QF3U^*%B:]'"K)5.4
M94L+A8X2A*C'*:L8J%&G3ERU99A/2K.G-JLJ56I&=*DHOY^.%S2CP\Z%&KB'
MFS@FJF(Q,L35C5>94Y-RJU)KFIQP4-:<:D4Z?M*<)1J5&UYA\'OVDM)^,_QV
M^*O@SP1X@\/^)_AUX)^'/PNU_3M5TNSU"&_3Q1XLUKXB6>O6-]<WOD+-;PV'
MAO0YK.*&R3R6N+AGN9S+Y5O/^UW\7_$OP9\ >"]<\,^(O#'@^3Q/\7_A_P"
M=9\7^+]%G\0Z)X6\.^*;N]@U779M)M]7T-KN:QCMXWA1]2MXBS'S&VG(])T3
MX62Z1\<_B!\8VUM;B+QO\//AUX%3P^+$QOIK^!-9\=ZL^I-J/VIQ<KJ8\9K
MMJ+2$VIT]I#//]I"PXW[07PE\1?%SP[X)M?"?B?2?"?B3P#\4_!'Q2T74=>T
M&Z\2:-<W_@NZNKJ#3=2TNRUG0;N2UO6N=LLEOJ=O+&$RC;B"MT:_#_\ K'D]
M6-*G3R:&%RU8RGBE[:,<3'*\;#%?6Y+#<E>7]H2PLJU6.#E0G)1J>PJ4J=6%
M2:M+.O[#S2G*I.>:2Q./>%J89^RDZ$LPPDL-]63Q'/2C]16)C2IRQ,:L4Y0]
MM3J3IRIV?@)XBUKQ;X3O/$6H_%_P9\9].O=4E@T?Q)X(\%2^"M,M$LD6&^TZ
M:VD\5^*_M]S'=$NURMQ:"('R3 Y&^O<:\Y^'5A\6+"TU-?BMXF\">);Z2Y@;
M2)O OA'7/"-M:VBQ,+B+4+?6_%WBZ2\GDFV/%-!<6:1QAD:&0L&7T:O"S.5.
M>/Q4J4L-*E*I>F\(J2P_(X0Y53]CA,!2?*M)NG@\/%U%-JGJY2]C+XSC@\/&
MHJ\:BIVFL2ZCK\W-.[G[7$XRHKO6"GB:TE!P3GHE'Q']I/X@Z]\)_@#\8?B7
MX6&G'Q'X&^'WB;Q-HO\ :]O)=Z6-2TG39[JU;4+:*XM))[1)8U>>)+JW9XU9
M1-'G</#?@W\=?%VM_&S3_A5=_%'X5?'S0=9^%^M>/M0\7?"O15TF;X;:OH^N
M>'=*L=!\6G3/&/C;0+BS\8P:W?S>'&^WZ9K:W'AG5C)87EBZW5M]%_'/X:O\
M8_@[\2OA5'JZ:"_Q \':YX476I++^T4TPZQ926@O'L/M%K]L6#S-[6_VF#S0
M"AD4'-=KX<\+Z!X5L5L=!T31=%C=(3=)HNDV&D0W=Q%$L7VB6"P@@C:0@':6
M#%%.P':*]3"8[*,/D&*P]?!4\7FF)Q6,A2FZ5!2PU"> P,<+B7BIP>)A]7Q<
M,74HT,'.$:U2<XXY2P[@CSL3A,SKYSAZ]'%3PV7X?#X6=2*J5G&O6CC,9+$8
M=8>$EAY>VPTL-"K6Q4)2I0C!X1QKJ;/ /VN/BSXC^#/PIT[Q9X9UWPWX6O-1
M^)GPM\&7_BGQ;H]SKVA>&="\:^-M(\.:YX@O-)M=3T>:]_LG3;^XO8H1J%NK
M20J';;D5TGP \3:UXQ\.ZOXAO_C1X'^->E3:HMAI6M^!O TG@JQTNXL8=^IV
M%VDGB[Q9_:5RYN[*4.)+(6J#:8YO.W1V/V@_A3KOQ?\ !&CZ!X8\2Z9X4\0^
M'/B+\.?B/HNK:UH=QXBTG^TOAUXNTOQ;:6.HZ3::MH=U<6>H3Z8EK<&WU.UE
MCCD9T?< *ZCX<Z?\7K"/5Q\5_%/@#Q-++)9G0V\">#=>\(1V<2+<B_74TUSQ
MEXO:_>=VM#:O;/8+;K%<"5+@S1F&G5RW_5>C1IO 1S18[&2Q?M*=/Z]/#NO@
MG@U1G/+ZM648TXXAWH9CA:<(>UC6H5I3@R53Q_\ K#5J5%C'ESP>%CAN2=3Z
MG&NJ.+6*=6,<;3I*3FZ&E; XB<YNG*E6I1A)'FGQK^(GCVU\?_"?X(_"R]T/
M0/&/Q1M_&WB75?&WB'2)?$=EX+\!_#RVT,:W?:?X;34=(CUKQ'K&M>*?#FB:
M-%>ZC%IMA%<ZEJM]!>BRAL;FQ\"_B1XSU[Q-\8/A-\2IM%U7QU\%_$/AJRN/
M%?AO3;C1='\9^$_''AJV\3^$O$#:%<WVI/H6MK&=4T7Q!I<.H7M@NHZ.VH:;
M.MEJ,-K:Z7QB^$7B#QIXC^''Q*^'GBG3O!_Q0^%=SXCCT&]U_1;CQ#X4\0^&
M?&=A9V/BSP?XJTFQU/1=2?3M2DTO0]6L=1TS5;6_TG6-#L;F-;FVDO+2XM?!
MCX2:K\/;KXA>,/&?B2S\8_$_XM>);+Q+XXU_2M'D\/:!;1:-H=CX;\+^%/"^
MBSZCJ]W9>'/"^B:?';VCZCJFH:IJ6H7>JZQJ%T9]1-O;Z2JY-_J]&FOJ7USZ
MI3BJ:P]19LLY6<U*E;$SQ7L^1Y5+(W3HPI*NZ?MK06%CBXSQ4HC3S7^VW-_6
M_JOUF<G-UJ?]FO*GE=.%+#QP_/SK,5F_/5G4]BJGLKS>(EAI0P\?-/VF/B[X
MK^'OC7X$^$-!^(?@#X4Z/\2]6^(%KXE\>?$+1[;6-+TB'PGX1&O:5:VT=_XJ
M\(:?#<ZMJ!6PWW6IEF$BK;PO+@'K/V8?BSXC^+W@OQ7J?B.X\,Z[)X1^)?B[
MP!I/C_P3:WEEX+^)VB^'#IYM/''ABUO;_5S#97,M]<Z'J"V>M:UI1U_0M8;2
M=4N=/-OLZ'XE?!;3OB5\2/@SXWUB?3+G2OA3>>/;N[\,:MHEOK%IXC?QEX5/
MARVRUW*;>R?2)]NH)(]G>&9E$2?9V_>U[1:6EK86T%E8VUO96=K$D%M:6D,=
MO;6\,:A8X8((52*&*-0%2.-%15 "@ 5EBL;E']@9?@:&"IU,T=+VF+QJI4*4
ML/6AFF85''VR@L7B:F(R^>#H2A4J2P-&C3ISHP6+51FN'PF9_P!LXW&5L5.&
M7JIR8;".I6J1KTIY?@H*7LG)X;#PH8V&*K1G3@L75JSG&K)X9P1X0?B9XC'[
M4R?!SR]-_P"$1;X 2?$PR_9I?[8_X2-?B+%X6$8O/M'D?V;_ &8[,;;[)YOV
MK$OVC9^ZKW^OESXB_!OXJ7_QOT[XV_"KQ[X'\-:I%\*9OA9J>C>.? ^M>+;&
MYL7\7#Q;'J=E-HGC/PE/:72W"):-',;J)HMS@!RNWZ0T6/6(='TN+Q#=:??:
M]'I]G'K-[I-E<:;I=WJB6\:W]SIVGW5[J5S8V,UT)9+6TN-0OI[>!DBEN[AT
M:5^/,Z>!=#*J^"K81REE>#HXW#T76CB:>84OKWUJKB*<Z$:;]KS851JTL155
M3EC[D.61TY?/&>VS&CBZ6)2CF&*JX2O55)X>>"J?5/JU.A.%:4_W?+B+TZE"
MFX7E[\^9'Y[>!/V@?'WQ"^,OQ"\#3?M!_"3P+>^%OCOXN^'?A_X4W?PON]<\
M7:]X8\*W%G+!<GQ _P 0M+2/4-:L6OE2YCT-X;4PB=8)]C0G]'*^/_!WP7^/
M/PU\4_$.?P/\3?A:?!/Q"^+_ (H^*EYI/B;X9^)M1\2V/_"775A+JFC6^NZ;
M\1])TY_(ALO+L;R70F*22;YH)441U]@5W<35<MJXC"RRIX#ZHL)0BH8.%.G4
MC56$RY5WB5#+\'54Y8B.*LL16Q]7F]M/ZS[.I")R9!3Q].AB5F*QGUEXFM)R
MQ4ZDX2IO$XYT5AW+&XJFX*A+#7="E@Z?+[*/U?GA.3****^9/?"BBB@#RCXN
M_!;P!\;/#4_ASQQHT-W^[D&F:U;I%%KFAW+@[;G2[]HW>,!]KS6<PFL+T*L=
MY:SH !_)M_P4J^ WB[X :KX<\*:T&N]$NM>U"^T+7H(I([#6]/-@RV5P@9I/
M)N8?])@N[*262:QNDEC,ES;26E_>_P!D%?$7_!0']E:']K/]GCQ'X(TR"U'Q
M!\/N/%?PWO;AHX<>(M.1C+HDEU(T:PVGB6P\_2G:::.SM]0DTO4[L/'IJK7Z
M]X2^(=?A'B#+\%F>*E+AK&8J%'%0KSE*GE=3$-TH9EA^9R]C3IU*L)8ZG!*E
M4P[J5W35?#JI4_*_$W@'#<495B<QR_#0AQ%@:$JN'J481C4S.E1BYSR_$<JC
M[:I.G&?U&K.]6E7C"BJCH8ATZ?\ #916SXB\/:WX3US5?#7B32[[1=>T._NM
M,U;2M2MIK._L+^RG>VNK2[M;A(YH)X)XI(IH9422.1&C=5=648U?Z QE&<8S
MA*,X3C&<)PE&4)PG&,H3A*+E&491E&491E*,HRC*,I1E&3_C1IQ<HR3C*+<9
M1DG&491;C*,HR491E&491E&48RC*,HRBI1:17W/^P+\,/&'Q?^+>J>!?!]D]
MW=ZKHMI]IE;<EEI\,6IQL^HZC.J2"ULK2W-W+-.R.P16BMX;FZE@M9_AN..2
M:1(HD:221@J(H)9F/0 #_/<\5_8%_P $D/V/]4_9S^"U_P#$#Q]I#:9\3OC"
M;#4Y].O(#%J?AGP5:Q>;H.CWD4N9;+4=4FGFUK5K3]S+'$VB66H6T&HZ7<11
M_G'BIQEAN"^$L9C6Z-3,\:XX')L)5DG[?&3<9SKRIJ2G/#8"C%XG$-6BW]7H
M.I&6)2/M> .$JW&'$.'P'[VGEV'7UO-L525G1PD'94H5'%PAB,;4MAL/>\HW
MK5U"2PY]O?L__LR_#WX :%!!HEE!JWBV>#&M>,KZV0ZE=2R(@N+;30YE.D:2
M60*EE;2&2=4CDU&YO;A!*/HVBBO\]<RS+'YOC:^89GBZV-QF(FYU:]>;G)ZO
MEA%?!2I03Y:5&E"G2I02A3IQ2][^W,NRW 91@Z&7Y;A*."P>'@H4J%""A%;<
MTY/XZM6;7-5K59U*M6;<ZE23?NE%%%<)W!1110 4444 %%%% !1110 4444
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)** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
M  $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!
M40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y
M.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4
ME9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/D
MY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M ***"<4 %%<)\<?C/)\'['P\;71;KQ!J'B?68M$L;.">.#,SQ32[FDD(55"0
MN?4G '6LM/BQ\12O_)*9O_"DLZ /3Z*\Q_X6O\1/^B4S?^%)9T?\+8^(G_1*
MIO\ PI+.@#TZBO,?^%K_ !$_Z)5-_P"%)9T?\+7^(G_1*IO_  I+.@#TZBO,
M?^%K_$3_ *)7-_X4EG1_PM?XB?\ 1*IO_"DLZ /3J*\Q_P"%K_$3_HE,W_A2
M6=!^*_Q$ _Y)5-_X4EG0!Z=17F(^+/Q$/_-*IO\ PI+.C_A:_P 1/^B53?\
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M^U7_ -$(^"/_ (>6_P#_ )G:/^%P_M5_]$(^"/\ X>6__P#F=H ^CJ*^<?\
MA</[5?\ T0CX(_\ AY;_ /\ F=H_X7#^U7_T0CX(_P#AY;__ .9V@#Z.HKYQ
M_P"%P_M5_P#1"/@C_P"'EO\ _P"9VC_A</[5?_1"/@C_ .'EO_\ YG: /HZB
MOG'_ (7#^U7_ -$(^"/_ (>6_P#_ )G:/^%P_M5_]$(^"/\ X>6__P#F=H ^
MCJ*^<?\ A</[5?\ T0CX(_\ AY;_ /\ F=H_X7#^U7_T0CX(_P#AY;__ .9V
M@#Z.HKYQ_P"%P_M5_P#1"/@C_P"'EO\ _P"9VC_A</[5?_1"/@C_ .'EO_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHHHH \C_ &ZO^37]?_Z^M._].%M7KE>1_MU?\FOZ_P#]?6G?^G"VKUR@#/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD8LQ6-]G#^.OB)^R_P",/"C:3;^#_'FBPF""T$EA\&O$T4@M8KZ*^-H#_9A
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M_P"&_P!5_P#C- 'LE%>-_P##:FB_]"3\8_\ PW^J_P#QFC_AM31?^A)^,?\
MX;_5?_C- 'LE%>(WG[=?AVPU"SMIO!_Q?CFOW:*W1OA_JN9752Y _<]E5C]!
M5H?MJZ*1_P B3\9/_#?:K_\ &: /9**\;_X;4T7_ *$GXQ_^&_U7_P",T?\
M#:FB_P#0D_&/_P -_JO_ ,9H ]DHKQO_ (;4T7_H2?C'_P"&_P!5_P#C-'_#
M:FB_]"3\8_\ PW^J_P#QF@#V2FS?ZIOH:\=_X;4T7_H2?C'_ .&_U7_XS39?
MVU-&,38\$?&1CM. /A_JO/'_ %QH 9_P3<_Y1V_ /_LG/A[_ --EO7M->4_L
M*>"]5^&W[$WP>\-ZY9R:=K7A[P1HFF7]K)_K+:XAL((Y8V_VE=6!^E>K4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !0.G-%% !1110 444
M4 %!Z44,<"@#AM.O9M-\2>/)XRIDM#!.H?)4E;-2,\CN!T(K;,?B!3C^T-']
MLZ?)_P#'_<5S^-FK_$1CD*T47)&!_P >8KG?VD6'Q \*:39Z#KFDPW-OK-M<
M2,]Z(Q&BAQO.)$8^6Q27:K!B(\#!(- 'H#C7X_O:AHZY;:,Z=+R>O_/>AO[?
M7KJ&C_CITHS_ .1_<#\:^4?@7^RSK7PFF_TKQUX7O&_LN\T<36NJSV]S%:W"
MVZI:H0OEX@DCFN$D6-6\RZ8!4^=YJ.C_ +%,DD&GQW7Q"TJV6SLGAMY;74CY
MEG_Q-H;VVC3Y &BM(DFBB7(0^<Q1(=Q8@'U]&NO2GY=2T5L=?^)?+Q_Y']JB
MU@^(=,TBZN3?Z.WV>%Y=HL)1NVJ3C/G<=.M>4?LL:/??"O\ MR'Q)XCT"XAF
M2RAM?LMVABN##"4:X )RI*&&$[@I)M2Q!W;F]2\4>/=%N/#.I1IK&FN[VLJJ
MJSJ2Q*'  S^E &[HETU]IEO.WRM-$DA7.0I(S_7]*MUG^& 1X?L<]?LT8/M\
M@K0H *",T44 %%%% !1110 4444 %%%% !39.4-.I'.$./3O0!Y9\,?#ZZ;^
MTU\4[M9I7DU*WT5G1L;8]D$Z?*/<#G-=AIGB;5M7L$NH-+L?)D+! ]ZP<@,5
MZ>61V]:R_"D,-I\;/&#*NR22RTQW8J1O&+D#GOC!KD?C8?$5[^RWXW\/^&['
M78?%USH&I6FEO#;NA^UO%((MDO127*[7Z*2#T% 'I"^(-4;I8:6>-W_'^W3_
M +]>]!U[5A)M_LW3V;OB^8X_\A5\S:SX7^,%Y\;KC6M,34+/PG;ZH]YINFMK
M^I#?"J::RB6+[/L57%I>0FW+.D?]H&1070YH?%[X"_$;QUXHF73]>\6:?X>U
M[5YFU2Q37-73['IYBMHPD)(8&201WC%0$CC:>+Y6"L)!Z ?5)UG6%./[+T_/
M3_C^;K_W[IXU36C_ ,PO3_QOF_\ C5?,_P"S=X ^)'PH^+UHOB1K_5/#=KI=
MY$EW;17+23EET\0Q3J^ 6C,4R1,@XCC)8AI2@^DH_',)"[=/UQACC_B6R#/Z
M4$Q;9-X>\27&I:]J&GW5G':S6<4,V8YS*KK)YF.JK@CRS^8K:KE_"$LNI>--
M:OC:WEM;S6MI#&;B Q%V0S%L \\;Q^==0.!04%%%% !1110 4444 %%%% !1
M110 444$X'I0!PGQ.G\OXJ_#E-N=VI7C9],:?<?XUU?BG6O^$<\-WU^8S,+.
M!IC&&V[]HSC/;-<OXZB6Z^+G@-F3?Y,M^ZOC[C?9BO\ )B*VOB<C/\.=:6-&
MD9K*0*JC)8[3QB@!?[6UF)E1M-TXLW 'V]LG_P A?7\J1M=U9#\VG::IQG!O
MF&>W_/+_ #FO*?VIM:U;QUX2T>U\%ZH]I>#47DFN/+N(TC5K"[6"1BJAMJ74
MEK(=O("$]B1Y7/X9^*&J?#GP7H=UK%Q;W6EW=]-JVLV'C/4[?4989(Y?L\?S
MV3I.0TH#-*I$?D H S80 ^JCKNL+C_B5V&#G!^W-^?\ J_\ /XC+EU;6716&
MFZ=AN1_I[?\ QNOBO7_@7\2- \(7^H:7XJFU37KZPD6ZCO+R\NIA*+>]CM_+
M;[.KN]O'+#&I8KYCF61@"JQG[)LOB/I,%O&LUXSR@ .PMI<,V.3]S'6CI<E2
M=[6+O]J:U_T"]/\ _ YO_C5']I:TW33-._\  ]O_ (U4/_"S=%_Y^I/_  %E
M_P#B:;)\3]%2-F-VRA1DDVLO [_PT%&EX5UEO$.@V]XT0A:8$L@;=M()!YXS
MTK0K#^&X*^"['*LN58X8$$99CT(%;E !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4V92T;8Z]J=01D4 ?%'[.7[!,W[
M)_\ P4:^-GQ>E\0?$'Q5H_Q(BMVT'0UN;J\L/#IE/FZ@!&[^4-\\<1BVC,4>
MY!@&OJ>/XK"- H\->+L*,?\ (./_ ,577")5;=WHV4 <E_PMG_J6O%W_ (+3
M_P#%4?\ "V?^I:\7?^"T_P#Q5=;LHV4 <E_PMG_J6O%W_@M/_P 52'XL;A_R
M+7B[_P %Q_\ BJZ[91LH Y-/BP$7'_"->+O_  6G_P"*H_X6U_U+7B[_ ,%I
M_P#BJZS91LH Y/\ X6U_U+7B[_P6G_XJC_A;7_4M>+O_  6G_P"*KK-E&R@#
MD_\ A;7_ %+7B[_P6G_XJC_A;7_4M>+O_!:?_BJZS91LH Y/_A;7_4M>+O\
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M?'3_ (2BZ\,C2!IW]GZ&84U'9]F;4U;^U.)&LE6VVE2-I9B1GGZO3]L#Q&J
M+\ /CAC''[C1/_EG0![G17AO_#87B3_HW_XX?]^-#_\ EG1_PV%XD_Z-_P#C
MA_WXT/\ ^6= 'N5%>&_\-A>)/^C?_CA_WXT/_P"6='_#87B3_HW_ ..'_?C0
M_P#Y9T >Y45X;_PV%XD_Z-_^.'_?C0__ )9T-^V'XD"_\F__ !P_\!]#_P#E
MG0![E17'?L^_&G2_VC?@EX5\>Z'#?V^B^,-+M]7L8KZ)8KJ.&:,.HE1695<
M\@,1[FNQH **** "BBB@ HHHH **** "BBB@ HHHH **AN'=9$"G&2 <CC_/
M'Z]^E?-OP%_:+^/7[07P1\&^/-*^'_P@L]+\;Z%9:]9P7?C?45N(8KJ!)T20
M+I3+N"N =I(R#@D8- 'TQ17B?_"5_M%?]"+\%?\ PN=3_P#E11_PE?[17_0B
M_!7_ ,+G4_\ Y44 >V45XG_PE?[17_0B_!7_ ,+G4_\ Y44?\)7^T5_T(OP5
M_P#"YU/_ .5% 'ME%>)_\)7^T5_T(OP5_P#"YU/_ .5%'_"5_M%?]"+\%?\
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M "C<^!?_ &(^E?\ I*E>^5X'_P $L/\ E&Y\"_\ L1]*_P#25*]\S0 4444
M%%&:* "BBC- !11FB@ HHHSB@ HHHH ;)]W\1_.O#_\ @F7_ ,HY/V??^R;>
M'?\ TV6]>W2R!6 ++R1@>^:\1_X)E_\ *.3]GW_LFWAW_P!-EO0![E111F@
MHIHE5@3NX'4TU;A7QAU93T([T 244T2*1]X4WSU+8W+]!U% $E%-60'O2>;N
M_/' Z4 /HJ,SJ!]X?C2^;G'*_-R/>@!]%1B9?F^9?EY;GI3U8,H(YSS0 M-E
M^Y^(IU-E^Y^(H \=_8G_ .1)\<?]E#\3_P#IVN*]DKQO]B?_ )$GQQ_V4/Q/
M_P"G:XKV2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@#P?_@J9_RC._:$_P"R<>(/_3=/7MVB?\@:S_ZX
MI_Z"*\1_X*F?\HS_ -H3_LG'B#_TW3U[;I#[-"M6_NP(?_'10!;JGK6O6OAS
M2KJ^OIEM;.QA>XN)G.$AC12S,3Z  D_2L6_^*^@:3X\L?"MUKFCV_B;5;>6[
MLM)DO8EOKN"(@2310%O,DC0G#,JD D GFH_BWX%A^+/PPU_PW<3-!#KFGS6+
MRQM@Q^8A7<"/0D'WP:F3L!CZS^T=X7TFRU>XN9M3MU\/QQW&I>;ITT2V$;))
M)YDCLH14589"[%ML> '*Y&?+_@WX>^&-])<:AH&IZAH)\!S>1,6DET:>*SN8
MHM5CM;Y)-OFVZ_;E9/.0&+S9$R':;=Z)\5?A%<?&;P?I-C?:A'IL<-[;ZAJ-
MFEO]HM-6\KYEMIP2CO!YWENR[EWB)4<LC.K>>:Q^P%I_B3XC:EXHU#Q-JE[J
MVKWGV^[$MA;_ &>\D\C1H1%-'C;-!MT:#,;@C=<3,"KB)HJ O1?LS^$_"/BF
MUGL=:&FZ3I-[<:UJD5U<RS:BVHW%NMG;S&Y>?$:! QV21.TLT-M)O5H<OR6H
M_L3_  5\#ZY8Z%<7WB13J<XTH6YU^=K=Y([#3$2"Y.["DVNDZ>%5L%O)##+M
MN.'XX_X)E_\ "/\ P^N-/^'^M:9-JBV:Z7&GB:*2:S:V=]-+R7+6^V:XF$>G
M*5+,H+W,['&X;=#PS^P?X3\7>%/%'AZQ^($FKK8ZA/9:G%;6-A*V@73Z>X:T
M$@0W(,0OS-$EW/<2Q))&H?:"6!'IWPT_9Y\$_"J^U>30_$.O1R>(OM.F2&;7
MVE87$EU=WLBQ!CE+A9KJZ8*,.H=A@!1C@1^RM\%;'4[/PO:S>)A=>%[+3?#,
MUUIMU=*]I$EC/:VEI=W<"CYC:7D@'FOE%N(VRGFJ7UKC_@G3X;U+Q5<:Q>^(
M_$%U<7NH2ZA<1KY$$+22/8R&2)8T"P2AM.M0)8\,JM.%VF8L.NA^ FF^(;KX
ME7&B>([B.P^)$\O]O6\<%I?)!?K91Z=(T?F)(H;RK:%)(95D0O ORKF57!G&
M']COX-ZCJ2W$>N:A)]HEANT@@\3L8O-,=RT,D:AOD(\R69 FT9A# 8C(K>\-
M_LS?#/PS<6IT&^MX[BY6"P>>74A>7=[&+EM4$ ED9F9GF;S<'=MC+^4$#AAY
MUXN_8E\%^&I?[#UK6-&T?19+"*SLKV\FBFO+^[FU0O:,ZS1X22W>ZFMK5EED
MD<:C(#M*H6T)?V&/!UCJC>=XV^RQ^&[JRUBYMHH+.W^Q20WTM_ \YY9$(9HR
M&PCPHPQD!T):[@M6>^>)OC]X6\&Z]I>F7%]-<WVNR7"645E:RW?G/!&TLJEH
MU*JRHK'#$$XP,G KJ]%UZS\1Z5:WVGW5O?6-[$L]O<P2"2&>-@&5T920RL""
M"."#7AGP?\ ^&?V2?@C>W5IXDT#^PY(+.>WU346@T_3K<)I]K9QRM(IV!91#
M$Y*_?>4X^\!7;_#[Q'X9^$O@*S\-_P#"3:/)_P (?86=I=R2WL,<B!T5(7D4
MO^[\YON;N&W*%)S0!Z,&S2L,BL31?'>DZ[XEU+1[/4M/N-4TA8S?6D5PCSV?
MF#<GFQ@[DW#D;@,CIGFMO- 'R3_P35^$_B#7?^"?7P7O+7XF>-]*@NO!NF2Q
MV5K:Z,8+13;(1'&9-/=]J]!O=FQU)/->]Z1\*_$6E!PWQ(\6WS,?O7EEI1V?
M3RK./]<UY]_P2O\ ^4;GP+_[$?2O_25*]\H Y'_A ?$/_0]:U_X 6/\ \9H_
MX0'Q#_T/6M?^ %C_ /&:ZZB@#C;CP3XBM0'7QMJ4C ])]-LWC'N0L:M^.X5F
M_;-0_B^)&BY[_P"A6_7_ +^5W6K_ /'C/_UR8?H:X7XF^/M/^#OP@LM:FTU+
MQI+C2])M[>-57SKF^N[>RMU+'[J^=<1[CR0N2 3Q0 &[OP?^2CZ+_P" 5M_\
M<I#>Z@!\OQ(T'=VW65N1^($@/ZUXU?\ _!1C0X[P6D/A#-R-9N/#\@GU"WB\
MB[&L:AI-N6*J_P"Y,VG2O.ZY-M'+$VV4$D8^F?\ !3[1Q<0IK?@6Z\/1ZC;P
MZAISSWMO/]OLB8Q-)'Y8;YXPY=0V%E0+AP[HC 'NW]J^)6.T?$7P$Q[?\20[
MC]?]._D!5^ST?QUJ$$<UOXR\)SPS*'22/PU(R.IZ$$7N"/I77KIEN,9M[<_-
MC_5BLGX51JO@C3_X=J-@#_KH] &9_P (O\0/^AN\+?\ A,2__)M8E]X-^,S7
MLC6?C[X8PV^X^6DW@&^ED4?[3+K"!C[A1]!7J5% 'E/_  A_QQ_Z*)\*?_#=
MZA_\NZ0^#_CEC_DHGPI_\-WJ'_R[KU>B@#XK_;&_9K_:]^*GQ7^$%U\.?CAX
M#\%V?AW5KN\\37MOX:N[:VO+1HXD2VDL)+ZX6^9B92%9X!& S"16V[O8O^"9
MXQ_P3G_9_P"__%MO#O.,9_XEEO7MTT2NRL1\RD?SKQ'_ ()E_P#*.3]GW_LF
MWAW_ --EO0![E3)^8FI](R[UP: /DC]LO]G>3XY_&NUN;SX+Q^,K/0=#N#IF
MM&#19I+K4)HIXXX9)+NZCGBM( Y<QI&PFEFC8E5@(E-(M?VC-%\(26.GZ;)8
MIIEDEMI+WLFDR3NL43^<+DK(REF5XEM&0X6:*0W(\HAI?K0VD9!^7[W)]Z!:
MH#WY]Z /B_6/C=\?-'^*WAGP>NA:O#J>L/J-RL]RNC"V6W2WE-JMTT4CR%6N
MG@1GM8I&MXXV:56$R.-+1-"^-FC?$J_US3/">O:?'XH2-];FO;C0/M+E;9O*
M=C#+L:>$>7 &"A'$2Y)7$B?7OV*,J5VY5B"0>1D8Q_(4OV5,]* /!_V?XOC9
M-XWA7X@?V3'HL>FI]K2(6QBGG:VLP#%Y9\P2+<)J/F[SY)CDMA&"=ZQ^8ZK^
MQ EQ\$H?"MG\-=+\.S>"=-N])TZZTBPT;_B:137T-[Y5K#(1$UE*T1%S:W0M
MQ,9&&<?OJ^QEME3&!T.11]F4?_KH%R]3YFTWPQ\6T^(_P]\1:AX>D9_#JQ>'
M-;TZPU"(6=Y:W5KNN]0@\Z[9F2.[6V 6?,X2&94#[][<G\6O@9J6L:;\=M!M
M?@3)JUM\2M9AU!K[9H"V^MK!:V<:O(LMXKR.+B*615GC7&XL2KG#?8JVRH,+
MD8&!ST^GI0+6,-NVT#/FVT^%NO>//CO:Z]XB^'EX/!LFEV5AX<TF>\T]+CP!
M>6[WJW-ZPAN&2-KF&:WB22TDFE1+?8517>OI*%&"J6QG'./6C[*A/W?_ *U2
M#B@ ILOW/Q%.ILOW/Q% 'CO[$_\ R)/CC_LH?B?_ -.UQ7LE>-_L3_\ (D^.
M/^RA^)__ $[7%>R4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC;8Z@D"?Z9I1^4VEM)_SX8'S2,>/7\!H2_LN:A;R%9/CQ\8HG'57O])4]O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:P?_ !=+#\;?!EQ,L<?B[PP\DC!55=5@)8G@ #=0!U%% ;-% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% '@/_!0#1+/Q'X?^%UCJ%K:WUC=_$K08Y[>XB$L4
MR^<YVLK<$=.H->A1?LP?#?RU_P"+>^!CQG/]@VG/_D.N(_;F_P"/+X3?]E-T
M'_T:]>XP_P"J7Z"@#A_^&8/AM_T3WP+_ ."&U_\ C=0W?[-WPRL;66:7X>^!
MUBA4N[?V!:G ').!'FO0*SO$<S1Z)>F&XAM9E@<I-*N^.!L'#LI(!53R02 <
M'D=:3E;<#QOP59? ?XA>,[CP[I?@GPO)K5FKFXM+GP2UF\&V.&4AS-;(%8QW
M$+!2<LL@(!&2.U;]FWX:*/\ DG?@GH#_ ,@"U[Y_V/;O7@_A[]G#P[\6-(TW
MPWI_Q0\+^)-6\&SM>ZA/8VMO<:JFH2WEO=2W\^R8F&XDFMGY$:A3(0JJJ!*F
MT_\ 85T/PWJ/AG4K7QE:I_8M^([97M4$%QJ*WFFO)(@\TA+R1M*E6610S/)>
MW3$99D+LK70'L'C3X.?"/X>>#=6\0:UX#\$V.CZ'9RZA?7!\-P2>1!$A=WVI
M$7.U5)P 3QTS6A#^SE\,[B&.1?AWX+V3 %2WAZU7.>F<Q\9]\>G7BODG]GS_
M ()_>(M2^&FJ>'O%7B[PS;:U#8ZGI-]IL6D0WEUHZ7MJ]M!<QL+R0VMP\3.S
MR!R;R.7,Z^<9)CV-O^R]X%\1ZOI&KV?Q4\+1K?#5UT$Z<MH(I8;F\N'OH(@D
MQ$\'VF\B65!\N8XE< M1H![?XU^%WP?^'NG0W6L>"?!5NMW.+6VB'AN":XNY
MB"1%#"D1EED*JS;8U9MJL<8!(N:#\"_A1XHT>UU#3_ ?@6\L;Q-\4\6@6I5Q
M[?N\]>,=1SZ&N9N?V;K'P%X-\$R6&N#0V^&-_>:I97$R Z>D4\5RDUM) 6 6
MU2.X98U213"L40#%$9&\Z\5?L!^&_"O@#5F\2^-HX],6.*2XU36E5EME6UD@
M:2:6:7^"5H;B)BZ^3/:V[ L5S0![O_PS7\-<\?#GP61CK_PC]K_\16+IOPO^
M#NK^-]2\-V_@3P;)K6D6=O?W5O\ \(M$HC@G:18G$AA",&:&4?*Q.8VR!BOG
M/XD?L&:3J7CWP3#HFL:+?:+XNU;4;BYW16JS?9);;Q#<+<09E4W<D5QK8*,B
MML6&*7&5);V+XU?L8P_&;QCJ^L7FO6T=CJVG:?ISV-WIHO(2EI#JL:F7=(!+
MN.JR.0PP#!&1DDF@#T:+]FCX:RC_ ))WX(7TW:!:@_\ HNI/^&8/AM_T3WP+
M_P""&U_^-UP?[+WPOA^%5I+J%GXWT/Q=8^,;A=0@U.*QB2ZUB$1,RM+<QS,M
MW(H8;9M@;R8T1M^T2#W5#E10!PW_  S!\-O^B>^!?_!#:_\ QNO)_P!NG]G;
MP#X>_8]^)%_I_@?P=8WUIH-S+!<V^BVT<T#A<AT8("K \@@Y! KZ2KQ__@H%
M_P F3?%#_L7;K_T T >N0C:S^YS4E-CZG_/<TZ@ HHHH **** "BBB@ HHHH
M **** "BBN'\<?&VS\#_ !&\.^%7T_5]0UCQ-;WE[;)911LD4%K+:QS22,[H
M  UY!@#+-N. <4 =Q17$P?M!^#+D70C\6^'7:Q:1;C&H0MY'EQR2ONPW&V.&
M5SG^&)ST&:HV'[37@^\\;+X?;7K.WUEH_.CM)9$/G1M=M91LCJ2AWW"E F[S
M-Q4%5R!0!Z)17*W_ ,8?#>D6]C-=Z]I-O#JDQ@LWEN41;EU<(50D_,0Q"GT)
M X)&67OQI\+Z79RW5SXET.&UAA%Q)*][$J11F.20.QW<*8X9GR>-L4AZ*<'6
MP774ZVBN/L/CGX3U 69A\3:'*NH&86S+>Q$3^2SK+MPW)1HY%8=C&P[''/\
MCW]K?P7X$\#+XB_MNQU;3WGTZ)387,,A:.]OX+&*X!+A3")9U)8'D*=NXX4@
M'J%%>=_\--^#8HYI9_$FAVMG&(6BO)=2MOL]V)8FE'EL)"3A$<G(7"JS<JI8
M>AH<H/I0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#^H%?$5Y<:G'<W$NDE8;I8XRK(KSN?*N9%?=&<[$V!&A.YJZ;XDZ!\;OB%\
M/CAH^H6,G]IZOX8O;#PC#IM[!:W*ZG(M_$AMKA)$,<'EG371YW699C<Y(0(
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'AG[<W_'E\)O^RFZ#_Z->O;P,VW_
M  'M7C?[;7@CQ3XQ\&>$;KPCH<?B35/"_B_2]?;36O8[(W4-O(QD599/D5MI
MR QYQ66/VA?C24V_\,\7VWI@^-M+_P : ./^)/QM^(GPR^._CQ=#T#Q!XDTN
M:6S^S+<Z??W%G:QQZ7<W,HMO+783+/%'"2K';)*GRL?DJ[IO[47Q*UV#3YK3
MX>:D6N-1O(;FSO-%OK&6W\F6U1;)I),1EV2>XF6_0O:.MFRJ SJ4Z/\ X7Y\
M9MRG_AG>^RIR"?&VF<'\Z:_QX^,CR*Q_9VOMR]#_ ,)OIF1^OL/RH \_\%_M
MA_%?7S:_;OA[9MJ4>AV>KZEI5MIM]'>:3]LLY[A5E\W[SP20>2]N!YDS3!DV
M&,J=35?VH/BYIN@:I<P_#[[9>:,\$,,<.DZD_P#;()E=Y8@VWRUDAMP55B[1
M/>0JQ=D9)-BP^(/Q*TOQ%JVL6O[+UO:ZOKP@74[Z'Q7I$=UJ(@!6$32#YI!&
MK,$#$[02!C-:W_"_?C,#G_AG>^S[>-M+_P ?<_F: .)_X:=^+VB>.&T>Z\#V
M^I6*V][/_:D&A:M&CC^U7M8F15CDA86UN$FE1[B.6Y#;[9& VF?X4_%GXH^%
M_P!G[X;Q7WAW5O$7B;4A>#5I=3LKA9G:&]5$@.2# \L+O)%/,QC"6H)+F137
M7GX]_&8_\V[WW_A;:9_C37^/GQF^]_PSO?97.#_PF^F<=_6AZH16^$_[1OC;
MQ;\)/$&J:QX+U#2_$%O]ABTNRATJ[0S27EO"RJPE4;A#-*RR2X2,!,L$P:\V
MTW]K7XN>#O"UAH\O@>;7O&F@:+*^J6EU97(NM7>WOI+0W*30QBW\LP+%>%HU
M99B7@C"2% /2$_:4^+DNMOIS?L\WOVI(5N64^--+V["Y4'KZJ:JQ_$?XEIXR
MD\2?\,PV_P#PD4UFNG2:K_PEFD?;9+97+B!IOOF(.2P0G:&.<9H&2>!_B)XT
M\0?M Z7;:OH^L:9I\(_>RPP7T>FWGFZ7%. ZRYBC,4P:,<@;U8'YV(%*7XD>
M(O$NOZG#X5N_B%-/%XPLXXK;6?#VI::BVZ-$E^89[BS$4D+Q^=)&"S08<^6Z
MN%$.ZOQ[^,B$D?L[WN2,9_X3;3.GYT'X]_&0KM_X9WO=O<?\)MI>#]>:8=#7
M^+GQ5M0O@6;2;KQO!)K^IP_8_P"S?#&I7EN5WH9%OTCM7-M&T9=-UR8E4RE]
MP:,.G!?#?Q9\5&G\+-X@DUVS,WB.TAO@NG^=%*9-'E:^C?=$72TBU$#RY 47
M(4!F3"UTW_"^OC(1_P F[7G.<_\ %;:7SG).>>^31_PO[XR;MO\ PSO>9(P1
M_P )MI?(_.DM Z'2?LF7OC*^\+:I)XR^V"Z-Z$MOM+[S,%@B6>5,HDBPO<B=
MHTE1&52 %";!4'_!0#/_  Q+\4,]?^$=NO\ T UBI\?OC/%]W]G>^&.!_P 5
MMI?'ZUQ_[0OB_P"-GQW^"/BCP9%\"IM)D\3:?)IPO;CQGITD=IY@VF1E3+,%
M!)P 2<8H ^J8^I_SW-.J.!BS/D$<\<=O\\_C4E !1110 4444 %%%% !1110
M 4444 -DDV'ZTV.X$N-O?O7$_M*:EXET;X%^+[OP;%//XLMM$O)='CAA6:1[
MM86:$(C JS[U7:K J3@'(.#Y'X>^,=YX.UC0=!\'P^(_$>@ZA+9RQ:CKO]HW
M]WJ,MQ?+%?0I+/@PO:P[K@B3*+N:)4C6-@H!]+4$X%?)NA_M+_%[79/A[=WV
M@V.AV.JR:?>:V!HETRQ17>GZFWV-M[[HW2[MK-/,'0W2JR#&7-<_;$^)WA_2
MO#JI\/[K5M8U'PJFM:C:P:/=0QV5U)8R70B5O,=F5'C,+*5#,Y"JVX[0"N?6
M ;-#OM%?+L'[2WCWP_\ &G5EO84USP'(^C&SO;;P]=6OD6UQ9Z@9[E/G>24-
M>V]I"%PQ07*GD$&N;U']J?XD?%&QT#1U\)^(-"NKJU\.:KJ4UOIUQ;R:?.VI
MZ!)=6H8N=T+P7]TI+A&Q9W (8(Y ,^QD?>.X]C3B:^3_ -H7]N;Q;\'_ (P:
MIH&G>!]<UG2[> >5=P:)<7=R;G[7I48BAACDS=>9!?W4J &$_P"@2CE4=UBT
MO]K[XJ7WPTN-:A\,>']04ZK8:5%?64=Q_9ZK+H%M?R7FZ20&6!M0G-DFS&TI
M\Q9R44 ^M:"<5\PZ/^T_\5/$'BNZTU_ ^GZ.T>N0Z6XFCN;I[")]06 3-MV"
M5'M2UPKGR=HP-L@#LO+W7[:'QGB^'VDWB?#"U;5M4L+.\<SPW=K:6D\^E_:5
MLG^_(&:ZW6_F@-L( \II"J. ?8N[BE!R*^8_%OQ\^*4%S:&WT>VTFQ_X29()
MYVTF>9K?38O$+Z;+OS)AC+:>5<"1<!%+$!E(=?IB"1GC4MG)/.1S0] )****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0NZ^7&N=K<CE6'(!X'% &]1110 449HH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS]5AMY;74+F>QLK(27%C#?0022S3J(Y)89BL3',<LD,B!P0NY@:P^-/QU/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4ED\B.&&)[MV\F/9<77D0/,B[DS;1')(-4XOV-+73]$\&^3XC\5?V]\/T?\
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M0![%17E/_"2?&[_H4/A7_P"%??\ _P K:/\ A)/C=_T*'PK_ /"OO_\ Y6T
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M3I+_ ,4%=HL=#W'=G-Y-LQVY\K.?:@#PJ+]@WP>/B=+I+>,/CN8%TI+I(_\
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MJGS"S>Y:-I&VMY<DT\$9.T,D+RG=MW,<K Z[_AA?P=C_ )"'[27_ (>/Q/\
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M\L* /7J*\?'[1/CPC/\ PHGQ]@_]1OP__P#+"E7]HCQXW3X$>/CSCC6_#_\
M\L* /7Z*\A'[0WCTC_D@_C[_ ,'?A_\ ^6%<O\9?VY=>^ 7PUU3QAXJ^"OQ#
MTWP[H:)+?72:GH4Y@1I%CW;$ORS8+CA03C.,GB@#Z&HID.[:=QW<D9I] !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %>/?"[_D\KXN?]@KP[_Z#?U[#7CWPN_Y/*^+G_8*\._^@W]
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MEV5%9B%R0JDG@$TP/=M[?W:-[?W:\7_X=X_ W&?^%:>$\>OV;_Z]4]2_8-^
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M *\>^%W_ ">5\7/^P5X=_P#0;^O8:\>^%W_)Y7Q<_P"P5X=_]!OZ /8:***
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M)G,R#8K*NP1I](P',0QT[<YH%O&H VK\O3C\*<J[%P* %HHHH \-\1_\I'?
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MBB@ HHHH **** "BBB@ HHHH **** "BFB13_$OYTN\>HH 6BDWCU%&\>HH
M6BDWCU%&\>HH 6BDWCU%&\>HH 6BDWCU%&\>HH 6BDWCU%&\>HH 6BDWCU%&
M\>HH 6O'/AE)L_;)^+ORL?\ B5>'<]OX;^O8MX]17BWQG_89\%?&[XF3^+-2
MU;XG:+K%W:06-P_A;XAZ[X;ANHH3(T7F1:?=PQR.OFR#>REL-C. , 'M&^C?
M7SI_P[)\ _\ 0Y_M$_\ A\_&7_RSH_X=D^ ?^AS_ &B?_#Y^,O\ Y9T ?1>^
MC?7SH/\ @F5X!)_Y'/\ :*_\/GXR_P#EG2_\.Q_ ?_0Y?M%?^'R\9?\ RSH
M^BM]&^OG7_AV/X#_ .AR_:*_\/EXR_\ EG1_P['\!_\ 0Y?M%?\ A\O&7_RS
MH ^BO,^OY4>9]:^//VF_^"?_ (5^&7[-_P 0/$FB^-_VAX-8\/\ AO4-2L7?
MXV^,)46>&VDDC+(VI88;E&1W&17:VO\ P3,\!S6T;MXR_:*RR@_\ER\8^G_8
M2H ^CM]&^OG7_AV/X#_Z'+]HK_P^7C+_ .6='_#L?P'_ -#E^T5_X?+QE_\
M+.@#Z*WT;Z^=?^'8_@/_ *'+]HK_ ,/EXR_^6='_  [(\!?]#E^T5_X?+QE_
M\LZ /HK?09,"OG0?\$R/ 1_YG+]HK_P^?C+_ .6=+_P[(\!_]#E^T5_X?+QE
M_P#+*@#9\0OG_@H[X%_[)KXA_P#3IH=>XQ?ZM?I7D7P/_8H\'? 'QW-XFT>^
M^(.L:Y-8/IBW7BGQUK/B9K:V>2.62.'^T+F<0AWAB+>7M+>6N<X%>OJ-JXH
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MIC1O">L^ H?#OC+09?$WBZ&>[\/:!(T$D?BVV\GS#L8*9@2/+$;PL 7<;E=
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M;\N43Y5R< 9P!FMIOVOM<?.[X$_')N<X-AI) _\ *A_G\\^[>6/\FCRQ_DT
M>#1_M;ZU'%M_X43\<MO3'V#2<'C'(_M#GCUIX_; UWYL_ KXZ;F[BQTK@?\
M@PKW;RQ_DT>6/\F@#PN']L/7(BW_ !8?XXL6[FPTK_Y85)_PV3KG_1!_CC_X
M :3_ /+"O</+'^31Y8_R: /#_P#ALG7/^B#_ !Q_\ -)_P#EA1_PV3KG_1!_
MCC_X :3_ /+"O</+'^31Y8_R: /#_P#ALG7/^B#_ !Q_\ -)_P#EA1_PV3KG
M_1!_CC_X :3_ /+"O</+'^31Y8_R: /CW]N;XP>-/VCOV)?C%\/O#WP)^,B^
M(/'?@C6O#NF&\MM*AMQ<WEA/;Q&1_MYVIOD7<P!P.<&OK3PE:R6/A32X9EV3
M0VD2.N<[6" $5>:%6ZC]:<.* /,/C)^T9<?#+XL^%?!>E^#]>\7Z]XJTK4]:
MACL+FSMH[>VL)K"&8N]S-&"Q?48-JKG(#DXQS67XZ^/BH_XLKXJZ?]![1_\
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M]O<^6LFZ2(*1C:Y)W*NX$Y&C^T=^T)XV^$+>%]0T:Q\,7GAWQ-$U@;W4IKB
MZ7J,J V<TZH&":>SD)+(3OB+QC:VXE0#IO\ A>GC[_HBWBK_ ,'NC_\ R51_
MPO/Q]_T17Q5_X/='_P#DJN<T3]MO0[:_U#3]7&L37VEWMY;W4UEHTHM(!!<W
MEOMRSLSG?93 ,OW]H;:H;BM\2/VV$L/A_>:AX9T76+K5%M;F\@6]M0;6..VN
MOL\IE:.3<H=E=8G^Y(P!4L ^ #K/^%Y^/C_S17Q5_P"#W1__ )*H_P"%Y^/_
M /HBOBK_ ,'NC_\ R563JO[;GA/28)FF37U:&]&F.J:<7:*\W0;K9E#_ 'U2
MXBD/\(C+$,<<:_PT_:G\/_%KQ;;Z+H\/B!KJXMGN?,N-/:&&)46%G#,2,8-Q
M$@8;E9MZJS-')M"5),3_ (7IX^'_ #17Q5_X/='_ /DJC_A>GC[_ *(KXJ_\
M'NC_ /R57"> ?V[HXO##1^,=-OH?$D*W<LD.BV4DEK/'"VILHB:9@QD,&EW#
MLIP%8*N?F&>DUC]NGP3H&JWMO-)X@NH--M$U&[U&RT>>ZTVTM9)52&>6\B#0
M+&Z-YX8N (0TC852:"C7_P"%Z>/A_P T5\5?^#W1_P#Y*H_X7GX^_P"B*^*O
M_![H_P#\E5R[?M^>%[,W2W>G^*(3;W5Y:Q-'9QW$5T+=M7'F1O'(0P==$O6'
M(./+SC>IJ=O^"@?@)M:FMH%\675I;W<]E_:*Z#<)83O!YWVCRIW"K*(OL\P?
MR]Q!7&"2 0#H?^%Z>/O^B+>*O_![H_\ \E4?\+T\??\ 1%O%7_@]T?\ ^2JZ
MWX,_$F/XO> ;?7HK&^TZ.YGN85M[S9YR^3<2P%CL9EPQC+#!/!&<'@=3L% '
ME/\ PO3Q]_T1;Q5_X/='_P#DJK_[,G[1=O\ M*^"M5U>'0]8\.S:+XAU3PU>
M66I- TL=U874EK,5:&1T:,O&Q5@<D=0.E>C[17SE_P $TU'_  KWXGMW_P"%
MN^-O_3[=4 ?1U<3\>+62[\,Z*L:,[+XDT=R!V5;^ D_@ 37;5S/Q2YT;3?\
ML,Z?_P"E4= '1P'<G3'?]*?34Z4Z@ HHHH Y'XY_&33?@#\+=8\7:Q;ZE=:=
MHL2220V$'GW4Y>18TCC3(#.SNH R.O45Y]_PVA?#K\%/C?\ ^"2T_P#DNG_\
M%#?^32_$W_7QIG/_ '$K6O:]M 'B'_#:-]_T13XX?^"2T_\ DJC_ (;1OO\
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M".:,QR1A@& 9&Y5@#RIY!X/2N?\ CY_R0KQI_P!@&^_])Y* ,7]C_P#Y-/\
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MV29F=DD%Y<E A8&MW0/V$O%D46EQZMX\AU*"PT_3()(9+2[D26[M)K"9KO\
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M^?L(6GQT^+FH^*KK7FM6U"QM+!;4Z7'<) +>RUJT60,6!WE-=NVW8&&B@ P
MXD/M6!['MLWCG2K>=XI+^R66.X2T>-KA R3NJLD1!/#LK*54X+ @C.1DB\<Z
M7/?):QWUBUW(658!<IYC%5W, N<\#D\9 YKP:Q_X)]VXCU0:AXV\1:Q'K%]/
M=,MU862-:PW.YYX8Y(X4G++,[R0S322RVY*A6(4EN%TC_@E;I]CXKUBQNKZW
MMO">J>'[6RDN]&C%AK<M]'>:Q-O#)'B*-(]31 5=S(L.QU\O*N ?5DOQ'T>#
M2X[YM0T_['+&LT<_VN,121GHX<G;M/ !S@GCMFF6/Q-T/6Y9(;/5M,N)8YY[
M1UBO(G9)H.)HR V=\?\ $/X>,XKPB[_X)QZ+J>E>+K>;5I(9?&EE%:ZE-;Z7
M!$RD7EY=R^1RQA1VO9!M3!7RXFW,WF&1OB?_ ()OZ7XKUBSNI/%NO6<=M#>I
M)!#IUA(DTER\LHE'FP.8I(Y9I26B9?.C<13>9&,%R TO '@'P5XWCM_&F@Z[
M?:/##XBUF/2M1M62TN%ENM0DBU.R(F5UEAGOH&=5V;BXC:,@[36=XX_9*\$W
MTOB#Q)>^+O%3-9&[N+[[*;"\-J'%]-(@B%G(S86_N"%(9R-@.[D'?G_8FT_4
M/AC:^&9M<U22U6_U>^GD^RVZAUU::XFNHDC5%$7EO<LT$BDR1&--S2#S%E=\
M-?V-3\,O!WB+1=/\226]MXBMHK-FATN*-[:,3W,L@ )9&:1+IXR2,C:K<D4A
M=3SR+X _##P7;VOB>R\8>(YYM<F6.UFOI8YX;%[RUEL_,DA6*-H08KC#EBF'
M2#S"-HKWS0_'/@WX1?!Y7AU/3[7PKX)TJ-9)8IO/CLK6&W1D!V@L3Y.T@ %F
M!7 .X9\OU;]@6P@^(X\3:5JUQ'Y-RLW]D75K#)8W48;3G:&1RC2*&;381N7A
M1+*624[2-W0_V/;+5OV75^'^L7%]I[WUM*EU-I-Z8Y+-GB>)(HYDCB,L5O"R
M0QEXU++!&SJ&S1+X;C/3_$WQ5T?PCX/;7KZ6X72U@%T98K66=Q%L+ES&BE]H
M0%B=O !SBL34/VG?!.F7-Q#-K2^9:SP6\FRVFD!>:X2V7:50AU$\B1NZDI&S
M .RUS7C3X!^*O$?P8F\'Z1\0M6\-OYT4=OJT6D6=[<QV**J_96CN(VCDW!?G
M=U+,IQU.1DZS^Q19WS:A<6>K7%C?7EPMS;S/:)*MLS:G%JMUN0,H=KB\B#L0
M4"AB% ZD#I<]/T[XU>&]5N/$$<.J6\A\*G;K$@),.GN$WLCR8V[E7YF7.5'W
M@*IP?M!^&)M9.G_:YH[J&:SMKM'MW5=.FNP#;PSOC8DCEHU"%MVZ:($#>I/%
MZ[^QSI.N>&_B)I[7UT@\?6&HZ:SJBQR6D5Y+/</EU4-*1<7,K+OR$1M@!^=G
MS[_]CBVU3Q)=ZP\T<>H:Y?V]U>XB'^C1_;;6_N(U?;NEW3VBB/?CR5E<J2<
MSK<#W83B5./0&OG+_@F1_P DA^(?_97_ !]_ZE&H5]%A=J=,,P_7_.:^=/\
M@F2P'PB^(0[_ /"W_'W_ *E&H50=#Z1HHH)P* "BF^8I/44NX4 +12;A1N%
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MA7C3_L WW_I/)765R?Q\_P"2%>-/^P#??^D\E &+^Q__ ,FG_#+_ +%/2?\
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M'PC_ /"#U#_Y:U[1BC% 'B__  B?[07_ $4#X1_^$'J'_P M:/\ A$_V@O\
MHH'PC_\ "#U#_P"6U>T8HQ0!X'+!^T!#XWM='_X3KX0DW5A->^;_ ,(+J&5\
MN2)-N/[5[^;G/^STYK4_X1/]H'_HH'PC_P#"#U#_ .6U=IK5PMK\9M/F<D+'
MX>OG8CL!/:DUK67BYK^TAFBT_5)(YHUE1MD0W*P!!P7SW[T >;#PI^T"/^9_
M^$?_ (0>H_\ RUH/A/\ :!_Z'_X1_P#A!ZC_ /+6O3QXBE)_Y!NI\=?EB_\
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M\D5ZY_PL*QS_ *G7/_!)>?\ QJC_ (6#8_\ /#7/_!)>?_&J /(_^'?/A_\
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MVK.9BH^5P,9#*!)MV0'?_P!L_M"?]"]\&O\ P?ZG_P#(5']L_M"?]"]\&O\
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M.H,",@BZMN1_WW0!YG_PRCX]_P"CE_C1_P""CPA_\I*/^&4?'O\ T<O\:/\
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MW_@'IW_R-0!V%%<?_P *]US_ *'[Q-_X!Z=_\C4?\*]US_H?O$W_ (!Z=_\
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M$2K'0%3P_P#MI>$9M-!U^QDT_5-(R-2C@T2:X15(C$+PRJ"%5@X&UOF_=R8
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC7T510!\Z_\ #J[X._\ /O\ $K_PZ/BG_P"6-'_#J[X._P#/O\2O_#H^*?\
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MMXQ%#&&=F=MJ*HRQ+'&22<FN@HH **** "BBB@ HHHH **** "BBB@ HHHH
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M[%']H1_WX_\ OL5B_P#"I/"G_0L>'O\ P70__$T?\*D\*?\ 0L>'O_!=#_\
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M /':/^%)Z#_SSU3_ ,&][_\ ': .N\P_W:/,/]VN1_X4GH/_ #SU3_P;WO\
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M?_D"@#VBBO%_^&^?A]_SZ_$[_P -EXE_^0*/^&^?A]_SZ_$[_P -EXE_^0*
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M<20HPJDDJJY.:DW[%7PWN(9$;P[,RRR3S%6U2\*J\Q!E909<*6P"< <BD[]
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M?;]3EG U/4KB>QM;$!U2(0>6L-G;2\+_ *^UA?9E<UC:C\/_ (7V_P .M/\
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M=T:O3J\Q^!'_ "53XT?]CI;_ /J.Z-0!Z=1110 4444 %%%% !1110 4444
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MWB*S>SU:&65/[*TUH;>=)=$DCC5GM2S_ #:3:@,&8YFE (*J$YC]FO\ 8M\
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M^%1??_(% 'I]%>8?VW\9O^A7^&/_ (5%]_\ (%']M_&;_H5_AC_X5%]_\@4
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M&FBPZG+::@VFR7$ZA5>5;P6L<Q^Q'<T32V)\[:.+>53$^[<>R_X0#]HS)/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$GEIM^8X]3DUX?\ \%&A_P 8DZ__ -A'1?\ T[V=>Y4#"BBB@ HHHH ****
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M3[#3_$,FDPZI!?:I<I?6-GE;61UGCBDCFVLMSLA9<EV@G+K"%C\T ^E %/\
M=J*ZT^.\1ED5'C<%61E!5@1@@@^H)'OFN2^&'C:[U[Q+XLTF^4M)X;U&.T2Y
M$92.Y22U@N!MY.=OG%">/NCC))KM-W- %>QTV'3XECABACC50@5(PH ' &!Z
M"IBBD=!^5*&!H#9% "&+/O\ 7O0$4#H/RIU% "!<4HXHHH \-_X*-?\ )I&O
M_P#81T7_ -.]G7N5>&_\%&O^32-?_P"PCHO_ *=[.O<J "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:MI;-#Y\S,\TH4QXW2.[LYZN78MG<: &ZU^W)\*=.L-<\ZSUR;1]/N9[6YU
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MIG/;*T?XP_LR^'[I9K%OAW9S))'*LL.@JL@:,8C;/DYRHX7^Z.F*F\!?&_\
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M(&HRZ/?3:;=2Z9X#US4+99X6*2HL\%H\3[7#*2C$94TO_#9'A/\ Z OQ6_\
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MPL&DD6TF=(OONJ/M5MC8?6P'9?\ #9'A/_H"_%;_ ,-EXC_^0:&_;)\)@?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:7')-XF\5:U>:;I6GW45GJNCZSJ-]KUI+)'/'');Q)'YVX_Z*7"RDR>7)NP
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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/ **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
